<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002118.pub5" GROUP_ID="MENSTR" ID="079100021717363687" MERGED_FROM="" MODIFIED="2016-06-30 04:10:31 +0100" MODIFIED_BY="Helen Nagels" NOTES="&lt;p&gt;I think this is relevant to keep in but just need to check the numbers. DB&lt;/p&gt;" NOTES_MODIFIED="2016-06-30 15:05:56 +1200" NOTES_MODIFIED_BY="Helen E Nagels" REVIEW_NO="DB551" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="12.0">
<COVER_SHEET MODIFIED="2016-06-30 04:09:52 +0100" MODIFIED_BY="Helen Nagels">
<TITLE MODIFIED="2012-05-04 23:42:17 +1200" MODIFIED_BY="Jane Clarke">Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology</TITLE>
<CONTACT MODIFIED="2016-06-30 04:09:52 +0100" MODIFIED_BY="Helen Nagels"><PERSON ID="F5700CAE82E26AA201D6C2751ED8C26F" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Demián</FIRST_NAME><LAST_NAME>Glujovsky</LAST_NAME><SUFFIX>MD, MSc</SUFFIX><POSITION>Medical staff</POSITION><EMAIL_1>demian.glujovsky@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Reproductive Medicine</DEPARTMENT><ORGANISATION>CEGYR (Centro de Estudios en Genética y Reproducción)</ORGANISATION><ADDRESS_1>Viamonte 1432,</ADDRESS_1><CITY>Buenos Aires</CITY><COUNTRY CODE="AR">Argentina</COUNTRY><PHONE_1>+54-11-4372-8289</PHONE_1><FAX_1>+54-11-4371-7275</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2016-06-30 04:09:52 +0100" MODIFIED_BY="Helen Nagels"><PERSON ID="F5700CAE82E26AA201D6C2751ED8C26F" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Demián</FIRST_NAME><LAST_NAME>Glujovsky</LAST_NAME><SUFFIX>MD, MSc</SUFFIX><POSITION>Medical staff</POSITION><EMAIL_1>demian.glujovsky@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Reproductive Medicine</DEPARTMENT><ORGANISATION>CEGYR (Centro de Estudios en Genética y Reproducción)</ORGANISATION><ADDRESS_1>Viamonte 1432,</ADDRESS_1><CITY>Buenos Aires</CITY><COUNTRY CODE="AR">Argentina</COUNTRY><PHONE_1>+54-11-4372-8289</PHONE_1><FAX_1>+54-11-4371-7275</FAX_1></ADDRESS></PERSON><PERSON ID="9CE26E7F82E26AA200CD32E53036321F" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Cindy</FIRST_NAME><LAST_NAME>Farquhar</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>c.farquhar@auckland.ac.nz</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>University of Auckland</ORGANISATION><ADDRESS_1>FMHS Park Road</ADDRESS_1><ADDRESS_2>Grafton</ADDRESS_2><CITY>Auckland</CITY><ZIP>1003</ZIP><COUNTRY CODE="NZ">New Zealand</COUNTRY><PHONE_1>+64 9 6309943</PHONE_1><FAX_1>+64 9 6309858</FAX_1></ADDRESS></PERSON><PERSON ID="z1412022250082322699074892201917" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Andrea Marta</FIRST_NAME><LAST_NAME>Quinteiro Retamar</LAST_NAME><POSITION>Coordinator</POSITION><EMAIL_1>aquinteiroretamar@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Eggs donation program &#150; Genetics unit</DEPARTMENT><ORGANISATION>CEGYR (Centro de Estudios en Ginecologia y Reproducción)</ORGANISATION><ADDRESS_1>Viamonte 1432</ADDRESS_1><CITY>Buenos Aires</CITY><COUNTRY CODE="AR">Argentina</COUNTRY><PHONE_1>005443728289</PHONE_1><FAX_1>005443728289</FAX_1></ADDRESS></PERSON><PERSON ID="z1411182055149427585076833405375" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Cristian Roberto</FIRST_NAME><LAST_NAME>Alvarez Sedo</LAST_NAME><POSITION>Research Director</POSITION><EMAIL_1>calvarez@cegyr.com</EMAIL_1><ADDRESS><DEPARTMENT>Laboratory of Reproductive Biology and Genetics</DEPARTMENT><ORGANISATION>CEGYR</ORGANISATION><ADDRESS_1>Viamonte 1432</ADDRESS_1><ADDRESS_2>Capital Federal</ADDRESS_2><CITY>Buenos Aires</CITY><COUNTRY CODE="AR">Argentina</COUNTRY><PHONE_1>54-11-43728289</PHONE_1><FAX_1>54-11-43717275</FAX_1></ADDRESS></PERSON><PERSON ID="9023" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Deborah</FIRST_NAME><LAST_NAME>Blake</LAST_NAME><EMAIL_1>dblake@repromed.co.nz</EMAIL_1><EMAIL_2>d.blake@xtra.co.nz</EMAIL_2><MOBILE_PHONE>021775494</MOBILE_PHONE><ADDRESS><ORGANISATION>Repromed Fertility Specialists</ORGANISATION><ADDRESS_1>105 Remuera Rd, Remuera</ADDRESS_1><CITY>Auckland</CITY><ZIP>1050</ZIP><COUNTRY CODE="NZ">New Zealand</COUNTRY><PHONE_1>021775494</PHONE_1><PHONE_2>09-524 1232</PHONE_2><FAX_1>+64 9 921 9719</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2016-05-05 09:40:00 +1200" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="4" MONTH="4" YEAR="2016"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="4" MONTH="4" YEAR="2016"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="4" MONTH="4" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2002"/>
<LAST_CITATION_ISSUE ISSUE="6" YEAR="2016"/>
</DATES>
<WHATS_NEW MODIFIED="2016-06-29 16:28:42 +1200" MODIFIED_BY="Helen E Nagels">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2016-06-29 16:28:42 +1200" MODIFIED_BY="Helen E Nagels">
<DATE DAY="5" MONTH="5" YEAR="2016"/>
<DESCRIPTION>
<P>Updated May-June 2016</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-06-20 14:54:28 +1200" MODIFIED_BY="Clare Dooley">
<DATE DAY="3" MONTH="5" YEAR="2016"/>
<DESCRIPTION>
<P>Updated with four new RCTs (<LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK>; <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>; <LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK>; <LINK REF="STD-Kaur-2014" TYPE="STUDY">Kaur 2014</LINK>)</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-06-30 15:05:56 +1200" MODIFIED_BY="Helen E Nagels">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-05-05 09:40:33 +1200" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="5" YEAR="2013"/>
<DESCRIPTION>
<P>Correction of author order</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-06-30 15:05:56 +1200" MODIFIED_BY="Helen E Nagels">
<DATE DAY="21" MONTH="2" YEAR="2012"/>
<DESCRIPTION>
<P>History of this review: the review was first published in <I>The Cochrane Library</I> in 2000 with 10 RCTs, and a journal paper version was published in Human Reproduction in 2003 with an additional four RCTs. The authors were Debbie Blake, Michelle Proctor, Neil Johnson and David Olive. There was no evidence for a difference in pregnancy rate and only one trial reported live birth rates</P>
<P>In the 2005 update, seven RCTs from the 2000 review were excluded (for quasi-randomisation or per cycle data only or other study design problems) and 13 new RCTs were added. In addition, the outcomes in Metaview were reconfigured. Cindy Farquhar and Quirine Lamberts assisted with the update and were added as authors. Some protocol changes were made to the outcome measures and to the sensitivity analysis (day of randomisation) and subgroup analyses (prognosis). More included trials reported live birth outcomes but there was still no evidence of a difference in success rates</P>
<P>The 2007 update had two new trials added, to bring the total to 18. There was a new subcategory for single embryo transfer. This update was performed by Debbie Blake, Neil Johnson and Cindy Farquar. It reported for the first time a significant difference in live birth and pregnancy outcomes in favour of blastocyst culture</P>
<P>In the 2012 update led by Demian Glujovsky with the assistance of Cindy Farquhar and Debbie Blake, five new studies were added (<LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>; <LINK REF="STD-Elgindy-2011" TYPE="STUDY">Elgindy 2011</LINK>; <LINK REF="STD-Fisch-2007" TYPE="STUDY">Fisch 2007</LINK>; <LINK REF="STD-Pantos-2004" TYPE="STUDY">Pantos 2004</LINK>; <LINK REF="STD-Ten-2011" TYPE="STUDY">Ten 2011</LINK>)</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2016-06-20 16:33:52 +1200" MODIFIED_BY="Clare Dooley">
<DATE DAY="21" MONTH="2" YEAR="2012"/>
<DESCRIPTION>
<P>5 new studies have been added. There are no changes to the conclusions reported in the 2007 update</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-06-20 16:33:48 +1200" MODIFIED_BY="Clare Dooley">
<DATE DAY="29" MONTH="8" YEAR="2011"/>
<DESCRIPTION>
<P>Plain Language Summary corrected</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-06-20 16:33:39 +1200" MODIFIED_BY="Clare Dooley">
<DATE DAY="17" MONTH="11" YEAR="2010"/>
<DESCRIPTION>
<P>New search strategies performed</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-04-19 03:44:33 +1200" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="11" YEAR="2010"/>
<DESCRIPTION>
<P>New author </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="23" MONTH="7" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2016-06-29 17:31:53 +1200" MODIFIED_BY="Helen E Nagels">
<INTERNAL_SOURCES MODIFIED="2016-06-29 17:31:53 +1200" MODIFIED_BY="Helen E Nagels">
<SOURCE MODIFIED="2016-06-29 17:30:48 +1200" MODIFIED_BY="Helen E Nagels">
<NAME>Cindy Farquhar</NAME>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<DESCRIPTION>
<P>University of Auckland</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2016-06-27 18:46:22 +1200" MODIFIED_BY="Helen E Nagels">
<SOURCE MODIFIED="2016-06-27 18:46:22 +1200" MODIFIED_BY="Helen E Nagels">
<NAME>None</NAME>
<COUNTRY CODE="NONE">Other</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-06-30 10:46:18 +1200" MODIFIED_BY="Helen E Nagels">
<SUMMARY MODIFIED="2016-06-29 17:00:52 +1200" MODIFIED_BY="Helen E Nagels">
<TITLE MODIFIED="2016-05-05 13:32:25 +1200" MODIFIED_BY="[Empty name]">Blastocyst versus cleavage stage embryo transfer in assisted conception</TITLE>
<SUMMARY_BODY MODIFIED="2016-06-29 17:00:52 +1200" MODIFIED_BY="Helen E Nagels">
<P>
<B>Review question</B>
</P>
<P>We aimed to determine whether blastocyst stage (day 5 to 6) embryo transfer improves live birth rates following fresh transfer and cumulative pregnancy rates (following fresh and frozen-thawed cycles) compared with cleavage stage (day 2 to 3) transfer.</P>
<P>
<B>Background</B>
</P>
<P>Embryos from assisted reproductive technologies (ARTs, e.g. in vitro fertilisation (IVF), intracytoplasmic sperm injection (ICSI), thawed embryo cycles) are commonly transferred into a woman&#8217;s uterus at either the cleavage stage (day 2 to 3 after egg collection) or blastocyst stage (day 5 to 6 after egg collection). Until recently, most ART cycles transferred embryos at cleavage stage, however there has been a trend to transferring embryos at the blastocyst stage as this timing is about the same as natural cycle embryos moving into the uterus.</P>
<P>
<B>Study characteristics</B>
</P>
<P>We included 27 randomised controlled trials (RCTs), which included 4031 women. The evidence is current to April 2016.</P>
<P>
<B>Key results</B>
</P>
<P>There was low quality evidence for live birth and moderate for clinical pregnancy that fresh blastocyst stage transfer is associated with higher rates than fresh cleavage stage transfer. This suggests that if 29% of women achieve live birth after fresh cleavage stage transfer, between 32% and 42% would do so after fresh blastocyst stage transfer. There was no evidence of a difference between the groups in cumulative pregnancy rates (i.e. pregnancies from both fresh and thawed cycles deriving from a single egg collection procedure), but the evidence for this outcome was very low quality. Thus, although there is a benefit favouring blastocyst transfer in fresh cycles, it remains unclear whether the day of transfer impacts on cumulative rates of live birth and pregnancy. There was no evidence of a difference between the groups in multiple pregnancy and miscarriage rates, but the quality of evIdence was low. Future RCTs should report rates of live birth, cumulative live birth, and miscarriage to enable ART consumers and service providers to make well informed decisions on the best treatment option available.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>The evidence was of low quality for most outcomes. The main limitation was serious risk of bias, associated with failure to describe acceptable methods of randomisation, and unclear or high risk of attrition bias.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2016-06-29 17:08:07 +1200" MODIFIED_BY="Helen E Nagels">
<ABS_BACKGROUND MODIFIED="2016-06-20 16:46:10 +1200" MODIFIED_BY="Clare Dooley">
<P>Advances in cell culture media have led to a shift in in vitro fertilisation (IVF) practice from cleavage stage embryo transfer to blastocyst stage transfer. The rationale for blastocyst transfer is to improve both uterine and embryonic synchronicity and enable self selection of viable embryos, thus resulting in better live birth rates.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-06-21 08:26:12 +1200" MODIFIED_BY="Clare Dooley">
<P>To determine whether blastocyst stage (day 5 to 6) embryo transfers improve the live birth rate, and other associated outcomes, compared with cleavage stage (day 2 to 3) embryo transfers.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2016-06-21 08:15:21 +1200" MODIFIED_BY="Clare Dooley">
<P>We searched the Cochrane Gynaecology and Fertility Group Specialised Register of controlled trials, Cochrane Central Register of Controlled Trials (CENTRAL; the Cochrane Library; 2016, Issue 4), MEDLINE, EMBASE, PsycINFO, CINAHL, and Bio extracts from inception to 4th April 2016. We also searched registers of ongoing trials and the reference lists of studies retrieved.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2016-05-06 10:10:10 +1200" MODIFIED_BY="[Empty name]">
<P>We included randomised controlled trials (RCTs) which compared the effectiveness of blastocyst versus cleavage stage transfers.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-06-24 13:50:15 +1200" MODIFIED_BY="Helen E Nagels">
<P>We used standard methodological procedures recommended by Cochrane. Our primary outcomes were live birth and cumulative clinical pregnancy rates. Secondary outcomes were clinical pregnancy, multiple pregnancy, high order pregnancy, miscarriage, failure to transfer embryos, and embryo freezing. We assessed the overall quality of the evidence for the main comparisons using GRADE methods. </P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2016-06-29 17:01:35 +1200" MODIFIED_BY="Helen E Nagels">
<P>We included 27 RCTs (4031 couples or women).</P>
<P>The live birth rate following fresh transfer was higher in the blastocyst transfer group (odds ratio (OR) 1.48, 95% confidence interval (CI) 1.20 to 1.82; 13 RCTs, 1630 women, I<SUP>2 </SUP>= 45%, low quality evidence) following fresh transfer. This suggests that if 29% of women achieve live birth after fresh cleavage stage transfer, between 32% and 42% would do so after fresh blastocyst stage transfer.</P>
<P>There was no evidence of a difference between the groups in rates per couple of cumulative pregnancy following fresh and frozen-thawed transfer after one oocyte retrieval (OR 0.89, 95% CI 0.64 to 1.22; 5 RCTs, 632 women, I<SUP>2 </SUP>= 71%, very low quality evidence).</P>
<P>The clinical pregnancy rate was also higher in the blastocyst transfer group, following fresh transfer (OR 1.30, 95% CI 1.14 to 1.47; 27 RCTs, 4031 women, I<SUP>2 </SUP>= 56%, moderate quality evidence). This suggests that if 36% of women achieve clinical pregnancy after fresh cleavage stage transfer, between 39% and 46% would do so after fresh blastocyst stage transfer.</P>
<P>There was no evidence of a difference between the groups in rates of multiple pregnancy (OR 1.05, 95% CI 0.83 to 1.33; 19 RCTs, 3019 women, I<SUP>2 </SUP>= 30%, low quality evidence), or miscarriage (OR 1.15, 95% CI 0.88 to 1.50; 18 RCTs, 2917 women, I<SUP>2 </SUP>= 0%, low quality evidence). These data are incomplete as under 70% of studies reported these outcomes.</P>
<P>Embryo freezing rates were lower in the blastocyst transfer group (OR 0.48, 95% CI 0.40 to 0.57; 14 RCTs, 2292 women, I<SUP>2 </SUP>= 84%, low quality evidence). This suggests that if 60% of women have embryos frozen after cleavage stage transfer, between 37% and 46% would do so after blastocyst stage transfer. Failure to transfer any embryos was higher in the blastocyst transfer group (OR 2.50, 95% CI 1.76 to 3.55; 17 RCTs, 2577 women, I<SUP>2 </SUP>= 36%, moderate quality evidence). This suggests that if 1% of women have no embryos transferred in (planned) fresh cleavage stage transfer, between 2% and 4% will have no embryos transferred in (planned) fresh blastocyst stage transfer.</P>
<P>The evidence was of low quality for most outcomes. The main limitation was serious risk of bias, associated with failure to describe acceptable methods of randomisation, and unclear or high risk of attrition bias.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-06-29 17:08:07 +1200" MODIFIED_BY="Helen E Nagels">
<P>There is low quality evidence for live birth and moderate quality evidence for clinical pregnancy that fresh blastocyst stage transfer is associated with higher rates than fresh cleavage stage transfer. There was no evidence of a difference between the groups in cumulative pregnancy rates derived from fresh and frozen-thawed cycles following a single oocyte retrieval, but the evidence for this outcome was very low quality. Thus, although there is a benefit favouring blastocyst transfer in fresh cycles, it remains unclear whether the day of transfer impacts on cumulative live birth and pregnancy rates. Future RCTs should report rates of live birth, cumulative live birth, and miscarriage to enable couples or women undergoing assisted reproductive technology (ART) and service providers to make well informed decisions on the best treatment option available.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-06-30 10:46:18 +1200" MODIFIED_BY="Helen E Nagels">
<BACKGROUND MODIFIED="2016-06-29 17:08:20 +1200" MODIFIED_BY="Helen E Nagels">
<CONDITION MODIFIED="2016-06-29 17:08:20 +1200" MODIFIED_BY="Helen E Nagels">
<P>Assisted reproductive technologies (ARTs) such as in vitro fertilisation (IVF), intracytoplasmic sperm injection (ICSI), and embryo freezing are considered beneficial for many couples or women who are unlikely to conceive without treatment, and for whom less invasive forms of treatment have failed or are unlikely to be effective. The fledgling era of IVF, from 1980 to the mid-1990s, was characterised by relatively static successful pregnancy rates of around 20%. The past decade however, has given rise to advances in ovarian stimulation, cell culture, embryo transfer, and new cryopreservation techniques as well as freeze all cycles that have culminated in significant overall improvements in successful pregnancies (<LINK REF="REF-Richter-2016" TYPE="REFERENCE">Richter 2016</LINK>; <LINK REF="REF-Roque-2015" TYPE="REFERENCE">Roque 2015</LINK>). This is evident in the annual statistical reports from different areas of the globe. One such report, for example has demonstrated a doubling of the pregnancy rate per embryo transfer cycle from 1994 to 2003 despite a decrease in the mean number of embryos transferred (<LINK REF="REF-Waters-2006" TYPE="REFERENCE">Waters 2006</LINK>).<BR/>
</P>
</CONDITION>
<INTERVENTION MODIFIED="2016-06-20 18:59:41 +1200" MODIFIED_BY="Clare Dooley">
<P>IVF involves the use of hormones to stimulate the ovaries to produce many eggs (oocytes), followed by egg collection (oocyte retrieval), addition or injection of sperm, fertilisation, embryo culture and, lastly, the return of a few selected embryos to the uterus (embryo transfer). Embryos have been conventionally transferred on either day 2 or day 3 when the embryos were two to eight cells, or 'cleavage stage', because the uterus was thought to provide the best environment for the survival of the embryo (<LINK REF="REF-Laverge-2001" TYPE="REFERENCE">Laverge 2001</LINK>). The question of optimal timing for embryo transfer arises when examining the differences between the IVF procedures and what happens naturally in vivo. Day 2 is the earliest time at which morphological grading of the embryos is possible, allowing selection of the 'best' embryos for transfer. Embryo morphology, along with other factors, is thought to be highly indicative of pregnancy outcome (<LINK REF="REF-De-Placido-2002" TYPE="REFERENCE">De Placido 2002</LINK>). Early replacement in the uterus may be advantageous for the embryos by limiting the time spent in the in vitro environment of the embryology laboratory.</P>
<P>Over the past decade there has been a steady shift in practice to transfer of embryos on day 5 or 6 when the embryos are 'blastocysts'. With the introduction of a variety of commercial preparations of sequential media in the late 1990s, the ART service sector witnessed an explosion of worldwide interest in blastocyst culture, with most clinics conducting research into its application in their own setting. As a result, a substantial volume of publications followed. These included conflicting trials and debates about the merits and drawbacks of extended culture. A lack of strong consensus about the best practice for blastocyst culture has not been aided by the fact that many of the trials were not prospectively randomised or were underpowered. The need for an evidence-based approach using meta-analysis of small trials was, therefore, required to assist in deciphering the overall effect of blastocyst culture to help identify participant subsets and practices that might best benefit from this approach.</P>
</INTERVENTION>
<THEORY MODIFIED="2016-06-29 17:02:08 +1200" MODIFIED_BY="Helen E Nagels">
<P>Blastocyst culture is not novel; indeed the very first report of an IVF pregnancy was from a transferred blastocyst (<LINK REF="REF-Edwards-1995" TYPE="REFERENCE">Edwards 1995</LINK>). Despite this, cleavage stage transfer was adopted as standard global practice early in the history of IVF for two reasons: the low developmental rate of embryos cultured past this stage; and the observation that unlike other primates, human embryos have an unusual propensity to survive when replaced prematurely into the uterus (<LINK REF="REF-Marston-1977" TYPE="REFERENCE">Marston 1977</LINK>). However, as knowledge of embryo metabolic requirements expanded, so did the range of more advanced culture media (<LINK REF="REF-Scholtes-1996" TYPE="REFERENCE">Scholtes 1996</LINK>), and co-culture techniques (<LINK REF="REF-Menezo-1990" TYPE="REFERENCE">Menezo 1990</LINK>; <LINK REF="REF-Van-Blerkom-1993" TYPE="REFERENCE">Van Blerkom 1993</LINK>; <LINK REF="REF-Yeung-1992" TYPE="REFERENCE">Yeung 1992</LINK>). One important finding was that the in vitro environment in which a cleavage stage embryo grows best is different from that for a blastocyst. This led to the evolution of stage-specific (or sequential) media (G1/G2) by Gardner in 1998 (<LINK REF="REF-Gardner-1998b" TYPE="REFERENCE">Gardner 1998b</LINK>); embryos are transferred on day 3 from a medium containing low concentrations of glucose and one or more amino acids to a medium containing higher concentrations of glucose and a wider range of amino acids (<LINK REF="REF-Gardner-1996" TYPE="REFERENCE">Gardner 1996</LINK>). At this stage, the embryo undergoes cell compaction and genomic activation so that the embryo is no longer under the control of transcripts and RNA messages of maternal origin (<LINK REF="REF-Braude-1998" TYPE="REFERENCE">Braude 1998</LINK>). With the application of stage-specific media, there have been reports of blastocyst development rates as high as 60% to 65% (<LINK REF="REF-Schoolcraft-2001" TYPE="REFERENCE">Schoolcraft 2001</LINK>). Interestingly, with the development of time-lapse systems stage-specific media is no longer considered essential (<LINK REF="REF-Armstrong-2015" TYPE="REFERENCE">Armstrong 2015</LINK>).</P>
<P>There are two central arguments why blastocyst culture has possible advantages over traditional cleavage stage transfer. Firstly, it is considered to be physiologically premature to expose early-stage embryos to the uterine environment, particularly one that has been subjected to superovulation and thus high levels of oestrogen (<LINK REF="REF-Valbuena-2001" TYPE="REFERENCE">Valbuena 2001</LINK>). In vivo, embryos travel through the fallopian tubes and do not reach the uterus before the morula (16 cell compacted) stage (<LINK REF="REF-Croxatto-1972" TYPE="REFERENCE">Croxatto 1972</LINK>), which equates to at least day 4 of in vitro culture. The uterus provides a different nutritional environment from the oviduct; therefore it is postulated that the uterine environment may cause stress on the embryo, if transferred at cleavage stage (<LINK REF="REF-Baart-2006" TYPE="REFERENCE">Baart 2006</LINK>; <LINK REF="REF-Munne-2002" TYPE="REFERENCE">Munne 2002</LINK>), and result in reduced implantation potential (<LINK REF="REF-Gardner-1996" TYPE="REFERENCE">Gardner 1996</LINK>). There is also evidence of a significant reduction in uterine pulsatility at the time when blastocysts are transferred and therefore less chance that embryos can be expelled (<LINK REF="REF-Fanchin-2001" TYPE="REFERENCE">Fanchin 2001</LINK>).</P>
<P>The second argument for blastocyst transfer is the reported higher implantation potential compared with cleavage stage embryos. As a consequence of self selection, it is postulated that only the most viable embryos are expected to develop into blastocysts. It is widely acknowledged that the morphological criteria used for selection of the best embryos on day 2 to 3 are limited. Many published studies that debate the correlation of morphological features with pregnancy rates can be found in the literature (<LINK REF="REF-Palmstierna-1998" TYPE="REFERENCE">Palmstierna 1998</LINK>; <LINK REF="REF-Puissant-1987" TYPE="REFERENCE">Puissant 1987</LINK>; <LINK REF="REF-Roseboom-1995" TYPE="REFERENCE">Roseboom 1995</LINK>; <LINK REF="REF-Scott-2000" TYPE="REFERENCE">Scott 2000</LINK>; <LINK REF="REF-Sjoblom-2006" TYPE="REFERENCE">Sjoblom 2006</LINK>; <LINK REF="REF-Steer-1992" TYPE="REFERENCE">Steer 1992</LINK>). It is now understood that a disturbingly large proportion of morphologically normal day 3 embryos are chromosomally abnormal or mosaic, thus contributing to the 80% to 90% rate of implantation failure post-transfer that is observed in cleavage stage protocols (<LINK REF="REF-Magli-1998" TYPE="REFERENCE">Magli 1998</LINK>). While the transfer of day 5 blastocysts cannot ensure the absence of chromosomal abnormality (<LINK REF="REF-Magli-2000" TYPE="REFERENCE">Magli 2000</LINK>), <LINK REF="REF-Staessen-2004" TYPE="REFERENCE">Staessen 2004</LINK> demonstrated that, at least in women older than 36 years, the incidence can be reduced from 59% in day 3 embryos to 35% in day 5 blastocysts. The question that this review aims to answer is whether the higher implantation rates do translate into higher live birth rates.</P>
<P>Arguments against blastocyst culture are largely related to this process of self selection. Women undergoing blastocyst culture are expected to have a higher incidence of cycle cancellation due to failed embryo development (<LINK REF="REF-Marek-1999" TYPE="REFERENCE">Marek 1999</LINK>) and of having fewer embryos cryopreserved (frozen) (<LINK REF="REF-Tsirigotis-1998" TYPE="REFERENCE">Tsirigotis 1998</LINK>). Overall utilisation rates have previously been described as the total number of embryos transferred plus the embryos thawed divided by the number of fertilised eggs. While this approach presents information about the comparative number of pregnancy opportunities that each treatment approach can provide a couple, it does not take into account the implantation potential for fresh and thawed embryos, and cumulative live birth rate is the only outcome that can assess this. An alternative efficacy formula was developed in the <LINK REF="REF-Schoolcraft-2001" TYPE="REFERENCE">Schoolcraft 2001</LINK> study that does take this into account. Using the formula (mean number of embryos transferred multiplied by implantation rate) plus (mean number of embryos cryopreserved multiplied by implantation rate) minus (1 minus cancellation rate), this group of researchers was able to demonstrate a 19% greater efficiency in blastocyst culture compared with cleavage stage transfers. Disappointingly, such a utilisation and efficiency analysis is not possible in the majority of RCTs due to the lack of reporting of frozen-thawed cycle outcomes within a reasonable time frame for trials. A simpler proposal to both of these approaches is to report the live birth rates for both fresh and frozen-thawed cycles following a single oocyte retrieval in women randomised to either cleavage stage or blastocyst stage transfers.</P>
</THEORY>
<IMPORTANCE MODIFIED="2016-06-29 17:02:18 +1200" MODIFIED_BY="Helen E Nagels">
<P>This is an update of a Cochrane review first published in 2002, and previously updated in 2005, 2007, and 2012.</P>
<P>Advocates of blastocyst culture are confident that only the most viable embryos will survive the extended culture to day 5 to 6. This would result in a higher probability of implantation and require fewer embryos to be transferred, thereby lowering the costly multiple birth rate (<LINK REF="REF-Gardner-1998b" TYPE="REFERENCE">Gardner 1998b</LINK>; <LINK REF="REF-Jones-1999" TYPE="REFERENCE">Jones 1999</LINK>). Critics of the approach express concern at the increased incidence of women failing to have embryos available for transfer (<LINK REF="REF-Marek-1999" TYPE="REFERENCE">Marek 1999</LINK>), although the day of participant recruitment into the blastocyst programme is crucial to this argument. It is important to be aware that clinic policies may differ on the minimum criteria for blastocyst culture and the day on which this decision is made (for example, number of follicles, fertilised eggs, eight-cell embryos on day 3) (<LINK REF="REF-Milki-1999" TYPE="REFERENCE">Milki 1999</LINK>). It is also yet to be clarified if there are patient groups for whom blastocyst culture is disadvantageous. Most importantly, does blastocyst culture achieve the primary aim of providing the subfertile couple with a normal, healthy baby? Methods for identification of viable blastocysts are indeed a popular research focus involving a range of approaches which include identification of chromosomally normal blastocysts by polar-body and blastomere, trophectoderm genetic analysis (using microarrays or next-generation sequencing known as pre-implantation genetic screening; <LINK REF="REF-Jones-2008" TYPE="REFERENCE">Jones 2008</LINK>), and metabolomic analysis of culture media (<LINK REF="REF-Nel_x002d_Themaat-2011" TYPE="REFERENCE">Nel-Themaat 2011</LINK>).</P>
<P>Other negative outcomes reported to be associated with blastocyst culture include a higher incidence of monozygotic twinning and altered sex ratio in favour of males (<LINK REF="REF-Menezo-1999" TYPE="REFERENCE">Menezo 1999</LINK>). Monozygotic twinning is frequently reported at above 1% in ART cycles (<LINK REF="REF-Sills-2000" TYPE="REFERENCE">Sills 2000</LINK>), while the background rate of monozygotic twins in spontaneous conceptions is in the order of 1 in 330. This twinning is associated with miscarriage, serious structural congenital anomalies, growth discrepancy and twin-to-twin transfusion syndrome. Extended culture of an embryo has been implicated as one of the interventions associated with an increase in monozygotic twinning (<LINK REF="REF-Behr-2000" TYPE="REFERENCE">Behr 2000</LINK>; <LINK REF="REF-Cohen-1990" TYPE="REFERENCE">Cohen 1990</LINK>; <LINK REF="REF-De-Felici-1982" TYPE="REFERENCE">De Felici 1982</LINK>; <LINK REF="REF-Jain-2004" TYPE="REFERENCE">Jain 2004</LINK>), but a recent report suggests that improvements in cell culture techniques over time can result in a significant decrease in its incidence (<LINK REF="REF-Moayeri-2007" TYPE="REFERENCE">Moayeri 2007</LINK>). Similarly, as the underlying mechanisms that lead to an altered sex ratio are elucidated, whether it be media constituents or simply the morphological selection criteria (<LINK REF="REF-Luna-2007" TYPE="REFERENCE">Luna 2007</LINK>), the imbalance may also be rectified.</P>
<P>The aim of this review is to determine whether the number of days between oocyte retrieval and embryo transfer (that is the number of days the embryos are grown in vitro) has any effect on the success of ART treatment, and in particular the live birth rate, the most important outcome for couples or women undergoing treatment and for service providers.<BR/>
</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-06-21 08:25:28 +1200" MODIFIED_BY="Clare Dooley">
<P>To determine whether blastocyst stage (day 5 to 6) embryo transfers improve the live birth rate, and other associated outcomes, compared with cleavage stage (day 2 to 3) embryo transfers.</P>
</OBJECTIVES>
<METHODS MODIFIED="2016-06-30 10:46:18 +1200" MODIFIED_BY="Helen E Nagels">
<SELECTION_CRITERIA MODIFIED="2016-06-29 17:11:37 +1200" MODIFIED_BY="Helen E Nagels">
<CRIT_STUDIES MODIFIED="2016-06-29 16:55:04 +1200" MODIFIED_BY="Helen E Nagels">
<P>We included randomised controlled trials (RCTs). </P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2016-06-29 17:03:06 +1200" MODIFIED_BY="Helen E Nagels">
<SUBSECTION>
<HEADING LEVEL="5">Inclusion criteria</HEADING>
<P>Couples or women undergoing in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) for therapeutic reasons or for oocyte donation within all patient prognosis groups.</P>
<P>'Patient prognosis groups' (participant subsets or populations) is a term used to describe the categories that couples or women are assigned to based on several factors such as their age, type of infertility, ovarian response to the superovulation drugs, and number of previous attempts. See the <LINK TAG="SUBGROUP_ANALYSIS" TYPE="SECTION">Subgroup analysis and investigation of heterogeneity</LINK> section below in the methods section of the review for the categories.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Exclusion criteria</HEADING>
<P>Couples or women whose IVF or ICSI cycle, or both, involved in vitro matured oocytes or pre-implantation genetic screening. Couples or women where frozen-thawed cycle results were shown, but no data were available from the fresh cycle.</P>
</SUBSECTION>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-06-29 17:00:43 +1200" MODIFIED_BY="Helen E Nagels">
<SUBSECTION>
<HEADING LEVEL="5">Inclusion criteria</HEADING>
<P>We compared blastocyst transfers (day 5 to 6) versus cleavage stage (day 2 to 3) transfers in settings using single and sequential media culture methods for IVF and ICSI, where the embryos were grown for between 2 and 6 days in vitro prior to embryo transfer.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Exclusion criteria</HEADING>
<P>Use of co-culture methods as an intervention.</P>
<P>Blastocyst stage transfers versus cleavage stage transfers in frozen-thawed cycles, where no data were available from the fresh cycle.</P>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2016-06-29 17:11:37 +1200" MODIFIED_BY="Helen E Nagels">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2016-06-29 17:10:50 +1200" MODIFIED_BY="Helen E Nagels">
<OL>
<LI>Live birth rate per couple or woman (number of live births after week 20 of pregnancy per couple or woman) following fresh transfer.</LI>
<LI>Cumulative pregnancy rate per couple or woman (from both fresh and thawed cycles deriving from a single egg collection procedure).</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2016-06-29 17:11:37 +1200" MODIFIED_BY="Helen E Nagels">
<OL>
<LI>Clinical pregnancy rate per couple or woman: number of couples or women achieving a clinical pregnancy following fresh transfer (defined by the demonstration of foetal heart activity on ultrasound scan).</LI>
<LI>Multiple pregnancy rate per couple or woman following fresh transfer: number of multiple pregnancies per couple or woman.</LI>
<LI>High order multiple pregnancy rate per couple or woman following fresh transfer: three or more foetal heartbeats per couple or woman.</LI>
<LI>Miscarriage rate for fresh transfer: number of occurrences per couple or woman and per pregnant woman.</LI>
<LI>Embryo freezing rate per couple or woman: number of couples or women that had embryos frozen-thawed per couple or woman.</LI>
<LI>Failure rate to transfer embryos (per couple or woman): percentage of couples or women that did not have an embryo transfer.</LI>
</OL>
<SUBSECTION>
<HEADING LEVEL="5">Additional outcomes not appropriate for statistical pooling</HEADING>
<P>We were unable to pool data per cycle or per embryo transfer or per oocyte pick up (OPU) (<LINK REF="REF-Vail-2003" TYPE="REFERENCE">Vail 2003</LINK>). If a study included multiple cycles, transfers, or OPUs per woman, then results reported per cycle/transfer/OPU cannot be validly pooled. If the study reported results per cycle/transfer/OPU and this did not coincide with the point of randomisation (i.e. if the denominator did not coincide with the point in the treatment where randomisation occurred), we calculated new results using randomised patients as the denominator and treated those excluded as having negative outcomes. However, due to the frequency that this form of data is reported in the literature, we have entered them into the 'Data and analyses tables' for the following outcomes.</P>
<OL>
<LI>Live births per OPU and embryo transfer.</LI>
<LI>Clinical pregnancy rate per OPU and embryo transfer.</LI>
<LI>Implantation rate, the number of foetal sacs divided by the number of embryos transferred.</LI>
</OL>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2016-06-24 14:27:51 +1200" MODIFIED_BY="Helen E Nagels">
<P>All reports that described (or might have described) RCTs comparing cleavage stage embryo transfer and blastocyst stage transfer in the treatment of subfertility, using IVF or ICSI, were obtained using the search strategy developed by the Gynaecology and Fertility Group.</P>
<P>We searched the Cochrane Gynaecology and Fertility Group Specialised Register of Controlled Trials, the Cochrane Central Register of Controlled Trials (CENTRAL; the Cochrane Library; 2016, Issue 4), MEDLINE (1966 to Apr 2016), EMBASE (1980 to Apr 2016), PsycINFO and CINAHL using the Cochrane highly sensitive search strategy and the following keywords: blastocyst/embryo or embryo transfer/cleavage stage, ovum/culture media or embryo culture/sequential culture/co-culture. See <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>; <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>; <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>; <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>; <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>; <LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>; <LINK REF="APP-07" TYPE="APPENDIX">Appendix 7</LINK>.</P>
<P>We combined the MEDLINE search with the Cochrane highly sensitive search strategy for identifying randomised trials, which appears in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>We combined the EMBASE search with trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (<A HREF="http://www.sign.ac.uk/mehodology/filters.html#random">http://www.sign.ac.uk/mehodology/filters.html#random</A>). We did not impose any language restrictions in these searches.</P>
<ELECTRONIC_SEARCHES MODIFIED="2016-06-23 13:35:10 +1200" MODIFIED_BY="Helen E Nagels">
<UL>
<LI>Gynaecology and Fertility Group Specialised Register (up to April 2016), see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</LI>
<LI>Ovid Cochrane Central Register of Controlled Trials (CENTRAL) (up to April 2016), see <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</LI>
<LI>
<A HREF="http://ovidsp.tx.ovid.com.ezproxy.auckland.ac.nz/sp-3.2/ovidweb.cgi?&amp;S=PIMIFPIINLDDAMEHMCDLNCNKPPBPAA00&amp;New+Database=Single%7c34&amp;Rerun=1">Ovid MEDLINE(R) In-Process &amp; Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R)</A> (up to April 2016), see <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>.</LI>
<LI>Ovid EMBASE (1 January 2010 to April 2016); EMBASE was only searched one year back as the UKCC has handsearched EMBASE to this point and these trials are already in CENTRAL, see <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>.</LI>
<LI>Ovid PsycINFO (up to April 2016), see <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>.</LI>
<LI>CINAHL (up to April 2016), see <LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>.</LI>
</UL>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-06-21 09:03:17 +1200" MODIFIED_BY="Clare Dooley">
<P>We searched the National Research Register, a register of ongoing and recently completed research projects funded by, or of interest to, the United Kingdom's National Health Service (NHS); entries from the Medical Research Council Clinical Trials Register; and details on reviews in progress that are collected by the NHS Centre for Reviews and Dissemination.</P>
<P>We also searched ClinicalTrials.gov and the World Health Organization (WHO) portal (ICTRP), see <LINK REF="APP-08" TYPE="APPENDIX">Appendix 8</LINK>; <LINK REF="APP-09" TYPE="APPENDIX">Appendix 9</LINK>.</P>
<P>We performed the search on titles, abstracts, and keywords of the listed articles. We also searched the citation lists of relevant publications, review articles, and included studies. We handsearched relevant conference abstracts.</P>
<P>We conduct a search for new trials bi-annually and update the review as and when we find new trials to be incorporated.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2016-06-30 10:46:18 +1200" MODIFIED_BY="Helen E Nagels">
<STUDY_SELECTION MODIFIED="2016-06-24 14:33:21 +1200" MODIFIED_BY="Helen E Nagels">
<P>Two review authors (DG, and AQR) performed the selection of trials for inclusion in the review after employing the search strategy described previously. This information was presented in a <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table and provides a context for assessing the reliability of results. Excluded articles were detailed in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2016-06-24 14:33:21 +1200" MODIFIED_BY="Helen E Nagels">
<P>Three review authors (DG, CF, and AQR) independently extracted data from eligible studies using a data extraction form designed and pilot-tested by the authors. Any disagreements were resolved by discussion. Data extracted included study characteristics and outcome data. Where studies had multiple publications, the main trial report was used as the reference and additional details derived from secondary papers. We corresponded with study investigators for further data, as required.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2016-06-24 14:33:30 +1200" MODIFIED_BY="Helen E Nagels">
<P>Three review authors (DG, CF, and AQR) independently assessed the included studies for risk of bias using the Cochrane risk of bias assessment tool (www.cochrane-handbook.org) to assess: selection (random sequence generation and allocation concealment); performance (blinding of participants and personnel); detection (blinding of outcome assessors); attrition (incomplete outcome data); reporting (selective reporting); and other bias. </P>
<P>Another co-author (CF) was available to resolve any discrepancies. Additional information on trial methodology or actual original trial data were sought from the principal author of trials that appeared to meet eligibility criteria but were unclear in aspects of methodology, or where the data were in a form unsuitable for meta-analysis. We sent reminder correspondence when a reply was not received within three weeks.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-06-21 09:27:14 +1200" MODIFIED_BY="Clare Dooley">
<P>For dichotomous data (for example, clinical pregnancy rate), we expressed results for each study as odds ratios (ORs) with 95% confidence intervals (CIs) and combined them for meta-analysis with Review Manager 5 software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>), using the Peto modified Mantel-Haenzel method.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-06-21 10:12:28 +1200" MODIFIED_BY="Clare Dooley">
<P>The primary analysis was per woman randomised. We counted multiple live births (for example, twins or triplets) as one live birth event.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2016-06-21 09:28:17 +1200" MODIFIED_BY="Clare Dooley">
<P>Where possible, we analysed data using an intention-to-treat analysis. Where this was not possible, we analysed only the available data.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2016-06-21 09:29:58 +1200" MODIFIED_BY="Clare Dooley">
<P>We considered whether the clinical and methodological characteristics of the included studies were sufficiently similar for meta-analysis to provide a clinically meaningful summary. We assessed statistical heterogeneity by the measure of the I<SUP>2 </SUP>statistic. An I<SUP>2</SUP> measurement greater than 50% was taken to indicate substantial heterogeneity. When we detected substantial heterogeneity, we explored possible explanations in sensitivity analyses. We took statistical heterogeneity into account when interpreting the results.</P>
<P>We examined heterogeneity between the results of different studies by inspecting the scatter of data points, the overlap in their confidence intervals, and more formally by checking the results of the Chi<SUP>2</SUP> tests. A priori, we had planned to look at the possible contribution of differences in trial design to the heterogeneity identified. Where possible, we pooled the outcomes statistically.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2016-06-21 09:31:20 +1200" MODIFIED_BY="Clare Dooley">
<P>In view of the difficulty of detecting and correcting for publication bias and other reporting biases, we aimed to minimise their potential impact by ensuring a comprehensive search for eligible studies and by being alert for duplication of data. If there were ten or more studies in an analysis, we used a funnel plot to explore the possibility of small study effects (a tendency for estimates of the intervention effect to be more beneficial in smaller studies).</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2016-06-29 16:33:18 +1200" MODIFIED_BY="Helen E Nagels">
<P>We performed statistical analyses in accordance with the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>We pooled data for meta-analysis with Review Manager 5 software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>), using the fixed effect Mantel-Haenzel method model. We entered the data on the graphs so that for beneficial outcomes (for example, pregnancy) data are displayed to the right of the line of no effect, and in detrimental outcomes (for example, miscarriage) to the left of the line of no effect. </P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2016-06-21 09:45:47 +1200" MODIFIED_BY="Clare Dooley">
<P>We planned the following subgroup analyses for the outcomes live birth, cumulative pregnancy, clinical pregnancy, and multiple pregnancy.<BR/>
</P>
<UL>
<LI>Studies that actively selected for good prognosis participants (for example, four or more zygotes, first two cycles, more than 10 follicles, young population, no male-factor individuals) versus participants with poor prognostic factors (for example, previous failed ART cycles or poor response to ovulation stimulation) versus studies with unselected participants.</LI>
<LI>Studies that randomised at the start of the cycle (that is, prior to ovarian stimulation) were compared with those that randomised at the days immediately prior to and post-OPU (that is, day of final ultrasound scan and prior to human chorionic gonadotropin trigger up to and including the day of fertilisation check, when numbers of oocytes are anticipated).</LI>
<LI>Studies where the policy for the number of embryos replaced was equal in both blastocyst stage and cleavage stage groups versus studies where fewer blastocyst stage than cleavage stage embryos were replaced.</LI>
<LI>We also included a posthoc analysis to investigate substantial heterogeneity for one of the primary outcomes: studies where freezing technique was slow freezing versus studies where vitrification was used.</LI>
</UL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2016-06-30 10:46:18 +1200" MODIFIED_BY="Helen E Nagels">
<P>For the outcomes live birth, cumulative pregnancy, clinical pregnancy, and multiple pregnancy, we planned the following sensitivity analyses.</P>
<OL>
<LI>Studies that clearly reported an acceptable method of allocation concealment.</LI>
<LI>Studies that reported the randomisation method.</LI>
<LI>Studies that reported the day of randomisation.</LI>
</OL>
<SUBSECTION>
<HEADING LEVEL="3">Overall quality of the body of evidence: Summary of findings table</HEADING>
<P>We prepared a Summary of findings table using <LINK REF="REF-GRADEpro" TYPE="REFERENCE">GRADEpro</LINK>. This table evaluated the overall quality of the body of evidence for the main review outcomes (live birth rate, cumulative pregnancy rate, clinical pregnancy rate, multiple pregnancy rate, miscarriage rate, embryo freezing rate and failure rate to transfer any embryos), using GRADE criteria (study limitations [i.e. risk of bias], consistency of effect, imprecision, indirectness and publication bias). Judgements about evidence quality (high, moderate, low or very low) were justified, documented, and incorporated into reporting of results for each outcome.</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-06-29 17:28:35 +1200" MODIFIED_BY="Helen E Nagels">
<STUDY_DESCRIPTION MODIFIED="2016-06-29 17:05:50 +1200" MODIFIED_BY="Helen E Nagels">
<SEARCH_RESULTS MODIFIED="2016-06-21 12:57:26 +1200" MODIFIED_BY="Clare Dooley">
<P>In our searches from 2000 to 2016, we identified 741 articles as potentially relevant for comparing blastocyst stage versus cleavage stage embryo transfer, and we retrieved 45 articles in full-text. Including studies retrieved in the latest update, we now have 27 studies included in the review (34 articles); we excluded eight studies. We also found three ongoing studies (one completed but apparently unpublished in any form, and two still recruiting) from Iran (<LINK REF="STD-NCT01107002" TYPE="STUDY">NCT01107002</LINK>), Italy (<LINK REF="STD-NCT02639000" TYPE="STUDY">NCT02639000</LINK>), and China (<LINK REF="STD-ChiCTR_x002d_ICR_x002d_15006184" TYPE="STUDY">ChiCTR-ICR-15006184</LINK>).</P>
<P>In this update we added four new studies (<LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK>; <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>; <LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK>; <LINK REF="STD-Kaur-2014" TYPE="STUDY">Kaur 2014</LINK>), and did not newly exclude any studies. See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<P>We attempted to contact study authors for information regarding methodology and outcome data. We received replies from 12 contact authors (<LINK REF="STD-Bungum-2003" TYPE="STUDY">Bungum 2003</LINK>; <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>; <LINK REF="STD-Frattarelli-2003" TYPE="STUDY">Frattarelli 2003</LINK>; <LINK REF="STD-Hreinsson-2004" TYPE="STUDY">Hreinsson 2004</LINK>; <LINK REF="STD-Karaki-2002" TYPE="STUDY">Karaki 2002</LINK>; <LINK REF="STD-Levitas-2004" TYPE="STUDY">Levitas 2004</LINK>; <LINK REF="STD-Levron-2002" TYPE="STUDY">Levron 2002</LINK>; <LINK REF="STD-Livingstone-2002" TYPE="STUDY">Livingstone 2002</LINK>, <LINK REF="STD-Papanikolaou-2005" TYPE="STUDY">Papanikolaou 2005</LINK>; <LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>; <LINK REF="REF-Plachot-1999" TYPE="REFERENCE">Plachot 1999</LINK>; <LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>). Cumulative live birth data were provided by <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2016-06-29 17:05:50 +1200" MODIFIED_BY="Helen E Nagels">
<SUBSECTION>
<HEADING LEVEL="4">Study design and setting</HEADING>
<P>We included 27 parallel-design RCTs in this review (4031 participants). The size of trials ranged from 20 in <LINK REF="STD-Fisch-2007" TYPE="STUDY">Fisch 2007</LINK> to 460 couples or women in <LINK REF="STD-Kolibianakis-2004" TYPE="STUDY">Kolibianakis 2004</LINK>, including both comparison groups.</P>
<P>The majority of trials were carried out in less than six months, except for the two largest studies. All studies were reported to have been performed at single private clinics or university-based clinics. Twelve countries were represented in the included studies, with Belgium being the most prolific, providing six studies. The countries represented were: Australia (<LINK REF="STD-Livingstone-2002" TYPE="STUDY">Livingstone 2002</LINK>), Belgium (<LINK REF="STD-Devreker-2000" TYPE="STUDY">Devreker 2000</LINK>; <LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>; <LINK REF="STD-Kolibianakis-2004" TYPE="STUDY">Kolibianakis 2004</LINK>; <LINK REF="STD-Papanikolaou-2005" TYPE="STUDY">Papanikolaou 2005</LINK>; <LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>; <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>), Brazil (<LINK REF="STD-Motta-1998" TYPE="STUDY">Motta 1998</LINK>), Denmark (<LINK REF="STD-Bungum-2003" TYPE="STUDY">Bungum 2003</LINK>), Egypt (<LINK REF="STD-Elgindy-2011" TYPE="STUDY">Elgindy 2011</LINK>; <LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK>), France (<LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>), Greece (<LINK REF="STD-Pantos-2004" TYPE="STUDY">Pantos 2004</LINK>), India (<LINK REF="STD-Kaur-2014" TYPE="STUDY">Kaur 2014</LINK>); Israel (<LINK REF="STD-Coskun-2000" TYPE="STUDY">Coskun 2000</LINK>; <LINK REF="STD-Levitas-2004" TYPE="STUDY">Levitas 2004</LINK>; <LINK REF="STD-Levron-2002" TYPE="STUDY">Levron 2002</LINK>), Iran (<LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK>); Italy (<LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>; <LINK REF="STD-Schillaci-2002" TYPE="STUDY">Schillaci 2002</LINK>), Jordan (<LINK REF="STD-Karaki-2002" TYPE="STUDY">Karaki 2002</LINK>), Spain (<LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>; <LINK REF="STD-Ten-2011" TYPE="STUDY">Ten 2011</LINK>), Sweden (<LINK REF="STD-Hreinsson-2004" TYPE="STUDY">Hreinsson 2004</LINK>), and the USA (<LINK REF="STD-Fisch-2007" TYPE="STUDY">Fisch 2007</LINK>; <LINK REF="STD-Frattarelli-2003" TYPE="STUDY">Frattarelli 2003</LINK>; <LINK REF="STD-Gardner-1998" TYPE="STUDY">Gardner 1998</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>Participant selection criteria comprised three main groups: unselected participants (<LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>; <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>; <LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK>; <LINK REF="STD-Karaki-2002" TYPE="STUDY">Karaki 2002</LINK>; <LINK REF="STD-Kolibianakis-2004" TYPE="STUDY">Kolibianakis 2004</LINK>; <LINK REF="STD-Motta-1998" TYPE="STUDY">Motta 1998</LINK>; <LINK REF="STD-Pantos-2004" TYPE="STUDY">Pantos 2004</LINK>; <LINK REF="STD-Schillaci-2002" TYPE="STUDY">Schillaci 2002</LINK>; <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>); good prognostic factors where participants were positively selected, that is, those that would be expected to do well with blastocyst culture (<LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>; <LINK REF="STD-Bungum-2003" TYPE="STUDY">Bungum 2003</LINK>; <LINK REF="STD-Coskun-2000" TYPE="STUDY">Coskun 2000</LINK>; <LINK REF="STD-Elgindy-2011" TYPE="STUDY">Elgindy 2011</LINK>; <LINK REF="STD-Fisch-2007" TYPE="STUDY">Fisch 2007</LINK>; <LINK REF="STD-Frattarelli-2003" TYPE="STUDY">Frattarelli 2003</LINK>; <LINK REF="STD-Gardner-1998" TYPE="STUDY">Gardner 1998</LINK>; <LINK REF="STD-Hreinsson-2004" TYPE="STUDY">Hreinsson 2004</LINK>; <LINK REF="STD-Kaur-2014" TYPE="STUDY">Kaur 2014</LINK>; <LINK REF="STD-Levron-2002" TYPE="STUDY">Levron 2002</LINK>; <LINK REF="STD-Livingstone-2002" TYPE="STUDY">Livingstone 2002</LINK>; <LINK REF="STD-Papanikolaou-2005" TYPE="STUDY">Papanikolaou 2005</LINK>; <LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>; <LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>; <LINK REF="STD-Ten-2011" TYPE="STUDY">Ten 2011</LINK>); and poor prognostic factors, where couples or women were selected who had experienced multiple failures with conventional treatment or had a poor response to ovulation induction (<LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK>; <LINK REF="STD-Devreker-2000" TYPE="STUDY">Devreker 2000</LINK>; <LINK REF="STD-Levitas-2004" TYPE="STUDY">Levitas 2004</LINK>). Most studies recruited women aged less than 40 years of age, with the exception of <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>, <LINK REF="STD-Gardner-1998" TYPE="STUDY">Gardner 1998 </LINK>and <LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK> which had no age limit. The mean age across all the studies varied from 29 years to 34 years.</P>
<P>We found no studies of participants using donor eggs.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>Eighteen trials used sequential media, of which 11 used Vitrolife G1/G2, while the remaining media were combinations of brands or made in-house. Three did not state the media used (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
<P>Freezing of embryos in both experimental groups was reported in 13 of the 27 included trials (<LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>; <LINK REF="STD-Bungum-2003" TYPE="STUDY">Bungum 2003</LINK>; <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>; <LINK REF="STD-Gardner-1998" TYPE="STUDY">Gardner 1998</LINK>; <LINK REF="STD-Hreinsson-2004" TYPE="STUDY">Hreinsson 2004</LINK>; <LINK REF="STD-Karaki-2002" TYPE="STUDY">Karaki 2002</LINK>; <LINK REF="STD-Kolibianakis-2004" TYPE="STUDY">Kolibianakis 2004</LINK>; <LINK REF="STD-Levron-2002" TYPE="STUDY">Levron 2002</LINK>; <LINK REF="STD-Motta-1998" TYPE="STUDY">Motta 1998</LINK>; <LINK REF="STD-Pantos-2004" TYPE="STUDY">Pantos 2004</LINK>; <LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>; <LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>; <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>). <LINK REF="STD-Coskun-2000" TYPE="STUDY">Coskun 2000</LINK> reported no provision for day 5 freezing. <LINK REF="STD-Levitas-2004" TYPE="STUDY">Levitas 2004</LINK> stated that most of the remaining embryos were not suitable for freezing. Other interventions, such as assisted hatching, were either not provided or not reported on for the majority of trials. <LINK REF="STD-Gardner-1998" TYPE="STUDY">Gardner 1998</LINK> was the only trial that practised assisted hatching, but only for the day 3 embryo transfer group.</P>
<P>All the studies compared blastocyst stage versus cleavage stage embryo transfers. For the cleavage stage transfer groups most transfers were on day 3, with the exception of five trials (<LINK REF="STD-Devreker-2000" TYPE="STUDY">Devreker 2000</LINK>; <LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>; <LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK>; <LINK REF="STD-Motta-1998" TYPE="STUDY">Motta 1998</LINK>; <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>) and <LINK REF="STD-Levitas-2004" TYPE="STUDY">Levitas 2004</LINK> had a policy of day 2 or 3.</P>
<P>The trials that provided details on the ovarian stimulation regimen mostly reported using a similar gonadotropin-releasing hormone pituitary down-regulation protocol prior to human menopausal gonadotropin (HMG) and follicle stimulating hormone (FSH) administration. However, in some trials (<LINK REF="STD-Kolibianakis-2004" TYPE="STUDY">Kolibianakis 2004</LINK>; <LINK REF="STD-Papanikolaou-2005" TYPE="STUDY">Papanikolaou 2005</LINK>; <LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>), gonadotropin-releasing hormone antagonists were used in varying degrees.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
<UL>
<LI>13/27 studies reported live birth rate</LI>
<LI>5/27 studies reported cumulative pregnancy rate</LI>
<LI>27/27 studies reported clinical pregnancy rate</LI>
<LI>19/27 studies reported multiple pregnancy rate</LI>
<LI>13/27 studies reported high-order multiple pregnancy rate</LI>
<LI>18/27 studies reported miscarriage rate</LI>
<LI>14/27 studies reported embryo freezing rate</LI>
<LI>17/27 studies reported failure rate to transfer embryos</LI>
</UL>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2016-06-29 16:49:14 +1200" MODIFIED_BY="Helen E Nagels">
<P>We excluded 8 studies from the review for the following reasons.</P>
<UL>
<LI>2/11 fresh embryo transfers on day 5/6 were not the main intervention.</LI>
<LI>3/11 used co-culture.</LI>
<LI>3/11 were not truly randomised studies.</LI>
</UL>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2016-06-29 17:28:35 +1200" MODIFIED_BY="Helen E Nagels">
<P>See <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>, <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<P>We made attempt to obtain additional information regarding all aspects of randomisation, blinding, power analysis, and intention-to-treat from all trial authors.</P>
<ALLOCATION MODIFIED="2016-06-24 14:54:35 +1200" MODIFIED_BY="Helen E Nagels">
<SUBSECTION>
<HEADING LEVEL="4">Sequence generation</HEADING>
<P>Fourteen studies used acceptable methods of sequence generation and we rated these studies at low risk of bias in this domain (<LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>; <LINK REF="STD-Bungum-2003" TYPE="STUDY">Bungum 2003</LINK>; <LINK REF="STD-Elgindy-2011" TYPE="STUDY">Elgindy 2011</LINK>; <LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>; <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>; <LINK REF="STD-Frattarelli-2003" TYPE="STUDY">Frattarelli 2003</LINK>; <LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK>; <LINK REF="STD-Gardner-1998" TYPE="STUDY">Gardner 1998</LINK>; <LINK REF="STD-Kolibianakis-2004" TYPE="STUDY">Kolibianakis 2004</LINK>; <LINK REF="STD-Levitas-2004" TYPE="STUDY">Levitas 2004</LINK>; <LINK REF="STD-Livingstone-2002" TYPE="STUDY">Livingstone 2002</LINK>; <LINK REF="STD-Papanikolaou-2005" TYPE="STUDY">Papanikolaou 2005</LINK>; <LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>; <LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>). The other studies did not clearly describe an acceptable method of sequence generation and we rated these studies at unclear risk of bias (<LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK>; <LINK REF="STD-Coskun-2000" TYPE="STUDY">Coskun 2000</LINK>; <LINK REF="STD-Devreker-2000" TYPE="STUDY">Devreker 2000</LINK>; <LINK REF="STD-Fisch-2007" TYPE="STUDY">Fisch 2007</LINK>; <LINK REF="STD-Hreinsson-2004" TYPE="STUDY">Hreinsson 2004</LINK>; <LINK REF="STD-Karaki-2002" TYPE="STUDY">Karaki 2002</LINK>; <LINK REF="STD-Kaur-2014" TYPE="STUDY">Kaur 2014</LINK>; <LINK REF="STD-Levron-2002" TYPE="STUDY">Levron 2002</LINK>; <LINK REF="STD-Motta-1998" TYPE="STUDY">Motta 1998</LINK>; <LINK REF="STD-Pantos-2004" TYPE="STUDY">Pantos 2004</LINK>; <LINK REF="STD-Schillaci-2002" TYPE="STUDY">Schillaci 2002</LINK>; <LINK REF="STD-Ten-2011" TYPE="STUDY">Ten 2011</LINK>; <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>). .</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<P>Eight studies used an acceptable method of allocation concealment and we rated these studies at low risk of bias in this domain (<LINK REF="STD-Elgindy-2011" TYPE="STUDY">Elgindy 2011</LINK>; <LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK>; <LINK REF="STD-Hreinsson-2004" TYPE="STUDY">Hreinsson 2004</LINK>; <LINK REF="STD-Karaki-2002" TYPE="STUDY">Karaki 2002</LINK>; <LINK REF="STD-Levitas-2004" TYPE="STUDY">Levitas 2004</LINK>; <LINK REF="STD-Levron-2002" TYPE="STUDY">Levron 2002</LINK>; <LINK REF="STD-Livingstone-2002" TYPE="STUDY">Livingstone 2002</LINK>; <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>). Five studies did not use acceptable methods of allocation concealment and we rated these at high risk of bias (<LINK REF="STD-Coskun-2000" TYPE="STUDY">Coskun 2000</LINK>; <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>; <LINK REF="STD-Kolibianakis-2004" TYPE="STUDY">Kolibianakis 2004</LINK>; <LINK REF="STD-Papanikolaou-2005" TYPE="STUDY">Papanikolaou 2005</LINK>; <LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>); the remaining studies did not clearly describe their methods and we rated them at unclear risk of bias (<LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK>; <LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>; <LINK REF="STD-Bungum-2003" TYPE="STUDY">Bungum 2003</LINK>; <LINK REF="STD-Devreker-2000" TYPE="STUDY">Devreker 2000</LINK>; <LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>; <LINK REF="STD-Fisch-2007" TYPE="STUDY">Fisch 2007</LINK>; <LINK REF="STD-Frattarelli-2003" TYPE="STUDY">Frattarelli 2003</LINK>; <LINK REF="STD-Gardner-1998" TYPE="STUDY">Gardner 1998</LINK>; <LINK REF="STD-Kaur-2014" TYPE="STUDY">Kaur 2014</LINK>; <LINK REF="STD-Motta-1998" TYPE="STUDY">Motta 1998</LINK>; <LINK REF="STD-Pantos-2004" TYPE="STUDY">Pantos 2004</LINK>; <LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>; <LINK REF="STD-Schillaci-2002" TYPE="STUDY">Schillaci 2002</LINK>; <LINK REF="STD-Ten-2011" TYPE="STUDY">Ten 2011</LINK>).</P>
</SUBSECTION>
</ALLOCATION>
<BLINDING MODIFIED="2016-06-24 14:55:08 +1200" MODIFIED_BY="Helen E Nagels">
<P>The length of culture and the day of embryo transfer was different for each of the experimental groups, making it unlikely that blinding was feasible.</P>
<P>Sixteen studies were clearly unblinded and we rated these studies at high risk of bias in this domain. Another 11 studies did not make it clear whether they attempted blinding, or mentioned blinding but failed to describe who was blinded and therefore we also rated these studies at high risk; it is not possible to blind with this intervention.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2016-06-29 17:06:45 +1200" MODIFIED_BY="Helen E Nagels">
<P>Eighteen studies provided sufficient information for us to be able to conduct an intention-to-treat analysis, and we rated these studies at low risk of bias in this domain (<LINK REF="STD-Bungum-2003" TYPE="STUDY">Bungum 2003</LINK>; <LINK REF="STD-Coskun-2000" TYPE="STUDY">Coskun 2000</LINK>; <LINK REF="STD-Devreker-2000" TYPE="STUDY">Devreker 2000</LINK>; <LINK REF="STD-Elgindy-2011" TYPE="STUDY">Elgindy 2011</LINK>; <LINK REF="STD-Fisch-2007" TYPE="STUDY">Fisch 2007</LINK>; <LINK REF="STD-Frattarelli-2003" TYPE="STUDY">Frattarelli 2003</LINK>; <LINK REF="STD-Hreinsson-2004" TYPE="STUDY">Hreinsson 2004</LINK>; <LINK REF="STD-Karaki-2002" TYPE="STUDY">Karaki 2002</LINK>; <LINK REF="STD-Kaur-2014" TYPE="STUDY">Kaur 2014</LINK>; <LINK REF="STD-Kolibianakis-2004" TYPE="STUDY">Kolibianakis 2004</LINK>; <LINK REF="STD-Levitas-2004" TYPE="STUDY">Levitas 2004</LINK>; <LINK REF="STD-Pantos-2004" TYPE="STUDY">Pantos 2004</LINK>; <LINK REF="STD-Papanikolaou-2005" TYPE="STUDY">Papanikolaou 2005</LINK>; <LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>; <LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>; <LINK REF="STD-Schillaci-2002" TYPE="STUDY">Schillaci 2002</LINK>; <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>). The latter trial also performed an interim analysis and was terminated after 50% of the intended participants were enrolled due to a significant difference being detected. We also rated <LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK> at low risk of bias, as outcomes were reported in all randomised participants.</P>
<P>Identification of participants failing to have an embryo transfer was not stated or unclear in some trials. <LINK REF="STD-Coskun-2000" TYPE="STUDY">Coskun 2000</LINK> implied that a 100% embryo transfer rate was achieved in both groups, which is unexpectedly high and is possibly explained by transferring embryos of a lesser stage when blastocysts were not available. We attempted to check this with the study authors, but were unsuccessful. Where the number of couples or women and the number of embryo transfers were different, we used the number of couples or women as the denominator, even when exclusions took place post-randomisation, assuming no pregnancies occurred. For example, <LINK REF="STD-Frattarelli-2003" TYPE="STUDY">Frattarelli 2003</LINK> excluded eight couples or women, including four for embryo quality. We were able to add these eight couples or women to the denominator and, therefore, an intention-to-treat analysis was possible.</P>
<P>
<LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK> excluded 10 women because of protocol violations. <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK> excluded seven women post-randomisation as three couples or women randomised to day 2 requested blastocyst transfer and four couples or women requested day 2 transfer. We added these numbers to the denominator, assuming they did not conceive. For the remaining studies the day 5 to 6 embryo transfer rate ranged from 71% to 96%.</P>
<P>We rated four studies reporting cumulative pregnancy rate at high risk in this domain (<LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>; <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>; <LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK> <LINK REF="STD-Levron-2002" TYPE="STUDY">Levron 2002</LINK>) and unclear for one (<LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>). The high risk of bias is because in three studies, there were more women having a frozen-thawed embryo transfer in the cleavage group than in the blastocyst group. In the other one, 120 women were randomised and final distribution of participants, due to some exclusions, was: day 5 group n = 58 and day 3 group n = 46 (<LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>).</P>
<P>We rated the other four studies at unclear risk of attrition bias.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2016-06-24 15:21:15 +1200" MODIFIED_BY="Helen E Nagels">
<P>We rated 12 studies at low risk of selection bias: these studies reported the live birth rate and/or had a published protocol and reported all their planned outcomes (<LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>; <LINK REF="STD-Elgindy-2011" TYPE="STUDY">Elgindy 2011</LINK>; <LINK REF="STD-Devreker-2000" TYPE="STUDY">Devreker 2000</LINK>; <LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>; <LINK REF="STD-Frattarelli-2003" TYPE="STUDY">Frattarelli 2003</LINK>; <LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK>; <LINK REF="STD-Levron-2002" TYPE="STUDY">Levron 2002</LINK>; <LINK REF="STD-Livingstone-2002" TYPE="STUDY">Livingstone 2002</LINK>; <LINK REF="STD-Papanikolaou-2005" TYPE="STUDY">Papanikolaou 2005</LINK>; <LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>; <LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>; <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>). Fourteen studies did not have a protocol available and failed to report the live birth rate, and we rated these at unclear risk of selective reporting. One study (<LINK REF="STD-Fisch-2007" TYPE="STUDY">Fisch 2007</LINK>), reported only preliminary data and we rated this study at high risk of bias in this domain.</P>
<P>(<LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>; <LINK REF="STD-Elgindy-2011" TYPE="STUDY">Elgindy 2011</LINK>; <LINK REF="STD-Devreker-2000" TYPE="STUDY">Devreker 2000</LINK>; <LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>; <LINK REF="STD-Frattarelli-2003" TYPE="STUDY">Frattarelli 2003</LINK>; <LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK>; <LINK REF="STD-Levron-2002" TYPE="STUDY">Levron 2002</LINK>; <LINK REF="STD-Livingstone-2002" TYPE="STUDY">Livingstone 2002</LINK>; <LINK REF="STD-Papanikolaou-2005" TYPE="STUDY">Papanikolaou 2005</LINK>; <LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>; <LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>; <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>). The other studies did not clearly describe an acceptable method of sequence generation and we rated these studies at unclear risk of bias (<LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK>; <LINK REF="STD-Bungum-2003" TYPE="STUDY">Bungum 2003</LINK>; <LINK REF="STD-Coskun-2000" TYPE="STUDY">Coskun 2000</LINK>; <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>; <LINK REF="STD-Gardner-1998" TYPE="STUDY">Gardner 1998</LINK>; <LINK REF="STD-Hreinsson-2004" TYPE="STUDY">Hreinsson 2004</LINK>; <LINK REF="STD-Karaki-2002" TYPE="STUDY">Karaki 2002</LINK>; <LINK REF="STD-Kaur-2014" TYPE="STUDY">Kaur 2014</LINK>; <LINK REF="STD-Kolibianakis-2004" TYPE="STUDY">Kolibianakis 2004</LINK>; <LINK REF="STD-Levitas-2004" TYPE="STUDY">Levitas 2004</LINK>; <LINK REF="STD-Motta-1998" TYPE="STUDY">Motta 1998</LINK>; <LINK REF="STD-Pantos-2004" TYPE="STUDY">Pantos 2004</LINK>; <LINK REF="STD-Schillaci-2002" TYPE="STUDY">Schillaci 2002</LINK>; <LINK REF="STD-Ten-2011" TYPE="STUDY">Ten 2011</LINK>).</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2016-06-29 17:28:35 +1200" MODIFIED_BY="Helen E Nagels">
<P>We rated four studies at high risk of other bias as they did not clearly distinguish between fresh and frozen-thawed cycles (<LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK>), reported no provision for day 5 freezing (<LINK REF="STD-Coskun-2000" TYPE="STUDY">Coskun 2000</LINK>), had no age limit (<LINK REF="STD-Gardner-1998" TYPE="STUDY">Gardner 1998</LINK>) or conducted either single blastocyst transfer (day 5) or double embryo transfer (day 3) (<LINK REF="STD-Livingstone-2002" TYPE="STUDY">Livingstone 2002</LINK>). We rated one study at unclear risk because it was an abstract and insufficient information was available (<LINK REF="STD-Ten-2011" TYPE="STUDY">Ten 2011</LINK>). We rated the other studies at low risk of other potential sources of bias.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-06-29 17:13:03 +1200" MODIFIED_BY="Helen E Nagels">
<SUBSECTION>
<HEADING LEVEL="3">Blastocyst stage versus cleavage stage transfer</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Live birth rate per couple or woman</HEADING>
<P>The live birth rate was higher in the fresh blastocyst transfer group (odds ratio (OR) 1.48, 95% confidence interval (CI) 1.20 to 1.82; 13 RCTs, 1630 women, I<SUP>2 </SUP>= 45%, low quality evidence). (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>; <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">Subgroup and sensitivity analyses</HEADING>
<P>Statistical tests for subgroup differences showed no evidence of a difference between fresh cleavage stage and blastocyst stage transfer based on number of embryos transferred, prognosis, or day of randomisation (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK> ).</P>
<P>Sensitivity analysis including only those studies with low risk of bias by allocation concealment, did not find differences between the interventions for live birth rates (OR 1.38, 95% CI 0.96 to 1.99; 5 RCTs, 539 women, I<SUP>2 </SUP>= 48%). This finding may be attributable to loss of statistical power as the analysis only included 539 women.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Cumulative pregnancy rate per couple or woman (following fresh and frozen-thawed transfer)</HEADING>
<P>There was no evidence of a difference between the groups in rates per couple or woman of cumulative pregnancy (OR 0.89, 95% CI 0.64 to 1.22; 5 RCTs, 632 women, I<SUP>2 </SUP>= 71%, very low quality evidence). There was substantial heterogeneity for this outcome, with differing directions of effect. The heterogeneity was largely attributable to a single study (<LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>). (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>; <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
<P>
<I>Subgroup and sensitivity analyses</I>
</P>
<P>Statistical tests for subgroup differences showed no evidence of a difference between the subgroups based on number of embryos transferred or day of randomisation, and no conclusive evidence of a difference based on prognosis (test for subgroup differences P = 0.05). (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>; <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>).</P>
<P>We investigated statistical heterogeneity by conducting a posthoc subgroup analysis according to the method of freezing. The test for subgroup differences showed a significant difference between the subgroups (Chi² = 9.12, df = 1 (P = 0.003), I² = 89.0%). The only study using vitrification showed evidence of higher cumulative pregnancy rate in blastocyst transfers (OR 2.44, 95% CI 1.17 to 5.12; <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>). When slow freezing was used there was evidence of benefit for cleavage transfers (OR 0.69, 95% CI 0.48 to 0.99; <LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>; <LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>; <LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>; <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>). (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3. Clinical pregnancy rate per couple or woman</HEADING>
<P>The clinical pregnancy rate was higher in the fresh blastocyst transfer group (OR 1.30, 95% CI 1.14 to 1.47; 27 RCTs, 4031 women, I<SUP>2 </SUP>= 56%, moderate quality evidence). (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>; <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">Subgroup and sensitivity analyses</HEADING>
<P>Statistical tests for subgroup differences showed no evidence of a difference between the groups based on number of embryos transferred, prognosis or day of randomisation.</P>
<P>Sensitivity analysis including only those studies with low risk of bias by allocation concealment did not substantially influence our findings (OR 1.52, 95% CI 1.19 to 1.94; 8 RCTs, 1097 women, I<SUP>2 </SUP>= 68%), though heterogeneity was high.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Multiple pregnancy rate per couple or woman</HEADING>
<P>There was no evidence of a difference between the groups in rates per couple of multiple pregnancy in fresh cycles (OR 1.05, 95% CI 0.83 to 1.33; 19 RCTs, 3019 women, I<SUP>2 </SUP>= 30%, low quality evidence). (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">Subgroup and sensitivity analyses</HEADING>
<P>Statistical tests for subgroup differences showed no evidence of a difference between the groups based on number of embryos transferred, prognosis, or day of randomisation (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>; <LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>).</P>
<P>Sensitivity analysis excluding the studies which did not report concealment of allocation did not substantially affect the results (OR 0.82, 95% CI 0.57 to 1.18).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. High order multiple pregnancy rate per couple or woman</HEADING>
<P>There was no evidence of a difference between the groups in rates of high order multiple pregnancy in fresh cycles (OR 0.45, 95% CI 0.18 to 1.15; 13 RCTS, 2335 women, I<SUP>2 </SUP>= 0%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Miscarriage rate for fresh transfer</HEADING>
<P>There was no evidence of a difference between the groups in miscarriage rate per couple or woman in fresh cycles (OR 1.15, 95% CI 0.88 to 1.50; 18 RCTs, 2917 women, I<SUP>2 </SUP>= 0%, low quality evidence). (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">7 Embryo freezing rate per couple or woman</HEADING>
<P>Rates of embryo freezing per couple or woman were lower in the blastocyst transfer group (OR 0.48, 95% CI 0.40 to 0.57; 14 studies, 2292 women, I<SUP>2</SUP>=84%, low quality evidence). There was very high heterogeneity, but the direction of effect was consistent in most studies. (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8 Failure rate to transfer embryos</HEADING>
<P>Rates of failure to transfer any embryos were higher in the blastocyst transfer group (OR 2.50, 95% CI 1.76 to 3.55; 17 studies, 2577 women, I<SUP>2 </SUP>= 36%, moderate quality evidence). (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">9 Other data</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Blastocyst rates</HEADING>
<P>Reported in <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>, blastocyst rates (day 5 to 6 transfer only) ranged from 22.4% in <LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK> to 60.3% in <LINK REF="STD-Schillaci-2002" TYPE="STUDY">Schillaci 2002</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Implantation data</HEADING>
<P>For blastocyst stage the implantation rate varied from 4.2% to 55.8% . For cleavage stage transfer, the implantation rate varied from 3% to 43.9% (see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of publication bias</HEADING>
<P>We generated funnel plots for the outcomes, live birth and clinical pregnancy. They did not suggest publication bias (see 
<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>; <LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>).</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2016-06-29 17:13:13 +1200" MODIFIED_BY="Helen E Nagels">
<SUMMARY_OF_RESULTS MODIFIED="2016-06-29 17:13:13 +1200" MODIFIED_BY="Helen E Nagels">
<P>In the 13 RCTs that reported live birth rates, there was low quality evidence of a benefit in live birth rate per couple or woman in the fresh blastocyst transfer group and there was no evidence of a difference in the miscarriage rate. Clinical pregnancy rates were also higher in the fresh blastocyst transfer group, based on moderate quality evidence.</P>
<P>We did not find any evidence of difference when pooling the five RCTs that reported cumulative pregnancy rates (derived from fresh and thawed cycles from a single oocyte retrieval cycle): three were published in 2002/2003, one in 2010, and one in 2015. We considered the evidence to be of very low quality. We note that the one study that used vitrification reported higher cumulative pregnancy rates in blastocyst transfers, whereas rates were higher in the cleavage stage transfers, where slow freezing was used. However, this finding should be regarded cautiously as it resulted from a posthoc subgroup analysis.</P>
<P>Embryo freezing rates and failure rates to transfer embryos favoured early cleavage stage transfers. We did not find any evidence of difference between fresh blastocyst and cleavage stage transfers for rates of miscarriage, multiple pregnancies, or high order multiples.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2016-06-29 17:07:06 +1200" MODIFIED_BY="Helen E Nagels">
<P>The data in this review of 27 RCTs are incomplete. Of 27 RCTs, only five reported cumulative pregnancy rates. Three of the four new studies (for the 2016 update) failed to report live birth data. This lack of data from frozen-thawed cycles does not inform patients adequately about the outcomes.</P>
<P>The applicability of the evidence to everyday practice is somewhat limited by the many variables present in an in vitro fertilisation (IVF) cycle which directly result from different clinic policies. Although the 27 studies all compared cleavage stage with blastocyst stage, they all used different media, different freezing protocols, different number of embryo transfer policies, and different embryo quality scores. However, the most serious limitation was the lack of the data from the frozen-thawed cycles as alluded to in the previous paragraph. For the most part, the variation in the different protocols can be a strength, as it means that in spite of the variation in cycles, the effect is still seen. With so few studies reporting the most useful outcome (cumulative pregnancy rate) then we are unable to report the applicability of the evidence.</P>
<P>Blastocyst culture is expected to result in higher implantation rates (number of foetal sacs observed divided by the number of embryos transferred). However, pooling of implantation data could not be included in the meta-analysis as this would not generate valid estimates or confidence intervals due to the unit of analysis used (<LINK REF="REF-Vail-2003" TYPE="REFERENCE">Vail 2003</LINK>). Implantation rate is also no longer considered a useful outcome for a number of methodological reasons (<LINK REF="REF-Griesinger-2016" TYPE="REFERENCE">Griesinger 2016</LINK>).</P>
<P>There was a significantly higher failure rate to transfer any embryos in the blastocyst stage group leading to cycle cancellation. The increased rates of failure to transfer with blastocyst stage is largely because of embryos with arrested development prior to the day of embryo transfer. Indeed, many of the studies that transferred fewer blastocysts than cleavage stage embryos did so from a lack of options rather than by policy. Only the reporting of fresh and frozen-thawed cycle embryos can overcome this challenge. Some advocate that it is better for women to learn that their embryos failed to develop by day 5 than go through with a transfer on cleavage stage with embryos that had a low potential of success. There has, however, been little research into the emotional status of couples or women given such choices (<LINK REF="REF-Borg-2000" TYPE="REFERENCE">Borg 2000</LINK>). Avoiding unnecessary embryo transfer needs to be balanced against the need for an additional oocyte retrieval. The possibility that extended culture may in fact cause harm to viable embryos through suboptimal culture conditions, must be considered, particularly when there are large variations between trials in blastocyst development rates.</P>
<P>The variable embryo transfer policies between the two experimental groups was also a concern, as significantly many of the studies had a policy to transfer fewer embryos in the blastocyst stage group than in the cleavage stage group (<LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>). There are two primary reasons for this difference. First, there is a reduced survival rate of day 5 to 6 blastocysts and second, many clinics that are worried about the high incidence of multiple pregnancies with blastocysts will have a policy to transfer no more than two blastocyst stage embryos. Some clinics state that by employing blastocyst culture they have been able to reduce the multiple pregnancy rate whilst maintaining the pregnancy rate. In this review, many of the studies were still transferring two to three embryos. Single embryo transfers for selected patient groups are now considered standard practice in many clinics throughout the world (<LINK REF="REF-Hamberger-2005" TYPE="REFERENCE">Hamberger 2005</LINK>).</P>
<P>The importance of selecting the single most viable embryo for transfer has intensified the search to improve assessment of the quality of embryos. Performing blastocyst culture may offer one of those mechanisms (<LINK REF="REF-Gardner-2004" TYPE="REFERENCE">Gardner 2004</LINK>; <LINK REF="REF-Milki-2004" TYPE="REFERENCE">Milki 2004</LINK>). In this meta-analysis, significantly fewer embryos were transferred in the blastocyst stage group than in the cleavage stage group. When a subgroup analysis was performed for trials where equal numbers of embryos were transferred (including single embryo transfers), the clinical pregnancy rate remained unchanged. It could be argued that this is the most valid comparison because trials with a greater number of cleavage stage embryos being transferred are probably advantaged inappropriately.</P>
<P>Regardless of the embryo transfer policy, for many women there is simply a lack of choice as only one, if any, embryo reaches the blastocyst stage. Only three studies in this review had a policy for single blastocyst transfer, although only one reported the live birth rate. None of the new studies added to this updated review had a single embryo transfer policy.</P>
<P>Studies have shown that women with a high oocyte yield and good quality eight-cell embryos on day 3 are more likely to have blastocysts by day 5 to 6 than poor responders and those with no eight-cell embryos by day 3. Therefore, we considered whether outcomes might be influenced by the time of randomisation. In subgroup analysis for live birth and pregnancy outcomes, we compared studies that randomised couples or women prior to the start of the treatment cycle (at a time when neither the number of oocytes retrieved nor fertilised nor the number of eight-cell embryos could be anticipated) versus studies that randomised women at a later stage. We found no evidence of a statistically significant difference between the subgroups.</P>
<P>Miscarriage rates were reported in just over half of the included trials. Theoretically, the rate of miscarriage might be expected to be lowest with the transfer of highly selected embryos that are transferred into a synchronous uterine environment, such as in blastocyst culture. However, the results to date reveal little change from the earlier reviews that showed no evidence of a difference in miscarriage rates for couples or women randomised (18 RCTs, Peto odds ratio (OR) 1.15, 95% confidence interval (CI) 0.88 to 1.50). Only seven of the included trials reported on the presence or absence of monozygotic twinning, so this analysis remains underpowered to comment meaningfully on monozygotic twin rates. A total of three sets of monozygotic twins were reported, two with cleavage stage embryo transfers and only one set of monozygotic twins from blastocyst transfer. Estimations of monozygotic twin rates in assisted reproductive technologies (ARTs) are thought to be underestimated, with up to one-third being missed without genetic testing.</P>
<P>Overall, this review found that women in the blastocyst group were less likely to have any embryos frozen but there was no clear evidence of a difference in cumulative pregnancy rate (fresh and frozen-thawed cycle transfers). The number of embryos frozen is an important consideration when assessing the effectiveness of a treatment, as it may offer a woman an additional opportunity to achieve a pregnancy. When considering an alteration in treatment procedure from cleavage stage to blastocyst stage, the benefits of possible higher implantation rates are weighed up against the disadvantages of not only higher failure rates to transfer, but also lower cryopreservation rates. Five trials reported data on pregnancies following transfer of frozen-thawed embryos in both groups (<LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>; <LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>; <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>; <LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>; <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>). <LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK> reported a cumulative live birth rate of 47% in the blastocyst stage transfer group and 52% in the cleavage stage transfer group. That is, the added benefit of a higher cryopreservation rate in the cleavage stage group cancelled out the higher implantation rates of the fresh day 5 to 6 transfers. Similarly, <LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK> and <LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK> reported no evidence of a difference in cryo-augmented pregnancy rates when at least one thawed cycle was carried out in the cleavage stage group. <LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>, on the other hand, reported significantly higher cumulative pregnancy rates in the cleavage stage group, presumably correlating to the much lower cryosurvival rate they reported in their blastocyst group (cleavage stage: 46% versus blastocyst stage: 27%). However, <LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK> reported significantly higher cumulative pregnancy rates in the blastocyst stage group (day 3: 43.3% versus day 5: 56.8%). This study was the only study to use vitrification, and also included women with a good prognosis. This pooled data for cumulative clinical pregnancy has 71% heterogeneity and this appears to be explained by the differences in freezing methods. This is supported by other reports of improved blastocyst outcomes with vitrification (<LINK REF="REF-Edgar-2012" TYPE="REFERENCE">Edgar 2012</LINK>; <LINK REF="REF-Gardner-2003" TYPE="REFERENCE">Gardner 2003</LINK>; <LINK REF="REF-Iwayama-2011" TYPE="REFERENCE">Iwayama 2011</LINK>; <LINK REF="REF-Richter-2016" TYPE="REFERENCE">Richter 2016)</LINK>.</P>
<P>Although the evidence is limited, there is a growing trend for freeze-only cycles to further reduce the risk of ovarian hyperstimulation (OHSS) and improve pregnancy outcomes if the progesterone levels are elevated (<LINK REF="REF-Roque-2015" TYPE="REFERENCE">Roque 2015</LINK>). This trend will also have an impact on the decision about cleavage stage or blastocyst transfers and should be considered in the next update.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2016-06-29 16:36:24 +1200" MODIFIED_BY="Helen E Nagels">
<P>The overall quality of the evidence in this review was low for most outcomes, but was very low for the cumulative pregnancy rate and moderate for clinical pregnancy rate and failure to transfer any embryos. The main limitation in evidence quality was serious risk of bias. Blinding is not possible with this intervention. Only half of the included studies adequately described their method of sequence generation, and less than one-third reported their allocation concealment method. For some outcomes, quality of evidence was also downgraded for inconsistency and imprecision.</P>
<P>Live birth rates were reported in 13 trials, providing low quality evidence (very serious risk of bias), but cumulative pregnancy rates after fresh and frozen-thawed embryo transfer data were only reported in five trials, and the quality of the evidence was very low with high heterogeneity. The most likely explanation for the heterogeneity was the difference in freezing protocols, with one study using vitrification and reporting benefit for blastocyst transfer for the cumulative pregnancy rate (<LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>), and the other four studies using slow freezing and reporting benefit for cleavage stage transfer.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2016-06-29 16:35:32 +1200" MODIFIED_BY="Helen E Nagels">
<P>As far as possible the protocol methodology was adhered to in order to limit any potential biases. However, one new outcome was added: cumulative pregnancy rates (derived from fresh and thawed cycles). This outcome reflects the policy of fresh embryo transfer and freezing remaining embryos for transfer later and more correctly reflects modern IVF practice than a single cycle transfer.</P>
<P>The issue of publication bias is important in systematic reviews as it may result in incorrect conclusions being reached. For example, it might be expected that the pressure for clinics to obtain high implantation rates with blastocyst culture could lead to a bias in publication towards those that do achieve this. However, the funnel plots for live birth and clinical pregnancy did not suggest publication bias.</P>
<P>Another point to consider is the widely variable policy for assessing minimal quality of embryos for transfer that may have existed amongst trials. Some trials accepted transfer of developmentally delayed embryos in blastocyst stage, whilst other trials were more selective and denied transfer of embryos that had not reached the late morula or early blastocyst stage.</P>
<P>Blastocyst formation rates may also influence the pregnancy rate per embryo transfer for each trial. They ranged from 22.4% in the <LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK> trial to 60% in the <LINK REF="STD-Schillaci-2002" TYPE="STUDY">Schillaci 2002</LINK> trial. Of the included trials that provided information on the media used, all used sequential media for the culture of blastocysts. However, while the majority reported using various versions of Vitrolife G1/G2, others used a combination of different brands, or made the media in-house. This highlights the possibility that different brands and formulations are likely to influence the blastulation rates and subsequent outcomes. The improvement in culture media and embryo laboratory procedures should prompt new studies.<BR/>
</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2016-06-24 15:27:30 +1200" MODIFIED_BY="Helen E Nagels">
<P>This review is in agreement with the <LINK REF="REF-Papanikolaou-2008" TYPE="REFERENCE">Papanikolaou 2008</LINK> systematic review, which reported that cycles where equal numbers of embryos were transferred had higher live birth rates in blastocyst transfers than in cleavage stage embryos. Our review also includes the cumulative pregnancy rate. Another systematic review was published by <LINK REF="REF-Wang-2014" TYPE="REFERENCE">Wang 2014</LINK>, which only included RCTs published after 2004. In that review, they show similar results with respect to live birth rates, but reported lower miscarriage rates in the blastocyst group, which was not observed in our review.</P>
<P>A more recently published review by <LINK REF="REF-Maheshwari-2016" TYPE="REFERENCE">Maheshwari 2016</LINK> cites the previous version of this review, and is in agreement that better studies are required.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2016-06-29 17:00:16 +1200" MODIFIED_BY="Helen E Nagels">
<IMPLICATIONS_PRACTICE MODIFIED="2016-06-29 17:00:16 +1200" MODIFIED_BY="Helen E Nagels">
<P>There is low quality evidence that blastocyst stage transfer is associated with higher rates of live birth and clinical pregnancy than cleavage stage transfer. There was no evidence of a difference between the groups in cumulative pregnancy rates (derived from fresh and thawed cycles) but the evidence for this outcome was of very low quality. Thus, although there is a benefit favouring blastocyst transfer in fresh cycles, it remains unclear whether the day of transfer impacts on the cumulative rate.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2016-06-23 10:29:27 +1200" MODIFIED_BY="Clare Dooley">
<P>Although this review provides evidence that there is a significant difference in live birth rates from fresh cycles in favour of blastocyst transfer compared to cleavage stage transfer cycles, findings for cumulative clinical pregnancy rates (derived from fresh and thawed cycles) still raise questions. Further new studies of blastocyst cycles must report live birth and cumulative live birth rates and miscarriage rates to enable consumers and service providers to make well informed decisions on the best treatment option. Finally, more studies with single embryo transfer are also needed in order to evaluate the best option with the fewest adverse event rates.</P>
<P>Based on the results of this review, we recommend the following to ensure valuable data are produced.</P>
<OL>
<LI>Adherence to Consolidated Standards of Reporting Trials (CONSORT) recommendations for RCTs, especially methods of concealment (<LINK REF="REF-Begg-1996" TYPE="REFERENCE">Begg 1996</LINK>).</LI>
<LI>Research into best patient selection and inclusion criteria; consider prognostic factors such as age, outcomes from previous cycles.</LI>
<LI>Same media composition and brand for both groups up to the cleavage stage.</LI>
<LI>Explicit prespecified embryo transfer policies for both groups; preferably single embryo transfer.</LI>
<LI>Long-term follow-up reports of cumulative live birth rates (including embryo thaws) presented as a survival analysis.</LI>
<LI>Research into improved blastocyst cryopreservation techniques, e.g. vitrification.</LI>
<LI>Application of blastocyst culture for single embryo transfer.</LI>
<LI>Reporting of miscarriage, live birth, and cumulative pregnancy rates.</LI>
</OL>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2016-06-22 15:16:49 +1200" MODIFIED_BY="Clare Dooley">
<P>The authors acknowledge the helpful comments of those who refereed previous versions of this review, in particular Mr Andy Vail and Dr Gayle Jones. Thanks to Dr Plachot, Dr Huisman, Dr Utsunomiya, Dr Hreinsson, Dr Rienzi, Dr Levron, Dr Levitas, Dr Bungum, Dr Papanikolaou, Dr Karaki, Dr Frattarelli, Dr Brugnon, Dr Vanderzwalmen and Dr Fernández-Shaw for supplying additional information. Thanks to the librarian Daniel Comandé. Finally, special thanks to the highly supportive team at the Cochrane office in Auckland. </P>
<P>Dr Neil Johnson was a review author for the previous version of this review and made a significant contribution to the interpretation of results and performed some data extraction. David Olive, for the initial review, commented on drafts of the protocol and review. Michelle Proctor, for the initial review, was involved in selecting trials for inclusion, performed independent data extraction and quality assessment of the included trials, contributed to the discussion and interpretation of results. Quirine Lamberts, for the 2005 update, checked the data and study information extracted. Ariel Bardach, for the 2012 update, was involved in selecting trials for inclusion, performed independent data extraction, and quality assessment of the included trials.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2016-06-24 15:28:07 +1200" MODIFIED_BY="Helen E Nagels">
<P>Cindy Farquhar is a director/shareholder of a fertility/gynaecology clinic and undertakes private practice within those premises.</P>
<P>Demián Glujovsky is part of medical staff of a fertility clinic and undertakes private practice within those premises.</P>
<P>Andrea Quinteiro Retamar is the egg donor coordinator of a fertility clinic and undertakes private practice within those premises.</P>
<P>No other authors have any conflict of interest to declare.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2016-06-22 15:19:00 +1200" MODIFIED_BY="Clare Dooley">
<P>Debbie Blake: for the initial review and updates to 2005, took the lead in writing the protocol and review, performed initial searches of databases for trials, involved in selecting trials for inclusion, performed independent data extraction and quality assessment of the included trials, and was responsible for statistical analysis and interpretation of the data. Also contributed to the final analysis and text of the 2012 and 2016 updates.</P>
<P>Cindy Farquhar: for the 2005 update, added in the new studies, redesigned the table of comparisons and rewrote the results section, as well as edited the review. Also contributed to the 2007, 2012, and 2016 updates with assistance in extraction and interpretation of the data and writing in all sections.</P>
<P>Demián Glujovsky: for the 2012 and 2016 updates, took the lead in writing the update of the review, performed new searches of databases for trials, involved in selecting trials for inclusion, performed independent data extraction and quality assessment of the included trials, and was responsible for statistical analysis and interpretation of the data in the update.</P>
<P>Andrea Quinteiro Retamar: for the 2016 update, involved in selecting trials for inclusion, and performed independent data extraction and quality assessment of the included trials.</P>
<P>Cristian Alvarez Sedo: for the final analysis and text of the 2016 update.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2016-06-29 17:07:12 +1200" MODIFIED_BY="Helen E Nagels">
<UL>
<LI>We only included RCTs and excluded quasi RCTs (2007 update)</LI>
<LI>We excluded couples or women where frozen-thawed cycle results were shown, but no data were available from the fresh cycle (2016 update)</LI>
<LI>Addition of cumulative pregnancy rate to the primary outcomes (previously a secondary outcome) (2007 update)</LI>
<LI>Subgroup and sensitivity analyses restricted to specific clinical outcomes: live birth, cumulative pregnancy, clinical pregnancy, and multiple pregnancy (2007 update)</LI>
<LI>Addition of a posthoc subgroup analysis according to freezing technique, to investigate statistical heterogeneity for the outcome cumulative pregnancy rate (2016 update)</LI>
<LI>Objectives shortened to current wording (2012 update)</LI>
</UL>
</PRO_REV_DIFF>
<PUBLIC_NOTES>
<P>Conflict of interest added.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-06-30 04:10:31 +0100" MODIFIED_BY="Helen Nagels">
<STUDIES MODIFIED="2016-06-29 16:48:27 +1200" MODIFIED_BY="Helen E Nagels">
<INCLUDED_STUDIES MODIFIED="2016-06-23 10:57:44 +1200" MODIFIED_BY="Clare Dooley">
<STUDY DATA_SOURCE="PUB" ID="STD-Aziminekoo-2015" MODIFIED="2016-06-20 14:14:37 +1200" MODIFIED_BY="Clare Dooley" NAME="Aziminekoo 2015" YEAR="2015">
<REFERENCE MODIFIED="2016-06-20 14:14:37 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aziminekoo E, Mohseni Salehi MS, Kalantari V, Shahrokh Tehraninejad E, Haghollahi F, Hossein Rashidi B, et al</AU>
<TI>Pregnancy outcome after blastocyst stage transfer comparing to early cleavage stage embryo transfer</TI>
<SO>Gynecological Endocrinology</SO>
<YR>2015</YR>
<VL>31</VL>
<NO>11</NO>
<PG>880-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204630"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204629"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brugnon-2010" MODIFIED="2016-06-20 14:14:57 +1200" MODIFIED_BY="Clare Dooley" NAME="Brugnon 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-06-20 14:14:57 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brugnon F, Bouraoui Z, Ouchchane L, Gremeau AS, Peikrishvili R, Pouly JL, et al</AU>
<TI>Cumulative pregnancy rates after single cleavage-stage versus blastocyst-stage embryo transfer: A randomized and prospective study</TI>
<SO>Human Reproduction</SO>
<YR>2010</YR>
<VL>25</VL>
<PG>i60-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204632"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204631"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bungum-2003" MODIFIED="2016-06-20 14:15:17 +1200" MODIFIED_BY="Clare Dooley" NAME="Bungum 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-06-20 14:15:17 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bungum M, Bungum L, Humaidan P, Yding Andersen C</AU>
<TI>Day 3 versus day 5 embryo transfer: a prospective randomized study</TI>
<SO>Reproductive Biomedicine Online</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>1</NO>
<PG>98-104</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204634"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204633"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coskun-2000" NAME="Coskun 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coskun S, Hollanders J, Al-Hassan S, Al-Sufyan H, Al-Mayman H, Jaroudi K</AU>
<TI>Day 5 versus day 3 embryo transfer: a controlled randomized trial</TI>
<SO>Human Reproduction</SO>
<YR>2000</YR>
<VL>15</VL>
<NO>9</NO>
<PG>1947-52</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204636"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204635"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Devreker-2000" MODIFIED="2016-06-20 14:24:35 +1200" MODIFIED_BY="Clare Dooley" NAME="Devreker 2000" YEAR="2000">
<REFERENCE MODIFIED="2016-06-20 14:24:35 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Devreker F, Delbaere A, Emiliani S, Van den Bergh M, Biramane J, Englert Y</AU>
<TI>Prospective and randomized comparison between transfer on day 2 or day 5 for patients with more than four IVF attempts</TI>
<SO>European Society of Human Reproduction and Embryology</SO>
<YR>2000</YR>
<PG>P135</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204638"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204637"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elgindy-2011" MODIFIED="2012-06-09 20:24:47 +1200" MODIFIED_BY="[Empty name]" NAME="Elgindy 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-06-09 20:24:47 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elgindy EA, Abou-Setta AM, Mostafa MI</AU>
<TI>Blastocyst-stage versus cleavage-stage embryo transfer in women with high oestradiol concentrations: randomized controlled trial</TI>
<SO>Reproductive Biomedicine Online</SO>
<YR>2011</YR>
<VL>23</VL>
<NO>6</NO>
<PG>789-98</PG>
<IDENTIFIERS MODIFIED="2012-02-23 13:49:05 +1300" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204640"/><IDENTIFIER TYPE="PUBMED" VALUE="22050864"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204639"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Emiliani-2003" MODIFIED="2016-06-20 14:34:52 +1200" MODIFIED_BY="Clare Dooley" NAME="Emiliani 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-06-20 14:34:52 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Emiliani S, Delbaere A, Vannin A, Biramane J, Verdoodt M, Englert Y, et al</AU>
<TI>Similar delivery rates in a selected group of patients, for day 2 and day 5 embryos both cultured in sequential medium: a randomized study</TI>
<SO>Human Reproduction</SO>
<YR>2003</YR>
<VL>18</VL>
<NO>10</NO>
<PG>2145-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204642"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204641"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernandez_x002d_Shaw-2015" MODIFIED="2016-06-20 14:42:15 +1200" MODIFIED_BY="Clare Dooley" NAME="Fernandez-Shaw 2015" YEAR="2015">
<REFERENCE MODIFIED="2016-06-20 14:38:31 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fernandez-Shaw S, Cercas R, Brana C, Villas C, Pons I</AU>
<TI>Ongoing and cumulative pregnancy rate after cleavage-stage versus blastocyst-stage embryo transfer using vitrification for cryopreservation: impact of age on the results</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>2015</YR>
<VL>32</VL>
<NO>2</NO>
<PG>177-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204644"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-06-20 14:42:15 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="OTHER">
<AU>Fernandez-Shaw S</AU>
<TI>Unpublished data including live birth and cumulative live birth rates [personal communication]</TI>
<SO>Email to: Demián Glujovsky</SO>
<YR>6 May 2016</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204645"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204643"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fisch-2007" MODIFIED="2016-06-20 14:44:54 +1200" MODIFIED_BY="Clare Dooley" NAME="Fisch 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-06-20 14:44:54 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fisch JD, Adamowicz M, Hackworth J, Ginsburg M, Keskintepe L, Sher G</AU>
<TI>Single embryo transfer (SET) day 3 vs day 5 based on graduated embryo score (GES) and soluble human leukocyte antigen-G (sHLA-G): preliminary results of a prospective, randomized controlled trial</TI>
<SO>Fertility and Sterility</SO>
<YR>2007</YR>
<VL>88</VL>
<NO>Suppl 1</NO>
<PG>332-3, abstract no. 679</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204647"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204646"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frattarelli-2003" NAME="Frattarelli 2003" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frattarelli JL, Leondires MP, McKeeby JL, Miller BT, Segars JH</AU>
<TI>Blastocyst transfer decreases multiple pregnancy rates in vitro fertilization cycles: a randomized controlled trial</TI>
<SO>Fertility and Sterility</SO>
<YR>2003</YR>
<VL>79</VL>
<NO>1</NO>
<PG>228-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204649"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204648"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gaafar-2015" MODIFIED="2016-06-20 14:45:52 +1200" MODIFIED_BY="Clare Dooley" NAME="Gaafar 2015" YEAR="2015">
<REFERENCE MODIFIED="2016-06-20 14:45:52 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gaafar SH, El Fourtia I, El Tawil S, El Guiziry D, El Maghraby H</AU>
<TI>Blastocyst versus day 2-3 transfer in ICSI cycles for male factor infertility: a multicenter randomized controlled trial</TI>
<SO>Human Reproduction</SO>
<YR>2015</YR>
<VL>30</VL>
<NO>Suppl 1</NO>
<PG>i217, abstract no: P-223</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204651"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204650"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gardner-1998" MODIFIED="2016-06-20 14:49:33 +1200" MODIFIED_BY="Clare Dooley" NAME="Gardner 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-06-20 14:49:33 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gardner DK, Schoolcraft WB, Wagley L, Schlenker T, Stevens J, Hesla J</AU>
<TI>A prospective randomized trial of blastocyst culture and transfer in in-vitro fertilization</TI>
<SO>Human Reproduction</SO>
<YR>1998</YR>
<VL>13</VL>
<NO>12</NO>
<PG>3434-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204653"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204652"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hreinsson-2004" MODIFIED="2016-06-20 14:50:05 +1200" MODIFIED_BY="Clare Dooley" NAME="Hreinsson 2004" YEAR="2004">
<REFERENCE MODIFIED="2016-06-20 14:50:05 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hreinsson J, Rosenlund B, Fridstrom M, Ek I, Levkov L, Sjoblom P, et al</AU>
<TI>Embryo transfer is equally effective at cleavage stage and blastocyst stage: a randomized prospective study</TI>
<SO>European Journal of Obstetrics, Gynecology and Reproductive Biology</SO>
<YR>2004</YR>
<VL>117</VL>
<PG>194-200</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204655"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204654"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karaki-2002" MODIFIED="2016-06-20 14:51:48 +1200" MODIFIED_BY="Clare Dooley" NAME="Karaki 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-06-20 14:51:48 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Karaki RZ, Samarraie SS, Younis NA, Lahloub TM, Ibrahim MH</AU>
<TI>Blastocyst culture and transfer: a step toward improved in vitro fertilization outcome</TI>
<SO>Fertility and Sterility</SO>
<YR>2002</YR>
<VL>77</VL>
<NO>1</NO>
<PG>114-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204657"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204656"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaur-2014" MODIFIED="2016-06-20 14:54:41 +1200" MODIFIED_BY="Clare Dooley" NAME="Kaur 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-06-20 14:51:13 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kaur P, Swarankar ML, Maheshwari M, Acharya V</AU>
<TI>A comparative study between cleavage stage embryo transfer at day 3 and blastocyst stage transfer at day 5 in in-vitro fertilization/intra-cytoplasmic sperm injection on clinical pregnancy rates</TI>
<SO>Journal of Human Reproductive Sciences</SO>
<YR>2014</YR>
<VL>7</VL>
<NO>3</NO>
<PG>194-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204659"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-06-20 14:54:41 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaur P, Swarankar ML, Maheshwari M, Sharma S</AU>
<TI>Implantation rates after two and five days of embryo culture: A comparative study</TI>
<SO>JK Science</SO>
<YR>2013</YR>
<VL>15</VL>
<NO>4</NO>
<PG>185-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204660"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204658"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kolibianakis-2004" MODIFIED="2012-06-09 20:26:17 +1200" MODIFIED_BY="[Empty name]" NAME="Kolibianakis 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-06-09 20:26:17 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kolibianakis EM, Zilopoulos K, Verpoest W, Camus M, Joris H, Van Steirteghem AC, et al</AU>
<TI>Should we advise patients undergoing in-vitro fertilization to start a cycle leading to a day 3 or day 5 transfer?</TI>
<SO>Human Reproduction</SO>
<YR>2004</YR>
<VL>19</VL>
<PG>2550-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204662"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204661"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Levitas-2004" MODIFIED="2016-06-20 15:25:35 +1200" MODIFIED_BY="Clare Dooley" NAME="Levitas 2004" YEAR="2004">
<REFERENCE MODIFIED="2016-06-20 14:56:48 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Levitas E, Lunenfeld E, Hackmon Ram R, Sonin Y, Har Vardi I, Potashnik G</AU>
<TI>A prospective, randomized study comparing blastocyst stage versus 48-72 hr embryo transfer in women failed to conceive three or more in-vitro fertilization treatment cycles</TI>
<SO>Fertility and Sterility</SO>
<YR>2001</YR>
<VL>Suppl 1</VL>
<NO>3</NO>
<PG>118</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204664"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-06-20 15:14:46 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Levitas E, Lunenfeld E, Hackmon-Ram R, Sonin Y, Har-Vardi I, Potashnik G</AU>
<TI>A prospective, randomized study comparing blastocyst versus 48-72 h embryo transfer in women failed to conceive three or more in-vitro fertilization treatment cycles</TI>
<SO>Proceedings of the 57th Annual Meeting of the American Society for Reproductive Medicine; 2001 Oct 22-24; Orlando (FL)</SO>
<YR>2001</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204665"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-06-09 20:26:44 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Levitas E, Lunenfeld E, Har-Vardi I, Albotiano S, Sonin Y, Hackmon-Ram R, et al</AU>
<TI>Blastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2-3 embryo transfer cycles: a prospective, randomized study</TI>
<SO>Fertility and Sterility</SO>
<YR>2004</YR>
<VL>81</VL>
<NO>3</NO>
<PG>567-71</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204666"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-06-20 15:25:35 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Levitas E, Lunenfeld E, Shoham-Vardi I, Hackmon-Ram R, Albotiano S, Sonin Y, et al</AU>
<TI>Blastocyst stage versus 48-72 h embryo transfer in women who failed to conceive on three or more IVF treatment cycles: a prospective, randomized study</TI>
<SO>Proceedings of the 16th Annual Meeting of the European Society of Human Reproduction and Embryology; 2000 June 25-28; Bologna</SO>
<YR>2000</YR>
<PG>O-021</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204667"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204663"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Levron-2002" NAME="Levron 2002" YEAR="2002">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Levron J, Shulman A, Bider D, Seidman D, Levin T, Dor J</AU>
<TI>A prospective randomized study comparing day 3 with blastocyst-stage embryo transfer</TI>
<SO>Fertility and Sterility</SO>
<YR>2002</YR>
<VL>77</VL>
<PG>1300-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204669"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204668"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Livingstone-2002" MODIFIED="2016-06-20 15:27:11 +1200" MODIFIED_BY="Clare Dooley" NAME="Livingstone 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-06-20 15:27:11 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Livingstone M, Bowman M</AU>
<TI>Single blastocyst transfer: a prospective randomised trial</TI>
<SO>Proceedings of the 17th World Congress on Fertility and Sterility</SO>
<YR>2001</YR>
<PG>218</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204671"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204670"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Motta-1998" MODIFIED="2016-06-20 15:27:31 +1200" MODIFIED_BY="Clare Dooley" NAME="Motta 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-06-20 15:27:31 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Motta LA, Alegretti JR, Pico M, Sousa JW, Baracat EC, Serafini P</AU>
<TI>Blastocyst vs. cleaving embryo transfer: a prospective randomized trial</TI>
<SO>Fertility and Sterility</SO>
<YR>1998</YR>
<VL>70</VL>
<NO>Suppl 1</NO>
<PG>17</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204673"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204672"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pantos-2004" MODIFIED="2016-05-06 15:20:58 +1200" MODIFIED_BY="[Empty name]" NAME="Pantos 2004" YEAR="2004">
<REFERENCE MODIFIED="2016-05-06 15:20:58 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pantos K, Makrakis E, Stavrou D, Karantzis P, Vaxevanoglou T, Tzigounis V</AU>
<TI>Comparison of embryo transfer on day 2, day 3, and day 6: a prospective randomized study</TI>
<SO>Fertility and Sterility</SO>
<YR>2004</YR>
<VL>81</VL>
<NO>2</NO>
<PG>454-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204675"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204674"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Papanikolaou-2005" MODIFIED="2016-06-20 15:28:42 +1200" MODIFIED_BY="Clare Dooley" NAME="Papanikolaou 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-06-20 15:28:23 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="OTHER">
<AU>Papanikolaou EG Sr, Verheyen G, Camus M, Van Steirteghem A, Devroey P, Tournaye H</AU>
<TI>Ongoing pregnancy rate is significantly higher with day 5 embryo transfer than after day 3 embryo transfer, when more than three embryos are available on the third day of embryo culture</TI>
<SO>Fertility and Sterility</SO>
<YR>2005</YR>
<NO>1</NO>
<PG>s51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204677"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-06-20 15:28:42 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Papanikolaou EG, D'haeseleer E, Verheycn G, Van de Velde H, Camus M, Van Steirteghem A, et al</AU>
<TI>Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage transfer when at least four embryos are available on day 3 of culture. A randomized prospective study</TI>
<SO>Human Reproduction</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>11</NO>
<PG>3198-203</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204678"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204676"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Papanikolaou-2006" MODIFIED="2016-06-20 15:30:47 +1200" MODIFIED_BY="Clare Dooley" NAME="Papanikolaou 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-05-06 15:09:59 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Papanikolaou EG, Camus M, Kolibianakis EM, Landuyt LV, Steirteghem AV, Devroey P</AU>
<TI>In vitro fertilization with single blastocyst-stage versus cleavage-stage embryos</TI>
<SO>The New England Journal of Medicine</SO>
<YR>2006</YR>
<VL>354</VL>
<PG>1139-46</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204681"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-06-20 15:30:47 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Papanikolaou EG, Camus M, Kolibianakis EM, Turki H, Van Landuyt L, Van Steirteghem A, et al</AU>
<TI>Single embryo transfer: comparison of cleavage stage embryo transfer with blastocyst stage embryo transfer. A randomized prospective study</TI>
<SO>Proceedings of the 21st Annual Meeting of the European Society of Human Reproduction and Embryology; 2005 June 19-22; Copenhagen</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204680"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204679"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rienzi-2002" MODIFIED="2016-06-23 10:57:44 +1200" MODIFIED_BY="Clare Dooley" NAME="Rienzi 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-06-23 10:57:44 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rienzi l, Ubaldi F, Lacobelli M, Ferrero S, Minasi MG, Martinez F, et al</AU>
<TI>Day 3 embryo transfer with combined evaluation at the pronuclear and cleavage stages compares favourably with day 5 blastocyst transfer</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<PG>1852-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204683"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204682"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schillaci-2002" MODIFIED="2016-06-20 15:36:16 +1200" MODIFIED_BY="Clare Dooley" NAME="Schillaci 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-06-20 15:36:16 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Schillaci R, Castelli A, Vassiliadis A, Venezia R, Sciacca GM, Perino A, et al</AU>
<TI>Blastocyst stage versus versus day 2 embryo transfer in IVF cycles</TI>
<SO>Abstracts of the 18th Annual Meeting of the European Society of Human Reproduction and Embryology; 2002 June 30-July 3; Vienna</SO>
<YR>2002</YR>
<PG>P-418</PG>
<CY>Vienna</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204685"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204684"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ten-2011" MODIFIED="2016-06-20 15:37:59 +1200" MODIFIED_BY="Clare Dooley" NAME="Ten 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-06-20 15:37:59 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Ten J, Carracedo MA, Guerrero J, Rodriguez-Arnedo A, Llacer J, Bernabeu R</AU>
<TI>Day 3 or day 5 embryo transfer?: A randomized prospective study</TI>
<SO>Human Reproduction</SO>
<YR>2011</YR>
<VL>Proceedings of the 27th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE); 2011 July 3-6; Stockholm</VL>
<PG>i165</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204687"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204686"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-der-Auwera-2002" MODIFIED="2012-06-09 20:28:48 +1200" MODIFIED_BY="[Empty name]" NAME="Van der Auwera 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-06-09 20:28:48 +1200" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Van der Auwera I, Debrock S, Spiessens C, Afschrift H, Bakelants E, Meuleman C, et al</AU>
<TI>A prospective randomized study: day 2 versus day 5 embryo transfer</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<PG>1507-12</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204689"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204688"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2016-06-29 16:48:27 +1200" MODIFIED_BY="Helen E Nagels">
<STUDY DATA_SOURCE="PUB" ID="STD-Bungum-2002" MODIFIED="2016-06-24 16:28:24 +1200" MODIFIED_BY="Helen E Nagels" NAME="Bungum 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-06-24 16:28:24 +1200" MODIFIED_BY="Helen E Nagels" PRIMARY="NO" TYPE="OTHER">
<AU>Bungum L, Bungum M, Humaiden P</AU>
<TI>Blastocyst stage transfer is not better than embryo transfer on day 3: A prospective randomized study</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<NO>Suppl 1</NO>
<PG>53</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204691"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204690"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guerin-1991" MODIFIED="2016-06-20 15:43:13 +1200" MODIFIED_BY="Clare Dooley" NAME="Guerin 1991" YEAR="1991">
<REFERENCE MODIFIED="2016-06-20 15:43:13 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guerin JF, Mathieu C, Pinatel MC, Reginier-Vigouroux G, Lornage J, Boulieu D, et al</AU>
<TI>Coculture of human embryos with monkey kidney epithelial cells: clinical data concerning transfers delayed at D3 and D5</TI>
<SO>Contraception, Fertilite, Sexualite</SO>
<YR>1991</YR>
<VL>19</VL>
<NO>7-8</NO>
<PG>635-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204693"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204692"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Levron-2001" MODIFIED="2016-05-06 15:20:58 +1200" MODIFIED_BY="[Empty name]" NAME="Levron 2001" YEAR="2001">
<REFERENCE MODIFIED="2016-05-06 15:20:58 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Levron J, Bider D, Shulman A, Rabinovichi Y, Seidman D, Dor J</AU>
<TI>A randomized prospective study on blastocyst versus day 2-3 embryo transfer</TI>
<SO>Fertility and Sterility</SO>
<YR>2001</YR>
<VL>Suppl 1</VL>
<NO>3</NO>
<PG>4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204695"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204694"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Loup-2009" MODIFIED="2016-05-06 15:20:58 +1200" MODIFIED_BY="[Empty name]" NAME="Loup 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-05-06 15:20:58 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Loup V, Anahory T, Reyftmann L, Dechaud H, Hedon B, Hamamah S</AU>
<TI>Efficiency of consecutive embryos transfer on day 3 and day 5 than replacement of 2 embryos on day 3 for women over 37 years: Prospective study</TI>
<SO>Molecular Human Reproduction</SO>
<YR>2009</YR>
<VL>24</VL>
<PG>i139</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204697"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204696"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Menezo-1992" MODIFIED="2012-06-13 15:14:52 +1200" MODIFIED_BY="[Empty name]" NAME="Menezo 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-06-13 15:14:52 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Menezo Y, Hazout A, Dumont M, Herbaut N, Nicollet B</AU>
<TI>Coculture of embryos on Vero cells and transfer of blastocysts in humans</TI>
<SO>Human Reproduction</SO>
<YR>1992</YR>
<VL>7</VL>
<NO>Suppl 1</NO>
<PG>101-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204699"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204698"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Utsonomiya-2004a" MODIFIED="2012-05-25 16:31:08 +1200" MODIFIED_BY="[Empty name]" NAME="Utsonomiya 2004a" YEAR="2004">
<REFERENCE MODIFIED="2012-05-25 16:31:08 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Utsunomiya T, Ito H, Nagaki M, Sato J</AU>
<TI>A prospective, randomised study: day 3 versus hatching blastocyst stage</TI>
<SO>Human Reproduction</SO>
<YR>2004</YR>
<VL>19</VL>
<PG>1598-1603</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204701"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-02-15 17:48:58 +1300" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204700"/><IDENTIFIER MODIFIED="2012-02-15 17:48:50 +1300" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/><IDENTIFIER MODIFIED="2012-02-15 17:48:58 +1300" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vanderzwalmen-2006" MODIFIED="2016-06-29 16:48:15 +1200" MODIFIED_BY="Helen E Nagels" NAME="Vanderzwalmen 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-06-29 16:48:15 +1200" MODIFIED_BY="Helen E Nagels" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vanderzwalmen P, Lejeune B, Puissant F, Vanderzwalmen S, Zech H, Zintz M, et al</AU>
<TI>A prospective evaluation of the optimal time for selecting a single embryo for transfer: day 3 vs. day 5</TI>
<SO>Human Reproduction</SO>
<YR>2006</YR>
<VL>Suppl</VL>
<PG>i80-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204703"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204702"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zech-2007" MODIFIED="2016-06-29 16:48:27 +1200" MODIFIED_BY="Helen E Nagels" NAME="Zech 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-06-27 18:39:43 +1200" MODIFIED_BY="Helen E Nagels" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zech NH, Lejeune B, Puissant F, Vanderzwalmen S, Zech H, Vanderzwalmen P</AU>
<TI>Prospective evaluation of the optimal time for selecting a single embryo for transfer: day 3 versus day 5</TI>
<SO>Fertility and Sterility</SO>
<YR>2007</YR>
<VL>88</VL>
<NO>1</NO>
<PG>244-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3204705"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3204704"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2012-05-25 11:56:57 +1200" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2016-06-20 15:56:19 +1200" MODIFIED_BY="Clare Dooley">
<STUDY DATA_SOURCE="PUB" ID="STD-ChiCTR_x002d_ICR_x002d_15006184" MODIFIED="2016-06-20 15:54:50 +1200" MODIFIED_BY="Clare Dooley" NAME="ChiCTR-ICR-15006184" YEAR="">
<REFERENCE MODIFIED="2016-06-20 15:54:50 +1200" MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="OTHER">
<AU>ChiCTR-ICR-15006184</AU>
<TI>Cumulative live birth rates compared blastocyst with cleavage-stage transfer: a prospective randomised, multi-center, open-label study</TI>
<SO>www.chictr.org.cn/showprojen.aspx?proj=10698</SO>
<YR>(accessed 12 May 2012)</YR>
<IDENTIFIERS MODIFIED="2016-05-13 02:22:55 +1200" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4300414"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2016-05-13 02:22:20 +1200" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4300413"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01107002" MODIFIED="2016-06-20 15:55:44 +1200" MODIFIED_BY="Clare Dooley" NAME="NCT01107002" YEAR="">
<REFERENCE MODIFIED="2016-06-20 15:55:44 +1200" MODIFIED_BY="Clare Dooley" NOTES="&lt;p&gt;Completed&lt;br&gt;No Results Available&lt;br&gt;Participants: 200 with infertility (Two previous or more failed IVF/ICSI cycles)&lt;br&gt;Ages Eligible for Study: 18 Years to 40 Years&lt;br&gt;Sponsor: Royan Institute&lt;br&gt;Study design: Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Single Blind (Outcomes Assessor)&lt;br&gt;Study completion: August 2010&lt;br&gt;Outcome measures: Clinical Pregnancy rate; Live birth rate; Implantation rate; Miscarriage rate&lt;/p&gt;" NOTES_MODIFIED="2016-06-20 15:55:44 +1200" NOTES_MODIFIED_BY="Clare Dooley" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01107002</AU>
<TI>Comparison of 5 day embryo transfer with 2-3 day transfer in patients with previous in vitro fertilization failure</TI>
<SO>clinicaltrials.gov/ct2/show/NCT01107002</SO>
<YR>(accessed 12 May 2016)</YR>
<IDENTIFIERS MODIFIED="2016-05-13 10:15:30 +1200" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4300416"/><IDENTIFIER MODIFIED="2016-05-13 10:15:30 +1200" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4300415"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02639000" MODIFIED="2016-06-20 15:56:19 +1200" MODIFIED_BY="Clare Dooley" NAME="NCT02639000" YEAR="">
<REFERENCE MODIFIED="2016-06-20 15:56:19 +1200" MODIFIED_BY="Clare Dooley" NOTES="&lt;p&gt;No Results Available&lt;br&gt;Age:18 Years to 37 Years&lt;br&gt;Participants: 388 infertility (IVF with at least 4 fertilized eggs)&lt;br&gt;Sponsor: Istituto Clinico Humanitas&lt;br&gt;Sudy design: Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label&lt;br&gt;Estimated study completion: April 2016 (still recruiting)&lt;br&gt;Outcome measures: Pregnancy rate; Multiple pregnancy rate; Implantation rate&lt;/p&gt;" NOTES_MODIFIED="2016-06-20 15:56:19 +1200" NOTES_MODIFIED_BY="Clare Dooley" PRIMARY="YES" TYPE="OTHER">
<AU>NCT02639000</AU>
<TI>Effects of blastocyst stage compared with cleavage stage embryo transfer in women below 39 years</TI>
<SO>clinicaltrials.gov/show/NCT02639000</SO>
<YR>(accessed 12 May 2016)</YR>
<IDENTIFIERS MODIFIED="2016-05-13 10:12:55 +1200" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4300418"/><IDENTIFIER MODIFIED="2016-05-13 10:12:55 +1200" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4300417"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2016-06-30 10:45:57 +1200" MODIFIED_BY="Helen E Nagels">
<ADDITIONAL_REFERENCES MODIFIED="2016-06-30 10:45:57 +1200" MODIFIED_BY="Helen E Nagels">
<REFERENCE ID="REF-Armstrong-2015" MODIFIED="2016-06-17 10:52:36 +1200" MODIFIED_BY="[Empty name]" NAME="Armstrong 2015" TYPE="COCHRANE_REVIEW">
<AU>Armstrong S, Arroll N, Cree LM, Jordan V, Farquhar C</AU>
<TI>Time-lapse systems for embryo incubation and assessment in assisted reproduction</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2015</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2016-06-17 10:52:36 +1200" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-06-17 10:52:36 +1200" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD011320.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Baart-2006" MODIFIED="2016-06-20 15:57:37 +1200" MODIFIED_BY="Clare Dooley" NAME="Baart 2006" TYPE="JOURNAL_ARTICLE">
<AU>Baart EB, Martini E, van den Berg I, Macklon NS, Galjaard RJ, Fauser BC, et al</AU>
<TI>Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF</TI>
<SO>Human Reproduction</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>1</NO>
<PG>223-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Begg-1996" MODIFIED="2012-06-09 20:37:02 +1200" MODIFIED_BY="Julie A Brown" NAME="Begg 1996" TYPE="JOURNAL_ARTICLE">
<AU>Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al</AU>
<TI>Improving the quality of reporting of randomized controlled trials: The CONSORT statement</TI>
<SO>JAMA</SO>
<YR>1996</YR>
<VL>276</VL>
<PG>637-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Behr-2000" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Behr 2000" TYPE="JOURNAL_ARTICLE">
<AU>Behr B, Fisch JD, Racowsky C, Miller K, Pool TB, Milki AA</AU>
<TI>Blastocyst-ET and monozygotic twinning</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>2000</YR>
<VL>17</VL>
<NO>6</NO>
<PG>349-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Borg-2000" MODIFIED="2016-06-20 15:58:37 +1200" MODIFIED_BY="Clare Dooley" NAME="Borg 2000" TYPE="CONFERENCE_PROC">
<AU>Borg K, Moller A, Hammar M, Blake D, Hillensjo T, Wikland M</AU>
<TI>Blastocyst culture - more or less stressful for patients?</TI>
<SO>Abstract Book European Society of Human Reproduction and Enbryology (ESHRE)</SO>
<YR>2000</YR>
<PG>48</PG>
<CY>Bologna</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Braude-1998" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Braude 1998" TYPE="JOURNAL_ARTICLE">
<AU>Braude P, Bolton V, Moore S</AU>
<TI>Human gene expression first occurs between the four and eight-cell stages of preimplantation development</TI>
<SO>Nature</SO>
<YR>1988</YR>
<VL>332</VL>
<PG>459-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-1990" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Cohen 1990" TYPE="JOURNAL_ARTICLE">
<AU>Cohen J, Elsner C, Kort HMH</AU>
<TI>Impairment of hatching process following IVF in the human and improvement of implanation by assisted hatching using micromanipulation</TI>
<SO>Human Reproduction</SO>
<YR>1990</YR>
<VL>5</VL>
<PG>7-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Croxatto-1972" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Croxatto 1972" TYPE="JOURNAL_ARTICLE">
<AU>Croxatto HB, Fuentaealba B, Diaz S, Pastene L, Tatum HJ</AU>
<TI>A simple non-surgical technique to obtain unimplanted eggs from human uteri</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1972</YR>
<VL>112</VL>
<NO>5</NO>
<PG>662-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-De-Felici-1982" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="De Felici 1982" TYPE="JOURNAL_ARTICLE">
<AU>De Felici M, Siracusa G</AU>
<TI>Spontaneous hardening of the zona pellucida of mouse oocytes during in vitro culture</TI>
<SO>Gamete Research</SO>
<YR>1982</YR>
<VL>6</VL>
<PG>107-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-De-Placido-2002" MODIFIED="2012-06-09 20:38:31 +1200" MODIFIED_BY="[Empty name]" NAME="De Placido 2002" TYPE="JOURNAL_ARTICLE">
<AU>De Placido G, Wilding M, Strina I, Alviggi E, Alviggi C, Mollo A, et al</AU>
<TI>High outcome predictability after IVF using a combined score for zygote and embryo morphology and growth rate</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<NO>9</NO>
<PG>2402-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Edgar-2012" MODIFIED="2016-05-06 15:13:48 +1200" MODIFIED_BY="[Empty name]" NAME="Edgar 2012" TYPE="JOURNAL_ARTICLE">
<AU>Edgar DH, Gook DA</AU>
<TI>A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos</TI>
<SO>Human Reproduction Update</SO>
<YR>2012</YR>
<VL>18</VL>
<NO>5</NO>
<PG>536-54</PG>
<IDENTIFIERS MODIFIED="2012-05-25 16:48:19 +1200" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2012-05-25 16:48:19 +1200" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1093"/><IDENTIFIER TYPE="PUBMED" VALUE="22537859"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Edwards-1995" MODIFIED="2016-06-20 15:59:40 +1200" MODIFIED_BY="Clare Dooley" NAME="Edwards 1995" TYPE="BOOK_SECTION">
<AU>Edwards RG, Brody SA</AU>
<TI>History and ethics of assisted human conception</TI>
<SO>Principles and Practice of Assisted Human Reproduction</SO>
<YR>1995</YR>
<PG>17-47</PG>
<PB>WB Sauders</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fanchin-2001" MODIFIED="2016-06-20 16:00:33 +1200" MODIFIED_BY="Clare Dooley" NAME="Fanchin 2001" TYPE="JOURNAL_ARTICLE">
<AU>Fanchin R, Ayoubi JM, Righini C, Olivennes F, Schönauer LM, Frydman R</AU>
<TI>Uterine contractility decreases at the time of blastocyst transfers</TI>
<SO>Human Reproduction</SO>
<YR>2001</YR>
<VL>16</VL>
<NO>6</NO>
<PG>1115-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gardner-1996" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Gardner 1996" TYPE="JOURNAL_ARTICLE">
<AU>Gardner DK, Lane M, Calderon I, Leeton J</AU>
<TI>Environment of the preimplantation human embryo in vivo: metabolite analysis of oviduct and uterine fluids and metabolism of cumulus cell</TI>
<SO>Fertility and Sterility</SO>
<YR>1996</YR>
<VL>65</VL>
<NO>2</NO>
<PG>349-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gardner-1998b" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Gardner 1998b" TYPE="JOURNAL_ARTICLE">
<AU>Gardner DK, Vella P, Lane M, Wagley L, Schlenker T, Schoolcraft WB</AU>
<TI>Culture and transfer of human blastocyts increases implantation rates and reduces the need for multiple embryo transfers</TI>
<SO>Fertility and Sterility</SO>
<YR>1998</YR>
<VL>69</VL>
<NO>1</NO>
<PG>84-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gardner-2003" MODIFIED="2016-06-17 10:36:47 +1200" MODIFIED_BY="[Empty name]" NAME="Gardner 2003" TYPE="JOURNAL_ARTICLE">
<AU>Gardner DK, Lane M, Stevens J, Schoolcraft WB</AU>
<TI>Changing the start temperature and cooling rate in a slow-freezing protocol increases human blastocyst viability</TI>
<SO>Fertility and Sterility</SO>
<YR>2003</YR>
<VL>79</VL>
<PG>407-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gardner-2004" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Gardner 2004" TYPE="JOURNAL_ARTICLE">
<AU>Gardner DK, Surry E, Minjarez D, Leitz A, Stevens J, Schoolcraft WB</AU>
<TI>Single blastocyst transfer a prospective randomised trial</TI>
<SO>Fertility and Sterility</SO>
<YR>2004</YR>
<VL>81</VL>
<PG>551-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GRADEpro" MODIFIED="2016-06-30 10:45:57 +1200" MODIFIED_BY="Helen E Nagels" NAME="GRADEpro" TYPE="COMPUTER_PROGRAM">
<AU>Computer program on www.gradepro.org. Version 30 May 2016</AU>
<TI>GRADEpro</TI>
<YR>2014</YR>
<PB>McMaster University</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Griesinger-2016" MODIFIED="2016-06-17 10:39:52 +1200" MODIFIED_BY="[Empty name]" NAME="Griesinger 2016" TYPE="JOURNAL_ARTICLE">
<AU>Greisinger G</AU>
<TI>Beware of the implantation rate</TI>
<SO>Human Reproducton</SO>
<YR>2016</YR>
<VL>31</VL>
<NO>2</NO>
<PG>249-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hamberger-2005" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Hamberger 2005" TYPE="JOURNAL_ARTICLE">
<AU>Hamberger L, Hardarson T, Nygren KG</AU>
<TI>Avoidance of multiple pregnancy by use of single embryo transfer</TI>
<SO>Minerva Ginecologica</SO>
<YR>2005</YR>
<VL>57</VL>
<PG>15-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2016-06-20 16:01:49 +1200" MODIFIED_BY="Clare Dooley" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Iwayama-2011" MODIFIED="2012-06-09 20:41:12 +1200" MODIFIED_BY="[Empty name]" NAME="Iwayama 2011" TYPE="JOURNAL_ARTICLE">
<AU>Iwayama H, Hochi S, Yamashita M</AU>
<TI>In vitro and in vivo viability of human blastocysts collapsed by laser pulse or osmotic shock prior to vitrification</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>2011</YR>
<VL>28</VL>
<NO>4</NO>
<PG>355-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jain-2004" MODIFIED="2012-06-09 20:41:49 +1200" MODIFIED_BY="Julie A Brown" NAME="Jain 2004" TYPE="JOURNAL_ARTICLE">
<AU>Jain JK, Boostanfar R, Slater CC, Francis MM, Paulson RJ</AU>
<TI>Monozygotic twins and triplets in association with blastocyst transfer</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>2004</YR>
<VL>21</VL>
<NO>4</NO>
<PG>103-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jones-1999" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Jones 1999" TYPE="JOURNAL_ARTICLE">
<AU>Jones GM, Trounson AO</AU>
<TI>The benefits of extended culture</TI>
<SO>Human Reproduction</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>6</NO>
<PG>1405-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jones-2008" MODIFIED="2016-06-20 16:03:09 +1200" MODIFIED_BY="Clare Dooley" NAME="Jones 2008" TYPE="JOURNAL_ARTICLE">
<AU>Jones GM, Cram DS, Song B, Kokkali G, Pantos K, Trounson AO</AU>
<TI>Novel strategy with potential to identify developmentally competent IVF blastocysts</TI>
<SO>Human Reproduction</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>8</NO>
<PG>1748-59</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Laverge-2001" MODIFIED="2012-06-09 20:43:07 +1200" MODIFIED_BY="[Empty name]" NAME="Laverge 2001" TYPE="JOURNAL_ARTICLE">
<AU>Laverge H, De Sutter P, Van der Elst J, Dhont M</AU>
<TI>A prospective, randomized study comparing day 2 and day 3 embryo transfer in human IVF</TI>
<SO>Human Reproduction</SO>
<YR>2001</YR>
<VL>16</VL>
<NO>3</NO>
<PG>476-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Luna-2007" MODIFIED="2012-06-09 20:43:31 +1200" MODIFIED_BY="Julie A Brown" NAME="Luna 2007" TYPE="JOURNAL_ARTICLE">
<AU>Luna M, Duke M, Copperman A, Grunfeld L, Sandler B, Barritt J</AU>
<TI>Blastocyst embryo transfer is associated with a sex-ratio imbalance in favor of male offspring</TI>
<SO>Fertility and Sterility</SO>
<YR>2007</YR>
<VL>87</VL>
<PG>519-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Magli-1998" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Magli 1998" TYPE="JOURNAL_ARTICLE">
<AU>Magli MC, Gianaroli L, Munne S, Ferraretti AP</AU>
<TI>Incidence of chromosomal abnormalities from a morphologically normal cohort of embryos in poor-prognosis patients</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>1998</YR>
<VL>15</VL>
<NO>5</NO>
<PG>297-301</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Magli-2000" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Magli 2000" TYPE="JOURNAL_ARTICLE">
<AU>Magli MC, Jones GM, Gras L, Gianaroli L, Korman I, Trounson A</AU>
<TI>Chromosome mosaicism in day 3 aneuploid embryos that develop to morphologically normal blastocysts in vitro</TI>
<SO>Human Reproduction</SO>
<YR>2000</YR>
<VL>15</VL>
<PG>1781-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maheshwari-2016" MODIFIED="2016-06-17 10:51:51 +1200" MODIFIED_BY="[Empty name]" NAME="Maheshwari 2016" TYPE="JOURNAL_ARTICLE">
<AU>Maheshwari A, Hamilton M, Bhattacharya S</AU>
<TI>Should we be promoting embryo transfer at blastocyst stage?</TI>
<SO>Reproductive BioMedicine Online</SO>
<YR>2016</YR>
<VL>32</VL>
<NO>2</NO>
<PG>142-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marek-1999" MODIFIED="2012-06-09 20:44:10 +1200" MODIFIED_BY="[Empty name]" NAME="Marek 1999" TYPE="JOURNAL_ARTICLE">
<AU>Marek D, Langley M, Gardner DK, Confer N, Doody KM, Doody KJ</AU>
<TI>Introduction of blastocyst culture and transfer for all patients in an in vitro fertilization program</TI>
<SO>Fertility and Sterility</SO>
<YR>1999</YR>
<VL>72</VL>
<NO>6</NO>
<PG>1035-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marston-1977" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Marston 1977" TYPE="JOURNAL_ARTICLE">
<AU>Marston JH, Penn R, Sivelle PC</AU>
<TI>Successful autotransfer of tubal eggs in the rhesus monkey (Macaca mulatta)</TI>
<SO>Journal of Reproduction and Fertility</SO>
<YR>1977</YR>
<VL>49</VL>
<PG>175-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Menezo-1990" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Menezo 1990" TYPE="JOURNAL_ARTICLE">
<AU>Menezo YJ, Guerin JF, Czyba JC</AU>
<TI>Improvement of human embryo development in vitro by coculture on monolayers of Vero cells</TI>
<SO>Biology of Reproduction</SO>
<YR>1990</YR>
<VL>42</VL>
<NO>2</NO>
<PG>301-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Menezo-1999" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Menezo 1999" TYPE="JOURNAL_ARTICLE">
<AU>Menezo YJ, Chouteau J, Torello J, Girard A, Veiga A</AU>
<TI>Birth weight and sex ratio after transfer at the blastocyst stage in humans</TI>
<SO>Fertility and Sterility</SO>
<YR>1999</YR>
<VL>72</VL>
<NO>2</NO>
<PG>221-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Milki-1999" MODIFIED="2012-06-09 20:44:58 +1200" MODIFIED_BY="[Empty name]" NAME="Milki 1999" TYPE="JOURNAL_ARTICLE">
<AU>Milki AA, Fisch JD, Behr B</AU>
<TI>Two-blastocyst transfer has similar pregnancy rates and a decreased multiple gestation rate compared with three-blastocyst transfer</TI>
<SO>Fertility and Sterility</SO>
<YR>1999</YR>
<VL>72</VL>
<NO>2</NO>
<PG>225-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Milki-2004" MODIFIED="2012-06-09 20:45:37 +1200" MODIFIED_BY="Julie A Brown" NAME="Milki 2004" TYPE="JOURNAL_ARTICLE">
<AU>Milki A, Hinckley M, Westphal L, Behr B</AU>
<TI>Elective single blastoyst transfer</TI>
<SO>Fertility and Sterility</SO>
<YR>2004</YR>
<VL>81</VL>
<PG>1697-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moayeri-2007" MODIFIED="2012-06-09 20:48:19 +1200" MODIFIED_BY="Julie A Brown" NAME="Moayeri 2007" TYPE="JOURNAL_ARTICLE">
<AU>Moayeri S, Behr B, Lathi R, Westphal L, Milki A</AU>
<TI>Risk of monozygotic twinning with blastocyst transfer decreases over time: an 8 year experience</TI>
<SO>Fertility and Sterility</SO>
<YR>2007</YR>
<VL>87</VL>
<NO>5</NO>
<PG>1028-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Munne-2002" MODIFIED="2016-06-20 16:04:52 +1200" MODIFIED_BY="Clare Dooley" NAME="Munne 2002" TYPE="JOURNAL_ARTICLE">
<AU>Munne S, Sandalinas M, Escudero T, Marquez C, Cohen J</AU>
<TI>Chromosome mosaicism in cleavage-stage human embryos: evidence of a maternal age effect</TI>
<SO>Reproductive Biomedicine Online</SO>
<YR>2002</YR>
<VL>4</VL>
<NO>3</NO>
<PG>223-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nel_x002d_Themaat-2011" MODIFIED="2012-06-09 20:48:44 +1200" MODIFIED_BY="[Empty name]" NAME="Nel-Themaat 2011" TYPE="JOURNAL_ARTICLE">
<AU>Nel-Themaat L, Nagy ZP</AU>
<TI>A review of the promises and pitfalls of oocyte and embryo metabolomics</TI>
<SO>Placenta</SO>
<YR>2011</YR>
<VL>32</VL>
<NO>3</NO>
<PG>S257-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Palmstierna-1998" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Palmstierna 1998" TYPE="JOURNAL_ARTICLE">
<AU>Palmstierna M, Murkes D, Csemizdy G, Andersson O, Wramsby H</AU>
<TI>Zona pellucida thickness variation and occurrence of visible mononucleated blastomeres in preembryos are associated with a high pregnancy rate in IVF treatments</TI>
<SO>Journal of Assisted Reproduction and Genetics</SO>
<YR>1998</YR>
<VL>15</VL>
<NO>2</NO>
<PG>70-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Papanikolaou-2008" MODIFIED="2016-06-20 16:05:15 +1200" MODIFIED_BY="Clare Dooley" NAME="Papanikolaou 2008" TYPE="JOURNAL_ARTICLE">
<AU>Papanikolaou EG, Kolibianakis EM, Tournaye H, Venetis CA, Fatemi H, Tarlatzis B, et al</AU>
<TI>Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis</TI>
<SO>Human Reproduction</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>1</NO>
<PG>91-9</PG>
<IDENTIFIERS MODIFIED="2016-05-05 02:21:34 +1200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="17965420"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Plachot-1999" MODIFIED="2016-06-20 16:05:59 +1200" MODIFIED_BY="Clare Dooley" NAME="Plachot 1999" TYPE="CONFERENCE_PROC">
<AU>Plachot M, Mayenga JM, Chouraqui A, Tesquier L, Serkine AM, Belaisch-Allart J</AU>
<TI>A prospective semi-randomized study of blastocyst transfer in an IVF programme</TI>
<SO>Proceedings of the European Society for Human Reproduction and Embryology (ESHRE) Conference</SO>
<YR>1999</YR>
<PG>215</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Puissant-1987" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Puissant 1987" TYPE="JOURNAL_ARTICLE">
<AU>Puissant F, Van Rysselberge M, Barlow P, Deweze J, Leroy F</AU>
<TI>Embryo scoring as a prognostic tool in IVF treatment</TI>
<SO>Human Reproduction</SO>
<YR>1987</YR>
<VL>2</VL>
<NO>8</NO>
<PG>705-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2016-06-21 09:26:46 +1200" MODIFIED_BY="Clare Dooley" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Richter-2016" MODIFIED="2016-06-17 10:51:04 +1200" MODIFIED_BY="[Empty name]" NAME="Richter 2016" TYPE="OTHER">
<AU>Richter KS, Schuff M, Murtinger M, Vanderzwalmen P</AU>
<TI>Pregnancy and birth outcomes following fresh or vitrified embryo transfer according to blastocyst morphology and expansion stage, and culturing strategy for delayed development</TI>
<SO>Human Reproduction</SO>
<YR>2016 Jun 6 [Epub ahead of print]</YR>
<IDENTIFIERS MODIFIED="2016-06-12 10:05:10 +1200" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-06-12 10:05:10 +1200" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="10.1093/humrep/dew127"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Roque-2015" MODIFIED="2016-06-20 16:07:29 +1200" MODIFIED_BY="Clare Dooley" NAME="Roque 2015" TYPE="JOURNAL_ARTICLE">
<AU>Roque M, Valle M, Guimaraes F, Sampaio M, Geber S</AU>
<TI>Freeze-all policy: fresh vs. frozen-thawed embryo policy</TI>
<SO>Fertility and Sterility</SO>
<YR>2015</YR>
<VL>103</VL>
<NO>5</NO>
<PG>1190-3</PG>
<IDENTIFIERS MODIFIED="2016-06-12 10:14:58 +1200" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-06-12 10:14:58 +1200" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="doi: 10.1016/j.fertnstert.2015.01.045. Epub 2015 Mar 4."/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Roseboom-1995" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Roseboom 1995" TYPE="JOURNAL_ARTICLE">
<AU>Roseboom TJ, Vermeiden JP, Schoute E, Lens JW, Schats R</AU>
<TI>The probability of pregnancy after embryo transfer is affected by the age of the patient, cause of infertility, number of embryos transferred and the average morphology score, as revealed by multiple logistic regression analysis</TI>
<SO>Human Reproduction</SO>
<YR>1995</YR>
<VL>10</VL>
<NO>11</NO>
<PG>3035-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Scholtes-1996" MODIFIED="2012-06-09 20:49:53 +1200" MODIFIED_BY="[Empty name]" NAME="Scholtes 1996" TYPE="JOURNAL_ARTICLE">
<AU>Scholtes MC, Zeilmaker GH</AU>
<TI>A prospective, randomized study of embryo transfer results after 3 or 5 days of embryo culture in in vitro fertilization</TI>
<SO>Fertility and Sterility</SO>
<YR>1996</YR>
<VL>65</VL>
<NO>6</NO>
<PG>1245-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schoolcraft-2001" MODIFIED="2012-06-09 20:50:21 +1200" MODIFIED_BY="Julie A Brown" NAME="Schoolcraft 2001" TYPE="JOURNAL_ARTICLE">
<AU>Schoolcraft WB, Gardner DK</AU>
<TI>Blastocyst versus day 2 or 3 transfer</TI>
<SO>Seminars in Reproductive Medicine</SO>
<YR>2001</YR>
<VL>19</VL>
<PG>259-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Scott-2000" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Scott 2000" TYPE="JOURNAL_ARTICLE">
<AU>Scott L, Alvero R, Leondires M, Miller B</AU>
<TI>The morphology of human pronuclear embryos is positively related to blastocyst development and implantation</TI>
<SO>Human Reproduction</SO>
<YR>2000</YR>
<VL>15</VL>
<NO>11</NO>
<PG>2394-403</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sills-2000" MODIFIED="2016-06-20 16:07:55 +1200" MODIFIED_BY="Clare Dooley" NAME="Sills 2000" TYPE="JOURNAL_ARTICLE">
<AU>Sills ES, Tucker MJ, Palermo GD</AU>
<TI>Assisted reproductive technologies and monozygous twins: implications for future study and clinical practice</TI>
<SO>Twin Research</SO>
<YR>2000</YR>
<VL>2</VL>
<PG>217-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sjoblom-2006" MODIFIED="2012-06-09 20:51:05 +1200" MODIFIED_BY="Julie A Brown" NAME="Sjoblom 2006" TYPE="JOURNAL_ARTICLE">
<AU>Sjoblom P, Menzes J, Cummins L, Mathiyalagan B</AU>
<TI>Prediction of embryo developmental potential and pregnancy based on early stage morphological characteristics</TI>
<SO>Fertility and Sterility</SO>
<YR>2006</YR>
<VL>86</VL>
<PG>848-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Staessen-2004" MODIFIED="2016-06-20 16:10:25 +1200" MODIFIED_BY="Clare Dooley" NAME="Staessen 2004" TYPE="JOURNAL_ARTICLE">
<AU>Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M,</AU>
<TI>Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised control trial</TI>
<SO>Human Reproduction</SO>
<YR>2004</YR>
<VL>19</VL>
<NO>12</NO>
<PG>2849-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Steer-1992" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Steer 1992" TYPE="JOURNAL_ARTICLE">
<AU>Steer CV, Mills CL, Tan SL, Campbell S, Edwards RG</AU>
<TI>The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme</TI>
<SO>Human Reproduction</SO>
<YR>1992</YR>
<VL>7</VL>
<NO>1</NO>
<PG>117-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tsirigotis-1998" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Tsirigotis 1998" TYPE="JOURNAL_ARTICLE">
<AU>Tsirgotis M</AU>
<TI>Blastocyst stage transfer: pitfalls and benefits - Too soon to abandon practice?</TI>
<SO>Human Reproduction</SO>
<YR>1998</YR>
<VL>13</VL>
<NO>12</NO>
<PG>3285-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vail-2003" MODIFIED="2016-06-20 16:10:51 +1200" MODIFIED_BY="Clare Dooley" NAME="Vail 2003" TYPE="JOURNAL_ARTICLE">
<AU>Vail A, Gardener E</AU>
<TI>Common statistical errors in the design and analysis of subfertility trials</TI>
<SO>Human Reproduction</SO>
<YR>2003</YR>
<VL>18</VL>
<PG>1000-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Valbuena-2001" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Valbuena 2001" TYPE="JOURNAL_ARTICLE">
<AU>Valbuena D, Martin J, dePablo J, Remohi J, Pellicer A, Simon C</AU>
<TI>Increasing levels of estradiol are deleterious to embryonic implantation because they affect the embryo</TI>
<SO>Fertility and Sterility</SO>
<YR>2001</YR>
<VL>76</VL>
<NO>5</NO>
<PG>962-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Van-Blerkom-1993" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Van Blerkom 1993" TYPE="JOURNAL_ARTICLE">
<AU>Van Blerkom J</AU>
<TI>Development of human embryos to the hatched blastocyst stage in the presence or absence of a monolayer of Vero cells</TI>
<SO>Human Reproduction</SO>
<YR>1993</YR>
<VL>8</VL>
<PG>1525-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wang-2014" MODIFIED="2016-06-20 16:11:14 +1200" MODIFIED_BY="Clare Dooley" NAME="Wang 2014" TYPE="JOURNAL_ARTICLE">
<AU>Wang SS, Sun HX</AU>
<TI>Blastocyst transfer ameliorates live birth rate compared with cleavage-stage embryos transfer in fresh in vitro fertilization or intracytoplasmic sperm injection cycles: reviews and meta-analysis</TI>
<SO>Yonsei Medical Journal</SO>
<YR>2014</YR>
<VL>55</VL>
<NO>3</NO>
<PG>815-25</PG>
<IDENTIFIERS MODIFIED="2016-05-05 02:19:43 +1200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="24719153"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Waters-2006" MODIFIED="2016-06-20 16:12:00 +1200" MODIFIED_BY="Clare Dooley" NAME="Waters 2006" TYPE="BOOK_SECTION">
<AU>Waters A-M, Dean JH and Sullivan EA</AU>
<TI>Assisted reproduction technology in Australia and New Zealand 2003</TI>
<SO>AIHW Cat. No. PER 31 Sydney Assisted Reproduction</SO>
<YR>2006</YR>
<EN>9th</EN>
<PB>AIHW National Perinatal Statistics Unit</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yeung-1992" MODIFIED="2008-05-05 13:11:50 +1200" MODIFIED_BY="Julie A Brown" NAME="Yeung 1992" TYPE="JOURNAL_ARTICLE">
<AU>Yeung WS, Ho PC, Lau EY, Chan ST</AU>
<TI>Improved development of human embryos in vitro by a human oviductal cell co-culture system</TI>
<SO>Human Reproduction</SO>
<YR>1992</YR>
<VL>7</VL>
<PG>1144-9</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2016-06-21 13:19:09 +1200" MODIFIED_BY="Clare Dooley">
<REFERENCE ID="REF-Blake-2000" MODIFIED="2016-06-21 13:13:20 +1200" MODIFIED_BY="Clare Dooley" NAME="Blake 2000" TYPE="COCHRANE_PROTOCOL">
<AU>Blake D, Jones G, Johnson NP, Olive D, Wilson ML</AU>
<TI>Cleavage stage versus blastocyst stage embryo transfer in assisted conception (In vitro fertilisation, Intracytoplasmic sperm injection)</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2016-06-21 13:13:20 +1200" MODIFIED_BY="Clare Dooley"><IDENTIFIER MODIFIED="2016-06-21 13:13:17 +1200" MODIFIED_BY="Clare Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD002118"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Blake-2002" MODIFIED="2016-06-21 13:14:37 +1200" MODIFIED_BY="Clare Dooley" NAME="Blake 2002" TYPE="COCHRANE_REVIEW">
<AU>Blake D, Proctor M, Johnson N, Olive D</AU>
<TI>Cleavage stage versus blastocyst stage embryo transfer in assisted conception</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2016-06-21 13:13:54 +1200" MODIFIED_BY="Clare Dooley"><IDENTIFIER MODIFIED="2016-06-21 13:13:51 +1200" MODIFIED_BY="Clare Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD002118"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Blake-2005" MODIFIED="2016-06-21 13:16:39 +1200" MODIFIED_BY="Clare Dooley" NAME="Blake 2005" TYPE="COCHRANE_REVIEW">
<AU>Blake D, Proctor M, Johnson N, Olive D</AU>
<TI>Cleavage stage versus blastocyst stage embryo transfer in assisted conception</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2016-06-21 13:16:39 +1200" MODIFIED_BY="Clare Dooley"><IDENTIFIER MODIFIED="2016-06-21 13:16:39 +1200" MODIFIED_BY="Clare Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD002118.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Blake-2007" MODIFIED="2016-06-21 13:17:49 +1200" MODIFIED_BY="Clare Dooley" NAME="Blake 2007" TYPE="COCHRANE_REVIEW">
<AU>Blake DA, Farquhar CM, Johnson N, Proctor M</AU>
<TI>Cleavage stage versus blastocyst stage embryo transfer in assisted conception</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2016-06-21 13:17:49 +1200" MODIFIED_BY="Clare Dooley"><IDENTIFIER MODIFIED="2016-06-21 13:17:22 +1200" MODIFIED_BY="Clare Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD002118.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Glujovsky-2012" MODIFIED="2016-06-21 13:19:09 +1200" MODIFIED_BY="Clare Dooley" NAME="Glujovsky 2012" TYPE="COCHRANE_REVIEW">
<AU>Glujovsky D, Blake D, Farquhar C, Bardach A</AU>
<TI>Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2016-06-21 13:19:09 +1200" MODIFIED_BY="Clare Dooley"><IDENTIFIER MODIFIED="2016-06-21 13:18:37 +1200" MODIFIED_BY="Clare Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD002118.pub4"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2016-05-06 04:47:54 +1200" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-06-29 17:00:12 +1200" MODIFIED_BY="Helen E Nagels">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2016-06-29 17:00:12 +1200" MODIFIED_BY="Helen E Nagels" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2016-06-24 14:24:51 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Aziminekoo-2015">
<CHAR_METHODS MODIFIED="2016-06-22 15:24:14 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomised controlled trial in parallel groups at fertilisation day<BR/>
<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 15:24:26 +1200" MODIFIED_BY="Clare Dooley">
<P>Inclusion criteria: Infertile women with at least two previous failures of implantation</P>
<P>Exclusion criteria: Female aged more than 40 years old with severe untreated uterus abnormalities and couples with severe male factor infertility, such as severe oligospermia</P>
<P>Age: BS 34.9 and CS: 35.1</P>
<P>Infertility duration: BS 10.3 years and CS: 8.5</P>
<P>Number of previous IVF: BS 3.7 and CS: 3.1</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 14:24:51 +1200" MODIFIED_BY="Helen E Nagels">
<P>Long protocol (down-regulation with GnRH agonist and stimulation with rFSH)</P>
<P>Injected oocytes were transferred to culture dish with cleavage medium (Sydney IVF cleavage medium, Cook)</P>
<P>In blastocyst group, on day 3, embryos were transferred to blastocyst medium (Sydney IVF blastocyst medium) for 48 h extended culture. Then, the day 5 embryo (blastocyst) were transferred to uterus</P>
<P>All embryo transfers were performed using the Sydney IVF catheter (k-jets-7019-SIVF; Cook IVF)</P>
<P>To support luteal phase, all patients received progesterone suppository</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-05-13 11:22:05 +1200" MODIFIED_BY="[Empty name]">
<P>Clinical pregnancy rate</P>
<P>Cancellation </P>
<P>Multiple pregnancy rate </P>
<P>Miscarriage rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-05-05 13:36:44 +1200" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:15:39 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Brugnon-2010">
<CHAR_METHODS MODIFIED="2016-06-22 15:35:02 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: computer-generated random list</P>
<P>Blinded: no</P>
<P>Size: 52 women for D2 and 55 women for D5-6</P>
<P>Single centre: Clermont Ferrand Université d'Auvergne, Biologie de la reproduction CECOS EA 975, Clermont Ferrand, France</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-24 16:15:30 +1200" MODIFIED_BY="Helen E Nagels">
<P>Criteria: If more than 5 oocytes were retrieved and 3 top quality embryos (4 blastomeres, &lt; 20% fragmentation without multinuclear blastomeres) were observed at day 2, the couples were included in the study. Cause/duration: NA Previous treatment: NA. Fertilisation rate: NA. blast rate: NA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:15:39 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: NS Luteal support: NS Media: Sequential commercial brand Culture method: NS AHA: NS</P>
<P>Freezing method: standard slow cooling method at day 3 (Freeze-kitTM, Vitrolife) and at day 5/6 (G- FreezeKit Blast<SUP>TM</SUP>, Vitrolife)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-16 17:32:03 +1200" MODIFIED_BY="[Empty name]">
<P>Cumulative pregnancy rate</P>
<P>Clinical pregnancy rate per ET</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-24 16:15:26 +1200" MODIFIED_BY="Helen E Nagels"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:15:51 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Bungum-2003">
<CHAR_METHODS MODIFIED="2016-06-22 16:50:28 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: sealed envelope on day 3<BR/>Blinded: no<BR/>Size 118 separate women<BR/>D3: 57 and D5: 61<BR/>No dropouts<BR/>Single centre: Denmark<BR/>Power calculation: Yes retrospective<BR/>Therapeutic<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-23 10:34:23 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: D3 3 or more eight-cell embryos &lt; 20% fragmentation, &lt; 40, BMI &lt; 30, FSH &lt; 12<BR/>Age: D3 31.3 and D5 31.2<BR/>Cause/duration: NS<BR/>Previous treatment: first or second cycle: D3 84% and D5 88%<BR/>ICSI: D3 51% and D5 64%<BR/>(lower blast rate in ICSI than IVF)<BR/>FSH: D3 6.5 and D5 6.5<BR/>#eggs: D3 12.8 ± 4.4<BR/>D5 13.5 ± 5.3<BR/>Fertilisation rate: D3 60.2% and D5 60.7%<BR/>Blast rate: 55.2%<BR/>ET policy: 2 embryos both groups<BR/>#ET: D3 2.0 and D5 1.96<BR/>(2 patients D5 had 1 only due to lack of blasts)<BR/>Pregnancy determination: HCG + US 7 weeks<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:15:50 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: GnRH agonist long + rFSH + HCG 35 hours<BR/>Luteal support: progesterone vaginal<BR/>Media: G1/G2 Vitrolife<BR/>Culture method: microdrops low oxygen incubator<BR/>AHA: NS<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-24 16:15:51 +1200" MODIFIED_BY="Helen E Nagels">
<P>Primary<BR/>a) Live Birth:<BR/>b) pregnancy/OPU/ET/woman:<BR/>c) multiple rate:<BR/>Secondary<BR/>a) Implantation<BR/>b) miscarriage pre-12 weeks<BR/>c) embryo freeze<BR/>d) embryo utilisation<BR/>e) ET rate<BR/>f) high order rate<BR/>g) monozygotic twin<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-22 16:08:17 +1200" MODIFIED_BY="Clare Dooley">
<P>Prognosis: good<BR/>3 or more 8C D3<BR/>Lower blast rate in ICSI than IVF<BR/>Outcome no advantage of blast culture for this selected group<BR/>Letter sent and reply received<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-29 17:00:12 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Coskun-2000">
<CHAR_METHODS MODIFIED="2016-06-22 16:50:34 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: enrolled consecutively sealed envelope until day of fertilisation check<BR/>Blinded: no<BR/>Size: 201 separate women randomised and analysed:<BR/>D3 101 D5 100<BR/>Single centre: Uni clinic in Israel<BR/>Power calculation: NS<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-29 17:00:12 +1200" MODIFIED_BY="Helen E Nagels">
<P>Criteria: 4 or more zygotes<BR/>Age: D3 30.7 and D5 30.4<BR/>Primary/secondary: NS<BR/>Cause/duration - similar except for Unexplained:<BR/>D3 15% and D5 6%<BR/>Previous treatment: NS<BR/>ICSI: D3 67% and D5 64%<BR/>FSH: NS<BR/>Criteria: 4 or more fertilised eggs<BR/>#eggs: NS<BR/>Fertilisation rate: D3 68% and D5 67%<BR/>Blast rate: 28% 197/703 (77% patients had at least 1) (lower in male infertility patients 26%)<BR/>ET policy: 2 for both D3 and D5<BR/>But women with at least 6 attempts had up to 3 embryos transferred<BR/>#ET: D3 2.3 (± 0.6), D5 2.2 (± 0.5)<BR/>Pregnancy determination: HCG + ultrasound<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-29 17:00:08 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: GnRH agonist down-regulation hMG + 36 hour trigger<BR/>Luteal support: progesterone IM<BR/>Media: Sequential medicult to D3 and G1/G2 for D5<BR/>Culture method: NS<BR/>AHA: NS</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 17:17:46 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB (ongoing) per OPU and ET<BR/>b) pregnancy OPU<BR/>b) pregnancy/ET<BR/>c) multiple pregnancy<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage<BR/>c) embryo freeze<BR/>d) embryo utilisation<BR/>e) ET rate<BR/>e) cancellation rate<BR/>f) high order<BR/>g) monozygotic twins<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-12 15:21:31 +1200" MODIFIED_BY="[Empty name]">
<P>Prognosis: good<BR/>4 or more zygotes<BR/>Young women<BR/>Good ET policy<BR/>Mixture of media brands<BR/>Low blast rate<BR/>High implantation rate considering<BR/>No dropouts unusual<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-22 17:17:56 +1200" MODIFIED_BY="Clare Dooley" STUDY_ID="STD-Devreker-2000">
<CHAR_METHODS MODIFIED="2016-06-22 16:50:40 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation:<BR/>"randomly allocated"<BR/>Size: 23 separate women<BR/>D2 12<BR/>D5 11<BR/>Single unit: Uni affiliated<BR/>Belgium<BR/>Power calculation: NS<BR/>Therapeutic<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 16:18:41 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: &lt; 40 years old, &gt; 4 previous cycles<BR/>Age: no difference<BR/>Cause/duration: no difference<BR/>Previous treatment: similar in both groups<BR/>ICSI: NS<BR/>FSH: NS<BR/>#eggs: NS<BR/>Fertilisation rate: NS<BR/>Blast rate: NS<BR/>ET policy: max 3 for both groups<BR/>#ET: D3 2.83 (34/12)<BR/>D5 1.73 (19/11)<BR/>Pregnancy determination: NS<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Ov Stim: NS<BR/>Luteal support: NS<BR/>Media: Sequential commercial brand<BR/>Culture method: NS<BR/>AHA: NS<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 17:17:56 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB<BR/>b) pregnancy/OPU<BR/>b) pregnancy/ET<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage<BR/>c) embryo freeze<BR/>d) embryo utilisation<BR/>e) ET rate<BR/>f) multiple rate<BR/>g) high order rate<BR/>h) monozygotic twin<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Prognosis: poor<BR/>Abstract only<BR/>Letter sent regarding randomisation<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-29 16:59:58 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Elgindy-2011">
<CHAR_METHODS MODIFIED="2016-06-22 16:50:45 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: computer-generated block randomisation</P>
<P>Allocation: identical, sequentially numbered, dark-sealed envelopes<BR/>Size: 200 separate women<BR/>D3 100<BR/>D5 100<BR/>Single unit: Uni affiliated<BR/>Egypt<BR/>Power calculation: 95 women would be required to be able to reject the null hypothesis that the success rates are equal with a probability (power) of 0.8 and type-I error probability of 0.05</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 16:24:38 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: &lt; 35 years old, with regular cycles, serum day-3 FSH concentration &lt; 9.5 IU/L and antral follicle count &gt; 6. At least four good quality embryos on day 3<BR/>Age: no difference<BR/>Duration: no difference<BR/>FSH: NS<BR/>#eggs: NS<BR/>Fertilisation rate: NS<BR/>#ET: D3 2.8<BR/>D5 1.96</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-29 16:59:58 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: long luteal-phase GnRH agonist down-regulation protocol and both recombinant FSH and human menopausal gonadotrophin<BR/>Media: Sequential commercial brand<BR/>Culture method: NS<BR/>AHA: N</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-05-13 11:34:10 +1200" MODIFIED_BY="[Empty name]">
<P>LB</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-29 16:59:54 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Emiliani-2003">
<CHAR_METHODS MODIFIED="2016-06-22 16:50:52 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: list with permuted blocks for each new cycle<BR/>Blinded: NS<BR/>Size: 171 separate women, but reported on 193 cycles<BR/>D2 94 cycles<BR/>89 women<BR/>D5 99 cycles<BR/>82 women<BR/>18 dropouts<BR/>Single centre: Uni affiliated<BR/>Belgium<BR/>Power calculation: Yes<BR/>Therapeutic<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-24 16:16:04 +1200" MODIFIED_BY="Helen E Nagels">
<P>Criteria: &lt; 39 years old, 3 or less previous cycles, 4 or more 2PN on day 1<BR/>Age: D3 31 ± 3<BR/>D5 32 ± 4<BR/>Cause/duration: NS<BR/>Previous treatment:<BR/>D2 1.7+/-0.9<BR/>D5 2.0+/- 1.0<BR/>ICSI: 67% both groups<BR/>FSH: NS<BR/>#eggs: D2 11.9 ± 4.4<BR/>D5 12.0 ± 4.9<BR/>Fertilisation rate: D2 67.2%<BR/>D5 67.5%<BR/>Blast rate: 48.3%<BR/>ET policy: D2 2-3 depending on age and embryo quality<BR/>D5 2 embryos<BR/>#ET: D2 2.1 ± 0.4<BR/>D5 1.9 ± 0.3<BR/>Pregnancy determination: NS<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:16:08 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: GnRH agonist, hMG, HCG 36 hours<BR/>Luteal support: NS<BR/>Media: in-house sequential media<BR/>Culture method: 30 ul microdrops low oxygen<BR/>AHA: no<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 17:18:16 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB/OPU<BR/>LB/woman<BR/>Note that 5% D2 and 17% D5 were from same women<BR/>LB/per ET<BR/>b) pregnancy/OPU<BR/>Pregnancy/randomised/cycle<BR/>b) pregnancy/ET<BR/>c) multiple rate per pregnancy<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage<BR/>c) embryo freeze<BR/>d) embryo utilisation<BR/>e) cancellation rate<BR/>f) high order rate<BR/>g) cumulative delivery rate including thaws to date<BR/>h) monozygotic twin</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-29 16:59:54 +1200" MODIFIED_BY="Helen E Nagels">
<P>Prognosis: mixed unselected<BR/>Outcome: discontinued blast culture<BR/>Gives cumulative fresh thawed rates<BR/>Not all different women - per cycle data only<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:16:44 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Fernandez_x002d_Shaw-2015">
<CHAR_METHODS MODIFIED="2016-06-22 16:34:30 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomised controlled trial in parallel groups on day 1<BR/>
<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-24 16:16:18 +1200" MODIFIED_BY="Helen E Nagels">
<P>Inclusion criteria: first IVF or ICSI cycle; presence of normal uterine cavity; ejaculated sperm origin; absence of any contraindications to pregnancy</P>
<P>Exclusion criteria: oocyte donation cycles; vitrified oocytes cycles; non-ejaculated sperm; PGD</P>
<P>Age: BS 35.2 and CS: 36.3</P>
<P>Infertility duration: BS 23.9 months and CS: 27.7 months</P>
<P>Antral follicle count: 13 in both</P>
<P>D5:60 and D3:60 women randomised</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:16:37 +1200" MODIFIED_BY="Helen E Nagels">
<P>Three ovarian stimulation protocols were used for the 120 patients in the present study depending on their age and diagnosis: long GnRH agonist protocol with intranasal nafarelin; short GnRH agonist protocol with nafarelin; GnRH antagonist protocol where the ganirelix was started on day 6 of the stimulation. All with recombinant daily FSH. Some patients were given added hMG when needed</P>
<P>Oocytes and embryos were cultured in sequential media of Vitrolife Sweden (G5 series, Kungsbacka, Sweden) using IVF, G1 and G2 medium as recommended by the manufacturer</P>
<P>All embryo transfers were performed using a Wallace catheter with EmbryoGlue media</P>
<P>To support luteal phase, all patients received progesterone suppository</P>
<P>Frozen embryos were vitrified in the day 3 and day 5 group respectively. The vitrification followed the Irvine Scientific procedure</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-24 16:16:44 +1200" MODIFIED_BY="Helen E Nagels">
<P>Cumulative live birth rate*</P>
<P>Live birth rate*</P>
<P>Cumulative pregnancy</P>
<P>Cumulative pregnancy rate in &lt; 35 years old</P>
<P>Cumulative pregnancy rate in &gt;= 35 years old</P>
<P>Clinical pregnancy</P>
<P>Multiple pregnancy</P>
<P>Miscarriage</P>
<P>The percentage of patients with embryos that were vitrified</P>
<P>Three patients from the day 3 group and 2 from the day 5 group (with a mean number of 3 vitrified embryos) had not done a FET cycle at the time of closing our interim analysis</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-22 17:26:01 +1200" MODIFIED_BY="Clare Dooley">
<P>*Additional unpublished data received from contact author May 2016 in personal communication (email) to Demián Glujovsky. This is source of data on live births (analysis 1.1)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:16:59 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Fisch-2007">
<CHAR_METHODS MODIFIED="2016-06-22 16:50:59 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: N/A</P>
<P>Blinded: N/A</P>
<P>Size: 20 - D3 8 and D5 12</P>
<P>No dropouts</P>
<P>Single centre: Private practice. USA</P>
<P>Power calculation: these are preliminary results and no ulterior study has been published (4 years later)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-24 16:16:59 +1200" MODIFIED_BY="Helen E Nagels">
<P>Criteria: D3 3 or more eight-cell embryos &lt; 20% fragmentation, &lt; 40, BMI &lt; 30, FSH &lt; 12</P>
<P>Age: D3 31.3 and D5 31.2<BR/>Cause/duration: NS previous treatment: first or second cycle: D3 84% and D5 88%; ICSI: D3 51% and D5 64% (lower blast rate in ICSI than IVF); FSH: D3 6.5 and D5 6.5 #eggs: D3 12.8 +/- 4.4 D5 13.5 +/- 5.3<BR/>Fertilisation rate: D3 60.2% and D5 60.7%<BR/>Blast rate: 55.2%<BR/>ET policy: 2 embryos both groups<BR/>#ET: D3 2.0 and D5 1.96 (2 patients D5 had 1 only due to lack of blasts)<BR/>Pregnancy determination: HCG + US 7 weeks<BR/>Inclusion criteria: "Women &lt; 41, with &lt;= 2 prior fresh cycles with at least one embryo on day 3 with graduated embryo score &gt;=70 and soluble human leukocyte antigen-G (sHLA-G): 0.148&#8211;0.210"</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-22 16:43:44 +1200" MODIFIED_BY="Clare Dooley">
<P>N/A</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-05-13 11:37:16 +1200" MODIFIED_BY="[Empty name]">
<P>Pregnancy</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-22 17:18:25 +1200" MODIFIED_BY="Clare Dooley" STUDY_ID="STD-Frattarelli-2003">
<CHAR_METHODS MODIFIED="2016-06-22 16:51:07 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: computer-generated randomisation table. Allocation concealed until intervention assigned Randomisation day of OPU<BR/>Blinded: no<BR/>Size: 57 separate women randomised, 8 withdrawals, 5 from day 3, and 3 from day 5 which were added to number of women randomised in order to achieve an intention-to-treat, including 4 who did not meet embryo criteria. Assumed no pregnancy for the withdrawals after randomisation (D3 28 and D5 29)<BR/>Single centre: Army Medical Centre, Hawaii<BR/>Power calculation: performed but not included - needed 68 women per group<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 16:47:00 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: &lt; 39 years old, 3 or less previous cycles, 4 or more 2PN on day 1<BR/>Age: D3 31 ± 3<BR/>D5 32 ± 4<BR/>Cause/duration: NS<BR/>Previous treatment: D2 1.7 ± 0.9; D5 2.0 ± 1.0<BR/>ICSI: 67% both groups<BR/>FSH: NS<BR/>#eggs: D2 11.9 ± 4.4; D5 12.0 ± 4.9<BR/>Fertilisation rate: D2 67.2%; D5 67.5%<BR/>Blast rate: 48.3%<BR/>ET policy: D2 2-3 depending on age and embryo quality<BR/>D5 2 embryos<BR/>#ET: D2 2.1 ± 0.4<BR/>D5 1.9 ± 0.3<BR/>Pregnancy determination: NS<BR/>Criteria: 6 or more high grade embryos day 3, less than 35 years old, FSH &lt; 12 mIU/mL, &gt; 10 or more follicles day of HCG<BR/>Age: D3 31.0 and D5 30.2<BR/>Primary/secondary: NS<BR/>Cause/duration: NS<BR/>Previous treatment: 1st<BR/>ICSI: 5x in each group<BR/>#eggs: D3 17 and D5 20<BR/>Blast rate: not calculated<BR/>ET policy:<BR/>D3 3-4 embryos<BR/>D5 2-3 embryos<BR/># ET: D3 2.96 (± 0.5); D5 2.04 (± 0.2)<BR/>Pregnancy determination: US 6 weeks, ongoing US 12 weeks<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Ov Stim: NS<BR/>Luteal support: NS<BR/>Media: sequential for both<BR/>Culture method: NS<BR/>AHA: NS<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 17:18:25 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB per OPU/ET/woman<BR/>b) pregnancy OPU/ET/ woman<BR/>c) multiple pregnancy (initial):<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage<BR/>c) embryo freeze<BR/>d) embryo utilisation<BR/>e) cancellation<BR/>f) high order<BR/>g) number of triplets<BR/>h) monozygotic twins<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-22 16:02:29 +1200" MODIFIED_BY="Clare Dooley">
<P>Prognosis: good<BR/>6 or greater high grade embryos D3, 1st cycle, young, high numbers of oocytes<BR/>No dropouts due to lack of blasts<BR/>High blast implantation rate<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-22 16:47:54 +1200" MODIFIED_BY="Clare Dooley" STUDY_ID="STD-Gaafar-2015">
<CHAR_METHODS MODIFIED="2016-06-22 16:47:54 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation was done by computer permuted blocks size of 4 in parallel groups<BR/>
<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-05-05 13:37:27 +1200" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: couples suffering of male factor</P>
<P>326 were eligible. 126 cases had day 2/3 transfer and 126 had blastocyst transfer</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-05-05 13:37:27 +1200" MODIFIED_BY="[Empty name]">
<P>Long agonist protocol was used and ICSI was done</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-05-13 11:38:15 +1200" MODIFIED_BY="[Empty name]">
<P>Clinical pregnancy </P>
<P>Miscarriage</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-05-05 13:37:27 +1200" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:17:14 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Gardner-1998">
<CHAR_METHODS MODIFIED="2016-06-22 16:49:59 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: computer-generated on day 8 prior to OPU<BR/>Blinding: NS<BR/>Inclusion decided on day of trigger<BR/>Size: 92 separate women randomised no cancellations: day 3 47 cycles day 5 45 cycles<BR/>Excluded patients: NS<BR/>Single private clinic: USA<BR/>Time: 5 months 97/98<BR/>Power calculation: NS<BR/>Intention-to-treat: needs clarification<BR/>Therapeutic</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 16:53:42 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: all ages and &gt; 10 follicles on day of trigger<BR/>Age: D3 34.5 D5 33.6<BR/>Primary/secondary: NS<BR/>Cause: no significant difference<BR/>Previous treatment: D3 0.21 D5 0.62 cycles (significantly different)<BR/>ICSI: D3 34%, D5 33%<BR/>FSH: comparative details NS<BR/>Criteria : &gt; 10 follicles on day of trigger<BR/># eggs retrieved: NS<BR/>Fertilisation rate: NS<BR/>#PN embryos: D2 512.3, D5 522.0<BR/>Blast rate 46.5% (85% patients had 2+ blasts)<BR/>ET policy: changed for day 5 mid-study from 2-3<BR/># ET: D3 3.7, D5 2.2 (4% had no ET)<BR/>Pregnancy determination: NS</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:17:14 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: NS<BR/>Luteal support: NS<BR/>Media: sequential for both<BR/>Culture method: NS<BR/>AHA: NS<BR/>Culture until day 3 in Ham´s F-10+ fetal cord serum (FCS), until D5 in G1 /G2<BR/>Method: tubes in humidicrib<BR/>AH for nearly all DOv Stim: Lupron D21. Human menopausal gonadotropin dose? HCG 2 follicles &gt; 18 mm OPU 35 hours trigger<BR/>Luteal: steroids and tetracyclin for 4 days post-OPU. Progesterone IM from 2 days post-OPU<BR/>Culture media: Sequential D3 H3 - nil for D5</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 17:26:04 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) live births<BR/>b) pregnancy/OPU<BR/>b) pregnancy/ET<BR/>c) multiple pregnancy<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage<BR/>b) MZ twinning<BR/>c) embryo freeze rate<BR/>d) embryo utilisation<BR/>e) embryo transfer<BR/>f) high order<BR/>g) monozygotic</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-24 16:17:14 +1200" MODIFIED_BY="Helen E Nagels">
<P>Prognosis: good &lt; 1 previous cycle and &gt; 10 follicles<BR/>Different media used for each arm of study<BR/>Excluded patients not mentioned<BR/>Number of ET policy change partway through unblinded interim analysis: Initially patients received three blastocysts. However, soon they reduced that number to two.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-29 16:59:50 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Hreinsson-2004">
<CHAR_METHODS MODIFIED="2016-06-22 16:51:17 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: NS</P>
<P>Allocation: sealed envelope on day prior to HCG<BR/>Blinded: no<BR/>Size: 144 separate women<BR/>D2/3 80<BR/>day5/6 64<BR/>no dropouts<BR/>Single centre: Sweden<BR/>Power calculation: Yes but not achieved<BR/>Study stopped early due to change of national guidelines<BR/>Therapeutic<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 17:23:06 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: 6 follicles day prior to HCG<BR/>Age: D3 33.1y<BR/>D5 32.1y<BR/>Cause/duration: similar<BR/>Previous cycles: NS<BR/>ICSI: D3 42 % D5 45%<BR/>FSH: NS<BR/># eggs: D3 14.6 D5 14.9<BR/>Fertilisation rate: D3 54%<BR/>D5 61%<BR/>Blast rate: 33%<BR/>ET policy: 1-2 at start of study but then only 1 at end of study<BR/>#ET D3 1.8 D5 1.9<BR/>HCG: NS<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-29 16:59:50 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: long-course GnRH agonist or short centrorelix<BR/>hMG: rFSH, HCG 36hr<BR/>Luteal supp: NS<BR/>Media: Vitrolife mixture of IVF/CCM and G1/G2 sequential<BR/>Culture method: microdrops 6% CO2<BR/>AHA: not done<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 17:18:52 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB<BR/>b) pregnancy/OPU<BR/>b) pregnancy/ET<BR/>c)multiple rate<BR/>Secondary<BR/>a) Implantation<BR/>b) miscarriage pre 12 weeks<BR/>c) embryo freeze<BR/>d) embryo utilisation<BR/>e) ET cancellation<BR/>f) high order rate<BR/>g) monozygotic twin<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-09 20:02:10 +1200" MODIFIED_BY="[Empty name]">
<P>Prognosis: good excluded poor responders.<BR/>Mixture of media types and ET policy change over course of study<BR/>Outcome no advantage of blast culture<BR/>Letter sent and reply received<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:17:25 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Karaki-2002">
<CHAR_METHODS MODIFIED="2016-06-22 17:52:01 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: sealed envelope on D1 fertilisation check<BR/>Blinded: no<BR/>Size: 162 separate women randomised and analysed<BR/>D3 82 D5 80<BR/>Single centre: Uni affiliated. Jordan<BR/>Power calculation: NS<BR/>Therapeutic<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 17:53:22 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: 5 or more zygotes<BR/>Age: D3 29.2 and D5 30.0<BR/>Primary/secondary: NS<BR/>Cause: No significant difference<BR/>(Average: 51% Male factor, 9% tubal, 6% unexplained)<BR/>Duration: D3 6.7 and D5 6.8<BR/>Previous treatment: D3 1.1 and D5 0.9<BR/>ICSI: Yes but no effect found in outcome of implantation or blast rate<BR/>FSH: D3 7.5 and D5 7.8<BR/># eggs: D3 13.4 (±5.2)<BR/>D5 13.0 (±3.2)<BR/>Fertilisation rate: D3 56.7% and D5 63.8%<BR/>Blast rate: 33% day 5/6<BR/>ET policy: 1-2 embryos but if &gt; 35 and/or &gt; 2 previous cycles then up to 3 (same policy for both groups)<BR/># Et: D3 3.5 ± 0.63<BR/>D5 2.0±1.0<BR/>Pregnancy determination: HCG for pregnancy rate<BR/>US for viable pregnancy rate</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:17:25 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: GnRH agonist long and short + rFSH and HP FSH + 35 hour trigger<BR/>Luteal support: Progesterone V pessary<BR/>Media: D3 Medicult, D5 G1/G2 Vitrolife<BR/>Culture method: NS<BR/>AHA: NS<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 17:53:52 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB<BR/>b) pregnancy/OPU/ET/woman (initial HCG)<BR/>Viable<BR/>c) multiple rate<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage: info only until 7 weeks<BR/>c) embryo freeze<BR/>d) embryo utilisation<BR/>e) cancellation<BR/>f) high order rate<BR/>g) monozygotic twin<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Prognosis: moderate, young women, moderately high oocyte numbers. Large difference in embryo ET# between groups<BR/>Sent letter<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:17:38 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Kaur-2014">
<CHAR_METHODS MODIFIED="2016-06-22 17:54:14 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomised controlled trial in parallel groups on day 2<BR/>
<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 17:54:49 +1200" MODIFIED_BY="Clare Dooley">
<P>Inclusion criteria: women aged 25-40 years, 2-20 years of infertility, having minimum five oocytes at oocyte pick up and endometrial thickness of 7 mm and more indicating good ovarian response, having normal uterine cavity and basal FSH &lt; 10 mIU/mL. Availability of minimum three good quality embryos</P>
<P>Age: BS 32.0 and CS: 32.4</P>
<P>Infertility duration: BS 7.7 years and CS: 8.9 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:17:38 +1200" MODIFIED_BY="Helen E Nagels">
<P>Patient was put on long protocol, GnRH agonists started on cycle day 21. Daily doses given subcutaneously until cycle day 3. Ovarian stimulation with rFSH. The dose schedule was modified according to parameters such as BMI, previous response, and ovarian reserve estimates</P>
<P>Group 1: Included patients undergoing embryo transfer on day 3, and Group 2 in which extended culture until day 5 was done in G2 plus media and blastocyst was transferred on day 5</P>
<P>All transfers were performed using Edward&#8211;Wallace catheter. Luteal support was given in the form of micronised vaginal progesterone in dose of 200 mg twice a day. Injection HCG 2000 IU was given IM on days 5th, 8th, and 11th after retrieval</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-24 16:17:33 +1200" MODIFIED_BY="Helen E Nagels">
<P>Clinical pregnancy</P>
<P>Multiple pregnancy</P>
<P>Miscarriage rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-24 16:17:33 +1200" MODIFIED_BY="Helen E Nagels">
<P>Attempt to contact authors for more details of randomisation methods was not successful</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:17:44 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Kolibianakis-2004">
<CHAR_METHODS MODIFIED="2016-06-22 17:57:44 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: computer-generated list. Sequence not concealed. Prior to stimulation<BR/>Size: 460 different women<BR/>D3 234 and D5 226<BR/>Power calculation: 5% difference in pregnancy rate, baseline pregnancy rate 30% need 1416 women in each group - unrealistic so aimed for estimate<BR/>Single centre: Uni affiliated<BR/>Belgium<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 17:59:28 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: &lt; 43 years, no PGD or azoospermia<BR/>Age: D3 31.3 years and D5 31.5 years<BR/>Cause: Similar in both groups (average: 65% male, 10% tubal, 16% unexplained)<BR/>Duration: NS<BR/>Previous treatment: D3 0.7 and D5 0.8<BR/>ICSI: 74% of all patients<BR/>FSH: D3 10.4 and D5 10.4<BR/>#eggs: D3 12.1 and D5 12.0<BR/>Fertilisation rate: D3 61.3% and D5 63.4%<BR/>Blast rate: 50.7% ± 2.4<BR/>ET policy: 1-2 embryos for both groups<BR/>#ET: D3 1.9 ± 0.1<BR/>D5 1.8 ± 0.1<BR/>Pregnancy determination: ongoing pregnancy beyond 12 weeks<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:17:44 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: initially GnRH agonist long protocol with hMG, replaced by GnRH antagonist with rFSH<BR/>HCG 36 hours<BR/>Luteal support: vag micronised progesterone until 7 weeks of gestation<BR/>Meida: Sequential G1/G2 Vitrolife<BR/>Culture method: NS<BR/>AHA: no<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 17:19:39 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB<BR/>b) pregnancy/randomised couple<BR/>pregnancy/OPU<BR/>b) pregnancy/ET<BR/>c) multiple rate<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage: (first 12 weeks)<BR/>c) embryo freeze:<BR/>d) embryo utilisation<BR/>e) cancellation rate (from randomisation to ET)<BR/>f) high order rate<BR/>g) monozygotic twin</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Prognosis: mixed unselected<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:18:04 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Levitas-2004">
<CHAR_METHODS MODIFIED="2016-06-22 18:00:54 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: computer-generated random number table, blinded sealed envelopes prior to treatment<BR/>Size: 54 different women were randomised and analysed: D2/3 31 and day 5/6/7 23<BR/>Setting: single Uni clinic in Israel<BR/>Time: NS<BR/>Therapeutic<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-24 16:18:04 +1200" MODIFIED_BY="Helen E Nagels">
<P>Criteria: min 3 failed IVF cycles, &lt; 37 years old, adequate ovarian response<BR/>Age: D2/3 31.2 and day 5 29.1. No statistical difference<BR/>Duration: D2/3 7.0 years and D5 7.1 years<BR/>Previous cycles: D2/3 4.3 and D5 4.9<BR/>Cause: D2/3 62% male, 33% tubal<BR/>D5 79% male, 21% tubal<BR/>ICSI: D2/3 62% and D5 51%<BR/># eggs: D2/3 12.8 +/- 5.3 and D5 13.0 +/- 5.1<BR/>Fertilisation rate: D2/3 53.9% and D5 66.1%<BR/>Blast rate: 43% (65/151)<BR/>ET policy: D2/3 was 3-4 embryos<BR/>D5 was 2-3 embryos<BR/># embryo ET: D2/3 3.4 ± 0.7<BR/>D5 1.9 ± 0.4<BR/>Pregnancy determination: HCG + US<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:18:04 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: GnRH agonist long and short +hMG doses adjusted daily, + HCG 36-38 hours<BR/>Luteal: HCG x5, or Progesterone +less HCG<BR/>Media: D2/3 P1 Irvine (23x) and Cook (8x)<BR/>D5 Sequential G1/G2 Vitrolife<BR/>Culture system: NS<BR/>AHA: NS<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 18:04:18 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) Live births<BR/>b) pregnancy/OPU<BR/>b) pregnancy/ET<BR/>c) Multiple pregnancy<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage<BR/>c) embryo freeze rate<BR/>d) embryo utilisation<BR/>e) cancellation<BR/>f) high order<BR/>g) monozygotic twinning</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-22 18:04:29 +1200" MODIFIED_BY="Clare Dooley">
<P>Prognosis: both good and poor<BR/>Note: young women with large numbers of failed cycles<BR/>Uneven number in each group<BR/>Similar figures to the 2001 abstract<BR/>Letter sent and reply received<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-23 10:54:10 +1200" MODIFIED_BY="Clare Dooley" STUDY_ID="STD-Levron-2002">
<CHAR_METHODS MODIFIED="2016-06-22 22:43:59 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: sealed envelope performed on day1 post-OPU<BR/>Blinded: Yes<BR/>Size: 90 different women<BR/>D3 44 and D5 46<BR/>Single centre: Uni clinc<BR/>Israel<BR/>Power calculation: No<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 22:45:00 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: &lt; 38 years, &lt; 5 previous IVF,<BR/>&gt; 5 or more oocytes D1<BR/>Age: D3 31.5 and D5 30.9<BR/>Primary/secondary: NS<BR/>Cause/duration: NS<BR/>Previous treatment: &lt; 5<BR/>ICSI: D3 59.1%; D5 51.2%<BR/>FSH: NS<BR/># eggs: D3 16.3<BR/>D5 15.2<BR/>Fertilisation rate: D3 60.1%<BR/>D5 62.0%<BR/>Blast rate: 34.2% (3 patients no blasts 6.5%)<BR/>ET policy: max 3 for both D3 and D5<BR/>#ET: D3 3.1 (± 0.6)<BR/>D5 2.3 (± 0.8)<BR/>Pregnancy determination: NS<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Ov Stim: NS<BR/>Luteal support: NS<BR/>Media: sequential Cook<BR/>Culture method: NS<BR/>AHA: NS<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-23 10:54:10 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB per woman<BR/>b) pregnancy/OPU/woman<BR/>b) pregnancy/ET<BR/>c) multiple pregnancy<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage<BR/>c) embryo freeze<BR/>d) cancellation rate<BR/>f) high order<BR/>g) monozygotic twin</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Prognosis: moderate<BR/>Young women<BR/>Moderately high numbers of oocytes<BR/>Clarification letter sent<BR/>Same ET policy<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:18:16 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Livingstone-2002">
<CHAR_METHODS MODIFIED="2012-05-23 16:35:39 +1200" MODIFIED_BY="[Empty name]">
<P>Randomisation: sealed envelope<BR/>
<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 22:46:26 +1200" MODIFIED_BY="Clare Dooley">
<P>Size: 79 recruited<BR/>59 separate women analysed<BR/>20 failed criteria or various reasons - outcomes given where possible<BR/>D3 29 and D5 30<BR/>Single centre: Uni affiliated Australia<BR/>Power calculation: Yes for reduction of twins<BR/>Intention-to-treat: not done (those with no ET were excluded)<BR/>Prognosis: moderate<BR/>Young women<BR/>Moderately high numbers of oocytes<BR/>Clarification letter sent<BR/>Criteria: &lt; 38 years old, 3 or less previous cycles<BR/>Age: D3 31.6 and D5 33.5<BR/>Primary/secondary: NS<BR/>Cause: similar in both<BR/>Duration: D3 3.8y D5 4.1y<BR/>Previous treatment: NS<BR/>ICSI: yes but no details<BR/>FSH: NS<BR/>ET policy: day2/3 2x embryos, day 5 1x embryo<BR/>#ET D3 2.0 D5 1.0<BR/>Pregnancy determination: NS</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:18:16 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: GnRH agonist long+ rFSH + HCG 36 hour trigger<BR/>Luteal support: HCG x2 or progesterone pessaries<BR/>Media: Syd IVF sequential<BR/>Culture method: microdrops under oil in Minc incubator<BR/>AHA: NS<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 22:46:54 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB/woman<BR/>b) pregnancy/woman<BR/>c) multiple rate<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage or ectopic<BR/>c) embryo freeze: performed but no details given<BR/>d) embryo utilisation<BR/>e) cancellation rate<BR/>f) high order rate<BR/>g) monozygotic twin<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-22 16:11:47 +1200" MODIFIED_BY="Clare Dooley">
<P>Prognosis: high<BR/>Data from Thesis 2002 and not abstract 2001<BR/>Low fertilisation rate<BR/>Aim to reduce twinning<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:18:24 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Motta-1998">
<CHAR_METHODS MODIFIED="2012-01-27 08:37:48 +1300" MODIFIED_BY="[Empty name]">
<P>Randomisation:"randomly assigned"<BR/>Blinding: NS<BR/>Size: 83 women in 116 cycles randomly assigned and analysed: D2 58 and D5 58<BR/>Setting: Uni clinic private in Brazil<BR/>Time: NS<BR/>Power analysis: NS<BR/>Therapeutic<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-24 16:18:24 +1200" MODIFIED_BY="Helen E Nagels">
<P>Criteria: unselected<BR/>Age overall: 33.8 ± 6.6y<BR/>
Baseline and population characteristics: NS<BR/>#eggs: D3 12.9, D5 11.7<BR/>Fertilisation rate: D3 7.8, D5 9.1<BR/># PN embryos: D3 452, D5 528<BR/>Cycles with no fertilisation: 2/116<BR/>Cycles with no blasts: 6<BR/>ET policy: D3 3-5 embryos<BR/>D5 1-3 embryos<BR/>#embryos ET: D3 4.6,<BR/>D5 2.3<BR/>Pregnancy determination: ultrasound<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-22 22:49:00 +1200" MODIFIED_BY="Clare Dooley">
<P>Ov Stim: down-regulation with gonadotropin 150-450<BR/>Luteal: NS<BR/>Media: sequential media P1/Irvines Blast<BR/>Culture method: NS<BR/>AH: NS<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 22:49:24 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) live births<BR/>b) pregnancy/ET<BR/>b) pregnancy/OPU<BR/>c) multiple pregnancy<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage<BR/>c) embryo freeze<BR/>d) embryo utilisation rate<BR/>e) ET rate<BR/>e) cancellation<BR/>f) high order<BR/>g) monozygotic twinning<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Prognosis: moderate to good. No letter sent</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:18:37 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Pantos-2004">
<CHAR_METHODS MODIFIED="2012-01-11 02:34:02 +1300" MODIFIED_BY="[Empty name]">
<P>Randomisation: not stated</P>
<P>Allocation: not stated</P>
<P>Blinded: no</P>
<P>Size: 243, D2 81, D3 81, D5 81</P>
<P>No dropouts Single centre: Greece</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 22:49:49 +1200" MODIFIED_BY="Clare Dooley">
<P>&lt; 41 years old. Fewer than 4 previous unsuccessful ART attempts</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:18:33 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: long or short protocol, using GnRH agonist and recombinant FSH<BR/>luteal support: NS<BR/>Media: sequential media commercial AHA: N</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-24 16:18:37 +1200" MODIFIED_BY="Helen E Nagels">
<P>Pregnancy<BR/>Multiple Pregnancy Rate</P>
<P>High order multiple</P>
<P>PR: 3.9%</P>
<P>Miscarriage</P>
<P>Embryo freezing</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-24 16:18:33 +1200" MODIFIED_BY="Helen E Nagels"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:18:55 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Papanikolaou-2005">
<CHAR_METHODS MODIFIED="2016-06-24 16:18:55 +1200" MODIFIED_BY="Helen E Nagels">
<P>Randomisation: computer-generated list<BR/>Randomised on day 3 following OPU<BR/>Concealment: no<BR/>Blinded: no<BR/>Size: 164 separate patients<BR/>D3 84 and D5 80<BR/>Single centre, Belgium<BR/>Power calculation: yes prospectively<BR/>Interim analysis terminated at halfway point<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 22:55:14 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: 4 good quality embryos on D3, &lt; 38 years old,<BR/>&lt; 4 cycles FSH &lt; 12 D3<BR/>Age: D3 29.6 and D5 29.9<BR/>Cause: no difference<BR/>Duration: D3 2.7 y and D5 2.9 y<BR/>Previous treatment: D3 1.3 and D5 1.4<BR/>ICSI: D3 66.7% and D5 67.5%<BR/>FSH: NS<BR/># eggs: D3 13.9 and D5 15.1<BR/>Fertilisation rate: D3 65%, D5 65%<BR/>Blast rate: NS<BR/>ET policy: 2 embryos<BR/># embryos transferred: D3 2.0 and D5 1.97<BR/>(4 women D5 had 1 embryo transferred due to lack of availability)<BR/>Pregnancy determinant: HCG + US 7 weeks</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:18:55 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: 2 types<BR/>a) GnRH agonist<BR/>b) GnRH antagonist<BR/>rFSH/HCG<BR/>Luteal support: progesterone vaginal<BR/>Media: G1/G2 Vitrolife<BR/>Culture method: NS<BR/>AHA: no<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 22:55:55 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB/woman, OPU and ET<BR/>b) Pregnancy/woman, OPU, ET<BR/>c) Multiple rate<BR/>Secondary:<BR/>a) implantation<BR/>b) miscarriage from positive HCG<BR/>c) embryo freeze<BR/>d) embryo utilisation<BR/>e) ET rate<BR/>f) high order rate<BR/>g) monozygotic twinning<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-22 22:56:00 +1200" MODIFIED_BY="Clare Dooley">
<P>Prognosis: high, 4 high quality embryos D3, young women<BR/>Letter sent regarding concealment<BR/>100% ET rate<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:19:03 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Papanikolaou-2006">
<CHAR_METHODS MODIFIED="2016-06-22 22:56:46 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: computer-generated list<BR/>Randomised prior to start of cycle<BR/>Concealment: no but used group A or B<BR/>Blinded: no<BR/>Size: 351 separate patients<BR/>D3 176 and D5 175<BR/>To OPU<BR/>D3 166 and D5 163<BR/>To ET<BR/>D3 156 and D5 149<BR/>Single centre, Belgium<BR/>Power calculation: yes prospectively<BR/>Interim analysis: Yes - study terminated at halfway point<BR/>Intention-to-treat: yes<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 22:58:02 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: single embryo transfer, &lt; 36 years old, &lt; 3 cycles FSH &#8804; 12 on D3<BR/>Age: D3 30.4 and D5 30.5<BR/>Cause: no difference<BR/>Duration: D3 3.5 y and D5 3.7 y<BR/>Previous treatment: D3 7.4% and D5 9.1%<BR/>ICSI: D3 63.2% and D5 64.5%<BR/>FSH: NS<BR/># eggs: D3 12.5 and D5 13.9<BR/>Fertilisation rate: D3 60% and D5 58%<BR/>Blast rate: NS<BR/>ET policy: 1 embryo<BR/># embryos transferred: D3 1.0 and D5 1.0<BR/>(Number patients where no embryos were available for ET: D3 8 and D5 11<BR/>Pregnancy determinant: HCG + US 7 weeks<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:19:03 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: GnRH antagonist<BR/>rFSH/HCG<BR/>Luteal support: progesterone vaginal<BR/>Media: NS<BR/>Culture method: NS<BR/>AHA: no<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-23 10:54:24 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB/woman<BR/>b) pregnancy/woman<BR/>c) multiple rate<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage from positive HCG<BR/>c) embryo freeze<BR/>d) embryo utilisation<BR/>e) cancellation rate (from those that had OPU)<BR/>f) High order rate<BR/>g) monozygotic twin rate (per clinical pregnancy)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-06-09 20:15:15 +1200" MODIFIED_BY="[Empty name]">
<P>Prognosis: high, young women<BR/>Letter sent regarding concealment, media and freezing<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:19:17 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Rienzi-2002">
<CHAR_METHODS MODIFIED="2016-06-22 22:59:06 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: computer-generated randomised list. Randomised on day 1 following OPU<BR/>Blinded: No<BR/>Size: 98 separate women randomised and analysed<BR/>No dropouts<BR/>D3 48 and D5 50<BR/>Single centre, Italy<BR/>Power calculation: No<BR/>Therapeutic<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-24 16:19:17 +1200" MODIFIED_BY="Helen E Nagels">
<P>Criteria: &lt; 38 years old, ICSI only, 8 or more zygotes<BR/>Age: D3 31.6 ± 3.1<BR/>D5 32.2 ± 2.5<BR/>Primary/secondary: NS<BR/>Cause/duration: NS<BR/>Previous treatment: NS<BR/>ICSI: 100% both groups<BR/>FSH: NS<BR/># eggs: D3 12.7 ± 7.1 and D5 13.1 ± 5.2<BR/>Fertilisation rate: D3 71.2% and D5 71.8%<BR/>Blast rate: 44.8% (211/470)<BR/>ET policy: Max 2 for both groups<BR/>#ET: D2 2.0 and D5 2.0<BR/>Pregnancy determination<BR/>HCG + US 8 weeks<BR/>Live-Birth Rate: yes<BR/>Cumulative including freezing: yes<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-22 23:00:35 +1200" MODIFIED_BY="Clare Dooley">
<P>Ov Stim: down-regulation with rFSH + HCG trigger 36 hours<BR/>Luteal support: NS<BR/>Media: G1/G2 Vitrolife both groups<BR/>Culture method: NS<BR/>AHA: NS<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 23:00:52 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>Fresh transfer cycles only<BR/>a) LB/woman<BR/>b) pregnancy/OPU/ET: (clinical)<BR/>c) multiple rate/pregnancy (from personal communication)<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage<BR/>c) embryo freeze<BR/>d) embryo utilisation: cumulative LBR results including fresh and thawed<BR/>e) ET rate<BR/>f) high order rate<BR/>g) monozygotic twinning<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-22 23:01:00 +1200" MODIFIED_BY="Clare Dooley">
<P>Prognosis: Good<BR/>&gt; 8 zygotes<BR/>Conclude that embryo/PN score system as good as blast culture<BR/>Cumulative fresh thawed results<BR/>Letter sent and reply received<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:19:32 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Schillaci-2002">
<CHAR_METHODS MODIFIED="2016-06-22 23:01:50 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: method NS "randomly allocated" on day 1 fertilisation check<BR/>Size 120 separate patients randomised and analysed no dropouts<BR/>D3 60 and D5 60<BR/>Single centre, Italy<BR/>Power calculation: NS<BR/>Therapeutic<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-24 16:19:32 +1200" MODIFIED_BY="Helen E Nagels">
<P>Criteria: 8 or more MII oocytes and 3 zygotes<BR/>Age: NS<BR/>Primary/secondary: NS<BR/>Cause/duration: NS<BR/>Previous treatment: NS<BR/>ICSI: yes but no details<BR/>FSH: NS<BR/>#eggs D3 9.0 and D5 8.9<BR/>Fertilisation rate: no difference<BR/>Blast rate: 60.3%<BR/>ET policy: 2-3 embryos for both groups except only 2 if expanded blasts for D5<BR/>#ET: D3 2.8 ± 0.2<BR/>D5 1.8 ± 0.4<BR/>Pregnancy determination: NS<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Ov Stim: NS<BR/>Luteal support: NS<BR/>Media: D3 IVF-20 D5 G1/G2 both Vitrolife<BR/>Culture method: NS<BR/>AHA: NS<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 23:02:47 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB<BR/>b) pregnancy/OPU/ET/woman<BR/>c) multiple rate<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage<BR/>c) embryo freeze<BR/>d) embryo utilisation<BR/>e) ET rate<BR/>f) high order rate<BR/>g) monozygotic twinning</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-24 16:19:32 +1200" MODIFIED_BY="Helen E Nagels">
<P>Prognosis: unclear<BR/>Abstract only<BR/>Error in No. of patients 51 or 60<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-22 23:04:08 +1200" MODIFIED_BY="Clare Dooley" STUDY_ID="STD-Ten-2011">
<CHAR_METHODS MODIFIED="2016-06-22 23:03:41 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: method NS "distributed randomly" on day 3 fertilisation check<BR/>55 separate patients randomised and analysed no dropouts<BR/>D3 27 and D5 28<BR/>Single centre, Spain<BR/>Power calculation: NS<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 23:03:55 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: at least one embryo type A and 2 type B<BR/>Age: NS<BR/>First or second cycle<BR/>Cause/duration: NS<BR/>IVF and ICSI<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-22 23:03:58 +1200" MODIFIED_BY="Clare Dooley">
<P>Day 3 versus day 5</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 23:04:05 +1200" MODIFIED_BY="Clare Dooley">
<P>Clinical pregnancy rate but cumulative pregnancy rate later</P>
<P>Number of frozen embryos</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-22 23:04:08 +1200" MODIFIED_BY="Clare Dooley">
<P>Abstract only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-06-24 16:19:51 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Van-der-Auwera-2002">
<CHAR_METHODS MODIFIED="2016-06-22 23:04:29 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomisation: blind randomisation with sealed envelope at start of hormone stimulation<BR/>Size: 136 separate patients randomised and 129 were analysed due to 7 dropouts<BR/>(3x D2 and 4xD5)<BR/>D2 63 and D5 66<BR/>Single centre, Belgium<BR/>Power calculation: performed but abandoned due to high multiple rate, difficulty in recruitment and high cancellation rate in D5<BR/>Therapeutic<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 23:05:57 +1200" MODIFIED_BY="Clare Dooley">
<P>Criteria: unselected<BR/>Age: D2 31.7 ± 3.3<BR/>D5 31.5 ± 3.5<BR/>Primary/secondary: no difference between groups<BR/>Duration: D2 3.3 ± 2.0<BR/>D5 3.4 ± 1.5<BR/>Cause: no difference (approx 50% male &lt; 10% tubal, slightly more unexplained in D5)<BR/>Previous treatment: D2 1.7 and D5 1.7<BR/>ICSI: D2 19/63 and D5 25/66<BR/>FSH: NS<BR/>#eggs: D2 10.7 ± 5.4 and D5 11.5 ± 5.1<BR/>Fertilisation rate: D2 51.4% and D5 55.7%<BR/>Blast rate: 44.7%<BR/>ET policy: max of two for both groups<BR/>Note that D2 group had only 5x PN cultured on for transfer with remaining frozen. While all D5 group were cultured to ET<BR/>#ET: D2 1.86 ± 0.28 and D5 1.87 ± 0.22<BR/>Pregnancy determination: +ve HCG also clinical pregnancy (definition NS)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-24 16:19:51 +1200" MODIFIED_BY="Helen E Nagels">
<P>Ov Stim: NS<BR/>Luteal support: NS<BR/>Media: D3 IVF-20 D5 G1/G2 both Vitrolife<BR/>Culture method: NS<BR/>AHA: NS<BR/>Ov Stim: GnRH down-regulation+Humegon+HCG trigger 36 hours<BR/>Luteal support: HCG every 3 days or progesterone pessaries<BR/>Media: either Cook sequential or Vitrolife G1/G2 simultaneous trial<BR/>Culture was performed in modified overflow Cellstar incubator at 37 degrees Celsius and 90% humidity in 5.5% carbon dioxide, 5% oxygen and 89.5% nitrogen.<BR/>AHA: NS<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 23:07:18 +1200" MODIFIED_BY="Clare Dooley">
<P>Primary<BR/>a) LB/OPU/woman<BR/>LB/ET<BR/>b) pregnancy/OPU/woman: (clinical only)<BR/>b) pregnancy/ET<BR/>c) multiple rate<BR/>Secondary<BR/>a) implantation<BR/>b) miscarriage per randomised<BR/>c) embryo freeze<BR/>d) embryo utilisation<BR/>e) cancellation<BR/>f) high order rate<BR/>g) monozygotic twinning</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-22 23:07:30 +1200" MODIFIED_BY="Clare Dooley">
<P>Prognosis: mixed - unselected<BR/>Aim to reach highest cryoaugmented pregnancy rate<BR/>Smaller cohort of embryos to choose from in D2 group due to freezing on day 1<BR/>New policy women with &gt; 5 zygotes go to D5 transfer with 79% pregnancy rate<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>2PN - two-pronuclear zygote<BR/>AH - assisted hatching<BR/>ART - assisted reproductive technology<BR/>Blast - blastocyst<BR/>Blastocyte rate - number of blastocysts developed divided by number of 2PN embryos available<BR/>BMI: body mass index<BR/>BS - blastocyst stage<BR/>CS: cleavage stage<BR/>D2 - embryo transfer on day 2 post-OPU (i.e early cleavage stage)<BR/>D3 - embryo transfer on day 3 post-OPU (i.e early cleavage stage)<BR/>D5 - embryo transfer on day 5 post-OPU (i.e. blastocyst stage)<BR/>ET - embryo transfer<BR/>FCS - foetal chord serum<BR/>FSH - follicle stimulating hormone<BR/>G1/G2 - sequential media from Vitrolife<BR/>GnRH - gonadotropin-releasing hormone<BR/>HCG - human chorionic gonadotropin (trigger injection that initiates ovulation and maturation of oocytes)<BR/>ICSI - intracytoplasmic sperm injection<BR/>IM - intramuscular injection<BR/>IU/L - international units per litre<BR/>IVF - in vitro fertilisation<BR/>MII - metaphase II<BR/>mIU/m - milli international units per millilitre<BR/>morula- embryonic stage prior to blastocysts (usually embryos with delayed development on day 5)<BR/>NS - not stated<BR/>OPU - oocyte pick up<BR/>Ov Stim - ovarian stimulation regimen<BR/>PGD - preimplantation genetic diagnosis<BR/>rFSH - recombinant follicle stimulating hormone (fertility ovarian stimulation drug)<BR/># - number<BR/>US - ultrasound<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2016-06-29 16:49:49 +1200" MODIFIED_BY="Helen E Nagels" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-06-14 13:01:18 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bungum-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-06-14 13:01:18 +1200" MODIFIED_BY="[Empty name]">
<P>Used co-culture</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-06-14 13:01:25 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guerin-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-06-14 13:01:25 +1200" MODIFIED_BY="[Empty name]">
<P>Used co-culture</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-06-22 23:11:21 +1200" MODIFIED_BY="Clare Dooley" STUDY_ID="STD-Levron-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-06-22 23:11:21 +1200" MODIFIED_BY="Clare Dooley">
<P>Quasi-randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-06-14 13:02:27 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Loup-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-06-14 13:02:27 +1200" MODIFIED_BY="[Empty name]">
<P>Included transfer of embryos on two separate days within the same cycle</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-06-14 13:02:38 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Menezo-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-06-14 13:02:38 +1200" MODIFIED_BY="[Empty name]">
<P>Used co-culture</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-06-22 23:11:27 +1200" MODIFIED_BY="Clare Dooley" STUDY_ID="STD-Utsonomiya-2004a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-06-22 23:11:27 +1200" MODIFIED_BY="Clare Dooley">
<P>Non-randomised study (sequentially numbered)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-06-29 16:49:49 +1200" MODIFIED_BY="Helen E Nagels" STUDY_ID="STD-Vanderzwalmen-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-06-29 16:49:49 +1200" MODIFIED_BY="Helen E Nagels">
<P>Non-randomised study; according to even or odd year of birth</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-06-22 23:11:48 +1200" MODIFIED_BY="Clare Dooley" STUDY_ID="STD-Zech-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-06-22 23:11:48 +1200" MODIFIED_BY="Clare Dooley">
<P>Non-randomised study; according to even or odd year of birth</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2012-05-25 11:56:57 +1200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2016-06-23 10:55:32 +1200" MODIFIED_BY="Clare Dooley" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2016-06-23 10:55:32 +1200" MODIFIED_BY="Clare Dooley" STUDY_ID="STD-ChiCTR_x002d_ICR_x002d_15006184">
<CHAR_STUDY_NAME MODIFIED="2016-05-13 10:39:29 +1200" MODIFIED_BY="[Empty name]">
<P>Cumulative live birth rates compared blastocyst with cleavage-stage transfer: a prospective randomised, multi-center, open-label study</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-06-22 23:12:37 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomised parallel control</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 23:12:48 +1200" MODIFIED_BY="Clare Dooley">
<P>600 women (infertility)</P>
<P>Age: 20-39 years old</P>
<P>&gt;= 4 top quality embryos (&gt;= 8-cell, &lt; 20% fragments)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-22 23:13:04 +1200" MODIFIED_BY="Clare Dooley">
<P>Blastocyst transfer group: extending embryo culture 2-3 days in vitro to the blastocyst stage</P>
<P>Cleavage transfer group: no intervention</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-23 10:55:32 +1200" MODIFIED_BY="Clare Dooley">
<P>Cumulative birth rates compare cleavage stage transfer compared to blastocyst transfer within one year; embryo freezing rate; cumulative pregnancy rate per woman; miscarriage rate; outcome of neonatal; monozygotic twinning; multiple pregnancy rate per transfer; live birth rate/per embryo</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-05-13 10:39:29 +1200" MODIFIED_BY="[Empty name]">
<P>May 2015</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-05-13 10:39:29 +1200" MODIFIED_BY="[Empty name]">
<P>Telephone:+86 025 68302608<BR/>Email: jyliu_nj@126.com</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-05-13 10:39:29 +1200" MODIFIED_BY="[Empty name]">
<P>ChiCTR-ICR-15006184</P>
<P>Recruitment status: pending</P>
<P>Jiangsu, China</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2016-06-22 23:15:25 +1200" MODIFIED_BY="Clare Dooley" STUDY_ID="STD-NCT01107002">
<CHAR_STUDY_NAME MODIFIED="2016-06-20 16:52:04 +1200" MODIFIED_BY="Clare Dooley">
<P>Comparison of 5 day embryo transfer with 2-3 day transfer in patients who failed to conceive in two or more day 2-3 embryo transfer cycle in Royan Institute</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-06-22 23:14:49 +1200" MODIFIED_BY="Clare Dooley">
<P>Prospective randomised clinical trial study divided into two groups. Random permuted blocks with a block size of 4 was used and complete allocation concealment</P>
<P>Single-blind (outcomes assessor)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 23:14:54 +1200" MODIFIED_BY="Clare Dooley">
<P>200 with infertility (two previous or more failed IVF/ICSI cycles)</P>
<P>18 Years to 40 Years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-22 23:15:02 +1200" MODIFIED_BY="Clare Dooley">
<P>Experimental: Day 5 embryo transfer group</P>
<P>Other group (day 2-3) not described (only mentioned in the title and objectives)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 23:15:16 +1200" MODIFIED_BY="Clare Dooley">
<P>Clinical pregnancy rate; live birth rate; implantation rate; miscarriage rate</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-05-13 10:39:33 +1200" MODIFIED_BY="[Empty name]">
<P>July 2008</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-05-13 10:39:33 +1200" MODIFIED_BY="[Empty name]">
<P>http://www.royaninstitute.org</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-06-22 23:15:25 +1200" MODIFIED_BY="Clare Dooley">
<P>Sponsor: Royan Institute</P>
<P>Study completion date: August 2010</P>
<P>ClinicalTrials.gov Identifier: NCT01107002<BR/>
</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2016-06-23 10:36:44 +1200" MODIFIED_BY="Clare Dooley" STUDY_ID="STD-NCT02639000">
<CHAR_STUDY_NAME MODIFIED="2016-06-22 23:15:58 +1200" MODIFIED_BY="Clare Dooley">
<P>Effects of blastocyst stage embryo transfer compared with cleavage stage embryo transfer in women &#8804; 38 years</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-06-23 10:36:44 +1200" MODIFIED_BY="Clare Dooley">
<P>Randomised parallel open-label<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-06-22 23:16:21 +1200" MODIFIED_BY="Clare Dooley">
<P>388 infertility (IVF with at least 4 fertilised eggs)</P>
<P>Age:18 Years to 37 Years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-22 23:16:47 +1200" MODIFIED_BY="Clare Dooley">
<P>Experimental: blastocyst: embryo transfer of at maximum 2 embryos at blastocyst stage</P>
<P>Active comparator: cleavage: embryo transfer of at maximum 2 embryos at cleavage stage<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-22 23:16:53 +1200" MODIFIED_BY="Clare Dooley">
<P>Pregnancy rate; multiple pregnancy rate; implantation rate</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-05-13 10:39:39 +1200" MODIFIED_BY="[Empty name]">
<P>July 2010</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-05-13 10:39:39 +1200" MODIFIED_BY="[Empty name]">
<P>+39-0282244505 paolo.levi_setti@humanitas.it</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-05-13 10:39:39 +1200" MODIFIED_BY="[Empty name]">
<P>Estimated study completion: April 2016 (still recruiting)</P>
<P>Sponsor: Istituto Clinico Humanitas</P>
<P>ClinicalTrials.gov Identifier: NCT02639000<BR/>
</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2016-06-25 07:30:03 +1200" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2016-06-22 23:01:33 +1200" MODIFIED_BY="Clare Dooley" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 15:34:27 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Aziminekoo-2015">
<DESCRIPTION>
<P>Not stated. Patients were randomly assigned to allocate in one of the two groups. In the first group or BS (n: 57), the culture was extended to day 5 and the embryos were transferred to the endometrium at the BS. In the second group or CS (n: 61), embryo culture was continued to day 3</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 15:57:38 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Brugnon-2010">
<DESCRIPTION>
<P>Computer-generated random list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-15 17:37:26 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bungum-2003">
<DESCRIPTION>
<P>Sealed envelope</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-09 19:51:41 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Coskun-2000">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-12 11:06:08 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Devreker-2000">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 16:30:56 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Elgindy-2011">
<DESCRIPTION>
<P>Computer-generated block randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-09 19:55:05 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Emiliani-2003">
<DESCRIPTION>
<P>Randomisation list with permuted blocks for each new cycle</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 16:36:53 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Fernandez_x002d_Shaw-2015">
<DESCRIPTION>
<P>Every patient entered the study only once. Randomisation was performed on day 1 of embryo culture by the embryologist using a computer-generated randomised list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-12 06:51:39 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fisch-2007">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 16:47:30 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Frattarelli-2003">
<DESCRIPTION>
<P>Computer-generated randomisation table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 16:48:16 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Gaafar-2015">
<DESCRIPTION>
<P>Randomisation was done by computer permuted blocks size of 4</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:25:07 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Gardner-1998">
<DESCRIPTION>
<P>Computer-generated random list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-15 17:39:07 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hreinsson-2004">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-15 17:39:19 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Karaki-2002">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-05 13:37:43 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kaur-2014">
<DESCRIPTION>
<P>Random allocation of patients was done equally so that study population in both groups was comparable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 18:00:31 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Kolibianakis-2004">
<DESCRIPTION>
<P>Computer-generated list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 18:04:32 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Levitas-2004">
<DESCRIPTION>
<P>Computer-generated randomisation list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-15 17:39:47 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Levron-2002">
<DESCRIPTION>
<P>Method of randomisation unknown</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 22:47:05 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Livingstone-2002">
<DESCRIPTION>
<P>Computer-generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-12 11:24:53 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Motta-1998">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-11 02:34:06 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pantos-2004">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 22:56:06 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Papanikolaou-2005">
<DESCRIPTION>
<P>Computer-generated list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-15 17:40:05 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Papanikolaou-2006">
<DESCRIPTION>
<P>Computer generation list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 23:01:33 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Rienzi-2002">
<DESCRIPTION>
<P>Computer-generated list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-12 11:48:17 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schillaci-2002">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-09 20:18:46 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ten-2011">
<DESCRIPTION>
<P>Distributed randomly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:10:55 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Van-der-Auwera-2002">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2016-06-23 10:42:50 +1200" MODIFIED_BY="Clare Dooley" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-05 13:36:55 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aziminekoo-2015">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-09 19:46:47 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Brugnon-2010">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-09 19:49:34 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bungum-2003">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-23 10:42:50 +1200" MODIFIED_BY="Clare Dooley" RESULT="NO" STUDY_ID="STD-Coskun-2000">
<DESCRIPTION>
<P>Patients were randomised to receive embryo transfer either at day 3 or day 5. An equal number of day 3 or day 5 labels placed in sealed envelopes in a block of 14 were kept in a box and an envelope was drawn by the embryologist as soon as a patient qualified for the study. The label was attached with adhesive to the patients' data collection sheet</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-12 11:06:03 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Devreker-2000">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:05:37 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Elgindy-2011">
<DESCRIPTION>
<P>Identical, sequentially numbered, dark-sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-09 19:55:08 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Emiliani-2003">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 16:37:03 +1200" MODIFIED_BY="Clare Dooley" RESULT="NO" STUDY_ID="STD-Fernandez_x002d_Shaw-2015">
<DESCRIPTION>
<P>The author replied that the allocation of participants was performed by the embryologists, blind to the clinical history of the participants. They gave participants a number for the study following the order of the computer-generated list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-12 06:51:41 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fisch-2007">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 16:47:33 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Frattarelli-2003">
<DESCRIPTION>
<P>The sequences of randomisation were concealed until intervention was assigned. Allocation was concealed but method not given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:13:28 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gaafar-2015">
<DESCRIPTION>
<P>Allocation by closed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-09 20:01:15 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gardner-1998">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-12 11:16:12 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hreinsson-2004">
<DESCRIPTION>
<P>Sealed envelope</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-12 11:19:15 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Karaki-2002">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-05 13:37:43 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kaur-2014">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-09 20:05:41 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kolibianakis-2004">
<DESCRIPTION>
<P>The sequence of randomisation was not concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-13 11:03:56 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Levitas-2004">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-12 11:23:17 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Levron-2002">
<DESCRIPTION>
<P>Sealed envelope</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-09 20:08:38 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Livingstone-2002">
<DESCRIPTION>
<P>Sealed envelope</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-12 11:25:08 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Motta-1998">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-11 02:34:11 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pantos-2004">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-12 11:25:57 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Papanikolaou-2005">
<DESCRIPTION>
<P>No concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 22:58:40 +1200" MODIFIED_BY="Clare Dooley" RESULT="NO" STUDY_ID="STD-Papanikolaou-2006">
<DESCRIPTION>
<P>The randomisation list was not concealed from the physicians, but it did not explicitly state the treatment strategy, identifying the strategies only as &#8220;A&#8221; or &#8220;B&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-15 17:40:19 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rienzi-2002">
<DESCRIPTION>
<P>Method of allocation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-12 11:48:21 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schillaci-2002">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-09 20:18:50 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ten-2011">
<DESCRIPTION>
<P>Distributed randomly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-11 02:44:16 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-der-Auwera-2002">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2016-06-23 10:36:40 +1200" MODIFIED_BY="Clare Dooley" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-05 13:36:55 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aziminekoo-2015">
<DESCRIPTION>
<P>No effort for blindness is described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-11 03:10:51 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Brugnon-2010">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-12 10:51:09 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bungum-2003">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-12 11:05:10 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Coskun-2000">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-06 14:50:11 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Devreker-2000">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-06-23 10:36:40 +1200" MODIFIED_BY="Clare Dooley" RESULT="NO" STUDY_ID="STD-Elgindy-2011">
<DESCRIPTION>
<P>Open-label</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-02-15 17:38:14 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Emiliani-2003">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-05 13:37:19 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fernandez_x002d_Shaw-2015">
<DESCRIPTION>
<P>No effort for blindness is described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-06 14:50:28 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fisch-2007">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-12 11:09:38 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Frattarelli-2003">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-06-22 16:48:37 +1200" MODIFIED_BY="Clare Dooley" RESULT="NO" STUDY_ID="STD-Gaafar-2015">
<DESCRIPTION>
<P>Single-blind (unclear who was blinded)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-06 14:51:00 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gardner-1998">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-12 11:18:15 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hreinsson-2004">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-12 11:19:43 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Karaki-2002">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-06 14:51:17 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kaur-2014">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-06 14:51:36 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kolibianakis-2004">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-06 14:51:42 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Levitas-2004">
<DESCRIPTION>
<P>Not clear which of participants or outcome assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-06 14:51:48 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Levron-2002">
<DESCRIPTION>
<P>Blinded, unclear who was blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-06 14:51:53 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Livingstone-2002">
<DESCRIPTION>
<P>Not possible to blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-06 14:51:58 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Motta-1998">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-11 02:34:22 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Pantos-2004">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-12 11:26:11 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Papanikolaou-2005">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-12 11:27:50 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Papanikolaou-2006">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-12 11:38:13 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rienzi-2002">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-06 14:52:18 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schillaci-2002">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-05-06 14:52:23 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ten-2011">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-01-12 12:00:22 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Van-der-Auwera-2002">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2016-06-22 16:38:20 +1200" MODIFIED_BY="Clare Dooley" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-06-22 15:34:42 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Aziminekoo-2015">
<DESCRIPTION>
<P>Outcomes reported in all 118 randomised women. BS group (n = 57) and CS group (n = 61)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-11-11 11:51:31 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Brugnon-2010">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-06-09 19:51:14 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bungum-2003">
<DESCRIPTION>
<P>No dropouts or exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-12 11:05:23 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Coskun-2000">
<DESCRIPTION>
<P>No dropouts or exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-13 11:02:13 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Devreker-2000">
<DESCRIPTION>
<P>No dropouts or exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-05-06 12:05:44 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Elgindy-2011">
<DESCRIPTION>
<P>Intention-to-treat analyses </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-12 11:08:15 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Emiliani-2003">
<DESCRIPTION>
<P>10 women were subsequently excluded for protocol violations</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-06-22 16:38:20 +1200" MODIFIED_BY="Clare Dooley" RESULT="NO" STUDY_ID="STD-Fernandez_x002d_Shaw-2015">
<DESCRIPTION>
<P>No analysis by intention-to-treat was performed. There were 16 patients eligible for the study that were excluded from it: 10 patients with a perceived risk of early ovarian hyperstimulation had their embryo transfer performed on day 5; and 6 patients were not randomised due to organisational reasons that fixed the transfer day on a given date</P>
<P>60 women were allocated to each group, but the final distribution of patients was: day 3 group n = 46; and day 5 group n = 58</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-12 11:08:27 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fisch-2007">
<DESCRIPTION>
<P>No dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-12 11:10:02 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Frattarelli-2003">
<DESCRIPTION>
<P>Intention-to-treat analysis was applied</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-05-05 14:26:44 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gaafar-2015">
<DESCRIPTION>
<P>326 were eligible. 126 cases had day 2/3 transfer and 126 had blastocyst transfer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-05-06 09:30:32 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gardner-1998">
<DESCRIPTION>
<P>Number of exclusions not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-12 11:18:49 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hreinsson-2004">
<DESCRIPTION>
<P>No dropouts or exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-12 11:20:03 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Karaki-2002">
<DESCRIPTION>
<P>No dropouts or exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-05-06 12:16:28 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaur-2014">
<DESCRIPTION>
<P>Outcomes reported for all women randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-12 11:20:56 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kolibianakis-2004">
<DESCRIPTION>
<P>No dropouts or exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-12 11:21:39 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Levitas-2004">
<DESCRIPTION>
<P>No dropouts or exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-06-21 09:49:11 +1200" MODIFIED_BY="Clare Dooley" RESULT="NO" STUDY_ID="STD-Levron-2002">
<DESCRIPTION>
<P>20 women were excluded post-randomisation as they did not have a transfer, not clear from which group they came</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-05-23 16:40:07 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Livingstone-2002">
<DESCRIPTION>
<P>20 recruited but not randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-15 17:39:54 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Motta-1998">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-05-06 12:10:02 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pantos-2004">
<DESCRIPTION>
<P>No dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-12 11:26:37 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Papanikolaou-2005">
<DESCRIPTION>
<P>No dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-12 11:27:34 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Papanikolaou-2006">
<DESCRIPTION>
<P>Intention-to-treat analysis was applied</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-01-12 11:46:11 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rienzi-2002">
<DESCRIPTION>
<P>No dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-05-06 12:10:19 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schillaci-2002">
<DESCRIPTION>
<P>No dropouts or exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-24 02:35:57 +1300" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ten-2011">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-06-12 12:32:30 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-der-Auwera-2002">
<DESCRIPTION>
<P>Fewer than 10% dropped out (66 and 70 were allocated and 63 and 66 were finally included)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2016-06-22 17:26:48 +1200" MODIFIED_BY="Clare Dooley" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:25:34 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Aziminekoo-2015">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:25:37 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Brugnon-2010">
<DESCRIPTION>
<P>Reported live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 16:08:28 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Bungum-2003">
<DESCRIPTION>
<P>Unclear - no protocol published or registered, did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 16:18:08 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Coskun-2000">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:25:39 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Devreker-2000">
<DESCRIPTION>
<P>Reported live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 16:31:23 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Elgindy-2011">
<DESCRIPTION>
<P>Trial registration number: ACTRN12611 000028909 . Reported live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:25:41 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Emiliani-2003">
<DESCRIPTION>
<P>Reported live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 16:37:51 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Fernandez_x002d_Shaw-2015">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-12 06:51:33 +1300" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fisch-2007">
<DESCRIPTION>
<P>Preliminary data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 16:47:41 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Frattarelli-2003">
<DESCRIPTION>
<P>Reported live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-05 14:26:44 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gaafar-2015">
<DESCRIPTION>
<P>Trial registration number: PACTR201308000581376</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:25:14 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Gardner-1998">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:07 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Hreinsson-2004">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:09 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Karaki-2002">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:11 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Kaur-2014">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:14 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Kolibianakis-2004">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:20 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Levitas-2004">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:22 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Levron-2002">
<DESCRIPTION>
<P>Reported live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:29 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Livingstone-2002">
<DESCRIPTION>
<P>Live births and multiple pregnancy rate reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:34 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Motta-1998">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:36 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Pantos-2004">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:38 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Papanikolaou-2005">
<DESCRIPTION>
<P>Reported live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:39 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Papanikolaou-2006">
<DESCRIPTION>
<P>Reported live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:41 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Rienzi-2002">
<DESCRIPTION>
<P>Reported live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:43 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Schillaci-2002">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:46 +1200" MODIFIED_BY="Clare Dooley" RESULT="UNKNOWN" STUDY_ID="STD-Ten-2011">
<DESCRIPTION>
<P>No protocol is available to check if there was selective reporting. Did not report live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-22 17:26:48 +1200" MODIFIED_BY="Clare Dooley" RESULT="YES" STUDY_ID="STD-Van-der-Auwera-2002">
<DESCRIPTION>
<P>Reported live births</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2016-06-25 07:30:03 +1200" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-05 13:36:55 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aziminekoo-2015">
<DESCRIPTION>
<P>Fresh and frozen cycles results are mixed in the report</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 11:56:27 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brugnon-2010">
<DESCRIPTION>
<P>No other potential source of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 11:56:35 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bungum-2003">
<DESCRIPTION>
<P>No other potential source of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-20 16:51:15 +1200" MODIFIED_BY="Clare Dooley" RESULT="NO" STUDY_ID="STD-Coskun-2000">
<DESCRIPTION>
<P>Reported no provision for day 5 freezing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 11:57:33 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Devreker-2000">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 11:57:40 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Elgindy-2011">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 11:57:45 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Emiliani-2003">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:43:02 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fernandez_x002d_Shaw-2015">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 11:57:56 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fisch-2007">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 11:58:02 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Frattarelli-2003">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:01:08 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gaafar-2015">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-09 01:11:50 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gardner-1998">
<DESCRIPTION>
<P>No age limit</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:01:15 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hreinsson-2004">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:01:21 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Karaki-2002">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:01:25 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaur-2014">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:01:30 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kolibianakis-2004">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:01:35 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Levitas-2004">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:01:40 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Levron-2002">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-25 07:30:03 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Livingstone-2002">
<DESCRIPTION>
<P>Single blastocyst transfer (day 5) but double embryo transfer (day 3)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:01:52 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Motta-1998">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:02:06 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pantos-2004">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:02:11 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Papanikolaou-2005">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:02:18 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Papanikolaou-2006">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:02:23 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rienzi-2002">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:43:10 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schillaci-2002">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:11:46 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ten-2011">
<DESCRIPTION>
<P>Insufficient information: it is an abstract</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-06 12:02:37 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Van-der-Auwera-2002">
<DESCRIPTION>
<P>No other source of potential bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2016-06-29 16:16:56 +1200" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2016-06-29 16:16:56 +1200" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2016-06-20 19:49:40 +1200" MODIFIED_BY="Clare Dooley">Blastocyst stage versus cleavage stage embryo transfer for assisted reproductive technology</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Blastocyst stage versus cleavage stage embryo transfer for assisted reproductive technology</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Population:</B> Couples with subfertility<BR/>
<B>Settings:</B> Assisted reproductive technology<BR/>
<B>Intervention:</B> Blastocyst stage embryo transfer<BR/>
<B>Comparison: </B>Cleavage stage embryo transfer</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes per couple</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No. of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Cleavage stage embryo transfer</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Blastocyst stage</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Live birth rate</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>286 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>372 per 1000</B>
</P>
<P>
<B>(324 to 421)</B>
</P>
<P>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>OR 1.48 </B>
<BR/>(1.20 to 1.82)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>1630</P>
<P>(13 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>low<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Cumulative pregnancy rate</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>481 per 1000</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>452 per 1000</P>
<P>(372 to 530)</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>OR 0.89</B>
</P>
<P>(0.64 to 1.22)</P>
</TD>
<TD VALIGN="TOP">
<P>632</P>
<P>(5 studies)</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>&#8853;&#8861;&#8861;&#8861;</B>
<BR/>very low<SUP>2,3,4</SUP>
</P>
</TD>
<TD VALIGN="TOP">
<P>I<SUP>2 </SUP>= 71%, attributable to the use of vitrification in one study and slow freezing in the other four</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Clinical pregnancy rate </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>362 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>425 per 1000</B>
<BR/>(393 to 455)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>OR 1.30</B>
<BR/>(1.14 to 1.47)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>4031<BR/>(27 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>moderate<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Multiple pregnancy rate</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>122 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>127 per 1000</B>
<BR/>(103 to 156)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>OR 1.05 </B>
<BR/>(0.83 to 1.33)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>3019<BR/>(19 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>low<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Miscarriage rate</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>68 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>78 per 1000</B>
<BR/>(68 to 119)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>OR 1.15</B>
<BR/>(0.88 to 1.50)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2917<BR/>(18 studies)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>low<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Embryo freezing rate</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>594 per 1000</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>412 per 1000</B>
</P>
<P>(369 to 455)</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>OR 0.48</B>
</P>
<P>(0.40 to 0.57)</P>
</TD>
<TD VALIGN="TOP">
<P>2292</P>
<P>(14 studies)</P>
</TD>
<TD VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>low<SUP>2,4</SUP>
</P>
</TD>
<TD VALIGN="TOP">
<P>I<SUP>2 </SUP>= 84%. Direction of effect largely consistent</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Failure rate to transfer any embryos</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>11 per 1000</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>26 per 1000</B>
</P>
<P>(19 to 37)</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>OR 2.50</B>
</P>
<P>(1.76 to 3.55)</P>
</TD>
<TD VALIGN="TOP">
<P>2577</P>
<P>(17 studies)</P>
</TD>
<TD VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>moderate<SUP>2</SUP>
</P>
</TD>
<TD VALIGN="TOP">
<P>I<SUP>2 </SUP>= 36%</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> is the median control group risk across studies. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>OR:</B> odds ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Downgraded two levels for very serious risk of bias: several studies did not describe acceptable methods of sequence generation and/or allocation concealment, several at unclear or high risk of attrition bias, none clearly had blinded outcome assessment, moreover sensitivity analysis restricted to five studies with clear description of allocation concealment results in a non-significant effect (OR 1.38, 95% CI 0.96 to 1.99).<BR/>
<SUP>2</SUP>Downgraded one level for serious risk of bias: several studies did not describe acceptable methods of sequence generation and/or allocation concealment, several at unclear or high risk of attrition bias, none clearly had blinded outcome assessment.<BR/>
<SUP>3</SUP>Downgraded one level for serious imprecision: findings compatible with benefit in either group or with no effect.<BR/>
<SUP>4</SUP>Downgraded one level for serious inconsistency.<BR/>
</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2016-06-29 16:59:41 +1200" MODIFIED_BY="Helen E Nagels">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2016-06-29 16:59:41 +1200" MODIFIED_BY="Helen E Nagels" NO="1">
<TITLE>Culture techniques of included studies</TITLE>
<TABLE COLS="3" ROWS="28">
<TR>
<TH>
<P>Trial</P>
</TH>
<TH>
<P>Culture technique day 2/3</P>
</TH>
<TH>
<P>Culture technique day 5/6</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK>
</P>
</TD>
<TD>
<P>Sydney IVF cleavage medium, Cook</P>
</TD>
<TD>
<P>Sydney IVF blastocyst medium</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>
</P>
</TD>
<TD>
<P>G series&#8482; medium (Vitrolife, Sweden)</P>
</TD>
<TD>
<P>G series&#8482; medium (Vitrolife, Sweden)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bungum-2003" TYPE="STUDY">Bungum 2003</LINK>
</P>
</TD>
<TD>
<P>Sequential G1 Vitrolife</P>
</TD>
<TD>
<P>Sequential G1/G2 Vitrolife</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Coskun-2000" TYPE="STUDY">Coskun 2000</LINK>
</P>
</TD>
<TD>
<P>Sequential Medicult</P>
</TD>
<TD>
<P>Sequential G1/G2 Vitrolife</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Devreker-2000" TYPE="STUDY">Devreker 2000</LINK>
</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Elgindy-2011" TYPE="STUDY">Elgindy 2011</LINK>
</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>
</P>
</TD>
<TD>
<P>In-house sequential (based on G1/G2)</P>
</TD>
<TD>
<P>In-house sequential (based on G1/G2)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>
</P>
</TD>
<TD>
<P>Sequential G1 Vitrolife</P>
</TD>
<TD>
<P>Sequential G1/G2 Vitrolife</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Fisch-2007" TYPE="STUDY">Fisch 2007</LINK>
</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Frattarelli-2003" TYPE="STUDY">Frattarelli 2003</LINK>
</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK>
</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gardner-1998" TYPE="STUDY">Gardner 1998</LINK>
</P>
</TD>
<TD>
<P>Single Hams F10 In-house</P>
</TD>
<TD>
<P>Sequential G1/G2 In-house</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Hreinsson-2004" TYPE="STUDY">Hreinsson 2004</LINK>
</P>
</TD>
<TD>
<P>Vitrolife IVF</P>
</TD>
<TD>
<P>Sequential G1/G2 or CCM Vitrolife</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Karaki-2002" TYPE="STUDY">Karaki 2002</LINK>
</P>
</TD>
<TD>
<P>Medicult</P>
</TD>
<TD>
<P>Sequential G1/G2 Vitrolife</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kaur-2014" TYPE="STUDY">Kaur 2014</LINK>
</P>
</TD>
<TD>
<P>Cleavage medium</P>
</TD>
<TD>
<P>G2 Plus media</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kolibianakis-2004" TYPE="STUDY">Kolibianakis 2004</LINK>
</P>
</TD>
<TD>
<P>Sequential G1 Vitrolife</P>
</TD>
<TD>
<P>Sequential G1/G2 Vitrolife</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Levitas-2004" TYPE="STUDY">Levitas 2004</LINK>
</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>Sequential - G1/G2 Vitrolife</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Levron-2002" TYPE="STUDY">Levron 2002</LINK>
</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Livingstone-2002" TYPE="STUDY">Livingstone 2002</LINK>
</P>
</TD>
<TD>
<P>Sequential - Sydney IVF Cook</P>
</TD>
<TD>
<P>Sequential - Sydney IVF Cook</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Motta-1998" TYPE="STUDY">Motta 1998</LINK>
</P>
</TD>
<TD>
<P>Sequential - Irvines P1</P>
</TD>
<TD>
<P>Sequential - Irvines P1 then Blast media</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Pantos-2004" TYPE="STUDY">Pantos 2004</LINK>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Papanikolaou-2005" TYPE="STUDY">Papanikolaou 2005</LINK>
</P>
</TD>
<TD>
<P>Sequential - Vitrolife G1/G2 GII or GIII</P>
</TD>
<TD>
<P>Sequential - Vitrolife G1/G2 GII or GIII</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>
</P>
</TD>
<TD>
<P>Assume sequential - Vitrolife G1/G2</P>
</TD>
<TD>
<P>Assume sequential - Vitrolife G1/G2</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>
</P>
</TD>
<TD>
<P>Sequential G1 Vitrolife</P>
</TD>
<TD>
<P>Sequential G1/G2 Vitrolife</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Schillaci-2002" TYPE="STUDY">Schillaci 2002</LINK>
</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Ten-2011" TYPE="STUDY">Ten 2011</LINK>
</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>
</P>
</TD>
<TD>
<P>Sequential both Cook and Vitrolife</P>
</TD>
<TD>
<P>Sequential both Cook and Vitrolife</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CCM - it is a trade mark from Vitrolife of medium for blastocyst culture<BR/>IVF - in vitro fertilisation<BR/>NS - not stated<BR/>G1/G2 - sequential media from Vitrolife</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2016-06-29 16:59:15 +1200" MODIFIED_BY="Helen E Nagels" NO="2">
<TITLE MODIFIED="2016-06-20 16:53:44 +1200" MODIFIED_BY="Clare Dooley">Blastocyst and implantation rate (in day 5 to 6 transfers)</TITLE>
<TABLE COLS="5" ROWS="28">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Blastocyst rate</P>
</TH>
<TH>
<P>Implantation D2/3</P>
</TH>
<TH>
<P>Implantation D5/6</P>
</TH>
<TH>
<P>Other</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK>
</P>
</TD>
<TD>
<P>22.4%</P>
</TD>
<TD>
<P>21/173; 12.1%</P>
</TD>
<TD>
<P>22/152; 14.5%</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>24/52; 46.2%</P>
</TD>
<TD>
<P>23/55; 41.8%</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bungum-2003" TYPE="STUDY">Bungum 2003</LINK>
</P>
</TD>
<TD>
<P>55.2%</P>
</TD>
<TD>
<P>50/114; 43.9%</P>
</TD>
<TD>
<P>44/120; 36.7%</P>
</TD>
<TD>
<P>2/61 patients had only 1 blastocyst</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Coskun-2000" TYPE="STUDY">Coskun 2000</LINK>
</P>
</TD>
<TD>
<P>28%</P>
</TD>
<TD>
<P>50/235; 21.3%</P>
</TD>
<TD>
<P>52/218; 23.9%</P>
</TD>
<TD>
<P>77% patients had at least 1 blastocyst</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Devreker-2000" TYPE="STUDY">Devreker 2000</LINK>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>1/34; 2.9%</P>
</TD>
<TD>
<P>8/19; 42.1%</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Elgindy-2011" TYPE="STUDY">Elgindy 2011</LINK>
</P>
</TD>
<TD>
<P>97%</P>
</TD>
<TD>
<P>71/197; 36%</P>
</TD>
<TD>
<P>53/280; 19%</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>
</P>
</TD>
<TD>
<P>48%</P>
</TD>
<TD>
<P>57/197; 28.9%</P>
</TD>
<TD>
<P>50/168; 29.8%</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>
</P>
</TD>
<TD>
<P>67.7 %</P>
</TD>
<TD>
<P>20/71; 28.1%</P>
</TD>
<TD>
<P>36/84; 42.8%</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Fisch-2007" TYPE="STUDY">Fisch 2007</LINK>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>11/12; 92%</P>
</TD>
<TD>
<P>4/8; 50%</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Frattarelli-2003" TYPE="STUDY">Frattarelli 2003</LINK>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>18/69; 26.1%</P>
</TD>
<TD>
<P>23/53; 43.4%</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gardner-1998" TYPE="STUDY">Gardner 1998</LINK>
</P>
</TD>
<TD>
<P>46.5%</P>
</TD>
<TD>
<P>64/174; 36.8%</P>
</TD>
<TD>
<P>53/95; 55.8%</P>
</TD>
<TD>
<P>85% women had at least 2 blastocysts</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Hreinsson-2004" TYPE="STUDY">Hreinsson 2004</LINK>
</P>
</TD>
<TD>
<P>33%</P>
</TD>
<TD>
<P>29/139; 20.9%</P>
</TD>
<TD>
<P>24/114; 21.1%</P>
</TD>
<TD>
<P>2 morula replaced (one implanted). 60% pregnancy rate when top quality blasts transferred</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Karaki-2002" TYPE="STUDY">Karaki 2002</LINK>
</P>
</TD>
<TD>
<P>33%</P>
</TD>
<TD>
<P>37/291 12.7%</P>
</TD>
<TD>
<P>37/142; 26.1%</P>
</TD>
<TD>
<P>9/80 cancelled due to lack of blastocysts (unselected)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kaur-2014" TYPE="STUDY">Kaur 2014</LINK>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>66/309; 21.4%</P>
</TD>
<TD>
<P>102/290; 35.2%</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kolibianakis-2004" TYPE="STUDY">Kolibianakis 2004</LINK>
</P>
</TD>
<TD>
<P>50.7%</P>
</TD>
<TD>
<P>96/234; 41.0%</P>
</TD>
<TD>
<P>94/226; 41.6%</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Levitas-2004" TYPE="STUDY">Levitas 2004</LINK>
</P>
</TD>
<TD>
<P>43%</P>
</TD>
<TD>
<P>4/56; 7.1%</P>
</TD>
<TD>
<P>10/24; 4.2%</P>
</TD>
<TD>
<P>Day 5-7 26% cancelled due to lack of blastocysts (poor prognosis)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Levron-2002" TYPE="STUDY">Levron 2002</LINK>
</P>
</TD>
<TD>
<P>34.2%</P>
</TD>
<TD>
<P>53/137; 38.7%</P>
</TD>
<TD>
<P>20/99; 20.2%</P>
</TD>
<TD>
<P>6.5% cancelled due to lack of blastocysts (good prognosis)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Livingstone-2002" TYPE="STUDY">Livingstone 2002</LINK>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Motta-1998" TYPE="STUDY">Motta 1998</LINK>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>51/262; 19.5%</P>
</TD>
<TD>
<P>36/120; 30.0%</P>
</TD>
<TD>
<P>6/58 cycles cancelled D5 no blastocysts</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Pantos-2004" TYPE="STUDY">Pantos 2004</LINK>
</P>
</TD>
<TD>
<P>44.6%</P>
</TD>
<TD>
<P>15.8%</P>
</TD>
<TD>
<P>15.8%</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Papanikolaou-2005" TYPE="STUDY">Papanikolaou 2005</LINK>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>35/170; 20.6%</P>
</TD>
<TD>
<P>59/158; 37.3%</P>
</TD>
<TD>
<P>4/158 women had only 1 blast transferred due to lack of availability and 1 had it on request</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>38/156; 24%</P>
</TD>
<TD>
<P>58/149; 38.9%</P>
</TD>
<TD>
<P>Number of patients with no embryos available D3: 8 and D5: 11</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>
</P>
</TD>
<TD>
<P>44.8%</P>
</TD>
<TD>
<P>34/96; 35.4%</P>
</TD>
<TD>
<P>38/100; 38.0%</P>
</TD>
<TD>
<P>Good prognosis</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Schillaci-2002" TYPE="STUDY">Schillaci 2002</LINK>
</P>
</TD>
<TD>
<P>60.3%</P>
</TD>
<TD>
<P>23/168; 13.7%</P>
</TD>
<TD>
<P>26/110; 23.6%</P>
</TD>
<TD>
<P>Unselected population nil cancellations D5</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Ten-2011" TYPE="STUDY">Ten 2011</LINK>
</P>
</TD>
<TD>
<P>Not stated</P>
</TD>
<TD>
<P>21/54; 38.9%</P>
</TD>
<TD>
<P>26/56; 46.4%</P>
</TD>
<TD>
<P>Good prognosis</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>
</P>
</TD>
<TD>
<P>44.7%</P>
</TD>
<TD>
<P>31/106; 29.2%</P>
</TD>
<TD>
<P>41/90; 45.6%</P>
</TD>
<TD>
<P>27% cancellation D5 (unselected population)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2016-06-29 16:59:00 +1200" MODIFIED_BY="Helen E Nagels" NO="3">
<TITLE>Mean number of embryos transferred</TITLE>
<TABLE COLS="3" ROWS="28">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Day 2/3</P>
</TH>
<TH>
<P>Day 5/6</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Aziminekoo-2015" TYPE="STUDY">Aziminekoo 2015</LINK>
</P>
</TD>
<TD>
<P>2.8</P>
</TD>
<TD>
<P>2.6</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Brugnon-2010" TYPE="STUDY">Brugnon 2010</LINK>
</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bungum-2003" TYPE="STUDY">Bungum 2003</LINK>
</P>
</TD>
<TD>
<P>2.00</P>
</TD>
<TD>
<P>1.97</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Coskun-2000" TYPE="STUDY">Coskun 2000</LINK>
</P>
</TD>
<TD>
<P>2.3</P>
</TD>
<TD>
<P>2.2</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Devreker-2000" TYPE="STUDY">Devreker 2000</LINK>
</P>
</TD>
<TD>
<P>2.83</P>
</TD>
<TD>
<P>1.73</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Elgindy-2011" TYPE="STUDY">Elgindy 2011</LINK>
</P>
</TD>
<TD>
<P>2.8</P>
</TD>
<TD>
<P>1.97</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Emiliani-2003" TYPE="STUDY">Emiliani 2003</LINK>
</P>
</TD>
<TD>
<P>2.1</P>
</TD>
<TD>
<P>1.9</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Fernandez_x002d_Shaw-2015" TYPE="STUDY">Fernandez-Shaw 2015</LINK>
</P>
</TD>
<TD>
<P>1.5</P>
</TD>
<TD>
<P>1.4</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Fisch-2007" TYPE="STUDY">Fisch 2007</LINK>
</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Frattarelli-2003" TYPE="STUDY">Frattarelli 2003</LINK>
</P>
</TD>
<TD>
<P>2.96</P>
</TD>
<TD>
<P>2.04</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gaafar-2015" TYPE="STUDY">Gaafar 2015</LINK>
</P>
</TD>
<TD>
<P>NS</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gardner-1998" TYPE="STUDY">Gardner 1998</LINK>
</P>
</TD>
<TD>
<P>3.7</P>
</TD>
<TD>
<P>2.2</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Hreinsson-2004" TYPE="STUDY">Hreinsson 2004</LINK>
</P>
</TD>
<TD>
<P>1.8</P>
</TD>
<TD>
<P>1.9</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Karaki-2002" TYPE="STUDY">Karaki 2002</LINK>
</P>
</TD>
<TD>
<P>3.5</P>
</TD>
<TD>
<P>2.0</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kaur-2014" TYPE="STUDY">Kaur 2014</LINK>
</P>
</TD>
<TD>
<P>2.04</P>
</TD>
<TD>
<P>1.93</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kolibianakis-2004" TYPE="STUDY">Kolibianakis 2004</LINK>
</P>
</TD>
<TD>
<P>1.9</P>
</TD>
<TD>
<P>1.8</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Levitas-2004" TYPE="STUDY">Levitas 2004</LINK>
</P>
</TD>
<TD>
<P>3.4</P>
</TD>
<TD>
<P>1.9</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Levron-2002" TYPE="STUDY">Levron 2002</LINK>
</P>
</TD>
<TD>
<P>3.1</P>
</TD>
<TD>
<P>2.3</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Livingstone-2002" TYPE="STUDY">Livingstone 2002</LINK>
</P>
</TD>
<TD>
<P>2.0</P>
</TD>
<TD>
<P>1.0</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Motta-1998" TYPE="STUDY">Motta 1998</LINK>
</P>
</TD>
<TD>
<P>4.6</P>
</TD>
<TD>
<P>2.3</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Pantos-2004" TYPE="STUDY">Pantos 2004</LINK>
</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>3.4</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Papanikolaou-2005" TYPE="STUDY">Papanikolaou 2005</LINK>
</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>1.97</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Papanikolaou-2006" TYPE="STUDY">Papanikolaou 2006</LINK>
</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Rienzi-2002" TYPE="STUDY">Rienzi 2002</LINK>
</P>
</TD>
<TD>
<P>2.0</P>
</TD>
<TD>
<P>2.0</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Schillaci-2002" TYPE="STUDY">Schillaci 2002</LINK>
</P>
</TD>
<TD>
<P>2.8</P>
</TD>
<TD>
<P>1.8</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Ten-2011" TYPE="STUDY">Ten 2011</LINK>
</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Van-der-Auwera-2002" TYPE="STUDY">Van der Auwera 2002</LINK>
</P>
</TD>
<TD>
<P>1.86</P>
</TD>
<TD>
<P>1.87</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>NS - not stated</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2016-06-23 15:04:49 +1200" MODIFIED_BY="Helen E Nagels">
<COMPARISON ID="CMP-001" MODIFIED="2016-06-23 15:04:49 +1200" MODIFIED_BY="Helen E Nagels" NO="1">
<NAME>Blastocyst versus cleavage stage transfer: Live birth rate following fresh transfer</NAME>
<DICH_OUTCOME CHI2="21.827955282743304" CI_END="1.8181990501246135" CI_START="1.2001952624510064" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="OR" EFFECT_SIZE="1.477225062795944" ESTIMABLE="YES" EVENTS_1="317" EVENTS_2="248" I2="45.02462624391148" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.2596414265419688" LOG_CI_START="0.07925190813625461" LOG_EFFECT_SIZE="0.1694466673391117" METHOD="MH" MODIFIED="2016-06-23 13:43:30 +1200" MODIFIED_BY="Helen E Nagels" NO="1" P_CHI2="0.0394939293899117" P_Q="1.0" P_Z="2.3128801061233364E-4" Q="0.0" RANDOM="NO" SCALE="76.92911967604381" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="811" TOTAL_2="819" WEIGHT="100.00000000000004" Z="3.6821359491414687">
<NAME>Live birth per couple</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1323325505466904" CI_START="0.4542002234307056" EFFECT_SIZE="0.9841269841269841" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.3288549365669254" LOG_CI_START="-0.34275265647758113" LOG_EFFECT_SIZE="-0.006948859955327855" MODIFIED="2016-06-16 15:34:14 +1200" MODIFIED_BY="[Empty name]" ORDER="335" O_E="0.0" SE="0.39450562466554573" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15563468789275242" WEIGHT="8.816004400865216"/>
<DICH_DATA CI_END="47.30448497075968" CI_START="0.35970426505050973" EFFECT_SIZE="4.125" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.6749023184484557" LOG_CI_START="-0.44405441267656814" LOG_EFFECT_SIZE="0.6154239528859439" MODIFIED="2016-06-16 15:34:13 +1200" MODIFIED_BY="[Empty name]" ORDER="1038" O_E="0.0" SE="1.2446856728678226" STUDY_ID="STD-Devreker-2000" TOTAL_1="11" TOTAL_2="12" VAR="1.549242424242424" WEIGHT="0.4734613066779989"/>
<DICH_DATA CI_END="3.550901669974837" CI_START="1.1399247704326718" EFFECT_SIZE="2.011904761904762" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="35" LOG_CI_END="0.5503386461741581" LOG_CI_START="0.056876190929425696" LOG_EFFECT_SIZE="0.30360741855179185" MODIFIED="2016-04-27 15:22:37 +1200" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="0.2898622888893043" STUDY_ID="STD-Elgindy-2011" TOTAL_1="100" TOTAL_2="100" VAR="0.08402014652014651" WEIGHT="11.434090556273674"/>
<DICH_DATA CI_END="1.4468409003152891" CI_START="0.4296647287161857" EFFECT_SIZE="0.7884519661523146" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="41" LOG_CI_END="0.16042077720471234" LOG_CI_START="-0.36687029619426126" LOG_EFFECT_SIZE="-0.10322475949477444" MODIFIED="2016-06-16 15:34:12 +1200" MODIFIED_BY="[Empty name]" ORDER="1039" O_E="0.0" SE="0.30973338664746614" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09593477080410877" WEIGHT="15.99212470589934"/>
<DICH_DATA CI_END="7.306306786464181" CI_START="1.3856476655079193" EFFECT_SIZE="3.1818181818181817" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="11" LOG_CI_END="0.8636979039655835" LOG_CI_START="0.14165281441851768" LOG_EFFECT_SIZE="0.5026753591920505" MODIFIED="2016-06-16 15:34:12 +1200" MODIFIED_BY="[Empty name]" ORDER="404" O_E="0.0" SE="0.42413285978078336" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.17988868274582562" WEIGHT="4.367187365243417"/>
<DICH_DATA CI_END="8.020331553622599" CI_START="0.8945696134866786" EFFECT_SIZE="2.6785714285714284" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="8" LOG_CI_END="0.9041923220163901" LOG_CI_START="-0.048385857917428665" LOG_EFFECT_SIZE="0.4279032320494808" MODIFIED="2016-06-16 15:34:10 +1200" MODIFIED_BY="[Empty name]" ORDER="1040" O_E="0.0" SE="0.5595491382311638" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.3130952380952381" WEIGHT="2.674641065795011"/>
<DICH_DATA CI_END="7.664068316488292" CI_START="0.2557388477061593" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.884459367331142" LOG_CI_START="-0.592203295974666" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2016-06-16 15:34:10 +1200" MODIFIED_BY="[Empty name]" ORDER="406" O_E="0.0" SE="0.8673989580239028" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.7523809523809523" WEIGHT="1.512445840776941"/>
<DICH_DATA CI_END="1.0897004940304065" CI_START="0.15202643471034236" EFFECT_SIZE="0.4070175438596491" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.037307147790392986" LOG_CI_START="-0.8180808893535765" LOG_EFFECT_SIZE="-0.39038687078159173" MODIFIED="2016-06-15 11:37:47 +1200" MODIFIED_BY="[Empty name]" ORDER="1042" O_E="0.0" SE="0.5024591672574404" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.25246521476104056" WEIGHT="8.620941292428563"/>
<DICH_DATA CI_END="4.042197701850479" CI_START="0.5071754171862021" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="11" LOG_CI_END="0.606617550822775" LOG_CI_START="-0.2948418048879865" LOG_EFFECT_SIZE="0.1558878729673943" MODIFIED="2016-04-27 15:22:39 +1200" MODIFIED_BY="[Empty name]" ORDER="355" O_E="0.0" SE="0.5295216878402791" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="0.2803932178932179" WEIGHT="4.060532562357076"/>
<DICH_DATA CI_END="4.5966780927107385" CI_START="1.25264647157961" EFFECT_SIZE="2.399585921325052" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="23" LOG_CI_END="0.6624440909910074" LOG_CI_START="0.09782851943316032" LOG_EFFECT_SIZE="0.38013630521208386" MODIFIED="2016-06-16 15:34:09 +1200" MODIFIED_BY="[Empty name]" ORDER="1043" O_E="0.0" SE="0.331657981625234" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.10999701677572406" WEIGHT="8.017807402265076"/>
<DICH_DATA CI_END="2.7601276066221136" CI_START="1.058141992840884" EFFECT_SIZE="1.7089783281733746" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="38" LOG_CI_END="0.4409291608952004" LOG_CI_START="0.02454394990099163" LOG_EFFECT_SIZE="0.232736555398096" MODIFIED="2016-06-16 15:34:08 +1200" MODIFIED_BY="[Empty name]" ORDER="1044" O_E="0.0" SE="0.24458673407803433" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.05982267048695908" WEIGHT="17.53661562049571"/>
<DICH_DATA CI_END="2.0388340908923595" CI_START="0.41792071739600173" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="24" LOG_CI_END="0.3093818867190319" LOG_CI_START="-0.3789060992374557" LOG_EFFECT_SIZE="-0.03476210625921192" MODIFIED="2016-06-16 15:34:08 +1200" MODIFIED_BY="[Empty name]" ORDER="1045" O_E="0.0" SE="0.40430377003131995" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.16346153846153844" WEIGHT="8.667240654901327"/>
<DICH_DATA CI_END="3.152659585156811" CI_START="0.7173383638954878" EFFECT_SIZE="1.5038363171355498" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="17" LOG_CI_END="0.49867707944776324" LOG_CI_START="-0.14427594208721992" LOG_EFFECT_SIZE="0.17720056868027165" MODIFIED="2016-04-27 15:09:36 +1200" MODIFIED_BY="[Empty name]" ORDER="1046" O_E="0.0" SE="0.37767378751843517" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.14263748977852012" WEIGHT="7.826907226020669"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="19.793780274113438" CI_END="1.7098632974446901" CI_START="1.1691312292553548" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="OR" EFFECT_SIZE="1.4138792659913098" ESTIMABLE="YES" EVENTS_1="370" EVENTS_2="296" I2="34.32280332523662" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.23296139019412188" LOG_CI_START="0.06786326132676809" LOG_EFFECT_SIZE="0.15041232576044497" METHOD="MH" MODIFIED="2016-06-23 15:04:49 +1200" MODIFIED_BY="Helen E Nagels" NO="2" P_CHI2="0.10047305525900385" P_Q="0.8721258050079448" P_Z="3.5529151417820624E-4" Q="0.2736432059480751" RANDOM="NO" SCALE="70.83824325151889" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="981" TOTAL_2="987" WEIGHT="300.0" Z="3.5712426705724134">
<NAME>Live birth per couple: grouped by number of embryos transferred</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favoursday 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Day 5/6</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="9.504946354036814" CI_END="2.223472127178493" CI_START="1.0306601353143834" DF="5" EFFECT_SIZE="1.5138177180445291" ESTIMABLE="YES" EVENTS_1="95" EVENTS_2="73" I2="47.395810415316376" ID="CMP-001.02.01" LOG_CI_END="0.34703168962554365" LOG_CI_START="0.013115478386349697" LOG_EFFECT_SIZE="0.18007358400594667" MODIFIED="2016-06-23 15:03:54 +1200" MODIFIED_BY="Helen E Nagels" NO="1" P_CHI2="0.09054097480137013" P_Z="0.03452125108048605" STUDIES="6" TAU2="0.0" TOTAL_1="239" TOTAL_2="244" WEIGHT="99.99999999999997" Z="2.113929946131808">
<NAME>More cleavage stage than blastocyst embryos transferred</NAME>
<DICH_DATA CI_END="47.30448497075968" CI_START="0.35970426505050973" EFFECT_SIZE="4.125" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.6749023184484557" LOG_CI_START="-0.44405441267656814" LOG_EFFECT_SIZE="0.6154239528859439" ORDER="1052" O_E="0.0" SE="1.2446856728678226" STUDY_ID="STD-Devreker-2000" TOTAL_1="11" TOTAL_2="12" VAR="1.549242424242424" WEIGHT="1.6453275425327318"/>
<DICH_DATA CI_END="3.550901669974837" CI_START="1.1399247704326718" EFFECT_SIZE="2.011904761904762" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="35" LOG_CI_END="0.5503386461741581" LOG_CI_START="0.056876190929425696" LOG_EFFECT_SIZE="0.30360741855179185" MODIFIED="2012-02-23 13:54:59 +1300" MODIFIED_BY="[Empty name]" ORDER="324" O_E="0.0" SE="0.2898622888893043" STUDY_ID="STD-Elgindy-2011" TOTAL_1="100" TOTAL_2="100" VAR="0.08402014652014651" WEIGHT="39.734660152165475"/>
<DICH_DATA CI_END="8.020331553622599" CI_START="0.8945696134866786" EFFECT_SIZE="2.6785714285714284" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="8" LOG_CI_END="0.9041923220163901" LOG_CI_START="-0.048385857917428665" LOG_EFFECT_SIZE="0.4279032320494808" ORDER="1053" O_E="0.0" SE="0.5595491382311638" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.3130952380952381" WEIGHT="9.294657345535782"/>
<DICH_DATA CI_END="7.664068316488292" CI_START="0.2557388477061593" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.884459367331142" LOG_CI_START="-0.592203295974666" LOG_EFFECT_SIZE="0.146128035678238" ORDER="1054" O_E="0.0" SE="0.8673989580239028" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.7523809523809523" WEIGHT="5.255907427535115"/>
<DICH_DATA CI_END="1.0897004940304065" CI_START="0.15202643471034236" EFFECT_SIZE="0.4070175438596491" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.037307147790392986" LOG_CI_START="-0.8180808893535765" LOG_EFFECT_SIZE="-0.39038687078159173" ORDER="1055" O_E="0.0" SE="0.5024591672574404" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.25246521476104056" WEIGHT="29.95867233695016"/>
<DICH_DATA CI_END="4.042197701850479" CI_START="0.5071754171862021" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="11" LOG_CI_END="0.606617550822775" LOG_CI_START="-0.2948418048879865" LOG_EFFECT_SIZE="0.1558878729673943" MODIFIED="2012-05-23 16:58:34 +1200" MODIFIED_BY="[Empty name]" ORDER="356" O_E="0.0" SE="0.5295216878402791" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="0.2803932178932179" WEIGHT="14.110775195280718"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.4136880180800457" CI_END="2.2001331626799145" CI_START="0.977478524758465" DF="1" EFFECT_SIZE="1.4664865898222659" ESTIMABLE="YES" EVENTS_1="78" EVENTS_2="59" I2="29.26303489803094" ID="CMP-001.02.02" LOG_CI_END="0.3424489672162593" LOG_CI_START="-0.009892775294088527" LOG_EFFECT_SIZE="0.16627809596108536" MODIFIED="2016-06-23 15:04:16 +1200" MODIFIED_BY="Helen E Nagels" NO="2" P_CHI2="0.2344453586907712" P_Z="0.06432748540198636" STUDIES="2" TAU2="0.0" TOTAL_1="230" TOTAL_2="228" WEIGHT="100.0" Z="1.8499033193153445">
<NAME>Single embryo transfer</NAME>
<DICH_DATA CI_END="2.1323325505466904" CI_START="0.4542002234307056" EFFECT_SIZE="0.9841269841269841" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.3288549365669254" LOG_CI_START="-0.34275265647758113" LOG_EFFECT_SIZE="-0.006948859955327855" MODIFIED="2012-02-13 02:47:04 +1300" MODIFIED_BY="[Empty name]" ORDER="336" O_E="0.0" SE="0.39450562466554573" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15563468789275242" WEIGHT="33.45399582174043"/>
<DICH_DATA CI_END="2.7601276066221136" CI_START="1.058141992840884" EFFECT_SIZE="1.7089783281733746" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="38" LOG_CI_END="0.4409291608952004" LOG_CI_START="0.02454394990099163" LOG_EFFECT_SIZE="0.232736555398096" MODIFIED="2012-01-27 07:26:27 +1300" MODIFIED_BY="[Empty name]" ORDER="1056" O_E="0.0" SE="0.24458673407803433" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.05982267048695908" WEIGHT="66.54600417825958"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.559612919635967" CI_END="1.7505002220348076" CI_START="1.04132883417926" DF="5" EFFECT_SIZE="1.3501282736992222" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="164" I2="41.58614359149495" ID="CMP-001.02.03" LOG_CI_END="0.24316217018730427" LOG_CI_START="0.01758789408162291" LOG_EFFECT_SIZE="0.13037503213446358" MODIFIED="2016-06-23 15:04:49 +1200" MODIFIED_BY="Helen E Nagels" NO="3" P_CHI2="0.12797249470262384" P_Z="0.02347597882163058" STUDIES="6" TAU2="0.0" TOTAL_1="512" TOTAL_2="515" WEIGHT="100.00000000000001" Z="2.2655984705196177">
<NAME>Equal number of embryos transferred</NAME>
<DICH_DATA CI_END="2.1323325505466904" CI_START="0.4542002234307056" EFFECT_SIZE="0.9841269841269841" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.3288549365669254" LOG_CI_START="-0.34275265647758113" LOG_EFFECT_SIZE="-0.006948859955327855" MODIFIED="2012-05-15 20:33:54 +1200" MODIFIED_BY="[Empty name]" ORDER="349" O_E="0.0" SE="0.39450562466554573" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15563468789275242" WEIGHT="13.186418712690854"/>
<DICH_DATA CI_END="1.4468409003152891" CI_START="0.4296647287161857" EFFECT_SIZE="0.7884519661523146" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="41" LOG_CI_END="0.16042077720471234" LOG_CI_START="-0.36687029619426126" LOG_EFFECT_SIZE="-0.10322475949477444" ORDER="1057" O_E="0.0" SE="0.30973338664746614" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09593477080410877" WEIGHT="23.920003086302998"/>
<DICH_DATA CI_END="4.5966780927107385" CI_START="1.25264647157961" EFFECT_SIZE="2.399585921325052" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="23" LOG_CI_END="0.6624440909910074" LOG_CI_START="0.09782851943316032" LOG_EFFECT_SIZE="0.38013630521208386" ORDER="1058" O_E="0.0" SE="0.331657981625234" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.10999701677572406" WEIGHT="11.992526405000811"/>
<DICH_DATA CI_END="2.7601276066221136" CI_START="1.058141992840884" EFFECT_SIZE="1.7089783281733746" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="38" LOG_CI_END="0.4409291608952004" LOG_CI_START="0.02454394990099163" LOG_EFFECT_SIZE="0.232736555398096" MODIFIED="2012-05-15 20:33:15 +1200" MODIFIED_BY="[Empty name]" ORDER="348" O_E="0.0" SE="0.24458673407803433" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.05982267048695908" WEIGHT="26.2301543715968"/>
<DICH_DATA CI_END="2.0388340908923595" CI_START="0.41792071739600173" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="24" LOG_CI_END="0.3093818867190319" LOG_CI_START="-0.3789060992374557" LOG_EFFECT_SIZE="-0.03476210625921192" ORDER="1059" O_E="0.0" SE="0.40430377003131995" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.16346153846153844" WEIGHT="12.96390736238394"/>
<DICH_DATA CI_END="3.152659585156811" CI_START="0.7173383638954878" EFFECT_SIZE="1.5038363171355498" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="17" LOG_CI_END="0.49867707944776324" LOG_CI_START="-0.14427594208721992" LOG_EFFECT_SIZE="0.17720056868027165" ORDER="1060" O_E="0.0" SE="0.37767378751843517" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.14263748977852012" WEIGHT="11.7069900620246"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="21.827955282743304" CI_END="1.818199050124613" CI_START="1.2001952624510062" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="OR" EFFECT_SIZE="1.4772250627959438" ESTIMABLE="YES" EVENTS_1="317" EVENTS_2="248" I2="45.02462624391148" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.2596414265419687" LOG_CI_START="0.07925190813625453" LOG_EFFECT_SIZE="0.16944666733911162" METHOD="MH" MODIFIED="2016-06-16 17:55:39 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0394939293899117" P_Q="0.8093972661392673" P_Z="2.3128801061233497E-4" Q="0.4229311044669647" RANDOM="NO" SCALE="53.36" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="811" TOTAL_2="819" WEIGHT="300.0" Z="3.6821359491414674">
<NAME>Live birth rate per couple: grouped by prognosis</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="13.713823795396383" CI_END="1.9322594918030687" CI_START="1.17860689634185" DF="7" EFFECT_SIZE="1.5090972011640253" ESTIMABLE="YES" EVENTS_1="229" EVENTS_2="175" I2="48.9566141111581" ID="CMP-001.03.01" LOG_CI_END="0.28606544935205047" LOG_CI_START="0.07136897793887612" LOG_EFFECT_SIZE="0.17871721364546328" MODIFIED="2012-05-23 16:59:37 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.056511797474352754" P_Z="0.0011023224006868261" STUDIES="8" TAU2="0.0" TOTAL_1="565" TOTAL_2="561" WEIGHT="100.00000000000001" Z="3.2630187152760484">
<NAME>good prognostic factors</NAME>
<DICH_DATA CI_END="2.1323325505466904" CI_START="0.4542002234307056" EFFECT_SIZE="0.9841269841269841" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.3288549365669254" LOG_CI_START="-0.34275265647758113" LOG_EFFECT_SIZE="-0.006948859955327855" MODIFIED="2012-05-11 02:05:20 +1200" MODIFIED_BY="[Empty name]" ORDER="346" O_E="0.0" SE="0.39450562466554573" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15563468789275242" WEIGHT="12.62533706382036"/>
<DICH_DATA CI_END="3.550901669974837" CI_START="1.1399247704326718" EFFECT_SIZE="2.011904761904762" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="35" LOG_CI_END="0.5503386461741581" LOG_CI_START="0.056876190929425696" LOG_EFFECT_SIZE="0.30360741855179185" MODIFIED="2012-02-23 13:58:44 +1300" MODIFIED_BY="[Empty name]" ORDER="325" O_E="0.0" SE="0.2898622888893043" STUDY_ID="STD-Elgindy-2011" TOTAL_1="100" TOTAL_2="100" VAR="0.08402014652014651" WEIGHT="16.374679585803378"/>
<DICH_DATA CI_END="8.020331553622599" CI_START="0.8945696134866786" EFFECT_SIZE="2.6785714285714284" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="8" LOG_CI_END="0.9041923220163901" LOG_CI_START="-0.048385857917428665" LOG_EFFECT_SIZE="0.4279032320494808" ORDER="1061" O_E="0.0" SE="0.5595491382311638" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.3130952380952381" WEIGHT="3.8303344060358775"/>
<DICH_DATA CI_END="1.0897004940304065" CI_START="0.15202643471034236" EFFECT_SIZE="0.4070175438596491" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.037307147790392986" LOG_CI_START="-0.8180808893535765" LOG_EFFECT_SIZE="-0.39038687078159173" ORDER="1062" O_E="0.0" SE="0.5024591672574404" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.25246521476104056" WEIGHT="12.345988576597783"/>
<DICH_DATA CI_END="4.042197701850479" CI_START="0.5071754171862021" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="11" LOG_CI_END="0.606617550822775" LOG_CI_START="-0.2948418048879865" LOG_EFFECT_SIZE="0.1558878729673943" MODIFIED="2012-05-23 16:59:37 +1200" MODIFIED_BY="[Empty name]" ORDER="357" O_E="0.0" SE="0.5295216878402791" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="0.2803932178932179" WEIGHT="5.815059739914032"/>
<DICH_DATA CI_END="4.5966780927107385" CI_START="1.25264647157961" EFFECT_SIZE="2.399585921325052" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="23" LOG_CI_END="0.6624440909910074" LOG_CI_START="0.09782851943316032" LOG_EFFECT_SIZE="0.38013630521208386" ORDER="1063" O_E="0.0" SE="0.331657981625234" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.10999701677572406" WEIGHT="11.482244831508465"/>
<DICH_DATA CI_END="2.7601276066221136" CI_START="1.058141992840884" EFFECT_SIZE="1.7089783281733746" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="38" LOG_CI_END="0.4409291608952004" LOG_CI_START="0.02454394990099163" LOG_EFFECT_SIZE="0.232736555398096" ORDER="1064" O_E="0.0" SE="0.24458673407803433" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.05982267048695908" WEIGHT="25.11406223273737"/>
<DICH_DATA CI_END="2.0388340908923595" CI_START="0.41792071739600173" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="24" LOG_CI_END="0.3093818867190319" LOG_CI_START="-0.3789060992374557" LOG_EFFECT_SIZE="-0.03476210625921192" ORDER="1065" O_E="0.0" SE="0.40430377003131995" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.16346153846153844" WEIGHT="12.412293563582734"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5088748185341008" CI_END="7.964157319227343" CI_START="0.5275062163334884" DF="1" EFFECT_SIZE="2.0496688741721854" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="0.9011398302350208" LOG_CI_START="-0.2777724181090861" LOG_EFFECT_SIZE="0.3116837060629673" NO="2" P_CHI2="0.4756264032858738" P_Z="0.30003416798195226" STUDIES="2" TAU2="0.0" TOTAL_1="34" TOTAL_2="43" WEIGHT="100.0" Z="1.0363601520120522">
<NAME>poor prognostic factors</NAME>
<DICH_DATA CI_END="47.30448497075968" CI_START="0.35970426505050973" EFFECT_SIZE="4.125" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.6749023184484557" LOG_CI_START="-0.44405441267656814" LOG_EFFECT_SIZE="0.6154239528859439" ORDER="1066" O_E="0.0" SE="1.2446856728678226" STUDY_ID="STD-Devreker-2000" TOTAL_1="11" TOTAL_2="12" VAR="1.549242424242424" WEIGHT="23.841059602649004"/>
<DICH_DATA CI_END="7.664068316488292" CI_START="0.2557388477061593" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.884459367331142" LOG_CI_START="-0.592203295974666" LOG_EFFECT_SIZE="0.146128035678238" ORDER="1067" O_E="0.0" SE="0.8673989580239028" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.7523809523809523" WEIGHT="76.15894039735099"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.184243449728465" CI_END="2.0248859366392775" CI_START="0.910660103130049" DF="2" EFFECT_SIZE="1.3579332958162968" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="69" I2="72.16129973886684" ID="CMP-001.03.03" LOG_CI_END="0.3064005641021176" LOG_CI_START="-0.040643689854392144" LOG_EFFECT_SIZE="0.13287843712386274" MODIFIED="2016-05-07 11:46:17 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.027539888895016684" P_Z="0.13338501998741004" STUDIES="3" TAU2="0.0" TOTAL_1="212" TOTAL_2="215" WEIGHT="100.00000000000001" Z="1.5008861153331647">
<NAME>unselected group</NAME>
<DICH_DATA CI_END="1.4468409003152891" CI_START="0.4296647287161857" EFFECT_SIZE="0.7884519661523146" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="41" LOG_CI_END="0.16042077720471234" LOG_CI_START="-0.36687029619426126" LOG_EFFECT_SIZE="-0.10322475949477444" ORDER="1068" O_E="0.0" SE="0.30973338664746614" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09593477080410877" WEIGHT="56.73738835739754"/>
<DICH_DATA CI_END="7.306306786464181" CI_START="1.3856476655079193" EFFECT_SIZE="3.1818181818181817" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="11" LOG_CI_END="0.8636979039655835" LOG_CI_START="0.14165281441851768" LOG_EFFECT_SIZE="0.5026753591920505" MODIFIED="2016-05-07 11:46:17 +1200" MODIFIED_BY="[Empty name]" ORDER="405" O_E="0.0" SE="0.42413285978078336" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.17988868274582562" WEIGHT="15.4940516115367"/>
<DICH_DATA CI_END="3.152659585156811" CI_START="0.7173383638954878" EFFECT_SIZE="1.5038363171355498" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="17" LOG_CI_END="0.49867707944776324" LOG_CI_START="-0.14427594208721992" LOG_EFFECT_SIZE="0.17720056868027165" ORDER="1069" O_E="0.0" SE="0.37767378751843517" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.14263748977852012" WEIGHT="27.76856003106577"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="21.8279552827433" CI_END="1.8181990501246126" CI_START="1.2001952624510057" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="OR" EFFECT_SIZE="1.4772250627959433" ESTIMABLE="YES" EVENTS_1="317" EVENTS_2="248" I2="45.02462624391147" I2_Q="33.15841400967898" ID="CMP-001.04" LOG_CI_END="0.25964142654196865" LOG_CI_START="0.07925190813625438" LOG_EFFECT_SIZE="0.1694466673391115" METHOD="MH" MODIFIED="2016-06-21 09:50:41 +1200" MODIFIED_BY="Clare Dooley" NO="4" P_CHI2="0.03949392938991114" P_Q="0.21334339918105827" P_Z="2.3128801061233782E-4" Q="4.488223843812465" RANDOM="NO" SCALE="58.37" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="811" TOTAL_2="819" WEIGHT="400.0" Z="3.6821359491414642">
<NAME>Live birth rate: grouped by day of randomisation</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.470156909069471" CI_END="1.7020938645788064" CI_START="0.9333246983558048" DF="4" EFFECT_SIZE="1.2603992394203039" ESTIMABLE="YES" EVENTS_1="138" EVENTS_2="120" I2="10.51768245798201" ID="CMP-001.04.01" LOG_CI_END="0.23098350624479733" LOG_CI_START="-0.02996724138505722" LOG_EFFECT_SIZE="0.10050813242987004" MODIFIED="2012-05-11 02:06:29 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.34610089161130186" P_Z="0.13109329066626604" STUDIES="5" TAU2="0.0" TOTAL_1="405" TOTAL_2="414" WEIGHT="100.0" Z="1.5098046010992938">
<NAME>randomisation at start of cycle</NAME>
<DICH_DATA CI_END="2.1323325505466904" CI_START="0.4542002234307056" EFFECT_SIZE="0.9841269841269841" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.3288549365669254" LOG_CI_START="-0.34275265647758113" LOG_EFFECT_SIZE="-0.006948859955327855" MODIFIED="2012-05-11 02:06:29 +1200" MODIFIED_BY="[Empty name]" ORDER="347" O_E="0.0" SE="0.39450562466554573" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15563468789275242" WEIGHT="17.057479528797717"/>
<DICH_DATA CI_END="1.4468409003152891" CI_START="0.4296647287161857" EFFECT_SIZE="0.7884519661523146" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="41" LOG_CI_END="0.16042077720471234" LOG_CI_START="-0.36687029619426126" LOG_EFFECT_SIZE="-0.10322475949477444" ORDER="1070" O_E="0.0" SE="0.30973338664746614" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09593477080410877" WEIGHT="30.942060301839987"/>
<DICH_DATA CI_END="7.664068316488292" CI_START="0.2557388477061593" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.884459367331142" LOG_CI_START="-0.592203295974666" LOG_EFFECT_SIZE="0.146128035678238" ORDER="1071" O_E="0.0" SE="0.8673989580239028" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.7523809523809523" WEIGHT="2.9263272560226965"/>
<DICH_DATA CI_END="2.7601276066221136" CI_START="1.058141992840884" EFFECT_SIZE="1.7089783281733746" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="38" LOG_CI_END="0.4409291608952004" LOG_CI_START="0.02454394990099163" LOG_EFFECT_SIZE="0.232736555398096" ORDER="1072" O_E="0.0" SE="0.24458673407803433" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.05982267048695908" WEIGHT="33.93038936342214"/>
<DICH_DATA CI_END="3.152659585156811" CI_START="0.7173383638954878" EFFECT_SIZE="1.5038363171355498" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="17" LOG_CI_END="0.49867707944776324" LOG_CI_START="-0.14427594208721992" LOG_EFFECT_SIZE="0.17720056868027165" ORDER="1073" O_E="0.0" SE="0.37767378751843517" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.14263748977852012" WEIGHT="15.143743549917454"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.163235065749316" CI_END="2.0606455018740424" CI_START="0.8696145043989235" DF="3" EFFECT_SIZE="1.338643797600417" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="58" I2="75.3355091488139" ID="CMP-001.04.02" LOG_CI_END="0.3140032854124193" LOG_CI_START="-0.06067322521444456" LOG_EFFECT_SIZE="0.12666503009898736" MODIFIED="2016-05-27 13:36:05 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.00684441545593939" P_Z="0.18510793853359372" STUDIES="4" TAU2="0.0" TOTAL_1="185" TOTAL_2="180" WEIGHT="99.99999999999999" Z="1.325190611385486">
<NAME>randomised on day of OPU and day 1 after OPU</NAME>
<DICH_DATA CI_END="7.306306786464181" CI_START="1.3856476655079193" EFFECT_SIZE="3.1818181818181817" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="11" LOG_CI_END="0.8636979039655835" LOG_CI_START="0.14165281441851768" LOG_EFFECT_SIZE="0.5026753591920505" MODIFIED="2016-05-27 13:36:05 +1200" MODIFIED_BY="[Empty name]" ORDER="407" O_E="0.0" SE="0.42413285978078336" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.17988868274582562" WEIGHT="17.9497965571205"/>
<DICH_DATA CI_END="8.020331553622599" CI_START="0.8945696134866786" EFFECT_SIZE="2.6785714285714284" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="8" LOG_CI_END="0.9041923220163901" LOG_CI_START="-0.048385857917428665" LOG_EFFECT_SIZE="0.4279032320494808" ORDER="1074" O_E="0.0" SE="0.5595491382311638" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.3130952380952381" WEIGHT="10.99317683881064"/>
<DICH_DATA CI_END="1.0897004940304065" CI_START="0.15202643471034236" EFFECT_SIZE="0.4070175438596491" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.037307147790392986" LOG_CI_START="-0.8180808893535765" LOG_EFFECT_SIZE="-0.39038687078159173" ORDER="1075" O_E="0.0" SE="0.5024591672574404" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.25246521476104056" WEIGHT="35.43336463223787"/>
<DICH_DATA CI_END="2.0388340908923595" CI_START="0.41792071739600173" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="24" LOG_CI_END="0.3093818867190319" LOG_CI_START="-0.3789060992374557" LOG_EFFECT_SIZE="-0.03476210625921192" ORDER="1076" O_E="0.0" SE="0.40430377003131995" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.16346153846153844" WEIGHT="35.623661971830984"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.16004526090027812" CI_END="3.3302889713181187" CI_START="1.416179833472583" DF="1" EFFECT_SIZE="2.1717016555726234" ESTIMABLE="YES" EVENTS_1="90" EVENTS_2="58" I2="0.0" ID="CMP-001.04.03" LOG_CI_END="0.5224819191531459" LOG_CI_START="0.151118405702472" LOG_EFFECT_SIZE="0.33680016242780897" MODIFIED="2016-06-21 09:50:41 +1200" MODIFIED_BY="Clare Dooley" NO="3" P_CHI2="0.6891150571882334" P_Z="3.7784329122353665E-4" STUDIES="2" TAU2="0.0" TOTAL_1="180" TOTAL_2="184" WEIGHT="100.0" Z="3.5550944798642714">
<NAME>randomised day 2 to 3 post-OPU</NAME>
<DICH_DATA CI_END="3.550901669974837" CI_START="1.1399247704326718" EFFECT_SIZE="2.011904761904762" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="35" LOG_CI_END="0.5503386461741581" LOG_CI_START="0.056876190929425696" LOG_EFFECT_SIZE="0.30360741855179185" MODIFIED="2012-02-23 13:57:57 +1300" MODIFIED_BY="[Empty name]" ORDER="326" O_E="0.0" SE="0.2898622888893043" STUDY_ID="STD-Elgindy-2011" TOTAL_1="100" TOTAL_2="100" VAR="0.08402014652014651" WEIGHT="58.781362007168454"/>
<DICH_DATA CI_END="4.5966780927107385" CI_START="1.25264647157961" EFFECT_SIZE="2.399585921325052" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="23" LOG_CI_END="0.6624440909910074" LOG_CI_START="0.09782851943316032" LOG_EFFECT_SIZE="0.38013630521208386" ORDER="1077" O_E="0.0" SE="0.331657981625234" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.10999701677572406" WEIGHT="41.21863799283154"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6131783003073771" CI_END="4.393909033347397" CI_START="0.6678679262706844" DF="1" EFFECT_SIZE="1.713053097345133" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="12" I2="0.0" ID="CMP-001.04.04" LOG_CI_END="0.6428510615229969" LOG_CI_START="-0.1753094126186984" LOG_EFFECT_SIZE="0.23377082445214925" MODIFIED="2012-05-23 17:00:52 +1200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.4335938159699868" P_Z="0.2627007269285867" STUDIES="2" TAU2="0.0" TOTAL_1="41" TOTAL_2="41" WEIGHT="100.0" Z="1.1200306322377938">
<NAME>day of randomisation unstated</NAME>
<DICH_DATA CI_END="47.30448497075968" CI_START="0.35970426505050973" EFFECT_SIZE="4.125" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.6749023184484557" LOG_CI_START="-0.44405441267656814" LOG_EFFECT_SIZE="0.6154239528859439" ORDER="1078" O_E="0.0" SE="1.2446856728678226" STUDY_ID="STD-Devreker-2000" TOTAL_1="11" TOTAL_2="12" VAR="1.549242424242424" WEIGHT="10.442477876106194"/>
<DICH_DATA CI_END="4.042197701850479" CI_START="0.5071754171862021" EFFECT_SIZE="1.4318181818181819" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="11" LOG_CI_END="0.606617550822775" LOG_CI_START="-0.2948418048879865" LOG_EFFECT_SIZE="0.1558878729673943" MODIFIED="2012-05-23 17:00:52 +1200" MODIFIED_BY="[Empty name]" ORDER="358" O_E="0.0" SE="0.5295216878402791" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="0.2803932178932179" WEIGHT="89.5575221238938"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2016-06-23 09:07:51 +1200" MODIFIED_BY="Clare Dooley" NO="2">
<NAME>Blastocyst versus cleavage stage transfer: Cumulative pregnancy rate following fresh and frozen transfer</NAME>
<DICH_OUTCOME CHI2="13.762738636076225" CI_END="1.2192652159654709" CI_START="0.6430048010783013" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8854340108972377" ESTIMABLE="YES" EVENTS_1="155" EVENTS_2="164" I2="70.9360171273266" I2_Q="100.0" ID="CMP-002.01" LOG_CI_END="0.08609818412713209" LOG_CI_START="-0.19178578434789434" LOG_EFFECT_SIZE="-0.05284380011038112" METHOD="MH" MODIFIED="2016-06-23 09:07:02 +1200" MODIFIED_BY="Clare Dooley" NO="1" P_CHI2="0.00809211517584274" P_Q="0.0" P_Z="0.4560099852338293" Q="7.2283354135174E-33" RANDOM="NO" SCALE="14.17" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="317" TOTAL_2="315" WEIGHT="100.0" Z="0.7454330351690568">
<NAME>Cumulative pregnancy rate from fresh and frozen transfers</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7905952927708428" CI_START="0.3904353828066712" EFFECT_SIZE="0.8361290322580646" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="25" LOG_CI_END="0.2529974384578329" LOG_CI_START="-0.4084508317292668" LOG_EFFECT_SIZE="-0.07772669663571694" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="0.38853798812964574" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15096176821983273" WEIGHT="18.150549458861548">
<FOOTNOTE>Study had policy of single embryo transfer</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="1.1965004690372363" CI_START="0.3528146821008027" EFFECT_SIZE="0.6497252747252747" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="56" LOG_CI_END="0.07791287319621219" LOG_CI_START="-0.4524533503466633" LOG_EFFECT_SIZE="-0.1872702385752256" MODIFIED="2016-06-16 15:46:44 +1200" MODIFIED_BY="[Empty name]" ORDER="1364" O_E="0.0" SE="0.3115397450642328" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09705701275468717" WEIGHT="32.00577703786031"/>
<DICH_DATA CI_END="5.120605776022609" CI_START="1.1669144049235096" EFFECT_SIZE="2.4444444444444446" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="20" LOG_CI_END="0.7093213417612939" LOG_CI_START="0.06703900100446884" LOG_EFFECT_SIZE="0.3881801713828814" MODIFIED="2016-06-16 16:12:06 +1200" MODIFIED_BY="[Empty name]" ORDER="757" O_E="0.0" SE="0.37727982630942164" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.14234006734006735" WEIGHT="11.276760728312047">
<FOOTNOTE>This study provides both cumulative pregnancy and live birth rates with the same numbers, except that there was one voluntary abortion in the blastocyst group (1/33 pregnancies) due to an anomaly after VET</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.7453121830738385" CI_START="0.10411332871292042" EFFECT_SIZE="0.2785622593068036" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="41" LOG_CI_END="-0.12766177961706449" LOG_CI_START="-0.9824936680310055" LOG_EFFECT_SIZE="-0.5550777238240349" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="1365" O_E="0.0" SE="0.5021324827404411" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.2521370302230793" WEIGHT="19.91972019808409"/>
<DICH_DATA CI_END="2.124500450041012" CI_START="0.5125190163581057" EFFECT_SIZE="1.0434782608695652" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="22" LOG_CI_END="0.3272568274237951" LOG_CI_START="-0.29029001603576887" LOG_EFFECT_SIZE="0.018483405694013133" MODIFIED="2016-06-16 15:48:58 +1200" MODIFIED_BY="[Empty name]" ORDER="1366" O_E="0.0" SE="0.36275007275432414" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.13158761528326746" WEIGHT="18.647192576882013"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.031028411669667" CI_END="0.9880183712275549" CI_START="0.5139018069650225" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="OR" EFFECT_SIZE="0.7125618754104649" ESTIMABLE="YES" EVENTS_1="146" EVENTS_2="169" I2="20.493392748054383" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-0.005234980059562135" LOG_CI_START="-0.2891198552598385" LOG_EFFECT_SIZE="-0.14717741765970033" METHOD="MH" MODIFIED="2016-06-23 09:07:26 +1200" MODIFIED_BY="Clare Dooley" NO="2" P_CHI2="0.2841286532389775" P_Q="0.6486272021658587" P_Z="0.04212841108204331" Q="0.2076352860006368" RANDOM="NO" SCALE="35.307969012952846" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="312" TOTAL_2="307" WEIGHT="200.0" Z="2.032249430316541">
<NAME>Cumulative pregnancy rate per couple: grouped by number of embryos transferred</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.7905952927708428" CI_START="0.3904353828066712" DF="0" EFFECT_SIZE="0.8361290322580646" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="25" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="0.2529974384578329" LOG_CI_START="-0.4084508317292668" LOG_EFFECT_SIZE="-0.07772669663571694" MODIFIED="2016-06-16 15:47:21 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6450639388717507" STUDIES="1" TAU2="0.0" TOTAL_1="55" TOTAL_2="52" WEIGHT="100.0" Z="0.46063020468761345">
<NAME>single embryo transfer</NAME>
<DICH_DATA CI_END="1.7905952927708428" CI_START="0.3904353828066712" EFFECT_SIZE="0.8361290322580646" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="25" LOG_CI_END="0.2529974384578329" LOG_CI_START="-0.4084508317292668" LOG_EFFECT_SIZE="-0.07772669663571694" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="0.38853798812964574" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15096176821983273" WEIGHT="100.0">
<FOOTNOTE>c</FOOTNOTE>
</DICH_DATA>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.846925505769619" CI_END="0.9871328644338472" CI_START="0.478515227054938" DF="3" EFFECT_SIZE="0.6872831343470853" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="144" I2="38.10509370468146" ID="CMP-002.02.02" LOG_CI_END="-0.005624388964578752" LOG_CI_START="-0.32010423778114805" LOG_EFFECT_SIZE="-0.1628643133728634" MODIFIED="2016-06-16 15:47:57 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.18335546800312041" P_Z="0.042349337036491845" STUDIES="4" TAU2="0.0" TOTAL_1="257" TOTAL_2="255" WEIGHT="100.0" Z="2.0300708600495803">
<NAME>equal number of embryos transferred</NAME>
<DICH_DATA CI_END="1.7905952927708428" CI_START="0.3904353828066712" EFFECT_SIZE="0.8361290322580646" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="25" LOG_CI_END="0.2529974384578329" LOG_CI_START="-0.4084508317292668" LOG_EFFECT_SIZE="-0.07772669663571694" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="0.38853798812964574" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15096176821983273" WEIGHT="20.45749186780817">
<FOOTNOTE>c</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="1.1965004690372363" CI_START="0.3528146821008027" EFFECT_SIZE="0.6497252747252747" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="56" LOG_CI_END="0.07791287319621219" LOG_CI_START="-0.4524533503466633" LOG_EFFECT_SIZE="-0.1872702385752256" MODIFIED="2016-06-16 15:47:47 +1200" MODIFIED_BY="[Empty name]" ORDER="1364" O_E="0.0" SE="0.3115397450642328" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09705701275468717" WEIGHT="36.073724652739905"/>
<DICH_DATA CI_END="0.7453121830738385" CI_START="0.10411332871292042" EFFECT_SIZE="0.2785622593068036" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="41" LOG_CI_END="-0.12766177961706449" LOG_CI_START="-0.9824936680310055" LOG_EFFECT_SIZE="-0.5550777238240349" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="1365" O_E="0.0" SE="0.5021324827404411" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.2521370302230793" WEIGHT="22.451524946114738"/>
<DICH_DATA CI_END="2.124500450041012" CI_START="0.5125190163581057" EFFECT_SIZE="1.0434782608695652" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="22" LOG_CI_END="0.3272568274237951" LOG_CI_START="-0.29029001603576887" LOG_EFFECT_SIZE="0.018483405694013133" MODIFIED="2016-06-16 15:47:57 +1200" MODIFIED_BY="[Empty name]" ORDER="1366" O_E="0.0" SE="0.36275007275432414" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.13158761528326746" WEIGHT="21.017258533337188"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="13.762738636076225" CI_END="1.219265215965471" CI_START="0.6430048010783014" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8854340108972378" ESTIMABLE="YES" EVENTS_1="155" EVENTS_2="164" I2="70.9360171273266" I2_Q="73.62867938486062" ID="CMP-002.03" LOG_CI_END="0.08609818412713216" LOG_CI_START="-0.19178578434789428" LOG_EFFECT_SIZE="-0.05284380011038106" METHOD="MH" MODIFIED="2016-06-17 10:45:11 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.00809211517584274" P_Q="0.05149817786911581" P_Z="0.45600998523382985" Q="3.7919981884635483" RANDOM="NO" SCALE="53.36" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="317" TOTAL_2="315" WEIGHT="200.0" Z="0.745433035169056">
<NAME>Cumulative pregnancy rate per couple: grouped by prognosis</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.000298702311226" CI_END="0.9805663436256129" CI_START="0.3022342610988722" DF="1" EFFECT_SIZE="0.5443902500266788" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="66" I2="66.66998525081293" ID="CMP-002.03.01" LOG_CI_END="-0.008523017298817806" LOG_CI_START="-0.5196563058381851" LOG_EFFECT_SIZE="-0.26408966156850144" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.08324936308111164" P_Z="0.042833717366245" STUDIES="2" TAU2="0.0" TOTAL_1="105" TOTAL_2="100" WEIGHT="100.00000000000001" Z="2.0253277842371196">
<NAME>good prognostic factors</NAME>
<DICH_DATA CI_END="1.7905952927708428" CI_START="0.3904353828066712" EFFECT_SIZE="0.8361290322580646" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="25" LOG_CI_END="0.2529974384578329" LOG_CI_START="-0.4084508317292668" LOG_EFFECT_SIZE="-0.07772669663571694" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="0.38853798812964574" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15096176821983273" WEIGHT="47.676440493901566">
<FOOTNOTE>Study had policy of single embryo transfer</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.7453121830738385" CI_START="0.10411332871292042" EFFECT_SIZE="0.2785622593068036" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="41" LOG_CI_END="-0.12766177961706449" LOG_CI_START="-0.9824936680310055" LOG_EFFECT_SIZE="-0.5550777238240349" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="1065" O_E="0.0" SE="0.5021324827404411" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.2521370302230793" WEIGHT="52.32355950609845"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.3554772365235985" CI_END="1.6100779268212313" CI_START="0.7448155719520761" DF="2" EFFECT_SIZE="1.0950849793293524" ESTIMABLE="YES" EVENTS_1="100" EVENTS_2="98" I2="72.80937815878205" ID="CMP-002.03.02" LOG_CI_END="0.2068468961370948" LOG_CI_START="-0.1279512520828857" LOG_EFFECT_SIZE="0.039447822027104534" MODIFIED="2016-06-17 10:45:11 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.025280152134979028" P_Z="0.6441758351010729" STUDIES="3" TAU2="0.0" TOTAL_1="212" TOTAL_2="215" WEIGHT="100.0" Z="0.461868208368164">
<NAME>unselected group</NAME>
<DICH_DATA CI_END="1.1965004690372363" CI_START="0.3528146821008027" EFFECT_SIZE="0.6497252747252747" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="56" LOG_CI_END="0.07791287319621219" LOG_CI_START="-0.4524533503466633" LOG_EFFECT_SIZE="-0.1872702385752256" MODIFIED="2016-06-16 15:49:34 +1200" MODIFIED_BY="[Empty name]" ORDER="1364" O_E="0.0" SE="0.3115397450642328" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09705701275468717" WEIGHT="51.68079508915521"/>
<DICH_DATA CI_END="5.120605776022609" CI_START="1.1669144049235096" EFFECT_SIZE="2.4444444444444446" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="20" LOG_CI_END="0.7093213417612939" LOG_CI_START="0.06703900100446884" LOG_EFFECT_SIZE="0.3881801713828814" MODIFIED="2016-06-16 16:02:08 +1200" MODIFIED_BY="[Empty name]" ORDER="405" O_E="0.0" SE="0.37727982630942164" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.14234006734006735" WEIGHT="18.20896145654988"/>
<DICH_DATA CI_END="2.124500450041012" CI_START="0.5125190163581057" EFFECT_SIZE="1.0434782608695652" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="22" LOG_CI_END="0.3272568274237951" LOG_CI_START="-0.29029001603576887" LOG_EFFECT_SIZE="0.018483405694013133" MODIFIED="2016-06-16 15:48:28 +1200" MODIFIED_BY="[Empty name]" ORDER="1069" O_E="0.0" SE="0.36275007275432414" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.13158761528326746" WEIGHT="30.1102434542949"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="13.762738636076225" CI_END="1.2192652159654707" CI_START="0.6430048010783012" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8854340108972375" ESTIMABLE="YES" EVENTS_1="155" EVENTS_2="164" I2="70.9360171273266" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.08609818412713201" LOG_CI_START="-0.19178578434789442" LOG_EFFECT_SIZE="-0.05284380011038123" METHOD="MH" MODIFIED="2016-06-17 09:26:02 +1200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.00809211517584274" P_Q="0.4229409089451174" P_Z="0.4560099852338284" Q="0.6421296858730046" RANDOM="NO" SCALE="58.37" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="317" TOTAL_2="315" WEIGHT="200.0" Z="0.7454330351690585">
<NAME>Cumulative pregnancy rate: grouped by day of randomisation</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.9943084510647652" CI_END="1.195489073613477" CI_START="0.5428861948032653" DF="2" EFFECT_SIZE="0.8056143705911043" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="103" I2="0.0" ID="CMP-002.04.01" LOG_CI_END="0.07754561115772485" LOG_CI_START="-0.265291201993231" LOG_EFFECT_SIZE="-0.09387279541775308" MODIFIED="2016-06-16 15:49:57 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6082592270533397" P_Z="0.2831262883493614" STUDIES="3" TAU2="0.0" TOTAL_1="207" TOTAL_2="207" WEIGHT="100.0" Z="1.073322881845133">
<NAME>randomisation at start of cycle</NAME>
<DICH_DATA CI_END="1.7905952927708428" CI_START="0.3904353828066712" EFFECT_SIZE="0.8361290322580646" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="25" LOG_CI_END="0.2529974384578329" LOG_CI_START="-0.4084508317292668" LOG_EFFECT_SIZE="-0.07772669663571694" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="0.38853798812964574" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15096176821983273" WEIGHT="26.380263252879047"/>
<DICH_DATA CI_END="1.1965004690372363" CI_START="0.3528146821008027" EFFECT_SIZE="0.6497252747252747" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="56" LOG_CI_END="0.07791287319621219" LOG_CI_START="-0.4524533503466633" LOG_EFFECT_SIZE="-0.1872702385752256" MODIFIED="2016-06-16 15:49:51 +1200" MODIFIED_BY="[Empty name]" ORDER="1070" O_E="0.0" SE="0.3115397450642328" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09705701275468717" WEIGHT="46.51764541813846"/>
<DICH_DATA CI_END="2.124500450041012" CI_START="0.5125190163581057" EFFECT_SIZE="1.0434782608695652" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="22" LOG_CI_END="0.3272568274237951" LOG_CI_START="-0.29029001603576887" LOG_EFFECT_SIZE="0.018483405694013133" MODIFIED="2016-06-16 15:49:57 +1200" MODIFIED_BY="[Empty name]" ORDER="1073" O_E="0.0" SE="0.36275007275432414" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.13158761528326746" WEIGHT="27.102091328982493"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.986309795222475" CI_END="1.8344357459186542" CI_START="0.6142106902318325" DF="1" EFFECT_SIZE="1.0614754098360655" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="61" I2="91.65714872146404" ID="CMP-002.04.02" LOG_CI_END="0.2635025044911628" LOG_CI_START="-0.21168262900611806" LOG_EFFECT_SIZE="0.025909937742522364" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="5.359308664574236E-4" P_Z="0.8307514264023951" STUDIES="2" TAU2="0.0" TOTAL_1="110" TOTAL_2="108" WEIGHT="100.0" Z="0.2137379359630554">
<NAME>randomised on day of OPU and day 1 after OPU</NAME>
<DICH_DATA CI_END="5.120605776022609" CI_START="1.1669144049235096" EFFECT_SIZE="2.4444444444444446" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="20" LOG_CI_END="0.7093213417612939" LOG_CI_START="0.06703900100446884" LOG_EFFECT_SIZE="0.3881801713828814" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="757" O_E="0.0" SE="0.37727982630942164" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.14234006734006735" WEIGHT="36.147540983606554">
<FOOTNOTE>This study provides both cumulative pregnancy and live birth rates with the same numbers, except that there was one voluntary abortion in the blastocyst group (1/33 pregnancies) due to an anomaly after VET</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.7453121830738385" CI_START="0.10411332871292042" EFFECT_SIZE="0.2785622593068036" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="41" LOG_CI_END="-0.12766177961706449" LOG_CI_START="-0.9824936680310055" LOG_EFFECT_SIZE="-0.5550777238240349" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="1365" O_E="0.0" SE="0.5021324827404411" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.2521370302230793" WEIGHT="63.85245901639344"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="13.762738636076229" CI_END="1.2192652159654709" CI_START="0.6430048010783013" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8854340108972377" ESTIMABLE="YES" EVENTS_1="155" EVENTS_2="164" I2="70.9360171273266" I2_Q="89.03895995075855" ID="CMP-002.05" LOG_CI_END="0.08609818412713209" LOG_CI_START="-0.19178578434789434" LOG_EFFECT_SIZE="-0.05284380011038112" METHOD="MH" MODIFIED="2016-06-23 09:07:51 +1200" MODIFIED_BY="Clare Dooley" NO="5" P_CHI2="0.008092115175843073" P_Q="0.002523858919560751" P_Z="0.4560099852338293" Q="9.123221843069572" RANDOM="NO" SCALE="23.88" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="317" TOTAL_2="315" WEIGHT="200.0" Z="0.7454330351690568">
<NAME>Cumulative pregnancy rate from fresh and frozen transfers: grouped by vitrification or slow freezing</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.846925505769619" CI_END="0.9871328644338471" CI_START="0.47851522705493793" DF="3" EFFECT_SIZE="0.6872831343470852" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="144" I2="38.10509370468146" ID="CMP-002.05.01" LOG_CI_END="-0.0056243889645788015" LOG_CI_START="-0.3201042377811481" LOG_EFFECT_SIZE="-0.16286431337286347" MODIFIED="2016-06-23 09:05:35 +1200" MODIFIED_BY="Clare Dooley" NO="1" P_CHI2="0.18335546800312041" P_Z="0.04234933703649175" STUDIES="4" TAU2="0.0" TOTAL_1="257" TOTAL_2="255" WEIGHT="100.0" Z="2.030070860049581">
<NAME>slow freezing</NAME>
<DICH_DATA CI_END="1.7905952927708428" CI_START="0.3904353828066712" EFFECT_SIZE="0.8361290322580646" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="25" LOG_CI_END="0.2529974384578329" LOG_CI_START="-0.4084508317292668" LOG_EFFECT_SIZE="-0.07772669663571694" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="0.38853798812964574" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15096176821983273" WEIGHT="20.45749186780817"/>
<DICH_DATA CI_END="1.1965004690372363" CI_START="0.3528146821008027" EFFECT_SIZE="0.6497252747252747" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="56" LOG_CI_END="0.07791287319621219" LOG_CI_START="-0.4524533503466633" LOG_EFFECT_SIZE="-0.1872702385752256" MODIFIED="2016-06-16 15:50:32 +1200" MODIFIED_BY="[Empty name]" ORDER="1364" O_E="0.0" SE="0.3115397450642328" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09705701275468717" WEIGHT="36.073724652739905"/>
<DICH_DATA CI_END="0.7453121830738385" CI_START="0.10411332871292042" EFFECT_SIZE="0.2785622593068036" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="41" LOG_CI_END="-0.12766177961706449" LOG_CI_START="-0.9824936680310055" LOG_EFFECT_SIZE="-0.5550777238240349" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="1365" O_E="0.0" SE="0.5021324827404411" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.2521370302230793" WEIGHT="22.451524946114738"/>
<DICH_DATA CI_END="2.124500450041012" CI_START="0.5125190163581057" EFFECT_SIZE="1.0434782608695652" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="22" LOG_CI_END="0.3272568274237951" LOG_CI_START="-0.29029001603576887" LOG_EFFECT_SIZE="0.018483405694013133" MODIFIED="2016-06-16 15:50:39 +1200" MODIFIED_BY="[Empty name]" ORDER="1366" O_E="0.0" SE="0.36275007275432414" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.13158761528326746" WEIGHT="21.017258533337188"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.120605776022609" CI_START="1.1669144049235096" DF="0" EFFECT_SIZE="2.4444444444444446" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="20" I2="0.0" ID="CMP-002.05.02" LOG_CI_END="0.7093213417612939" LOG_CI_START="0.06703900100446884" LOG_EFFECT_SIZE="0.3881801713828814" MODIFIED="2016-06-23 09:05:43 +1200" MODIFIED_BY="Clare Dooley" NO="2" P_CHI2="1.0" P_Z="0.017830889725951298" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.0" Z="2.36911123705046">
<NAME>vitrification</NAME>
<DICH_DATA CI_END="5.120605776022609" CI_START="1.1669144049235096" EFFECT_SIZE="2.4444444444444446" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="20" LOG_CI_END="0.7093213417612939" LOG_CI_START="0.06703900100446884" LOG_EFFECT_SIZE="0.3881801713828814" MODIFIED="2016-06-16 15:45:48 +1200" MODIFIED_BY="[Empty name]" ORDER="757" O_E="0.0" SE="0.37727982630942164" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.14234006734006735" WEIGHT="100.0">
<FOOTNOTE>This study provides both cumulative pregnancy and live birth rates with the same numbers, except that there was one voluntary abortion in the blastocyst group (1/33 pregnancies) due to an anomaly after VET</FOOTNOTE>
</DICH_DATA>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2016-06-23 09:11:00 +1200" MODIFIED_BY="Clare Dooley" NO="3">
<NAME>Blastocyst versus cleavage stage transfer: Clinical pregnancy following fresh transfer</NAME>
<DICH_OUTCOME CHI2="58.738923070489506" CI_END="1.4726373460814601" CI_START="1.1389644161743728" CI_STUDY="95" CI_TOTAL="95" DF="26" EFFECT_MEASURE="OR" EFFECT_SIZE="1.2950990445198576" ESTIMABLE="YES" EVENTS_1="845" EVENTS_2="773" I2="55.73633522562414" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.16809580998791745" LOG_CI_START="0.05651015594870604" LOG_EFFECT_SIZE="0.11230298296831175" METHOD="MH" MODIFIED="2016-06-23 09:10:40 +1200" MODIFIED_BY="Clare Dooley" NO="1" P_CHI2="2.471873791646262E-4" P_Q="1.0" P_Z="7.975761379774678E-5" Q="0.0" RANDOM="NO" SCALE="9.730260234668899" SORT_BY="STUDY" STUDIES="27" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1955" TOTAL_2="2076" WEIGHT="100.0" Z="3.9451272454245605">
<NAME>Clinical pregnancy rate per couple</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.837814603142948" CI_START="0.5901514787379876" EFFECT_SIZE="1.2941176470588236" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.45298401921798814" LOG_CI_START="-0.2290365003301235" LOG_EFFECT_SIZE="0.11197375944393233" MODIFIED="2016-06-16 15:44:31 +1200" MODIFIED_BY="[Empty name]" ORDER="369" O_E="0.0" SE="0.4006222292385809" STUDY_ID="STD-Aziminekoo-2015" TOTAL_1="57" TOTAL_2="61" VAR="0.16049817056009005" WEIGHT="2.676504169576513"/>
<DICH_DATA CI_END="1.800956832712845" CI_START="0.39043252673465145" EFFECT_SIZE="0.8385416666666666" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.25550330330299453" LOG_CI_START="-0.40845400864639436" LOG_EFFECT_SIZE="-0.07647535267169991" MODIFIED="2016-06-16 15:44:32 +1200" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.3900118116807715" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15210921325051757" WEIGHT="3.5090928194164217"/>
<DICH_DATA CI_END="1.3441307311186634" CI_START="0.30824499823758894" EFFECT_SIZE="0.6436781609195402" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="36" LOG_CI_END="0.12844151056477918" LOG_CI_START="-0.5111039617896154" LOG_EFFECT_SIZE="-0.1913312256124181" MODIFIED="2016-06-16 15:44:32 +1200" MODIFIED_BY="[Empty name]" ORDER="1088" O_E="0.0" SE="0.3756721762621169" STUDY_ID="STD-Bungum-2003" TOTAL_1="61" TOTAL_2="57" VAR="0.14112958401751505" WEIGHT="4.325495902535417"/>
<DICH_DATA CI_END="1.7925706705288267" CI_START="0.5762984116560224" EFFECT_SIZE="1.0163934426229508" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="39" LOG_CI_END="0.2534762863569622" LOG_CI_START="-0.23935257738198842" LOG_EFFECT_SIZE="0.007061854487486849" MODIFIED="2016-06-16 15:44:33 +1200" MODIFIED_BY="[Empty name]" ORDER="1089" O_E="0.0" SE="0.28949011410247955" STUDY_ID="STD-Coskun-2000" TOTAL_1="100" TOTAL_2="101" VAR="0.08380452616306662" WEIGHT="5.7864978781930745"/>
<DICH_DATA CI_END="68.42310139003123" CI_START="0.5774395383865049" EFFECT_SIZE="6.285714285714286" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.835202755409563" LOG_CI_START="-0.23849348246570173" LOG_EFFECT_SIZE="0.7983546364719306" MODIFIED="2016-06-16 15:44:34 +1200" MODIFIED_BY="[Empty name]" ORDER="1090" O_E="0.0" SE="1.218099435089859" STUDY_ID="STD-Devreker-2000" TOTAL_1="11" TOTAL_2="12" VAR="1.4837662337662336" WEIGHT="0.14879475326895947"/>
<DICH_DATA CI_END="3.6382297653692612" CI_START="1.1786435857008422" EFFECT_SIZE="2.070791195716835" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="41" LOG_CI_END="0.5608901226221997" LOG_CI_START="0.07138249706743506" LOG_EFFECT_SIZE="0.31613630984481733" MODIFIED="2016-06-16 15:44:34 +1200" MODIFIED_BY="[Empty name]" ORDER="327" O_E="0.0" SE="0.28753920235269453" STUDY_ID="STD-Elgindy-2011" TOTAL_1="100" TOTAL_2="100" VAR="0.0826787928896238" WEIGHT="4.1091796754555565"/>
<DICH_DATA CI_END="1.545716926252437" CI_START="0.4650328022652552" EFFECT_SIZE="0.8478260869565217" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="46" LOG_CI_END="0.18912996265936055" LOG_CI_START="-0.33251641196951026" LOG_EFFECT_SIZE="-0.07169322465507487" MODIFIED="2016-06-16 15:44:35 +1200" MODIFIED_BY="[Empty name]" ORDER="1091" O_E="0.0" SE="0.3064176626481982" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09389178398278498" WEIGHT="5.655195075370127"/>
<DICH_DATA CI_END="6.311331843171402" CI_START="1.3692153649073278" EFFECT_SIZE="2.939655172413793" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="16" LOG_CI_END="0.8001210155208941" LOG_CI_START="0.13647176401026445" LOG_EFFECT_SIZE="0.46829638976557925" MODIFIED="2016-06-16 17:02:01 +1200" MODIFIED_BY="[Empty name]" ORDER="753" O_E="0.0" SE="0.3898308554541205" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.1519680958640914" WEIGHT="1.8904019129599232"/>
<DICH_DATA CI_END="1.0770563284825603" CI_START="0.007673194605857768" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.03223841686292603" LOG_CI_START="-2.1150237871793762" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2016-06-16 15:44:36 +1200" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="1.2613124477737825" STUDY_ID="STD-Fisch-2007" TOTAL_1="8" TOTAL_2="12" VAR="1.5909090909090908" WEIGHT="1.0755735022013357"/>
<DICH_DATA CI_END="8.64851911044926" CI_START="1.0031431241051127" EFFECT_SIZE="2.9454545454545453" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="10" LOG_CI_END="0.9369417494047214" LOG_CI_START="0.0013629006920527062" LOG_EFFECT_SIZE="0.46915232504838705" MODIFIED="2016-06-16 15:44:37 +1200" MODIFIED_BY="[Empty name]" ORDER="1092" O_E="0.0" SE="0.5495636469238135" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.302020202020202" WEIGHT="0.9434855282467856"/>
<DICH_DATA CI_END="4.723913882887663" CI_START="1.6986642857146503" EFFECT_SIZE="2.8327272727272725" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="44" LOG_CI_END="0.6743019718103199" LOG_CI_START="0.23010755587428364" LOG_EFFECT_SIZE="0.4522047638423018" MODIFIED="2016-06-16 15:44:37 +1200" MODIFIED_BY="[Empty name]" ORDER="389" O_E="0.0" SE="0.2609219987186484" STUDY_ID="STD-Gaafar-2015" TOTAL_1="126" TOTAL_2="126" VAR="0.06808028941533435" WEIGHT="4.2681488182592675"/>
<DICH_DATA CI_END="3.0719430291075756" CI_START="0.5254321859470332" EFFECT_SIZE="1.2704714640198511" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="31" LOG_CI_END="0.4874131572013897" LOG_CI_START="-0.27948332753194705" LOG_EFFECT_SIZE="0.10396491483472131" MODIFIED="2016-06-16 15:44:38 +1200" MODIFIED_BY="[Empty name]" ORDER="345" O_E="0.0" SE="0.45047879133118574" STUDY_ID="STD-Gardner-1998" TOTAL_1="45" TOTAL_2="47" VAR="0.20293114143920596" WEIGHT="2.141581627406809"/>
<DICH_DATA CI_END="2.3199109324563767" CI_START="0.5724279500697607" EFFECT_SIZE="1.1523809523809523" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="25" LOG_CI_END="0.36547131149208656" LOG_CI_START="-0.2422791689990626" LOG_EFFECT_SIZE="0.06159607124651197" MODIFIED="2016-05-04 14:08:10 +1200" MODIFIED_BY="[Empty name]" ORDER="1094" O_E="0.0" SE="0.35699564065389855" STUDY_ID="STD-Hreinsson-2004" TOTAL_1="64" TOTAL_2="80" VAR="0.12744588744588745" WEIGHT="3.5648742970688208"/>
<DICH_DATA CI_END="2.521070145339392" CI_START="0.6716730909368898" EFFECT_SIZE="1.3012820512820513" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="24" LOG_CI_END="0.4015849294963663" LOG_CI_START="-0.17284205037886363" LOG_EFFECT_SIZE="0.11437143955875133" MODIFIED="2016-06-15 15:20:31 +1200" MODIFIED_BY="[Empty name]" ORDER="1095" O_E="0.0" SE="0.3374212514381192" STUDY_ID="STD-Karaki-2002" TOTAL_1="80" TOTAL_2="82" VAR="0.11385310092206644" WEIGHT="3.76631798750636"/>
<DICH_DATA CI_END="3.0496833052761207" CI_START="1.1748459773074391" EFFECT_SIZE="1.8928571428571428" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="44" LOG_CI_END="0.48425474232640997" LOG_CI_START="0.06998093419072958" LOG_EFFECT_SIZE="0.27711783825856984" MODIFIED="2016-06-16 15:44:38 +1200" MODIFIED_BY="[Empty name]" ORDER="393" O_E="0.0" SE="0.24334648558732203" STUDY_ID="STD-Kaur-2014" TOTAL_1="150" TOTAL_2="150" VAR="0.059217512047700725" WEIGHT="6.023211612327479"/>
<DICH_DATA CI_END="1.5551100863940843" CI_START="0.7129830672670086" EFFECT_SIZE="1.0529801324503312" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="75" LOG_CI_END="0.19176113819964685" LOG_CI_START="-0.14692078414508275" LOG_EFFECT_SIZE="0.022420177027282065" MODIFIED="2016-06-16 15:44:39 +1200" MODIFIED_BY="[Empty name]" ORDER="1096" O_E="0.0" SE="0.19894343768784808" STUDY_ID="STD-Kolibianakis-2004" TOTAL_1="226" TOTAL_2="234" VAR="0.03957849139905869" WEIGHT="12.036432719792614"/>
<DICH_DATA CI_END="7.943352926499268" CI_START="0.4425870325202053" EFFECT_SIZE="1.875" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.9000038588638924" LOG_CI_START="-0.3540013147364171" LOG_EFFECT_SIZE="0.27300127206373764" ORDER="1097" O_E="0.0" SE="0.7366088463985432" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.5425925925925925" WEIGHT="0.65186272860687"/>
<DICH_DATA CI_END="0.6638539547564517" CI_START="0.09613969190686694" EFFECT_SIZE="0.25263157894736843" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="20" LOG_CI_END="-0.17792745319173398" LOG_CI_START="-1.0170972739627495" LOG_EFFECT_SIZE="-0.5975123635772417" MODIFIED="2016-06-15 15:19:59 +1200" MODIFIED_BY="[Empty name]" ORDER="1098" O_E="0.0" SE="0.49293250667850147" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.24298245614035088" WEIGHT="4.12846394784351"/>
<DICH_DATA CI_END="2.59121009954922" CI_START="0.3361792666919035" EFFECT_SIZE="0.9333333333333333" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.4135026277197603" LOG_CI_START="-0.4734290744746467" LOG_EFFECT_SIZE="-0.02996322337744321" MODIFIED="2016-06-15 15:19:56 +1200" MODIFIED_BY="[Empty name]" ORDER="359" O_E="0.0" SE="0.5209880722517277" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="0.27142857142857146" WEIGHT="1.8644378890238869"/>
<DICH_DATA CI_END="2.1325055279097764" CI_START="0.4689319614473275" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.32889016562507095" LOG_CI_START="-0.3288901656250709" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-06-16 15:44:40 +1200" MODIFIED_BY="[Empty name]" ORDER="1099" O_E="0.0" SE="0.3863834226414861" STUDY_ID="STD-Motta-1998" TOTAL_1="58" TOTAL_2="58" VAR="0.1492921492921493" WEIGHT="3.274767285307358"/>
<DICH_DATA CI_END="1.1213429986412193" CI_START="0.3760279114624602" EFFECT_SIZE="0.6493506493506493" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="77" LOG_CI_END="0.04973847578176835" LOG_CI_START="-0.4247799174546944" LOG_EFFECT_SIZE="-0.18752072083646307" MODIFIED="2016-06-16 15:44:40 +1200" MODIFIED_BY="[Empty name]" ORDER="347" O_E="0.0" SE="0.2787344530910274" STUDY_ID="STD-Pantos-2004" TOTAL_1="81" TOTAL_2="162" VAR="0.07769289533995416" WEIGHT="7.900817701355489"/>
<DICH_DATA CI_END="4.399582498994487" CI_START="1.2374911586926165" EFFECT_SIZE="2.3333333333333335" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="27" LOG_CI_END="0.6434114658076036" LOG_CI_START="0.09254210478158532" LOG_EFFECT_SIZE="0.36797678529459443" MODIFIED="2016-06-16 15:44:41 +1200" MODIFIED_BY="[Empty name]" ORDER="1100" O_E="0.0" SE="0.3235833895139982" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.10470620996936786" WEIGHT="3.058587619896259"/>
<DICH_DATA CI_END="2.6124961265547486" CI_START="1.0198315232142572" EFFECT_SIZE="1.6322701688555348" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="41" LOG_CI_END="0.4170556552082412" LOG_CI_START="0.008528431975851325" LOG_EFFECT_SIZE="0.2127920435920463" MODIFIED="2016-06-16 15:44:42 +1200" MODIFIED_BY="[Empty name]" ORDER="1101" O_E="0.0" SE="0.23997091316907515" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.0575860391671998" WEIGHT="6.681592968220418"/>
<DICH_DATA CI_END="2.3912825643749662" CI_START="0.48243362527908407" EFFECT_SIZE="1.0740740740740742" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="27" LOG_CI_END="0.37863089727771837" LOG_CI_START="-0.31656242979778076" LOG_EFFECT_SIZE="0.03103423373996882" MODIFIED="2016-06-16 15:44:42 +1200" MODIFIED_BY="[Empty name]" ORDER="1102" O_E="0.0" SE="0.4083600015866171" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.16675789089582194" WEIGHT="2.8286186259190966"/>
<DICH_DATA CI_END="2.232625600508882" CI_START="0.5151685681913194" EFFECT_SIZE="1.0724637681159421" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="23" LOG_CI_END="0.34881590029230375" LOG_CI_START="-0.2880506423048619" LOG_EFFECT_SIZE="0.030382628993720916" MODIFIED="2016-06-16 15:44:43 +1200" MODIFIED_BY="[Empty name]" ORDER="1103" O_E="0.0" SE="0.3740985596618045" STUDY_ID="STD-Schillaci-2002" TOTAL_1="60" TOTAL_2="60" VAR="0.1399497323410367" WEIGHT="3.3733896205405527"/>
<DICH_DATA CI_END="4.184107755146951" CI_START="0.4921984538566448" EFFECT_SIZE="1.4350649350649352" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.6216028605779355" LOG_CI_START="-0.3078597548806402" LOG_EFFECT_SIZE="0.15687155284864765" MODIFIED="2016-06-16 15:44:44 +1200" MODIFIED_BY="[Empty name]" ORDER="336" O_E="0.0" SE="0.5459709412345165" STUDY_ID="STD-Ten-2011" TOTAL_1="28" TOTAL_2="27" VAR="0.2980842686725039" WEIGHT="1.368911730074427"/>
<DICH_DATA CI_END="3.3034578805412496" CI_START="0.801152478366118" EFFECT_SIZE="1.6268292682926828" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="20" LOG_CI_END="0.5189687738762484" LOG_CI_START="-0.09628481948262156" LOG_EFFECT_SIZE="0.21134197719681344" ORDER="1104" O_E="0.0" SE="0.3614030062934055" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.1306121329579113" WEIGHT="2.9477616036266547"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="46.97884477242221" CI_END="1.3167909353821035" CI_START="1.0056904343377349" CI_STUDY="95" CI_TOTAL="95" DF="25" EFFECT_MEASURE="OR" EFFECT_SIZE="1.150775411510178" ESTIMABLE="YES" EVENTS_1="738" EVENTS_2="728" I2="46.78455777040383" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.11951682825163712" LOG_CI_START="0.0024643193397331288" LOG_EFFECT_SIZE="0.060990573795685094" METHOD="MH" MODIFIED="2016-06-23 09:11:00 +1200" MODIFIED_BY="Clare Dooley" NO="2" P_CHI2="0.004931383984474569" P_Q="0.7085317783630827" P_Z="0.04110288505888748" Q="0.6891209747250869" RANDOM="NO" SCALE="28.440485852660274" SORT_BY="STUDY" STUDIES="23" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1800" TOTAL_2="1919" WEIGHT="300.0" Z="2.04249065905871">
<NAME>Clinical pregnancy rate per couple: grouped by number of embryos transferred</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="15.311084672627732" CI_END="1.4449195067635685" CI_START="0.986376659910591" DF="10" EFFECT_SIZE="1.1938320136941827" ESTIMABLE="YES" EVENTS_1="370" EVENTS_2="339" I2="34.687840778012166" ID="CMP-003.02.01" LOG_CI_END="0.15984365419145646" LOG_CI_START="-0.005957212762652636" LOG_EFFECT_SIZE="0.0769432207144019" MODIFIED="2016-06-20 19:04:18 +1200" MODIFIED_BY="Clare Dooley" NO="1" P_CHI2="0.12112520269580662" P_Z="0.06889293138928229" STUDIES="11" TAU2="0.0" TOTAL_1="917" TOTAL_2="937" WEIGHT="100.00000000000001" Z="1.8191212654694329">
<NAME>equal numbers of embryo transfers</NAME>
<DICH_DATA CI_END="1.800956832712845" CI_START="0.39043252673465145" EFFECT_SIZE="0.8385416666666666" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.25550330330299453" LOG_CI_START="-0.40845400864639436" LOG_EFFECT_SIZE="-0.07647535267169991" MODIFIED="2012-05-15 20:37:54 +1200" MODIFIED_BY="[Empty name]" ORDER="350" O_E="0.0" SE="0.3900118116807715" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15210921325051757" WEIGHT="7.437128035145769"/>
<DICH_DATA CI_END="1.3441307311186634" CI_START="0.30824499823758894" EFFECT_SIZE="0.6436781609195402" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="36" LOG_CI_END="0.12844151056477918" LOG_CI_START="-0.5111039617896154" LOG_EFFECT_SIZE="-0.1913312256124181" ORDER="1105" O_E="0.0" SE="0.3756721762621169" STUDY_ID="STD-Bungum-2003" TOTAL_1="61" TOTAL_2="57" VAR="0.14112958401751505" WEIGHT="9.16740265878866"/>
<DICH_DATA CI_END="1.7925706705288267" CI_START="0.5762984116560224" EFFECT_SIZE="1.0163934426229508" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="39" LOG_CI_END="0.2534762863569622" LOG_CI_START="-0.23935257738198842" LOG_EFFECT_SIZE="0.007061854487486849" ORDER="1106" O_E="0.0" SE="0.28949011410247955" STUDY_ID="STD-Coskun-2000" TOTAL_1="100" TOTAL_2="101" VAR="0.08380452616306662" WEIGHT="12.263832223844716"/>
<DICH_DATA CI_END="1.0770563284825603" CI_START="0.007673194605857768" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.03223841686292603" LOG_CI_START="-2.1150237871793762" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2012-05-25 06:37:11 +1200" MODIFIED_BY="[Empty name]" ORDER="368" O_E="0.0" SE="1.2613124477737825" STUDY_ID="STD-Fisch-2007" TOTAL_1="8" TOTAL_2="12" VAR="1.5909090909090908" WEIGHT="2.279557212855878"/>
<DICH_DATA CI_END="2.3199109324563767" CI_START="0.5724279500697607" EFFECT_SIZE="1.1523809523809523" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="25" LOG_CI_END="0.36547131149208656" LOG_CI_START="-0.2422791689990626" LOG_EFFECT_SIZE="0.06159607124651197" ORDER="1107" O_E="0.0" SE="0.35699564065389855" STUDY_ID="STD-Hreinsson-2004" TOTAL_1="64" TOTAL_2="80" VAR="0.12744588744588745" WEIGHT="7.555350610791262"/>
<DICH_DATA CI_END="1.5551100863940843" CI_START="0.7129830672670086" EFFECT_SIZE="1.0529801324503312" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="75" LOG_CI_END="0.19176113819964685" LOG_CI_START="-0.14692078414508275" LOG_EFFECT_SIZE="0.022420177027282065" ORDER="1108" O_E="0.0" SE="0.19894343768784808" STUDY_ID="STD-Kolibianakis-2004" TOTAL_1="226" TOTAL_2="234" VAR="0.03957849139905869" WEIGHT="25.5098670312182"/>
<DICH_DATA CI_END="4.399582498994487" CI_START="1.2374911586926165" EFFECT_SIZE="2.3333333333333335" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="27" LOG_CI_END="0.6434114658076036" LOG_CI_START="0.09254210478158532" LOG_EFFECT_SIZE="0.36797678529459443" ORDER="1109" O_E="0.0" SE="0.3235833895139982" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.10470620996936786" WEIGHT="6.482332872478189"/>
<DICH_DATA CI_END="2.6124961265547486" CI_START="1.0198315232142572" EFFECT_SIZE="1.6322701688555348" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="41" LOG_CI_END="0.4170556552082412" LOG_CI_START="0.008528431975851325" LOG_EFFECT_SIZE="0.2127920435920463" MODIFIED="2012-05-15 20:38:26 +1200" MODIFIED_BY="[Empty name]" ORDER="351" O_E="0.0" SE="0.23997091316907515" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.0575860391671998" WEIGHT="14.160885716225907"/>
<DICH_DATA CI_END="2.3912825643749662" CI_START="0.48243362527908407" EFFECT_SIZE="1.0740740740740742" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="27" LOG_CI_END="0.37863089727771837" LOG_CI_START="-0.31656242979778076" LOG_EFFECT_SIZE="0.03103423373996882" ORDER="1111" O_E="0.0" SE="0.4083600015866171" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.16675789089582194" WEIGHT="5.9949394234196784"/>
<DICH_DATA CI_END="4.184107755146951" CI_START="0.4921984538566448" EFFECT_SIZE="1.4350649350649352" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.6216028605779355" LOG_CI_START="-0.3078597548806402" LOG_EFFECT_SIZE="0.15687155284864765" MODIFIED="2012-02-24 02:31:45 +1300" MODIFIED_BY="[Empty name]" ORDER="337" O_E="0.0" SE="0.5459709412345165" STUDY_ID="STD-Ten-2011" TOTAL_1="28" TOTAL_2="27" VAR="0.2980842686725039" WEIGHT="2.9012546345438444"/>
<DICH_DATA CI_END="3.3034578805412496" CI_START="0.801152478366118" EFFECT_SIZE="1.6268292682926828" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="20" LOG_CI_END="0.5189687738762484" LOG_CI_START="-0.09628481948262156" LOG_EFFECT_SIZE="0.21134197719681344" ORDER="1112" O_E="0.0" SE="0.3614030062934055" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.1306121329579113" WEIGHT="6.2474495806879"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="24.304018732285435" CI_END="1.3331762922496007" CI_START="0.8610192055650081" DF="11" EFFECT_SIZE="1.0713964681810624" ESTIMABLE="YES" EVENTS_1="283" EVENTS_2="313" I2="54.7399953844357" ID="CMP-003.02.02" LOG_CI_END="0.12488758203865451" LOG_CI_START="-0.06498716123173429" LOG_EFFECT_SIZE="0.029950210403460107" MODIFIED="2016-06-23 09:08:28 +1200" MODIFIED_BY="Clare Dooley" NO="2" P_CHI2="0.011510635334521568" P_Z="0.5363667977410876" STUDIES="12" TAU2="0.0" TOTAL_1="645" TOTAL_2="742" WEIGHT="100.00000000000001" Z="0.618316398580571">
<NAME>more cleavage stage than blastocyst embryos transferred</NAME>
<DICH_DATA CI_END="68.42310139003123" CI_START="0.5774395383865049" EFFECT_SIZE="6.285714285714286" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.835202755409563" LOG_CI_START="-0.23849348246570173" LOG_EFFECT_SIZE="0.7983546364719306" ORDER="1113" O_E="0.0" SE="1.218099435089859" STUDY_ID="STD-Devreker-2000" TOTAL_1="11" TOTAL_2="12" VAR="1.4837662337662336" WEIGHT="0.39199536727023787"/>
<DICH_DATA CI_END="3.6382297653692612" CI_START="1.1786435857008422" EFFECT_SIZE="2.070791195716835" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="41" LOG_CI_END="0.5608901226221997" LOG_CI_START="0.07138249706743506" LOG_EFFECT_SIZE="0.31613630984481733" MODIFIED="2012-02-23 14:00:56 +1300" MODIFIED_BY="[Empty name]" ORDER="328" O_E="0.0" SE="0.28753920235269453" STUDY_ID="STD-Elgindy-2011" TOTAL_1="100" TOTAL_2="100" VAR="0.0826787928896238" WEIGHT="10.825512060549432"/>
<DICH_DATA CI_END="1.545716926252437" CI_START="0.4650328022652552" EFFECT_SIZE="0.8478260869565217" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="46" LOG_CI_END="0.18912996265936055" LOG_CI_START="-0.33251641196951026" LOG_EFFECT_SIZE="-0.07169322465507487" ORDER="1114" O_E="0.0" SE="0.3064176626481982" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09389178398278498" WEIGHT="14.898443808347704"/>
<DICH_DATA CI_END="8.64851911044926" CI_START="1.0031431241051127" EFFECT_SIZE="2.9454545454545453" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="10" LOG_CI_END="0.9369417494047214" LOG_CI_START="0.0013629006920527062" LOG_EFFECT_SIZE="0.46915232504838705" ORDER="1115" O_E="0.0" SE="0.5495636469238135" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.302020202020202" WEIGHT="2.485584659633338"/>
<DICH_DATA CI_END="3.0719430291075756" CI_START="0.5254321859470332" EFFECT_SIZE="1.2704714640198511" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="31" LOG_CI_END="0.4874131572013897" LOG_CI_START="-0.27948332753194705" LOG_EFFECT_SIZE="0.10396491483472131" MODIFIED="2012-01-10 08:43:31 +1300" MODIFIED_BY="[Empty name]" ORDER="350" O_E="0.0" SE="0.45047879133118574" STUDY_ID="STD-Gardner-1998" TOTAL_1="45" TOTAL_2="47" VAR="0.20293114143920596" WEIGHT="5.641933321782352"/>
<DICH_DATA CI_END="2.521070145339392" CI_START="0.6716730909368898" EFFECT_SIZE="1.3012820512820513" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="24" LOG_CI_END="0.4015849294963663" LOG_CI_START="-0.17284205037886363" LOG_EFFECT_SIZE="0.11437143955875133" ORDER="1117" O_E="0.0" SE="0.3374212514381192" STUDY_ID="STD-Karaki-2002" TOTAL_1="80" TOTAL_2="82" VAR="0.11385310092206644" WEIGHT="9.922253105930253"/>
<DICH_DATA CI_END="7.943352926499268" CI_START="0.4425870325202053" EFFECT_SIZE="1.875" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.9000038588638924" LOG_CI_START="-0.3540013147364171" LOG_EFFECT_SIZE="0.27300127206373764" ORDER="1118" O_E="0.0" SE="0.7366088463985432" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.5425925925925925" WEIGHT="1.7173130375648515"/>
<DICH_DATA CI_END="0.6638539547564517" CI_START="0.09613969190686694" EFFECT_SIZE="0.25263157894736843" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="20" LOG_CI_END="-0.17792745319173398" LOG_CI_START="-1.0170972739627495" LOG_EFFECT_SIZE="-0.5975123635772417" ORDER="1119" O_E="0.0" SE="0.49293250667850147" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.24298245614035088" WEIGHT="10.876315904577393"/>
<DICH_DATA CI_END="2.59121009954922" CI_START="0.3361792666919035" EFFECT_SIZE="0.9333333333333333" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.4135026277197603" LOG_CI_START="-0.4734290744746467" LOG_EFFECT_SIZE="-0.02996322337744321" MODIFIED="2012-05-23 17:09:13 +1200" MODIFIED_BY="[Empty name]" ORDER="360" O_E="0.0" SE="0.5209880722517277" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="0.27142857142857146" WEIGHT="4.911806357441843"/>
<DICH_DATA CI_END="2.1325055279097764" CI_START="0.4689319614473275" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.32889016562507095" LOG_CI_START="-0.3288901656250709" LOG_EFFECT_SIZE="0.0" ORDER="1120" O_E="0.0" SE="0.3863834226414861" STUDY_ID="STD-Motta-1998" TOTAL_1="58" TOTAL_2="58" VAR="0.1492921492921493" WEIGHT="8.627277350352735"/>
<DICH_DATA CI_END="1.1213429986412193" CI_START="0.3760279114624602" EFFECT_SIZE="0.6493506493506493" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="77" LOG_CI_END="0.04973847578176835" LOG_CI_START="-0.4247799174546944" LOG_EFFECT_SIZE="-0.18752072083646307" MODIFIED="2012-01-10 08:41:09 +1300" MODIFIED_BY="[Empty name]" ORDER="348" O_E="0.0" SE="0.2787344530910274" STUDY_ID="STD-Pantos-2004" TOTAL_1="81" TOTAL_2="162" VAR="0.07769289533995416" WEIGHT="20.814470057151766"/>
<DICH_DATA CI_END="2.232625600508882" CI_START="0.5151685681913194" EFFECT_SIZE="1.0724637681159421" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="23" LOG_CI_END="0.34881590029230375" LOG_CI_START="-0.2880506423048619" LOG_EFFECT_SIZE="0.030382628993720916" ORDER="1121" O_E="0.0" SE="0.3740985596618045" STUDY_ID="STD-Schillaci-2002" TOTAL_1="60" TOTAL_2="60" VAR="0.1399497323410367" WEIGHT="8.887094969398108"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.611764323651556" CI_END="1.8238617542311606" CI_START="0.8401887678719862" DF="2" EFFECT_SIZE="1.237896667762022" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="76" I2="69.75088793099273" ID="CMP-003.02.03" LOG_CI_END="0.26099191642115854" LOG_CI_START="-0.07562312865832509" LOG_EFFECT_SIZE="0.09268439388141671" MODIFIED="2016-06-23 09:08:58 +1200" MODIFIED_BY="Clare Dooley" NO="3" P_CHI2="0.03666693621392225" P_Z="0.2804440609283292" STUDIES="3" TAU2="0.0" TOTAL_1="238" TOTAL_2="240" WEIGHT="99.99999999999999" Z="1.079322368930997">
<NAME>single embryo transfer</NAME>
<DICH_DATA CI_END="1.800956832712845" CI_START="0.39043252673465145" EFFECT_SIZE="0.8385416666666666" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.25550330330299453" LOG_CI_START="-0.40845400864639436" LOG_EFFECT_SIZE="-0.07647535267169991" MODIFIED="2011-11-11 11:38:35 +1300" MODIFIED_BY="[Empty name]" ORDER="335" O_E="0.0" SE="0.3900118116807715" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15210921325051757" WEIGHT="31.146920456388898"/>
<DICH_DATA CI_END="1.0770563284825603" CI_START="0.007673194605857768" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.03223841686292603" LOG_CI_START="-2.1150237871793762" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2011-11-12 06:48:48 +1300" MODIFIED_BY="[Empty name]" ORDER="342" O_E="0.0" SE="1.2613124477737825" STUDY_ID="STD-Fisch-2007" TOTAL_1="8" TOTAL_2="12" VAR="1.5909090909090908" WEIGHT="9.546855566971287"/>
<DICH_DATA CI_END="2.6124961265547486" CI_START="1.0198315232142572" EFFECT_SIZE="1.6322701688555348" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="41" LOG_CI_END="0.4170556552082412" LOG_CI_START="0.008528431975851325" LOG_EFFECT_SIZE="0.2127920435920463" ORDER="1122" O_E="0.0" SE="0.23997091316907515" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.0575860391671998" WEIGHT="59.3062239766398"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="58.738923070489506" CI_END="1.472637346081461" CI_START="1.1389644161743733" CI_STUDY="95" CI_TOTAL="95" DF="26" EFFECT_MEASURE="OR" EFFECT_SIZE="1.2950990445198582" ESTIMABLE="YES" EVENTS_1="845" EVENTS_2="773" I2="55.73633522562414" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.16809580998791773" LOG_CI_START="0.0565101559487062" LOG_EFFECT_SIZE="0.11230298296831197" METHOD="MH" MODIFIED="2016-06-23 09:09:27 +1200" MODIFIED_BY="Clare Dooley" NO="3" P_CHI2="2.471873791646262E-4" P_Q="0.7675028538616453" P_Z="7.975761379774392E-5" Q="0.5292261995585323" RANDOM="NO" SCALE="208.56458286382917" SORT_BY="STUDY" STUDIES="27" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1955" TOTAL_2="2076" WEIGHT="300.0" Z="3.945127245424569">
<NAME>Clinical pregnancy rate per couple: grouped by prognosis</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="33.129469276063226" CI_END="1.5598222983761072" CI_START="1.0906097226480767" DF="14" EFFECT_SIZE="1.3042842344413474" ESTIMABLE="YES" EVENTS_1="464" EVENTS_2="405" I2="57.741550631735265" ID="CMP-003.03.01" LOG_CI_END="0.19307512448871897" LOG_CI_START="0.03766936504857218" LOG_EFFECT_SIZE="0.11537224476864558" MODIFIED="2016-06-23 09:09:15 +1200" MODIFIED_BY="Clare Dooley" NO="1" P_CHI2="0.0027596930359808924" P_Z="0.0036127899745549193" STUDIES="15" TAU2="0.0" TOTAL_1="1021" TOTAL_2="1035" WEIGHT="100.00000000000001" Z="2.9101295264307785">
<NAME>good prognostic factors</NAME>
<DICH_DATA CI_END="1.800956832712845" CI_START="0.39043252673465145" EFFECT_SIZE="0.8385416666666666" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.25550330330299453" LOG_CI_START="-0.40845400864639436" LOG_EFFECT_SIZE="-0.07647535267169991" MODIFIED="2011-11-11 11:39:50 +1300" MODIFIED_BY="[Empty name]" ORDER="336" O_E="0.0" SE="0.3900118116807715" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15210921325051757" WEIGHT="6.825753235869783"/>
<DICH_DATA CI_END="1.3441307311186634" CI_START="0.30824499823758894" EFFECT_SIZE="0.6436781609195402" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="36" LOG_CI_END="0.12844151056477918" LOG_CI_START="-0.5111039617896154" LOG_EFFECT_SIZE="-0.1913312256124181" ORDER="1123" O_E="0.0" SE="0.3756721762621169" STUDY_ID="STD-Bungum-2003" TOTAL_1="61" TOTAL_2="57" VAR="0.14112958401751505" WEIGHT="8.413789310475611"/>
<DICH_DATA CI_END="1.7925706705288267" CI_START="0.5762984116560224" EFFECT_SIZE="1.0163934426229508" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="39" LOG_CI_END="0.2534762863569622" LOG_CI_START="-0.23935257738198842" LOG_EFFECT_SIZE="0.007061854487486849" ORDER="1124" O_E="0.0" SE="0.28949011410247955" STUDY_ID="STD-Coskun-2000" TOTAL_1="100" TOTAL_2="101" VAR="0.08380452616306662" WEIGHT="11.25567451447425"/>
<DICH_DATA CI_END="3.6382297653692612" CI_START="1.1786435857008422" EFFECT_SIZE="2.070791195716835" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="41" LOG_CI_END="0.5608901226221997" LOG_CI_START="0.07138249706743506" LOG_EFFECT_SIZE="0.31613630984481733" MODIFIED="2012-02-23 14:01:31 +1300" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.28753920235269453" STUDY_ID="STD-Elgindy-2011" TOTAL_1="100" TOTAL_2="100" VAR="0.0826787928896238" WEIGHT="7.993019253100196"/>
<DICH_DATA CI_END="1.0770563284825603" CI_START="0.007673194605857768" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.03223841686292603" LOG_CI_START="-2.1150237871793762" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2011-11-04 05:43:23 +1300" MODIFIED_BY="[Empty name]" ORDER="321" O_E="0.0" SE="1.2613124477737825" STUDY_ID="STD-Fisch-2007" TOTAL_1="8" TOTAL_2="12" VAR="1.5909090909090908" WEIGHT="2.092164468390296"/>
<DICH_DATA CI_END="8.64851911044926" CI_START="1.0031431241051127" EFFECT_SIZE="2.9454545454545453" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="10" LOG_CI_END="0.9369417494047214" LOG_CI_START="0.0013629006920527062" LOG_EFFECT_SIZE="0.46915232504838705" ORDER="1125" O_E="0.0" SE="0.5495636469238135" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.302020202020202" WEIGHT="1.8352319898160487"/>
<DICH_DATA CI_END="3.0719430291075756" CI_START="0.5254321859470332" EFFECT_SIZE="1.2704714640198511" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="31" LOG_CI_END="0.4874131572013897" LOG_CI_START="-0.27948332753194705" LOG_EFFECT_SIZE="0.10396491483472131" MODIFIED="2012-01-10 08:44:26 +1300" MODIFIED_BY="[Empty name]" ORDER="351" O_E="0.0" SE="0.45047879133118574" STUDY_ID="STD-Gardner-1998" TOTAL_1="45" TOTAL_2="47" VAR="0.20293114143920596" WEIGHT="4.165722731034037"/>
<DICH_DATA CI_END="2.3199109324563767" CI_START="0.5724279500697607" EFFECT_SIZE="1.1523809523809523" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="25" LOG_CI_END="0.36547131149208656" LOG_CI_START="-0.2422791689990626" LOG_EFFECT_SIZE="0.06159607124651197" ORDER="1127" O_E="0.0" SE="0.35699564065389855" STUDY_ID="STD-Hreinsson-2004" TOTAL_1="64" TOTAL_2="80" VAR="0.12744588744588745" WEIGHT="6.934257234248139"/>
<DICH_DATA CI_END="3.0496833052761207" CI_START="1.1748459773074391" EFFECT_SIZE="1.8928571428571428" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="44" LOG_CI_END="0.48425474232640997" LOG_CI_START="0.06998093419072958" LOG_EFFECT_SIZE="0.27711783825856984" MODIFIED="2016-05-03 12:24:28 +1200" MODIFIED_BY="[Empty name]" ORDER="394" O_E="0.0" SE="0.24334648558732203" STUDY_ID="STD-Kaur-2014" TOTAL_1="150" TOTAL_2="150" VAR="0.059217512047700725" WEIGHT="11.716121022985655"/>
<DICH_DATA CI_END="0.6638539547564517" CI_START="0.09613969190686694" EFFECT_SIZE="0.25263157894736843" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="20" LOG_CI_END="-0.17792745319173398" LOG_CI_START="-1.0170972739627495" LOG_EFFECT_SIZE="-0.5975123635772417" ORDER="1128" O_E="0.0" SE="0.49293250667850147" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.24298245614035088" WEIGHT="8.030530282710226"/>
<DICH_DATA CI_END="2.59121009954922" CI_START="0.3361792666919035" EFFECT_SIZE="0.9333333333333333" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.4135026277197603" LOG_CI_START="-0.4734290744746467" LOG_EFFECT_SIZE="-0.02996322337744321" MODIFIED="2012-05-23 17:09:38 +1200" MODIFIED_BY="[Empty name]" ORDER="361" O_E="0.0" SE="0.5209880722517277" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="0.27142857142857146" WEIGHT="3.6266333234808665"/>
<DICH_DATA CI_END="4.399582498994487" CI_START="1.2374911586926165" EFFECT_SIZE="2.3333333333333335" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="27" LOG_CI_END="0.6434114658076036" LOG_CI_START="0.09254210478158532" LOG_EFFECT_SIZE="0.36797678529459443" ORDER="1129" O_E="0.0" SE="0.3235833895139982" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.10470620996936786" WEIGHT="5.949447739934709"/>
<DICH_DATA CI_END="2.6124961265547486" CI_START="1.0198315232142572" EFFECT_SIZE="1.6322701688555348" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="41" LOG_CI_END="0.4170556552082412" LOG_CI_START="0.008528431975851325" LOG_EFFECT_SIZE="0.2127920435920463" ORDER="1130" O_E="0.0" SE="0.23997091316907515" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.0575860391671998" WEIGHT="12.996779273333653"/>
<DICH_DATA CI_END="2.3912825643749662" CI_START="0.48243362527908407" EFFECT_SIZE="1.0740740740740742" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="27" LOG_CI_END="0.37863089727771837" LOG_CI_START="-0.31656242979778076" LOG_EFFECT_SIZE="0.03103423373996882" ORDER="1131" O_E="0.0" SE="0.4083600015866171" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.16675789089582194" WEIGHT="5.502120842195257"/>
<DICH_DATA CI_END="4.184107755146951" CI_START="0.4921984538566448" EFFECT_SIZE="1.4350649350649352" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.6216028605779355" LOG_CI_START="-0.3078597548806402" LOG_EFFECT_SIZE="0.15687155284864765" MODIFIED="2012-02-24 02:32:11 +1300" MODIFIED_BY="[Empty name]" ORDER="338" O_E="0.0" SE="0.5459709412345165" STUDY_ID="STD-Ten-2011" TOTAL_1="28" TOTAL_2="27" VAR="0.2980842686725039" WEIGHT="2.6627547779512852"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.5917808934263695" CI_END="3.1029581323161395" CI_START="0.8422438259022388" DF="2" EFFECT_SIZE="1.6166160116046144" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="22" I2="0.0" ID="CMP-003.03.02" LOG_CI_END="0.4917759157624643" LOG_CI_START="-0.07456216394603049" LOG_EFFECT_SIZE="0.20860687590821692" MODIFIED="2016-06-23 09:09:21 +1200" MODIFIED_BY="Clare Dooley" NO="2" P_CHI2="0.4511794778519962" P_Z="0.1487728819863606" STUDIES="3" TAU2="0.0" TOTAL_1="91" TOTAL_2="104" WEIGHT="100.0" Z="1.4438794718446997">
<NAME>poor prognostic factors</NAME>
<DICH_DATA CI_END="2.837814603142948" CI_START="0.5901514787379876" EFFECT_SIZE="1.2941176470588236" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.45298401921798814" LOG_CI_START="-0.2290365003301235" LOG_EFFECT_SIZE="0.11197375944393233" MODIFIED="2016-04-29 04:05:39 +1200" MODIFIED_BY="[Empty name]" ORDER="370" O_E="0.0" SE="0.4006222292385809" STUDY_ID="STD-Aziminekoo-2015" TOTAL_1="57" TOTAL_2="61" VAR="0.16049817056009005" WEIGHT="76.97382054293017"/>
<DICH_DATA CI_END="68.42310139003123" CI_START="0.5774395383865049" EFFECT_SIZE="6.285714285714286" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.835202755409563" LOG_CI_START="-0.23849348246570173" LOG_EFFECT_SIZE="0.7983546364719306" ORDER="1132" O_E="0.0" SE="1.218099435089859" STUDY_ID="STD-Devreker-2000" TOTAL_1="11" TOTAL_2="12" VAR="1.4837662337662336" WEIGHT="4.279201492021829"/>
<DICH_DATA CI_END="7.943352926499268" CI_START="0.4425870325202053" EFFECT_SIZE="1.875" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.9000038588638924" LOG_CI_START="-0.3540013147364171" LOG_EFFECT_SIZE="0.27300127206373764" ORDER="1133" O_E="0.0" SE="0.7366088463985432" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.5425925925925925" WEIGHT="18.74697796504801"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="23.557026950326204" CI_END="1.5273206044365357" CI_START="1.039220847288775" DF="8" EFFECT_SIZE="1.2598505517021217" ESTIMABLE="YES" EVENTS_1="353" EVENTS_2="346" I2="66.0398571650434" ID="CMP-003.03.03" LOG_CI_END="0.18393021067976006" LOG_CI_START="0.01670785031638072" LOG_EFFECT_SIZE="0.10031903049807037" MODIFIED="2016-06-23 09:09:27 +1200" MODIFIED_BY="Clare Dooley" NO="3" P_CHI2="0.0027180784490021814" P_Z="0.018691881518097846" STUDIES="9" TAU2="0.0" TOTAL_1="843" TOTAL_2="937" WEIGHT="100.00000000000001" Z="2.3516195598833574">
<NAME>unselected group</NAME>
<DICH_DATA CI_END="1.545716926252437" CI_START="0.4650328022652552" EFFECT_SIZE="0.8478260869565217" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="46" LOG_CI_END="0.18912996265936055" LOG_CI_START="-0.33251641196951026" LOG_EFFECT_SIZE="-0.07169322465507487" ORDER="1134" O_E="0.0" SE="0.3064176626481982" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09389178398278498" WEIGHT="12.535557160973624"/>
<DICH_DATA CI_END="6.311331843171402" CI_START="1.3692153649073278" EFFECT_SIZE="2.939655172413793" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="16" LOG_CI_END="0.8001210155208941" LOG_CI_START="0.13647176401026445" LOG_EFFECT_SIZE="0.46829638976557925" MODIFIED="2016-05-03 07:05:32 +1200" MODIFIED_BY="[Empty name]" ORDER="754" O_E="0.0" SE="0.3898308554541205" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.1519680958640914" WEIGHT="4.190349036822933"/>
<DICH_DATA CI_END="4.723913882887663" CI_START="1.6986642857146503" EFFECT_SIZE="2.8327272727272725" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="44" LOG_CI_END="0.6743019718103199" LOG_CI_START="0.23010755587428364" LOG_EFFECT_SIZE="0.4522047638423018" MODIFIED="2016-05-04 09:08:45 +1200" MODIFIED_BY="[Empty name]" ORDER="804" O_E="0.0" SE="0.2609219987186484" STUDY_ID="STD-Gaafar-2015" TOTAL_1="126" TOTAL_2="126" VAR="0.06808028941533435" WEIGHT="9.460968679197917"/>
<DICH_DATA CI_END="2.521070145339392" CI_START="0.6716730909368898" EFFECT_SIZE="1.3012820512820513" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="24" LOG_CI_END="0.4015849294963663" LOG_CI_START="-0.17284205037886363" LOG_EFFECT_SIZE="0.11437143955875133" ORDER="1135" O_E="0.0" SE="0.3374212514381192" STUDY_ID="STD-Karaki-2002" TOTAL_1="80" TOTAL_2="82" VAR="0.11385310092206644" WEIGHT="8.348588119340707"/>
<DICH_DATA CI_END="1.5551100863940843" CI_START="0.7129830672670086" EFFECT_SIZE="1.0529801324503312" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="75" LOG_CI_END="0.19176113819964685" LOG_CI_START="-0.14692078414508275" LOG_EFFECT_SIZE="0.022420177027282065" ORDER="1136" O_E="0.0" SE="0.19894343768784808" STUDY_ID="STD-Kolibianakis-2004" TOTAL_1="226" TOTAL_2="234" VAR="0.03957849139905869" WEIGHT="26.68049260233492"/>
<DICH_DATA CI_END="2.1325055279097764" CI_START="0.4689319614473275" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.32889016562507095" LOG_CI_START="-0.3288901656250709" LOG_EFFECT_SIZE="0.0" ORDER="1137" O_E="0.0" SE="0.3863834226414861" STUDY_ID="STD-Motta-1998" TOTAL_1="58" TOTAL_2="58" VAR="0.1492921492921493" WEIGHT="7.258994950084911"/>
<DICH_DATA CI_END="1.1213429986412193" CI_START="0.3760279114624602" EFFECT_SIZE="0.6493506493506493" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="77" LOG_CI_END="0.04973847578176835" LOG_CI_START="-0.4247799174546944" LOG_EFFECT_SIZE="-0.18752072083646307" MODIFIED="2012-01-10 08:46:19 +1300" MODIFIED_BY="[Empty name]" ORDER="353" O_E="0.0" SE="0.2787344530910274" STUDY_ID="STD-Pantos-2004" TOTAL_1="81" TOTAL_2="162" VAR="0.07769289533995416" WEIGHT="17.51330424393748"/>
<DICH_DATA CI_END="2.232625600508882" CI_START="0.5151685681913194" EFFECT_SIZE="1.0724637681159421" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="23" LOG_CI_END="0.34881590029230375" LOG_CI_START="-0.2880506423048619" LOG_EFFECT_SIZE="0.030382628993720916" ORDER="1138" O_E="0.0" SE="0.3740985596618045" STUDY_ID="STD-Schillaci-2002" TOTAL_1="60" TOTAL_2="60" VAR="0.1399497323410367" WEIGHT="7.477605608813337"/>
<DICH_DATA CI_END="3.3034578805412496" CI_START="0.801152478366118" EFFECT_SIZE="1.6268292682926828" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="20" LOG_CI_END="0.5189687738762484" LOG_CI_START="-0.09628481948262156" LOG_EFFECT_SIZE="0.21134197719681344" ORDER="1139" O_E="0.0" SE="0.3614030062934055" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.1306121329579113" WEIGHT="6.5341395984941775"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="45.84243156293163" CI_END="1.3577230576135837" CI_START="1.0286843483697825" CI_STUDY="95" CI_TOTAL="95" DF="24" EFFECT_MEASURE="OR" EFFECT_SIZE="1.1818072849614094" ESTIMABLE="YES" EVENTS_1="703" EVENTS_2="685" I2="47.64675611272222" I2_Q="48.206615704047564" ID="CMP-003.04" LOG_CI_END="0.1328111934968179" LOG_CI_START="0.012282132010801826" LOG_EFFECT_SIZE="0.07254666275380985" METHOD="MH" MODIFIED="2016-06-23 09:10:04 +1200" MODIFIED_BY="Clare Dooley" NO="4" P_CHI2="0.004624022514137294" P_Q="0.1221674038191447" P_Z="0.01830393039063954" Q="5.792245555644151" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="25" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1679" TOTAL_2="1800" WEIGHT="399.99999999999994" Z="2.3594118205680648">
<NAME>Clinical pregnancy rate per couple: grouped by day of randomisation</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.292699567989803" CI_END="1.4938159229674746" CI_START="0.9500614127098073" DF="6" EFFECT_SIZE="1.1913088877796907" ESTIMABLE="YES" EVENTS_1="261" EVENTS_2="241" I2="0.0" ID="CMP-003.04.01" LOG_CI_END="0.17429708438377223" LOG_CI_START="-0.022248320670156613" LOG_EFFECT_SIZE="0.07602438185680782" MODIFIED="2016-06-23 09:09:46 +1200" MODIFIED_BY="Clare Dooley" NO="1" P_CHI2="0.5068570701330344" P_Z="0.12945855382300878" STUDIES="7" TAU2="0.0" TOTAL_1="676" TOTAL_2="695" WEIGHT="99.99999999999999" Z="1.516240487488162">
<NAME>randomised start of cycle</NAME>
<DICH_DATA CI_END="1.800956832712845" CI_START="0.39043252673465145" EFFECT_SIZE="0.8385416666666666" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.25550330330299453" LOG_CI_START="-0.40845400864639436" LOG_EFFECT_SIZE="-0.07647535267169991" MODIFIED="2011-11-11 11:40:35 +1300" MODIFIED_BY="[Empty name]" ORDER="337" O_E="0.0" SE="0.3900118116807715" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="0.15210921325051757" WEIGHT="10.436423275044756"/>
<DICH_DATA CI_END="1.545716926252437" CI_START="0.4650328022652552" EFFECT_SIZE="0.8478260869565217" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="46" LOG_CI_END="0.18912996265936055" LOG_CI_START="-0.33251641196951026" LOG_EFFECT_SIZE="-0.07169322465507487" ORDER="1140" O_E="0.0" SE="0.3064176626481982" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.09389178398278498" WEIGHT="16.81916453818015"/>
<DICH_DATA CI_END="3.0719430291075756" CI_START="0.5254321859470332" EFFECT_SIZE="1.2704714640198511" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="31" LOG_CI_END="0.4874131572013897" LOG_CI_START="-0.27948332753194705" LOG_EFFECT_SIZE="0.10396491483472131" MODIFIED="2012-01-10 08:47:16 +1300" MODIFIED_BY="[Empty name]" ORDER="354" O_E="0.0" SE="0.45047879133118574" STUDY_ID="STD-Gardner-1998" TOTAL_1="45" TOTAL_2="47" VAR="0.20293114143920596" WEIGHT="6.3692964227129325"/>
<DICH_DATA CI_END="1.5551100863940843" CI_START="0.7129830672670086" EFFECT_SIZE="1.0529801324503312" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="75" LOG_CI_END="0.19176113819964685" LOG_CI_START="-0.14692078414508275" LOG_EFFECT_SIZE="0.022420177027282065" ORDER="1142" O_E="0.0" SE="0.19894343768784808" STUDY_ID="STD-Kolibianakis-2004" TOTAL_1="226" TOTAL_2="234" VAR="0.03957849139905869" WEIGHT="35.79765855445358"/>
<DICH_DATA CI_END="7.943352926499268" CI_START="0.4425870325202053" EFFECT_SIZE="1.875" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.9000038588638924" LOG_CI_START="-0.3540013147364171" LOG_EFFECT_SIZE="0.27300127206373764" ORDER="1143" O_E="0.0" SE="0.7366088463985432" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.5425925925925925" WEIGHT="1.938710573662828"/>
<DICH_DATA CI_END="2.6124961265547486" CI_START="1.0198315232142572" EFFECT_SIZE="1.6322701688555348" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="41" LOG_CI_END="0.4170556552082412" LOG_CI_START="0.008528431975851325" LOG_EFFECT_SIZE="0.2127920435920463" ORDER="1144" O_E="0.0" SE="0.23997091316907515" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.0575860391671998" WEIGHT="19.871783380043986"/>
<DICH_DATA CI_END="3.3034578805412496" CI_START="0.801152478366118" EFFECT_SIZE="1.6268292682926828" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="20" LOG_CI_END="0.5189687738762484" LOG_CI_START="-0.09628481948262156" LOG_EFFECT_SIZE="0.21134197719681344" ORDER="1145" O_E="0.0" SE="0.3614030062934055" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.1306121329579113" WEIGHT="8.766963255901759"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="22.694866658921715" CI_END="1.4619961484309032" CI_START="0.9018543175236469" DF="9" EFFECT_SIZE="1.1482628351842414" ESTIMABLE="YES" EVENTS_1="222" EVENTS_2="212" I2="60.3434550409136" ID="CMP-003.04.02" LOG_CI_END="0.1649462284922871" LOG_CI_START="-0.04486361124459063" LOG_EFFECT_SIZE="0.06004130862384821" MODIFIED="2016-06-23 09:09:52 +1200" MODIFIED_BY="Clare Dooley" NO="2" P_CHI2="0.006919220787978575" P_Z="0.2619618420590707" STUDIES="10" TAU2="0.0" TOTAL_1="554" TOTAL_2="576" WEIGHT="99.99999999999999" Z="1.1217662873674326">
<NAME>randomised on day of OPU or day 1</NAME>
<DICH_DATA CI_END="2.837814603142948" CI_START="0.5901514787379876" EFFECT_SIZE="1.2941176470588236" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.45298401921798814" LOG_CI_START="-0.2290365003301235" LOG_EFFECT_SIZE="0.11197375944393233" MODIFIED="2016-04-29 09:30:50 +1200" MODIFIED_BY="[Empty name]" ORDER="755" O_E="0.0" SE="0.4006222292385809" STUDY_ID="STD-Aziminekoo-2015" TOTAL_1="57" TOTAL_2="61" VAR="0.16049817056009005" WEIGHT="8.911542951414146"/>
<DICH_DATA CI_END="1.7925706705288267" CI_START="0.5762984116560224" EFFECT_SIZE="1.0163934426229508" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="39" LOG_CI_END="0.2534762863569622" LOG_CI_START="-0.23935257738198842" LOG_EFFECT_SIZE="0.007061854487486849" ORDER="1146" O_E="0.0" SE="0.28949011410247955" STUDY_ID="STD-Coskun-2000" TOTAL_1="100" TOTAL_2="101" VAR="0.08380452616306662" WEIGHT="19.26640913395008"/>
<DICH_DATA CI_END="6.311331843171402" CI_START="1.3692153649073278" EFFECT_SIZE="2.939655172413793" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="16" LOG_CI_END="0.8001210155208941" LOG_CI_START="0.13647176401026445" LOG_EFFECT_SIZE="0.46829638976557925" MODIFIED="2016-05-03 07:06:00 +1200" MODIFIED_BY="[Empty name]" ORDER="756" O_E="0.0" SE="0.3898308554541205" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.1519680958640914" WEIGHT="6.294179562381673"/>
<DICH_DATA CI_END="1.0770563284825603" CI_START="0.007673194605857768" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.03223841686292603" LOG_CI_START="-2.1150237871793762" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2011-11-12 06:50:12 +1300" MODIFIED_BY="[Empty name]" ORDER="343" O_E="0.0" SE="1.2613124477737825" STUDY_ID="STD-Fisch-2007" TOTAL_1="8" TOTAL_2="12" VAR="1.5909090909090908" WEIGHT="3.581171130320608"/>
<DICH_DATA CI_END="8.64851911044926" CI_START="1.0031431241051127" EFFECT_SIZE="2.9454545454545453" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="10" LOG_CI_END="0.9369417494047214" LOG_CI_START="0.0013629006920527062" LOG_EFFECT_SIZE="0.46915232504838705" ORDER="1147" O_E="0.0" SE="0.5495636469238135" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.302020202020202" WEIGHT="3.141378184491761"/>
<DICH_DATA CI_END="2.3199109324563767" CI_START="0.5724279500697607" EFFECT_SIZE="1.1523809523809523" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="25" LOG_CI_END="0.36547131149208656" LOG_CI_START="-0.2422791689990626" LOG_EFFECT_SIZE="0.06159607124651197" ORDER="1148" O_E="0.0" SE="0.35699564065389855" STUDY_ID="STD-Hreinsson-2004" TOTAL_1="64" TOTAL_2="80" VAR="0.12744588744588745" WEIGHT="11.869411890267166"/>
<DICH_DATA CI_END="2.521070145339392" CI_START="0.6716730909368898" EFFECT_SIZE="1.3012820512820513" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="24" LOG_CI_END="0.4015849294963663" LOG_CI_START="-0.17284205037886363" LOG_EFFECT_SIZE="0.11437143955875133" ORDER="1149" O_E="0.0" SE="0.3374212514381192" STUDY_ID="STD-Karaki-2002" TOTAL_1="80" TOTAL_2="82" VAR="0.11385310092206644" WEIGHT="12.540127863748928"/>
<DICH_DATA CI_END="0.6638539547564517" CI_START="0.09613969190686694" EFFECT_SIZE="0.25263157894736843" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="20" LOG_CI_END="-0.17792745319173398" LOG_CI_START="-1.0170972739627495" LOG_EFFECT_SIZE="-0.5975123635772417" ORDER="1150" O_E="0.0" SE="0.49293250667850147" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.24298245614035088" WEIGHT="13.745909389109404"/>
<DICH_DATA CI_END="2.3912825643749662" CI_START="0.48243362527908407" EFFECT_SIZE="1.0740740740740742" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="27" LOG_CI_END="0.37863089727771837" LOG_CI_START="-0.31656242979778076" LOG_EFFECT_SIZE="0.03103423373996882" ORDER="1151" O_E="0.0" SE="0.4083600015866171" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.16675789089582194" WEIGHT="9.418014985583415"/>
<DICH_DATA CI_END="2.232625600508882" CI_START="0.5151685681913194" EFFECT_SIZE="1.0724637681159421" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="23" LOG_CI_END="0.34881590029230375" LOG_CI_START="-0.2880506423048619" LOG_EFFECT_SIZE="0.030382628993720916" ORDER="1152" O_E="0.0" SE="0.3740985596618045" STUDY_ID="STD-Schillaci-2002" TOTAL_1="60" TOTAL_2="60" VAR="0.1399497323410367" WEIGHT="11.231854908732815"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.079669274434533" CI_END="2.2291044920432395" CI_START="1.1279082523520465" DF="3" EFFECT_SIZE="1.585630900282467" ESTIMABLE="YES" EVENTS_1="150" EVENTS_2="118" I2="62.86976733698101" ID="CMP-003.04.03" LOG_CI_END="0.3481304270509581" LOG_CI_START="0.05227377418830783" LOG_EFFECT_SIZE="0.20020210061963295" MODIFIED="2016-06-23 09:09:58 +1200" MODIFIED_BY="Clare Dooley" NO="3" P_CHI2="0.04439369146766503" P_Z="0.007988369637116246" STUDIES="4" TAU2="0.0" TOTAL_1="269" TOTAL_2="268" WEIGHT="100.0" Z="2.652560982131498">
<NAME>randomised on day 2 to 3</NAME>
<DICH_DATA CI_END="1.3441307311186634" CI_START="0.30824499823758894" EFFECT_SIZE="0.6436781609195402" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="36" LOG_CI_END="0.12844151056477918" LOG_CI_START="-0.5111039617896154" LOG_EFFECT_SIZE="-0.1913312256124181" ORDER="1153" O_E="0.0" SE="0.3756721762621169" STUDY_ID="STD-Bungum-2003" TOTAL_1="61" TOTAL_2="57" VAR="0.14112958401751505" WEIGHT="33.62958385157729"/>
<DICH_DATA CI_END="3.6382297653692612" CI_START="1.1786435857008422" EFFECT_SIZE="2.070791195716835" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="41" LOG_CI_END="0.5608901226221997" LOG_CI_START="0.07138249706743506" LOG_EFFECT_SIZE="0.31613630984481733" MODIFIED="2012-05-09 06:49:35 +1200" MODIFIED_BY="[Empty name]" ORDER="345" O_E="0.0" SE="0.28753920235269453" STUDY_ID="STD-Elgindy-2011" TOTAL_1="100" TOTAL_2="100" VAR="0.0826787928896238" WEIGHT="31.947782536547738"/>
<DICH_DATA CI_END="4.399582498994487" CI_START="1.2374911586926165" EFFECT_SIZE="2.3333333333333335" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="27" LOG_CI_END="0.6434114658076036" LOG_CI_START="0.09254210478158532" LOG_EFFECT_SIZE="0.36797678529459443" ORDER="1154" O_E="0.0" SE="0.3235833895139982" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.10470620996936786" WEIGHT="23.779707841222542"/>
<DICH_DATA CI_END="4.184107755146951" CI_START="0.4921984538566448" EFFECT_SIZE="1.4350649350649352" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" LOG_CI_END="0.6216028605779355" LOG_CI_START="-0.3078597548806402" LOG_EFFECT_SIZE="0.15687155284864765" MODIFIED="2012-02-24 02:32:41 +1300" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.5459709412345165" STUDY_ID="STD-Ten-2011" TOTAL_1="28" TOTAL_2="27" VAR="0.2980842686725039" WEIGHT="10.642925770652429"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.827640025485915" CI_END="1.246630917431137" CI_START="0.5662083724003699" DF="3" EFFECT_SIZE="0.8401505000549986" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="114" I2="21.62272366197359" ID="CMP-003.04.04" LOG_CI_END="0.09573789353563052" LOG_CI_START="-0.2470237131051479" LOG_EFFECT_SIZE="-0.07564290978475863" MODIFIED="2016-06-23 09:10:04 +1200" MODIFIED_BY="Clare Dooley" NO="4" P_CHI2="0.28068779521783316" P_Z="0.3869972165845107" STUDIES="4" TAU2="0.0" TOTAL_1="180" TOTAL_2="261" WEIGHT="99.99999999999999" Z="0.865075761062798">
<NAME>day of randomisation unstated</NAME>
<DICH_DATA CI_END="68.42310139003123" CI_START="0.5774395383865049" EFFECT_SIZE="6.285714285714286" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.835202755409563" LOG_CI_START="-0.23849348246570173" LOG_EFFECT_SIZE="0.7983546364719306" ORDER="1155" O_E="0.0" SE="1.218099435089859" STUDY_ID="STD-Devreker-2000" TOTAL_1="11" TOTAL_2="12" VAR="1.4837662337662336" WEIGHT="1.1281887236220827"/>
<DICH_DATA CI_END="2.59121009954922" CI_START="0.3361792666919035" EFFECT_SIZE="0.9333333333333333" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.4135026277197603" LOG_CI_START="-0.4734290744746467" LOG_EFFECT_SIZE="-0.02996322337744321" MODIFIED="2012-05-23 17:10:12 +1200" MODIFIED_BY="[Empty name]" ORDER="362" O_E="0.0" SE="0.5209880722517277" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="0.27142857142857146" WEIGHT="14.136505193085418"/>
<DICH_DATA CI_END="2.1325055279097764" CI_START="0.4689319614473275" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.32889016562507095" LOG_CI_START="-0.3288901656250709" LOG_EFFECT_SIZE="0.0" ORDER="1156" O_E="0.0" SE="0.3863834226414861" STUDY_ID="STD-Motta-1998" TOTAL_1="58" TOTAL_2="58" VAR="0.1492921492921493" WEIGHT="24.829877684544627"/>
<DICH_DATA CI_END="1.1213429986412193" CI_START="0.3760279114624602" EFFECT_SIZE="0.6493506493506493" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="77" LOG_CI_END="0.04973847578176835" LOG_CI_START="-0.4247799174546944" LOG_EFFECT_SIZE="-0.18752072083646307" MODIFIED="2012-01-10 08:48:11 +1300" MODIFIED_BY="[Empty name]" ORDER="355" O_E="0.0" SE="0.2787344530910274" STUDY_ID="STD-Pantos-2004" TOTAL_1="81" TOTAL_2="162" VAR="0.07769289533995416" WEIGHT="59.905428398747866"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2016-06-23 13:41:31 +1200" MODIFIED_BY="Helen E Nagels" NO="4">
<NAME>Blastocyst versus cleavage stage transfer: Multiple pregnancy following fresh transfer</NAME>
<DICH_OUTCOME CHI2="25.673370330359514" CI_END="1.3259398445564266" CI_START="0.8337284399304306" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="OR" EFFECT_SIZE="1.051415121654443" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="159" I2="29.88844172627202" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.12252382137658467" LOG_CI_START="-0.07897538370845081" LOG_EFFECT_SIZE="0.021774218834066928" METHOD="MH" MODIFIED="2016-06-23 13:41:31 +1200" MODIFIED_BY="Helen E Nagels" NO="1" P_CHI2="0.10746422186976734" P_Q="1.0" P_Z="0.6718636881763876" Q="0.0" RANDOM="NO" SCALE="4.295252861366694" SORT_BY="STUDY" STUDIES="19" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1500" TOTAL_2="1519" WEIGHT="100.00000000000003" Z="0.42359159370633515">
<NAME>Multiple pregnancy rate per couple</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 5/6</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 2/3</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.7316466622704207" CI_START="0.1417315420675126" EFFECT_SIZE="0.6222222222222222" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.436424522772927" LOG_CI_START="-0.8485334876391759" LOG_EFFECT_SIZE="-0.20605448243312446" MODIFIED="2016-05-06 14:31:49 +1200" MODIFIED_BY="[Empty name]" ORDER="371" O_E="0.0" SE="0.754790695960804" STUDY_ID="STD-Aziminekoo-2015" TOTAL_1="57" TOTAL_2="61" VAR="0.5697089947089947" WEIGHT="3.2869636412477146"/>
<DICH_DATA CI_END="1.7748456279684888" CI_START="0.3240109648875076" EFFECT_SIZE="0.7583333333333333" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.2491605850885882" LOG_CI_START="-0.4894402925416507" LOG_EFFECT_SIZE="-0.12013985372653124" ORDER="1157" O_E="0.0" SE="0.433857811653312" STUDY_ID="STD-Bungum-2003" TOTAL_1="61" TOTAL_2="57" VAR="0.18823260073260073" WEIGHT="8.765236376660571"/>
<DICH_DATA CI_END="2.6592969081589772" CI_START="0.5366071779497429" EFFECT_SIZE="1.1945701357466063" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.42476682863524434" LOG_CI_START="-0.27034352226580366" LOG_EFFECT_SIZE="0.07721165318472036" ORDER="1158" O_E="0.0" SE="0.4083112609710059" STUDY_ID="STD-Coskun-2000" TOTAL_1="100" TOTAL_2="101" VAR="0.1667180858357329" WEIGHT="7.897313233504505"/>
<DICH_DATA CI_END="2.8606453051799225" CI_START="0.38774898490749987" EFFECT_SIZE="1.053191489361702" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="0.4564640124530605" LOG_CI_START="-0.41144933045735804" LOG_EFFECT_SIZE="0.02250734099785122" MODIFIED="2012-02-23 14:02:24 +1300" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="0.5098165938659162" STUDY_ID="STD-Elgindy-2011" TOTAL_1="59" TOTAL_2="41" VAR="0.25991295938104453" WEIGHT="5.4013334383288365"/>
<DICH_DATA CI_END="4.4883067020938645" CI_START="0.6712340046252143" EFFECT_SIZE="1.7357142857142858" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="0.6520825261616224" LOG_CI_START="-0.17312605032147405" LOG_EFFECT_SIZE="0.23947823792007417" MODIFIED="2016-05-06 14:31:51 +1200" MODIFIED_BY="[Empty name]" ORDER="1159" O_E="0.0" SE="0.48473160267450405" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.23496472663139328" WEIGHT="4.7044088675254265"/>
<DICH_DATA CI_END="4.990720264880209" CI_START="0.3245693256227179" EFFECT_SIZE="1.2727272727272727" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6981632278858368" LOG_CI_START="-0.48869252684581094" LOG_EFFECT_SIZE="0.10473535052001298" MODIFIED="2016-05-06 14:31:55 +1200" MODIFIED_BY="[Empty name]" ORDER="758" O_E="0.0" SE="0.6971649453601071" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.48603896103896105" WEIGHT="2.633628892802181"/>
<DICH_DATA CI_END="2.2669359908027595" CI_START="0.1723140845550179" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3554392575620653" LOG_CI_START="-0.7636792228739149" LOG_EFFECT_SIZE="-0.2041199826559248" MODIFIED="2016-05-06 14:31:56 +1200" MODIFIED_BY="[Empty name]" ORDER="1160" O_E="0.0" SE="0.6573757351339165" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.4321428571428571" WEIGHT="4.233967980772884"/>
<DICH_DATA CI_END="3.4578730750038384" CI_START="0.10863625010398546" EFFECT_SIZE="0.6129032258064516" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.5388090479786476" LOG_CI_START="-0.9640252337415349" LOG_EFFECT_SIZE="-0.21260809288144372" ORDER="1161" O_E="0.0" SE="0.8827722962321068" STUDY_ID="STD-Hreinsson-2004" TOTAL_1="64" TOTAL_2="80" VAR="0.7792869269949066" WEIGHT="2.47401502051114"/>
<DICH_DATA CI_END="2.379701306030249" CI_START="0.3500345113489413" EFFECT_SIZE="0.9126760563380282" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.3765224489541457" LOG_CI_START="-0.4558891346511096" LOG_EFFECT_SIZE="-0.03968334284848195" ORDER="1162" O_E="0.0" SE="0.4889626847135204" STUDY_ID="STD-Karaki-2002" TOTAL_1="80" TOTAL_2="82" VAR="0.23908450704225354" WEIGHT="6.295880518146628"/>
<DICH_DATA CI_END="5.1725242442129185" CI_START="1.341699174227464" EFFECT_SIZE="2.6343825665859564" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="14" LOG_CI_END="0.7137025349304669" LOG_CI_START="0.12765515248105327" LOG_EFFECT_SIZE="0.4206788437057601" MODIFIED="2016-05-06 14:31:57 +1200" MODIFIED_BY="[Empty name]" ORDER="395" O_E="0.0" SE="0.3442471334321151" STUDY_ID="STD-Kaur-2014" TOTAL_1="150" TOTAL_2="150" VAR="0.11850608887622846" WEIGHT="7.910463510744006"/>
<DICH_DATA CI_END="1.5255756287497235" CI_START="0.37927255794035364" EFFECT_SIZE="0.7606635071090048" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="20" LOG_CI_END="0.18343374218788733" LOG_CI_START="-0.42104857930149087" LOG_EFFECT_SIZE="-0.11880741855680177" MODIFIED="2016-05-06 14:31:58 +1200" MODIFIED_BY="[Empty name]" ORDER="1163" O_E="0.0" SE="0.35507590787861026" STUDY_ID="STD-Kolibianakis-2004" TOTAL_1="226" TOTAL_2="234" VAR="0.12607890035581934" WEIGHT="13.178554064377714"/>
<DICH_DATA CI_END="5.805116090819391" CI_START="0.136108123322405" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.7638109091905498" LOG_CI_START="-0.8661159540853126" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="1164" O_E="0.0" SE="0.9574271077563381" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.9166666666666666" WEIGHT="1.6759456590559336"/>
<DICH_DATA CI_END="1.5416082312746573" CI_START="0.11914406375210339" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.18797402052883078" LOG_CI_START="-0.9239275911180196" LOG_EFFECT_SIZE="-0.36797678529459443" ORDER="1165" O_E="0.0" SE="0.653136510683105" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.4265873015873016" WEIGHT="5.363026108978987"/>
<DICH_DATA CI_END="1.8083694285973242" CI_START="0.0047720886937039474" EFFECT_SIZE="0.09289617486338798" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.2572871564557577" LOG_CI_START="-2.3212914931600688" LOG_EFFECT_SIZE="-1.0320021683521554" MODIFIED="2012-05-23 17:14:15 +1200" MODIFIED_BY="[Empty name]" ORDER="363" O_E="0.0" SE="1.51466986295451" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="2.2942247937426337" WEIGHT="3.2321809138935857"/>
<DICH_DATA CI_END="1.0069555705037576" CI_START="0.06807525807348687" EFFECT_SIZE="0.26181818181818184" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.0030103087753369563" LOG_CI_START="-1.1670107035733255" LOG_EFFECT_SIZE="-0.5820001973989941" MODIFIED="2016-05-06 14:32:01 +1200" MODIFIED_BY="[Empty name]" ORDER="1166" O_E="0.0" SE="0.6872761343510226" STUDY_ID="STD-Motta-1998" TOTAL_1="58" TOTAL_2="58" VAR="0.47234848484848485" WEIGHT="6.811109205522882"/>
<DICH_DATA CI_END="6.769048900481383" CI_START="1.1237797195687425" EFFECT_SIZE="2.7580645161290325" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="8" LOG_CI_END="0.830527651507883" LOG_CI_START="0.05068119027991701" LOG_EFFECT_SIZE="0.4406044208939" MODIFIED="2016-05-06 14:32:01 +1200" MODIFIED_BY="[Empty name]" ORDER="1167" O_E="0.0" SE="0.4580856716275485" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.20984248255046217" WEIGHT="4.344611743336636"/>
<DICH_DATA CI_END="4.172151473815636" CI_START="0.009478433005873263" EFFECT_SIZE="0.19886039886039886" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6203600675033164" LOG_CI_START="-2.023263455188643" LOG_EFFECT_SIZE="-0.701451693842663" MODIFIED="2016-05-06 14:32:02 +1200" MODIFIED_BY="[Empty name]" ORDER="1168" O_E="0.0" SE="1.5528775433767448" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="2.4114286647237937" WEIGHT="1.785482374530451"/>
<DICH_DATA CI_END="3.780051875349956" CI_START="0.4373117827481551" EFFECT_SIZE="1.2857142857142858" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.5774977598963902" LOG_CI_START="-0.359208821046254" LOG_EFFECT_SIZE="0.10914446942506807" MODIFIED="2016-05-06 14:32:03 +1200" MODIFIED_BY="[Empty name]" ORDER="1169" O_E="0.0" SE="0.5502260824180657" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.30274874177313205" WEIGHT="4.206965633956731"/>
<DICH_DATA CI_END="2.519746707961364" CI_START="0.3465238690992641" EFFECT_SIZE="0.9344262295081968" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.40135688647066037" LOG_CI_START="-0.46026684514721156" LOG_EFFECT_SIZE="-0.02945497933827562" ORDER="1170" O_E="0.0" SE="0.5061220450585963" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.2561595244942958" WEIGHT="5.798912816103199"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="18.34486976904846" CI_END="1.1655011748702948" CI_START="0.6967596911321443" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9011516179959829" ESTIMABLE="YES" EVENTS_1="128" EVENTS_2="138" I2="12.782155439471884" I2_Q="21.422682747117378" ID="CMP-004.02" LOG_CI_END="0.06651271564246322" LOG_CI_START="-0.15691698203203358" LOG_EFFECT_SIZE="-0.04520213319478521" METHOD="MH" MODIFIED="2016-06-23 09:12:51 +1200" MODIFIED_BY="Clare Dooley" NO="2" P_CHI2="0.30409254540744435" P_Q="0.28009358599731615" P_Z="0.42775343343542116" Q="2.5452637859389755" RANDOM="NO" SCALE="672.941436970733" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1408" TOTAL_2="1424" WEIGHT="300.0" Z="0.7930418740952717">
<NAME>Multiple pregnancy rate per couple: grouped by number of embryo transfer</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 5/6</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 2/3</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.63957505509645" CI_END="1.4631542618349824" CI_START="0.7509456168395703" DF="7" EFFECT_SIZE="1.0482124210698502" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="78" I2="8.371866896834554" ID="CMP-004.02.01" LOG_CI_END="0.16529011664608892" LOG_CI_START="-0.12439151327769082" LOG_EFFECT_SIZE="0.020449301684199044" MODIFIED="2016-06-23 09:12:40 +1200" MODIFIED_BY="Clare Dooley" NO="1" P_CHI2="0.3654455203648903" P_Z="0.7819975288752806" STUDIES="8" TAU2="0.0" TOTAL_1="826" TOTAL_2="846" WEIGHT="100.0" Z="0.2767168551251947">
<NAME>equal number of embryos transferred</NAME>
<DICH_DATA CI_END="1.7748456279684888" CI_START="0.3240109648875076" EFFECT_SIZE="0.7583333333333333" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.2491605850885882" LOG_CI_START="-0.4894402925416507" LOG_EFFECT_SIZE="-0.12013985372653124" ORDER="1171" O_E="0.0" SE="0.433857811653312" STUDY_ID="STD-Bungum-2003" TOTAL_1="61" TOTAL_2="57" VAR="0.18823260073260073" WEIGHT="18.09089568093516"/>
<DICH_DATA CI_END="2.6592969081589772" CI_START="0.5366071779497429" EFFECT_SIZE="1.1945701357466063" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.42476682863524434" LOG_CI_START="-0.27034352226580366" LOG_EFFECT_SIZE="0.07721165318472036" ORDER="1172" O_E="0.0" SE="0.4083112609710059" STUDY_ID="STD-Coskun-2000" TOTAL_1="100" TOTAL_2="101" VAR="0.1667180858357329" WEIGHT="16.29955699168833"/>
<DICH_DATA CI_END="3.4578730750038384" CI_START="0.10863625010398546" EFFECT_SIZE="0.6129032258064516" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.5388090479786476" LOG_CI_START="-0.9640252337415349" LOG_EFFECT_SIZE="-0.21260809288144372" ORDER="1173" O_E="0.0" SE="0.8827722962321068" STUDY_ID="STD-Hreinsson-2004" TOTAL_1="64" TOTAL_2="80" VAR="0.7792869269949066" WEIGHT="5.1062111420417295"/>
<DICH_DATA CI_END="1.5255756287497235" CI_START="0.37927255794035364" EFFECT_SIZE="0.7606635071090048" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="20" LOG_CI_END="0.18343374218788733" LOG_CI_START="-0.42104857930149087" LOG_EFFECT_SIZE="-0.11880741855680177" ORDER="1174" O_E="0.0" SE="0.35507590787861026" STUDY_ID="STD-Kolibianakis-2004" TOTAL_1="226" TOTAL_2="234" VAR="0.12607890035581934" WEIGHT="27.199705354101667"/>
<DICH_DATA CI_END="6.769048900481383" CI_START="1.1237797195687425" EFFECT_SIZE="2.7580645161290325" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="8" LOG_CI_END="0.830527651507883" LOG_CI_START="0.05068119027991701" LOG_EFFECT_SIZE="0.4406044208939" ORDER="1175" O_E="0.0" SE="0.4580856716275485" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.20984248255046217" WEIGHT="8.967004932365963"/>
<DICH_DATA CI_END="4.172151473815636" CI_START="0.009478433005873263" EFFECT_SIZE="0.19886039886039886" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6203600675033164" LOG_CI_START="-2.023263455188643" LOG_EFFECT_SIZE="-0.701451693842663" ORDER="1176" O_E="0.0" SE="1.5528775433767448" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="2.4114286647237937" WEIGHT="3.6851231375559315"/>
<DICH_DATA CI_END="3.780051875349956" CI_START="0.4373117827481551" EFFECT_SIZE="1.2857142857142858" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.5774977598963902" LOG_CI_START="-0.359208821046254" LOG_EFFECT_SIZE="0.10914446942506807" ORDER="1177" O_E="0.0" SE="0.5502260824180657" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.30274874177313205" WEIGHT="8.682912034163124"/>
<DICH_DATA CI_END="2.519746707961364" CI_START="0.3465238690992641" EFFECT_SIZE="0.9344262295081968" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.40135688647066037" LOG_CI_START="-0.46026684514721156" LOG_EFFECT_SIZE="-0.02945497933827562" ORDER="1178" O_E="0.0" SE="0.5061220450585963" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.2561595244942958" WEIGHT="11.968590727148095"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.70299565631848" CI_END="1.1263994803557873" CI_START="0.4933872633600616" DF="7" EFFECT_SIZE="0.7454871944325653" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="58" I2="19.56792492573617" ID="CMP-004.02.02" LOG_CI_END="0.05169244144410749" LOG_CI_START="-0.3068120658796005" LOG_EFFECT_SIZE="-0.1275598122177465" MODIFIED="2016-06-23 09:12:45 +1200" MODIFIED_BY="Clare Dooley" NO="2" P_CHI2="0.27468893728974475" P_Z="0.163090303982331" STUDIES="8" TAU2="0.0" TOTAL_1="407" TOTAL_2="402" WEIGHT="100.0" Z="1.3947531075012634">
<NAME>more cleavage stage than blastocyst embryos transferred</NAME>
<DICH_DATA CI_END="2.8606453051799225" CI_START="0.38774898490749987" EFFECT_SIZE="1.053191489361702" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="0.4564640124530605" LOG_CI_START="-0.41144933045735804" LOG_EFFECT_SIZE="0.02250734099785122" MODIFIED="2012-02-23 14:03:01 +1300" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.5098165938659162" STUDY_ID="STD-Elgindy-2011" TOTAL_1="59" TOTAL_2="41" VAR="0.25991295938104453" WEIGHT="14.32036304506333"/>
<DICH_DATA CI_END="4.4883067020938645" CI_START="0.6712340046252143" EFFECT_SIZE="1.7357142857142858" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="0.6520825261616224" LOG_CI_START="-0.17312605032147405" LOG_EFFECT_SIZE="0.23947823792007417" ORDER="1179" O_E="0.0" SE="0.48473160267450405" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.23496472663139328" WEIGHT="12.472631742620791"/>
<DICH_DATA CI_END="2.2669359908027595" CI_START="0.1723140845550179" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3554392575620653" LOG_CI_START="-0.7636792228739149" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="1180" O_E="0.0" SE="0.6573757351339165" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.4321428571428571" WEIGHT="11.225368568358713"/>
<DICH_DATA CI_END="2.379701306030249" CI_START="0.3500345113489413" EFFECT_SIZE="0.9126760563380282" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.3765224489541457" LOG_CI_START="-0.4558891346511096" LOG_EFFECT_SIZE="-0.03968334284848195" ORDER="1181" O_E="0.0" SE="0.4889626847135204" STUDY_ID="STD-Karaki-2002" TOTAL_1="80" TOTAL_2="82" VAR="0.23908450704225354" WEIGHT="16.692043869836755"/>
<DICH_DATA CI_END="5.805116090819391" CI_START="0.136108123322405" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.7638109091905498" LOG_CI_START="-0.8661159540853126" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="1182" O_E="0.0" SE="0.9574271077563381" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.9166666666666666" WEIGHT="4.443375058308657"/>
<DICH_DATA CI_END="1.5416082312746573" CI_START="0.11914406375210339" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.18797402052883078" LOG_CI_START="-0.9239275911180196" LOG_EFFECT_SIZE="-0.36797678529459443" ORDER="1183" O_E="0.0" SE="0.653136510683105" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.4265873015873016" WEIGHT="14.218800186587703"/>
<DICH_DATA CI_END="1.8083694285973242" CI_START="0.0047720886937039474" EFFECT_SIZE="0.09289617486338798" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.2572871564557577" LOG_CI_START="-2.3212914931600688" LOG_EFFECT_SIZE="-1.0320021683521554" MODIFIED="2012-05-23 17:16:32 +1200" MODIFIED_BY="[Empty name]" ORDER="364" O_E="0.0" SE="1.51466986295451" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="2.2942247937426337" WEIGHT="8.569366183880982"/>
<DICH_DATA CI_END="1.0069555705037576" CI_START="0.06807525807348687" EFFECT_SIZE="0.26181818181818184" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.0030103087753369563" LOG_CI_START="-1.1670107035733255" LOG_EFFECT_SIZE="-0.5820001973989941" ORDER="1184" O_E="0.0" SE="0.6872761343510226" STUDY_ID="STD-Motta-1998" TOTAL_1="58" TOTAL_2="58" VAR="0.47234848484848485" WEIGHT="18.058051345343063"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.172151473815636" CI_START="0.009478433005873263" DF="0" EFFECT_SIZE="0.19886039886039886" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-004.02.03" LOG_CI_END="0.6203600675033164" LOG_CI_START="-2.023263455188643" LOG_EFFECT_SIZE="-0.701451693842663" MODIFIED="2016-06-23 09:12:51 +1200" MODIFIED_BY="Clare Dooley" NO="3" P_CHI2="1.0" P_Z="0.29829217796889596" STUDIES="1" TAU2="0.0" TOTAL_1="175" TOTAL_2="176" WEIGHT="100.00000000000001" Z="1.0401027567089274">
<NAME>single embryo transfer</NAME>
<DICH_DATA CI_END="4.172151473815636" CI_START="0.009478433005873263" EFFECT_SIZE="0.19886039886039886" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6203600675033164" LOG_CI_START="-2.023263455188643" LOG_EFFECT_SIZE="-0.701451693842663" ORDER="1185" O_E="0.0" SE="1.5528775433767448" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="2.4114286647237937" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="24.724326218505453" CI_END="1.3386552275992634" CI_START="0.8370130297436666" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0585234375464045" ESTIMABLE="YES" EVENTS_1="165" EVENTS_2="155" I2="31.24180675436977" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.12666873830294995" LOG_CI_START="-0.07726778131172198" LOG_EFFECT_SIZE="0.02470047849561397" METHOD="MH" MODIFIED="2016-06-23 09:13:36 +1200" MODIFIED_BY="Clare Dooley" NO="3" P_CHI2="0.10105239081317285" P_Q="0.8862388559769526" P_Z="0.6349468822307313" Q="0.24153755991115494" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1443" TOTAL_2="1458" WEIGHT="300.0" Z="0.47477566395446663">
<NAME>Multiple pregnancy rate per couple: grouped by prognosis</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 5/6</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 2/3</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="22.815670339872558" CI_END="1.475287014106489" CI_START="0.8257232045378752" DF="11" EFFECT_SIZE="1.1037113394819877" ESTIMABLE="YES" EVENTS_1="113" EVENTS_2="100" I2="51.78752218918394" ID="CMP-004.03.01" LOG_CI_END="0.16887651964761874" LOG_CI_START="-0.08316551065520558" LOG_EFFECT_SIZE="0.04285550449620657" MODIFIED="2016-06-23 09:13:25 +1200" MODIFIED_BY="Clare Dooley" NO="1" P_CHI2="0.01876328574406072" P_Z="0.5050802168314057" STUDIES="12" TAU2="0.0" TOTAL_1="902" TOTAL_2="896" WEIGHT="99.99999999999997" Z="0.6665177649215122">
<NAME>good prognostic factors</NAME>
<DICH_DATA CI_END="1.7748456279684888" CI_START="0.3240109648875076" EFFECT_SIZE="0.7583333333333333" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.2491605850885882" LOG_CI_START="-0.4894402925416507" LOG_EFFECT_SIZE="-0.12013985372653124" ORDER="1186" O_E="0.0" SE="0.433857811653312" STUDY_ID="STD-Bungum-2003" TOTAL_1="61" TOTAL_2="57" VAR="0.18823260073260073" WEIGHT="14.04106898069429"/>
<DICH_DATA CI_END="2.6592969081589772" CI_START="0.5366071779497429" EFFECT_SIZE="1.1945701357466063" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.42476682863524434" LOG_CI_START="-0.27034352226580366" LOG_EFFECT_SIZE="0.07721165318472036" ORDER="1187" O_E="0.0" SE="0.4083112609710059" STUDY_ID="STD-Coskun-2000" TOTAL_1="100" TOTAL_2="101" VAR="0.1667180858357329" WEIGHT="12.650739250917141"/>
<DICH_DATA CI_END="2.8606453051799225" CI_START="0.38774898490749987" EFFECT_SIZE="1.053191489361702" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="0.4564640124530605" LOG_CI_START="-0.41144933045735804" LOG_EFFECT_SIZE="0.02250734099785122" MODIFIED="2012-02-23 14:03:30 +1300" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="0.5098165938659162" STUDY_ID="STD-Elgindy-2011" TOTAL_1="59" TOTAL_2="41" VAR="0.25991295938104453" WEIGHT="8.652418729658947"/>
<DICH_DATA CI_END="2.2669359908027595" CI_START="0.1723140845550179" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3554392575620653" LOG_CI_START="-0.7636792228739149" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="1188" O_E="0.0" SE="0.6573757351339165" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.4321428571428571" WEIGHT="6.782411098276891"/>
<DICH_DATA CI_END="3.4578730750038384" CI_START="0.10863625010398546" EFFECT_SIZE="0.6129032258064516" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.5388090479786476" LOG_CI_START="-0.9640252337415349" LOG_EFFECT_SIZE="-0.21260809288144372" ORDER="1189" O_E="0.0" SE="0.8827722962321068" STUDY_ID="STD-Hreinsson-2004" TOTAL_1="64" TOTAL_2="80" VAR="0.7792869269949066" WEIGHT="3.9631350564336203"/>
<DICH_DATA CI_END="5.1725242442129185" CI_START="1.341699174227464" EFFECT_SIZE="2.6343825665859564" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="14" LOG_CI_END="0.7137025349304669" LOG_CI_START="0.12765515248105327" LOG_EFFECT_SIZE="0.4206788437057601" MODIFIED="2016-05-03 12:27:00 +1200" MODIFIED_BY="[Empty name]" ORDER="396" O_E="0.0" SE="0.3442471334321151" STUDY_ID="STD-Kaur-2014" TOTAL_1="150" TOTAL_2="150" VAR="0.11850608887622846" WEIGHT="12.67180473528066"/>
<DICH_DATA CI_END="1.5416082312746573" CI_START="0.11914406375210339" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.18797402052883078" LOG_CI_START="-0.9239275911180196" LOG_EFFECT_SIZE="-0.36797678529459443" ORDER="1190" O_E="0.0" SE="0.653136510683105" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.4265873015873016" WEIGHT="8.591054057817395"/>
<DICH_DATA CI_END="1.8083694285973242" CI_START="0.0047720886937039474" EFFECT_SIZE="0.09289617486338798" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.2572871564557577" LOG_CI_START="-2.3212914931600688" LOG_EFFECT_SIZE="-1.0320021683521554" MODIFIED="2012-05-23 17:17:16 +1200" MODIFIED_BY="[Empty name]" ORDER="365" O_E="0.0" SE="1.51466986295451" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="2.2942247937426337" WEIGHT="5.17764418663102"/>
<DICH_DATA CI_END="1.0069555705037576" CI_START="0.06807525807348687" EFFECT_SIZE="0.26181818181818184" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.0030103087753369563" LOG_CI_START="-1.1670107035733255" LOG_EFFECT_SIZE="-0.5820001973989941" ORDER="1191" O_E="0.0" SE="0.6872761343510226" STUDY_ID="STD-Motta-1998" TOTAL_1="58" TOTAL_2="58" VAR="0.47234848484848485" WEIGHT="10.910744454586439"/>
<DICH_DATA CI_END="6.769048900481383" CI_START="1.1237797195687425" EFFECT_SIZE="2.7580645161290325" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="8" LOG_CI_END="0.830527651507883" LOG_CI_START="0.05068119027991701" LOG_EFFECT_SIZE="0.4406044208939" ORDER="1192" O_E="0.0" SE="0.4580856716275485" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.20984248255046217" WEIGHT="6.959651806420016"/>
<DICH_DATA CI_END="4.172151473815636" CI_START="0.009478433005873263" EFFECT_SIZE="0.19886039886039886" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6203600675033164" LOG_CI_START="-2.023263455188643" LOG_EFFECT_SIZE="-0.701451693842663" ORDER="1193" O_E="0.0" SE="1.5528775433767448" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="2.4114286647237937" WEIGHT="2.860171717827334"/>
<DICH_DATA CI_END="3.780051875349956" CI_START="0.4373117827481551" EFFECT_SIZE="1.2857142857142858" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.5774977598963902" LOG_CI_START="-0.359208821046254" LOG_EFFECT_SIZE="0.10914446942506807" ORDER="1194" O_E="0.0" SE="0.5502260824180657" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.30274874177313205" WEIGHT="6.739155925456248"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.7018217326767213E-32" CI_END="5.805116090819391" CI_START="0.136108123322405" DF="0" EFFECT_SIZE="0.8888888888888887" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="100.0" ID="CMP-004.03.02" LOG_CI_END="0.7638109091905498" LOG_CI_START="-0.8661159540853126" LOG_EFFECT_SIZE="-0.05115252244738137" MODIFIED="2016-06-23 09:13:31 +1200" MODIFIED_BY="Clare Dooley" NO="2" P_CHI2="0.0" P_Z="0.9020909687290528" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="31" WEIGHT="100.0" Z="0.12302036855045785">
<NAME>poor prognostic factors</NAME>
<DICH_DATA CI_END="5.805116090819391" CI_START="0.136108123322405" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.7638109091905498" LOG_CI_START="-0.8661159540853126" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="1195" O_E="0.0" SE="0.9574271077563381" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.9166666666666666" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.5604104609961333" CI_END="1.4792371887596265" CI_START="0.6520641136771935" DF="4" EFFECT_SIZE="0.982118875903976" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="52" I2="0.0" ID="CMP-004.03.03" LOG_CI_END="0.1700378166679314" LOG_CI_START="-0.1857097005145602" LOG_EFFECT_SIZE="-0.007835941923314386" MODIFIED="2016-06-23 09:13:36 +1200" MODIFIED_BY="Clare Dooley" NO="3" P_CHI2="0.815889463112849" P_Z="0.9311937122682634" STUDIES="5" TAU2="0.0" TOTAL_1="518" TOTAL_2="531" WEIGHT="100.0" Z="0.08634305631297085">
<NAME>unselected</NAME>
<DICH_DATA CI_END="3.8308422368695982" CI_START="0.6061318428894749" EFFECT_SIZE="1.5238095238095237" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" LOG_CI_END="0.5832942670789325" LOG_CI_START="-0.21743289990695913" LOG_EFFECT_SIZE="0.1829306835859867" ORDER="1196" O_E="0.0" SE="0.47035110155091453" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.22123015873015872" WEIGHT="15.941415189521372"/>
<DICH_DATA CI_END="4.990720264880209" CI_START="0.3245693256227179" EFFECT_SIZE="1.2727272727272727" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6981632278858368" LOG_CI_START="-0.48869252684581094" LOG_EFFECT_SIZE="0.10473535052001298" MODIFIED="2016-05-03 07:06:35 +1200" MODIFIED_BY="[Empty name]" ORDER="759" O_E="0.0" SE="0.6971649453601071" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.48603896103896105" WEIGHT="7.932751844309444"/>
<DICH_DATA CI_END="2.379701306030249" CI_START="0.3500345113489413" EFFECT_SIZE="0.9126760563380282" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.3765224489541457" LOG_CI_START="-0.4558891346511096" LOG_EFFECT_SIZE="-0.03968334284848195" ORDER="1197" O_E="0.0" SE="0.4889626847135204" STUDY_ID="STD-Karaki-2002" TOTAL_1="80" TOTAL_2="82" VAR="0.23908450704225354" WEIGHT="18.96381754026837"/>
<DICH_DATA CI_END="1.5255756287497235" CI_START="0.37927255794035364" EFFECT_SIZE="0.7606635071090048" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="20" LOG_CI_END="0.18343374218788733" LOG_CI_START="-0.42104857930149087" LOG_EFFECT_SIZE="-0.11880741855680177" ORDER="1198" O_E="0.0" SE="0.35507590787861026" STUDY_ID="STD-Kolibianakis-2004" TOTAL_1="226" TOTAL_2="234" VAR="0.12607890035581934" WEIGHT="39.695113971919994"/>
<DICH_DATA CI_END="2.519746707961364" CI_START="0.3465238690992641" EFFECT_SIZE="0.9344262295081968" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.40135688647066037" LOG_CI_START="-0.46026684514721156" LOG_EFFECT_SIZE="-0.02945497933827562" ORDER="1199" O_E="0.0" SE="0.5061220450585963" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.2561595244942958" WEIGHT="17.466901453980824"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="17.59181013624067" CI_END="1.1899600208706074" CI_START="0.717158060263732" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9237907881977147" ESTIMABLE="YES" EVENTS_1="134" EVENTS_2="141" I2="9.048586381462828" I2_Q="60.74970331995045" ID="CMP-004.04" LOG_CI_END="0.07553237063038695" LOG_CI_START="-0.14438511611014843" LOG_EFFECT_SIZE="-0.034426372739880716" METHOD="MH" MODIFIED="2016-06-23 09:14:07 +1200" MODIFIED_BY="Clare Dooley" NO="4" P_CHI2="0.3483351673977013" P_Q="0.05398971836423194" P_Z="0.5394570508564731" Q="7.643254328635084" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1286" TOTAL_2="1289" WEIGHT="400.00000000000006" Z="0.6136342469948823">
<NAME>Multiple pregnancy rate per couple: grouped by day of randomisation</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 5/6</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.961362743283845" CI_END="1.483168461155211" CI_START="0.5928922677150016" DF="4" EFFECT_SIZE="0.9377414954760626" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="42" I2="0.0" ID="CMP-004.04.01" LOG_CI_END="0.17119048184095045" LOG_CI_START="-0.22702421352854732" LOG_EFFECT_SIZE="-0.027916865843798426" MODIFIED="2016-06-23 09:13:51 +1200" MODIFIED_BY="Clare Dooley" NO="1" P_CHI2="0.5643119953343309" P_Z="0.7834646794703262" STUDIES="5" TAU2="0.0" TOTAL_1="576" TOTAL_2="596" WEIGHT="100.00000000000001" Z="0.2748067926740427">
<NAME>randomised start of cycle</NAME>
<DICH_DATA CI_END="4.4883067020938645" CI_START="0.6712340046252143" EFFECT_SIZE="1.7357142857142858" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="0.6520825261616224" LOG_CI_START="-0.17312605032147405" LOG_EFFECT_SIZE="0.23947823792007417" MODIFIED="2016-06-16 16:30:59 +1200" MODIFIED_BY="[Empty name]" ORDER="1159" O_E="0.0" SE="0.48473160267450405" STUDY_ID="STD-Emiliani-2003" TOTAL_1="82" TOTAL_2="89" VAR="0.23496472663139328" WEIGHT="17.331747473996625"/>
<DICH_DATA CI_END="1.5255756287497235" CI_START="0.37927255794035364" EFFECT_SIZE="0.7606635071090048" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="20" LOG_CI_END="0.18343374218788733" LOG_CI_START="-0.42104857930149087" LOG_EFFECT_SIZE="-0.11880741855680177" MODIFIED="2016-06-16 16:31:10 +1200" MODIFIED_BY="[Empty name]" ORDER="1163" O_E="0.0" SE="0.35507590787861026" STUDY_ID="STD-Kolibianakis-2004" TOTAL_1="226" TOTAL_2="234" VAR="0.12607890035581934" WEIGHT="48.55176868084412"/>
<DICH_DATA CI_END="5.805116090819391" CI_START="0.136108123322405" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.7638109091905498" LOG_CI_START="-0.8661159540853126" LOG_EFFECT_SIZE="-0.05115252244738131" MODIFIED="2016-06-16 16:31:17 +1200" MODIFIED_BY="[Empty name]" ORDER="1164" O_E="0.0" SE="0.9574271077563381" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.9166666666666666" WEIGHT="6.174435037611298"/>
<DICH_DATA CI_END="4.172151473815636" CI_START="0.009478433005873263" EFFECT_SIZE="0.19886039886039886" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6203600675033164" LOG_CI_START="-2.023263455188643" LOG_EFFECT_SIZE="-0.701451693842663" MODIFIED="2016-06-16 16:31:27 +1200" MODIFIED_BY="[Empty name]" ORDER="1168" O_E="0.0" SE="1.5528775433767448" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="2.4114286647237937" WEIGHT="6.577984717325674"/>
<DICH_DATA CI_END="2.519746707961364" CI_START="0.3465238690992641" EFFECT_SIZE="0.9344262295081968" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.40135688647066037" LOG_CI_START="-0.46026684514721156" LOG_EFFECT_SIZE="-0.02945497933827562" MODIFIED="2016-06-16 16:31:35 +1200" MODIFIED_BY="[Empty name]" ORDER="1170" O_E="0.0" SE="0.5061220450585963" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.2561595244942958" WEIGHT="21.364064090222286"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.979007054303411" CI_END="1.3780790714735702" CI_START="0.6034653097036388" DF="6" EFFECT_SIZE="0.9119336125304852" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="54" I2="0.0" ID="CMP-004.04.02" LOG_CI_END="0.13927413725189658" LOG_CI_START="-0.2193476903343321" LOG_EFFECT_SIZE="-0.040036776541217726" MODIFIED="2016-06-23 09:13:56 +1200" MODIFIED_BY="Clare Dooley" NO="2" P_CHI2="0.8114770864031762" P_Z="0.661659353985545" STUDIES="7" TAU2="0.0" TOTAL_1="422" TOTAL_2="424" WEIGHT="100.00000000000001" Z="0.437623334898638">
<NAME>randomised on day of OPU or day 1</NAME>
<DICH_DATA CI_END="2.7316466622704207" CI_START="0.1417315420675126" EFFECT_SIZE="0.6222222222222222" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.436424522772927" LOG_CI_START="-0.8485334876391759" LOG_EFFECT_SIZE="-0.20605448243312446" MODIFIED="2016-06-16 16:32:03 +1200" MODIFIED_BY="[Empty name]" ORDER="371" O_E="0.0" SE="0.754790695960804" STUDY_ID="STD-Aziminekoo-2015" TOTAL_1="57" TOTAL_2="61" VAR="0.5697089947089947" WEIGHT="9.69098489131863"/>
<DICH_DATA CI_END="2.6592969081589772" CI_START="0.5366071779497429" EFFECT_SIZE="1.1945701357466063" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.42476682863524434" LOG_CI_START="-0.27034352226580366" LOG_EFFECT_SIZE="0.07721165318472036" MODIFIED="2016-06-16 16:32:10 +1200" MODIFIED_BY="[Empty name]" ORDER="1158" O_E="0.0" SE="0.4083112609710059" STUDY_ID="STD-Coskun-2000" TOTAL_1="100" TOTAL_2="101" VAR="0.1667180858357329" WEIGHT="23.283720655593072"/>
<DICH_DATA CI_END="4.990720264880209" CI_START="0.3245693256227179" EFFECT_SIZE="1.2727272727272727" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6981632278858368" LOG_CI_START="-0.48869252684581094" LOG_EFFECT_SIZE="0.10473535052001298" MODIFIED="2016-06-16 16:32:17 +1200" MODIFIED_BY="[Empty name]" ORDER="758" O_E="0.0" SE="0.6971649453601071" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.48603896103896105" WEIGHT="7.764752091933074"/>
<DICH_DATA CI_END="2.2669359908027595" CI_START="0.1723140845550179" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3554392575620653" LOG_CI_START="-0.7636792228739149" LOG_EFFECT_SIZE="-0.2041199826559248" MODIFIED="2016-06-16 16:32:25 +1200" MODIFIED_BY="[Empty name]" ORDER="1160" O_E="0.0" SE="0.6573757351339165" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.4321428571428571" WEIGHT="12.483046425308673"/>
<DICH_DATA CI_END="2.379701306030249" CI_START="0.3500345113489413" EFFECT_SIZE="0.9126760563380282" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.3765224489541457" LOG_CI_START="-0.4558891346511096" LOG_EFFECT_SIZE="-0.03968334284848195" MODIFIED="2016-06-16 16:32:34 +1200" MODIFIED_BY="[Empty name]" ORDER="1162" O_E="0.0" SE="0.4889626847135204" STUDY_ID="STD-Karaki-2002" TOTAL_1="80" TOTAL_2="82" VAR="0.23908450704225354" WEIGHT="18.56220197061442"/>
<DICH_DATA CI_END="1.5416082312746573" CI_START="0.11914406375210339" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.18797402052883078" LOG_CI_START="-0.9239275911180196" LOG_EFFECT_SIZE="-0.36797678529459443" MODIFIED="2016-06-16 16:32:41 +1200" MODIFIED_BY="[Empty name]" ORDER="1165" O_E="0.0" SE="0.653136510683105" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.4265873015873016" WEIGHT="15.811858805390989"/>
<DICH_DATA CI_END="3.780051875349956" CI_START="0.4373117827481551" EFFECT_SIZE="1.2857142857142858" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.5774977598963902" LOG_CI_START="-0.359208821046254" LOG_EFFECT_SIZE="0.10914446942506807" MODIFIED="2016-06-16 16:32:47 +1200" MODIFIED_BY="[Empty name]" ORDER="1169" O_E="0.0" SE="0.5502260824180657" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.30274874177313205" WEIGHT="12.403435159841145"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.413420710559607" CI_END="2.1927607263227062" CI_START="0.7870601568185694" DF="2" EFFECT_SIZE="1.3137102424527067" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="31" I2="54.68367664984273" ID="CMP-004.04.03" LOG_CI_END="0.3409912441229795" LOG_CI_START="-0.10399207224588893" LOG_EFFECT_SIZE="0.11849958593854529" MODIFIED="2016-06-23 09:14:01 +1200" MODIFIED_BY="Clare Dooley" NO="3" P_CHI2="0.11006221484324885" P_Z="0.29654024441911664" STUDIES="3" TAU2="0.0" TOTAL_1="200" TOTAL_2="182" WEIGHT="100.00000000000001" Z="1.0438814763559825">
<NAME>randomised on day 2 to 3</NAME>
<DICH_DATA CI_END="1.7748456279684888" CI_START="0.3240109648875076" EFFECT_SIZE="0.7583333333333333" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.2491605850885882" LOG_CI_START="-0.4894402925416507" LOG_EFFECT_SIZE="-0.12013985372653124" MODIFIED="2016-06-16 16:32:58 +1200" MODIFIED_BY="[Empty name]" ORDER="1157" O_E="0.0" SE="0.433857811653312" STUDY_ID="STD-Bungum-2003" TOTAL_1="61" TOTAL_2="57" VAR="0.18823260073260073" WEIGHT="47.35103671822669"/>
<DICH_DATA CI_END="2.8606453051799225" CI_START="0.38774898490749987" EFFECT_SIZE="1.053191489361702" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="0.4564640124530605" LOG_CI_START="-0.41144933045735804" LOG_EFFECT_SIZE="0.02250734099785122" MODIFIED="2016-06-16 16:33:03 +1200" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="0.5098165938659162" STUDY_ID="STD-Elgindy-2011" TOTAL_1="59" TOTAL_2="41" VAR="0.25991295938104453" WEIGHT="29.17876107103169"/>
<DICH_DATA CI_END="6.769048900481383" CI_START="1.1237797195687425" EFFECT_SIZE="2.7580645161290325" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="8" LOG_CI_END="0.830527651507883" LOG_CI_START="0.05068119027991701" LOG_EFFECT_SIZE="0.4406044208939" MODIFIED="2016-06-16 16:33:13 +1200" MODIFIED_BY="[Empty name]" ORDER="1167" O_E="0.0" SE="0.4580856716275485" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.20984248255046217" WEIGHT="23.47020221074163"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.39603387208121077" CI_END="0.6961775351463545" CI_START="0.061819754261894275" DF="1" EFFECT_SIZE="0.2074548725515959" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" I2="0.0" ID="CMP-004.04.04" LOG_CI_END="-0.15727999501235473" LOG_CI_START="-1.2088727256220413" LOG_EFFECT_SIZE="-0.6830763603171981" MODIFIED="2016-06-23 09:14:07 +1200" MODIFIED_BY="Clare Dooley" NO="4" P_CHI2="0.5291450699124254" P_Z="0.010888950694358648" STUDIES="2" TAU2="0.0" TOTAL_1="88" TOTAL_2="87" WEIGHT="100.0" Z="2.54624252515745">
<NAME>day of randomisation unstated</NAME>
<DICH_DATA CI_END="1.8083694285973242" CI_START="0.0047720886937039474" EFFECT_SIZE="0.09289617486338798" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.2572871564557577" LOG_CI_START="-2.3212914931600688" LOG_EFFECT_SIZE="-1.0320021683521554" MODIFIED="2016-06-16 16:33:29 +1200" MODIFIED_BY="[Empty name]" ORDER="363" O_E="0.0" SE="1.51466986295451" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="2.2942247937426337" WEIGHT="32.18249075215783"/>
<DICH_DATA CI_END="1.0069555705037576" CI_START="0.06807525807348687" EFFECT_SIZE="0.26181818181818184" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.0030103087753369563" LOG_CI_START="-1.1670107035733255" LOG_EFFECT_SIZE="-0.5820001973989941" MODIFIED="2016-06-16 16:49:17 +1200" MODIFIED_BY="[Empty name]" ORDER="1166" O_E="0.0" SE="0.6872761343510226" STUDY_ID="STD-Motta-1998" TOTAL_1="58" TOTAL_2="58" VAR="0.47234848484848485" WEIGHT="67.81750924784217"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.3100461191986263" CI_END="1.1511094104067545" CI_START="0.17943378934999588" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="OR" EFFECT_SIZE="0.45447543769242743" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="0.061116604322826854" LOG_CI_START="-0.7460957711777891" LOG_EFFECT_SIZE="-0.3424895834274812" METHOD="MH" MODIFIED="2016-06-17 09:27:07 +1200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.8047903785565469" P_Q="1.0" P_Z="0.09627764478215285" Q="0.0" RANDOM="NO" SCALE="217.1867229987089" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1154" TOTAL_2="1181" WEIGHT="100.0" Z="1.6631738287750695">
<NAME>High order pregnancies (more than 2 gestational sacs) per couple</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 5/6</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 2/3</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1200" O_E="0.0" SE="0.0" STUDY_ID="STD-Bungum-2003" TOTAL_1="61" TOTAL_2="57" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.280603595706568" CI_START="0.013418238154610063" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9180619948441125" LOG_CI_START="-1.8723045042834372" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="1201" O_E="0.0" SE="1.6390750941244592" STUDY_ID="STD-Coskun-2000" TOTAL_1="100" TOTAL_2="101" VAR="2.6865671641791047" WEIGHT="10.433657947061858"/>
<DICH_DATA CI_END="7.954058203426513" CI_START="0.012139200418014081" EFFECT_SIZE="0.3107344632768362" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9005887645899262" LOG_CI_START="-1.9158099183250517" LOG_EFFECT_SIZE="-0.5076105768675627" ORDER="1202" O_E="0.0" SE="1.6543665277425823" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="2.7369286081150483" WEIGHT="10.537475439072425"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1203" O_E="0.0" SE="0.0" STUDY_ID="STD-Hreinsson-2004" TOTAL_1="64" TOTAL_2="80" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.2580305572577086" CI_START="0.026982688849768104" EFFECT_SIZE="0.2468354430379747" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.35372981480711085" LOG_CI_START="-1.5689147746629577" LOG_EFFECT_SIZE="-0.6075924799279234" ORDER="1204" O_E="0.0" SE="1.1293709490989283" STUDY_ID="STD-Karaki-2002" TOTAL_1="80" TOTAL_2="82" VAR="1.275478740668614" WEIGHT="27.40610896087972"/>
<DICH_DATA CI_END="2.734512030261918" CI_START="0.08896976656628955" EFFECT_SIZE="0.49324324324324326" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4368798383578962" LOG_CI_START="-1.050757548906899" LOG_EFFECT_SIZE="-0.3069388552745015" MODIFIED="2016-05-03 12:28:46 +1200" MODIFIED_BY="[Empty name]" ORDER="397" O_E="0.0" SE="0.8738455652031714" STUDY_ID="STD-Kaur-2014" TOTAL_1="150" TOTAL_2="150" VAR="0.76360607182525" WEIGHT="27.725268710803892"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1205" O_E="0.0" SE="0.0" STUDY_ID="STD-Kolibianakis-2004" TOTAL_1="226" TOTAL_2="234" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="107.88795869779521" CI_START="0.16350295448087382" EFFECT_SIZE="4.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.0329729760738235" LOG_CI_START="-0.7864743952780227" LOG_EFFECT_SIZE="0.6232492903979004" ORDER="1206" O_E="0.0" SE="1.65615734242165" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="2.742857142857143" WEIGHT="2.8225380640372566"/>
<DICH_DATA CI_END="3.0364480529549285" CI_START="0.03037626135365213" EFFECT_SIZE="0.3037037037037037" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.48236585568482837" LOG_CI_START="-1.5174656792353696" LOG_EFFECT_SIZE="-0.5175499117752707" ORDER="1207" O_E="0.0" SE="1.1747109429378764" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="1.3799457994579944" WEIGHT="21.07495087814485"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1208" O_E="0.0" SE="0.0" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1209" O_E="0.0" SE="0.0" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1210" O_E="0.0" SE="0.0" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1211" O_E="0.0" SE="0.0" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2016-06-23 13:42:51 +1200" MODIFIED_BY="Helen E Nagels" NO="5">
<NAME>Blastocyst versus cleavage stage transfer: Miscarriage rate following fresh transfer</NAME>
<DICH_OUTCOME CHI2="10.348040224418853" CI_END="1.5003932929439086" CI_START="0.8759836666640826" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="OR" EFFECT_SIZE="1.146437969622082" ESTIMABLE="YES" EVENTS_1="124" EVENTS_2="110" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.17620511410041215" LOG_CI_START="-0.0575039914846488" LOG_EFFECT_SIZE="0.059350561307881695" METHOD="MH" MODIFIED="2016-06-23 13:42:51 +1200" MODIFIED_BY="Helen E Nagels" NO="1" P_CHI2="0.888384597295375" P_Q="1.0" P_Z="0.31950873575768557" Q="0.0" RANDOM="NO" SCALE="29.402977755848397" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1451" TOTAL_2="1466" WEIGHT="100.0" Z="0.9954679543570188">
<NAME>Miscarriage rate per couple</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours day 5/6</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours day 2/3</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.217275493026309" CI_START="0.5514580957655972" EFFECT_SIZE="1.995" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.8583732832134715" LOG_CI_START="-0.2584874831679374" LOG_EFFECT_SIZE="0.2999429000227671" MODIFIED="2016-04-29 04:08:29 +1200" MODIFIED_BY="[Empty name]" ORDER="373" O_E="0.0" SE="0.6560495427223966" STUDY_ID="STD-Aziminekoo-2015" TOTAL_1="57" TOTAL_2="61" VAR="0.4304010025062656" WEIGHT="3.4164605911355515"/>
<DICH_DATA CI_END="5.981399377468031" CI_START="0.7244449381885256" EFFECT_SIZE="2.0816326530612246" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.7768028011815268" LOG_CI_START="-0.13999461771471883" LOG_EFFECT_SIZE="0.3184040917334039" ORDER="1263" O_E="0.0" SE="0.5385313420800696" STUDY_ID="STD-Bungum-2003" TOTAL_1="61" TOTAL_2="57" VAR="0.290016006402561" WEIGHT="5.022197068969261"/>
<DICH_DATA CI_END="2.5541356851031836" CI_START="0.13805671440380926" EFFECT_SIZE="0.5938144329896907" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.4072439648641012" LOG_CI_START="-0.8599424665501668" LOG_EFFECT_SIZE="-0.2263492508430328" ORDER="1264" O_E="0.0" SE="0.7443515824867409" STUDY_ID="STD-Coskun-2000" TOTAL_1="100" TOTAL_2="101" VAR="0.5540592783505155" WEIGHT="4.863782080365363"/>
<DICH_DATA CI_END="225.9283738891898" CI_START="0.469037404675262" EFFECT_SIZE="10.294117647058824" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.35397077651437" LOG_CI_START="-0.32879252189832914" LOG_EFFECT_SIZE="1.0125891273080205" ORDER="1265" O_E="0.0" SE="1.575868441380122" STUDY_ID="STD-Devreker-2000" TOTAL_1="11" TOTAL_2="12" VAR="2.483361344537815" WEIGHT="0.34267099729089584"/>
<DICH_DATA CI_END="2.859903849772719" CI_START="0.15824377575037718" EFFECT_SIZE="0.6727272727272727" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.4563514323545396" LOG_CI_START="-0.8006733632090371" LOG_EFFECT_SIZE="-0.17216096542724885" MODIFIED="2012-02-23 14:04:35 +1300" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.7383825872871361" STUDY_ID="STD-Elgindy-2011" TOTAL_1="59" TOTAL_2="41" VAR="0.5452088452088453" WEIGHT="4.434565847293946"/>
<DICH_DATA CI_END="4.243833368458742" CI_START="0.3519994850873115" EFFECT_SIZE="1.2222222222222223" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.627758323254848" LOG_CI_START="-0.4534579718170475" LOG_EFFECT_SIZE="0.0871501757189002" MODIFIED="2016-05-03 07:07:10 +1200" MODIFIED_BY="[Empty name]" ORDER="761" O_E="0.0" SE="0.6351118038322098" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.4033670033670034" WEIGHT="4.535351434732444"/>
<DICH_DATA CI_END="9.731956723606517" CI_START="0.2311970823444213" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.988200169027721" LOG_CI_START="-0.6360176509163584" LOG_EFFECT_SIZE="0.17609125905568124" ORDER="1266" O_E="0.0" SE="0.9540735874430285" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.9102564102564102" WEIGHT="1.8388949287024337"/>
<DICH_DATA CI_END="2.3191754569670495" CI_START="0.4311877296717218" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.36533360638273826" LOG_CI_START="-0.3653336063827382" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-05-03 07:03:34 +1200" MODIFIED_BY="[Empty name]" ORDER="390" O_E="0.0" SE="0.42919753763947605" STUDY_ID="STD-Gaafar-2015" TOTAL_1="126" TOTAL_2="126" VAR="0.18421052631578946" WEIGHT="10.942435207608439"/>
<DICH_DATA CI_END="11.841208961460703" CI_START="0.3106819399556452" EFFECT_SIZE="1.9180327868852458" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="1.0733960451645461" LOG_CI_START="-0.507683991693757" LOG_EFFECT_SIZE="0.2828560267353946" ORDER="1267" O_E="0.0" SE="0.9287342401229735" STUDY_ID="STD-Hreinsson-2004" TOTAL_1="64" TOTAL_2="80" VAR="0.8625472887767969" WEIGHT="1.7077557871523403"/>
<DICH_DATA CI_END="7.6034626223888395" CI_START="0.4053383914279949" EFFECT_SIZE="1.7555555555555555" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8810114153504089" LOG_CI_START="-0.3921822603202134" LOG_EFFECT_SIZE="0.24441457751509774" ORDER="1268" O_E="0.0" SE="0.7478802674992621" STUDY_ID="STD-Karaki-2002" TOTAL_1="80" TOTAL_2="82" VAR="0.5593248945147679" WEIGHT="2.79959965106941"/>
<DICH_DATA CI_END="4.020663487630454" CI_START="0.1090513370114622" EFFECT_SIZE="0.6621621621621622" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.604297726029822" LOG_CI_START="-0.962369005434747" LOG_EFFECT_SIZE="-0.17903563970246253" MODIFIED="2016-05-03 12:31:44 +1200" MODIFIED_BY="[Empty name]" ORDER="401" O_E="0.0" SE="0.9202677931876816" STUDY_ID="STD-Kaur-2014" TOTAL_1="150" TOTAL_2="150" VAR="0.8468928111785254" WEIGHT="2.9832533881795635"/>
<DICH_DATA CI_END="1.782247751302497" CI_START="0.4863165539580984" EFFECT_SIZE="0.9309868875086267" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="21" LOG_CI_END="0.25096807542737093" LOG_CI_START="-0.31308094702591155" LOG_EFFECT_SIZE="-0.031056435799270317" ORDER="1269" O_E="0.0" SE="0.33132518787674947" STUDY_ID="STD-Kolibianakis-2004" TOTAL_1="226" TOTAL_2="234" VAR="0.10977638012156334" WEIGHT="19.048476025876266"/>
<DICH_DATA CI_END="33.58908107111031" CI_START="0.2430333026628586" EFFECT_SIZE="2.857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.5261981225911405" LOG_CI_START="-0.614334211291692" LOG_EFFECT_SIZE="0.4559319556497244" ORDER="1270" O_E="0.0" SE="1.2573592887287155" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="1.580952380952381" WEIGHT="0.7838879022994348"/>
<DICH_DATA CI_END="3.0539707342470725" CI_START="0.0292444406898013" EFFECT_SIZE="0.2988505747126437" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.48486487096011954" LOG_CI_START="-1.5339566802557205" LOG_EFFECT_SIZE="-0.5245459046478005" MODIFIED="2012-05-23 17:18:17 +1200" MODIFIED_BY="[Empty name]" ORDER="366" O_E="0.0" SE="1.1858657725120334" STUDY_ID="STD-Livingstone-2002" TOTAL_1="30" TOTAL_2="29" VAR="1.4062776304155615" WEIGHT="2.97232071428793"/>
<DICH_DATA CI_END="3.1749278564687407" CI_START="0.603843567471148" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" LOG_CI_END="0.5017338613150811" LOG_CI_START="-0.21907555572214263" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="1271" O_E="0.0" SE="0.4234070196318246" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.17927350427350427" WEIGHT="9.58692173195476"/>
<DICH_DATA CI_END="1.5624758055064332" CI_START="0.4036409081116271" EFFECT_SIZE="0.7941531042796866" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="21" LOG_CI_END="0.19381330114161607" LOG_CI_START="-0.394004825421169" LOG_EFFECT_SIZE="-0.10009576213977649" ORDER="1272" O_E="0.0" SE="0.34528727728963426" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.11922330385808877" WEIGHT="19.054505932817033"/>
<DICH_DATA CI_END="7.393693964381482" CI_START="0.37569553069947115" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8688614705363834" LOG_CI_START="-0.42516397130367073" LOG_EFFECT_SIZE="0.2218487496163564" ORDER="1273" O_E="0.0" SE="0.760116950066092" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.5777777777777778" WEIGHT="2.776745776366803"/>
<DICH_DATA CI_END="7.0447008229766235" CI_START="0.37041565301260215" EFFECT_SIZE="1.6153846153846154" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8478625540544166" LOG_CI_START="-0.4313106692002516" LOG_EFFECT_SIZE="0.2082759424270825" ORDER="1274" O_E="0.0" SE="0.7513926833493686" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.5645909645909646" WEIGHT="2.8901749338981264"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2016-06-20 16:14:12 +1200" MODIFIED_BY="Clare Dooley" NO="6">
<NAME>Blastocyst versus cleavage stage transfer: Embryo freezing rate per couple</NAME>
<DICH_OUTCOME CHI2="82.95046486684353" CI_END="0.5684260402587943" CI_START="0.39974475361724904" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="OR" EFFECT_SIZE="0.4766815786380676" ESTIMABLE="YES" EVENTS_1="519" EVENTS_2="744" I2="84.32799620729277" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="-0.24532603475291537" LOG_CI_START="-0.39821722736917076" LOG_EFFECT_SIZE="-0.32177163106104306" METHOD="MH" MODIFIED="2016-06-16 17:52:21 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="3.063105324940807E-12" P_Q="1.0" P_Z="1.5866108617295422E-16" Q="0.0" RANDOM="NO" SCALE="215.43473885233445" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1099" TOTAL_2="1193" WEIGHT="100.00000000000001" Z="8.249799054275964">
<NAME>Embryo freezing per couple</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Day 2/3</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Day 5/6</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.5043124646249915" CI_START="0.007957411580900822" EFFECT_SIZE="0.06334841628959276" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="51" LOG_CI_END="-0.29730029765297394" LOG_CI_START="-2.099228178360771" LOG_EFFECT_SIZE="-1.1982642380068727" MODIFIED="2011-11-11 11:44:02 +1300" MODIFIED_BY="[Empty name]" ORDER="338" O_E="0.0" SE="1.0584613568146244" STUDY_ID="STD-Brugnon-2010" TOTAL_1="55" TOTAL_2="52" VAR="1.1203404438698557" WEIGHT="3.3884046270026325"/>
<DICH_DATA CI_END="0.28476614330698824" CI_START="0.02247458186453214" EFFECT_SIZE="0.08" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="54" LOG_CI_END="-0.5455116465274692" LOG_CI_START="-1.6483083794886437" LOG_EFFECT_SIZE="-1.0969100130080565" MODIFIED="2016-05-05 13:55:12 +1200" MODIFIED_BY="[Empty name]" ORDER="1288" O_E="0.0" SE="0.6477882598732626" STUDY_ID="STD-Bungum-2003" TOTAL_1="61" TOTAL_2="57" VAR="0.4196296296296296" WEIGHT="6.256295835193526"/>
<DICH_DATA CI_END="3.1686006008043734" CI_START="0.7286563817777088" EFFECT_SIZE="1.5194805194805194" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="33" LOG_CI_END="0.5008675002195472" LOG_CI_START="-0.13747722707218774" LOG_EFFECT_SIZE="0.18169513657367975" MODIFIED="2016-05-06 09:01:57 +1200" MODIFIED_BY="[Empty name]" ORDER="763" O_E="0.0" SE="0.3749668526685267" STUDY_ID="STD-Fernandez_x002d_Shaw-2015" TOTAL_1="60" TOTAL_2="60" VAR="0.1406001406001406" WEIGHT="3.158039108809354"/>
<DICH_DATA CI_END="10.235459446120242" CI_START="1.7832839341617752" EFFECT_SIZE="4.272321428571429" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="14" LOG_CI_END="1.0101073419117004" LOG_CI_START="0.2512204969736611" LOG_EFFECT_SIZE="0.6306639194426807" MODIFIED="2016-05-06 09:01:57 +1200" MODIFIED_BY="[Empty name]" ORDER="805" O_E="0.0" SE="0.44577388926707157" STUDY_ID="STD-Gardner-1998" TOTAL_1="45" TOTAL_2="47" VAR="0.19871436035229137" WEIGHT="1.3314525886943258"/>
<DICH_DATA CI_END="0.8583016264058377" CI_START="0.19985188637271886" EFFECT_SIZE="0.4141656662665066" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="34" LOG_CI_END="-0.06636006452457807" LOG_CI_START="-0.699291748142449" LOG_EFFECT_SIZE="-0.3828259063335135" MODIFIED="2013-09-06 09:32:03 +1200" MODIFIED_BY="[Empty name]" ORDER="1290" O_E="0.0" SE="0.3717872040195006" STUDY_ID="STD-Hreinsson-2004" TOTAL_1="64" TOTAL_2="80" VAR="0.13822572507263775" WEIGHT="6.326711345931198"/>
<DICH_DATA CI_END="0.9830643322089291" CI_START="0.26391681564844477" EFFECT_SIZE="0.50935960591133" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="35" LOG_CI_END="-0.007418060795380469" LOG_CI_START="-0.5785329375151981" LOG_EFFECT_SIZE="-0.29297549915528925" MODIFIED="2013-09-06 09:32:03 +1200" MODIFIED_BY="[Empty name]" ORDER="1291" O_E="0.0" SE="0.3354757056494549" STUDY_ID="STD-Karaki-2002" TOTAL_1="80" TOTAL_2="82" VAR="0.1125439490809997" WEIGHT="6.852460468048729"/>
<DICH_DATA CI_END="0.9053947112420009" CI_START="0.4311016775849415" EFFECT_SIZE="0.6247536945812808" ESTIMABLE="YES" EVENTS_1="114" EVENTS_2="145" LOG_CI_END="-0.04316204671410826" LOG_CI_START="-0.365420287133434" LOG_EFFECT_SIZE="-0.2042911669237711" MODIFIED="2013-09-06 09:32:04 +1200" MODIFIED_BY="[Empty name]" ORDER="1292" O_E="0.0" SE="0.18929608562632913" STUDY_ID="STD-Kolibianakis-2004" TOTAL_1="226" TOTAL_2="234" VAR="0.035833008033450534" WEIGHT="19.306062536067724"/>
<DICH_DATA CI_END="0.6520302180992813" CI_START="0.1103479118193647" EFFECT_SIZE="0.26823529411764707" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="25" LOG_CI_END="-0.18573227658454658" LOG_CI_START="-0.9572358808431313" LOG_EFFECT_SIZE="-0.5714840787138389" MODIFIED="2013-09-06 09:32:05 +1200" MODIFIED_BY="[Empty name]" ORDER="1293" O_E="0.0" SE="0.4531850361459258" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="0.2053766769865841" WEIGHT="5.164662323209141"/>
<DICH_DATA CI_END="0.23630475363839956" CI_START="0.04297687426405113" EFFECT_SIZE="0.10077519379844961" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="45" LOG_CI_END="-0.6265275417694056" LOG_CI_START="-1.3667651742154188" LOG_EFFECT_SIZE="-0.9966463579924122" MODIFIED="2013-09-06 09:32:05 +1200" MODIFIED_BY="[Empty name]" ORDER="1294" O_E="0.0" SE="0.4348192495341647" STUDY_ID="STD-Motta-1998" TOTAL_1="58" TOTAL_2="58" VAR="0.1890677797654542" WEIGHT="9.121966973497685"/>
<DICH_DATA CI_END="0.4845025653296969" CI_START="0.13804452074142531" EFFECT_SIZE="0.25861733203505355" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="79" LOG_CI_END="-0.3147039191176903" LOG_CI_START="-0.8599808266849065" LOG_EFFECT_SIZE="-0.5873423729012983" MODIFIED="2013-09-06 09:32:06 +1200" MODIFIED_BY="[Empty name]" ORDER="344" O_E="0.0" SE="0.3202983546692068" STUDY_ID="STD-Pantos-2004" TOTAL_1="81" TOTAL_2="162" VAR="0.10259103600380098" WEIGHT="11.555791298335048"/>
<DICH_DATA CI_END="1.1958013038604731" CI_START="0.4837634755485027" EFFECT_SIZE="0.7605820105820106" ESTIMABLE="YES" EVENTS_1="115" EVENTS_2="126" LOG_CI_END="0.07765902262410442" LOG_CI_START="-0.31536692424725654" LOG_EFFECT_SIZE="-0.11885395081157604" MODIFIED="2016-05-04 09:36:29 +1200" MODIFIED_BY="[Empty name]" ORDER="806" O_E="0.0" SE="0.23086538670205123" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.05329882677708765" WEIGHT="11.778234438449806"/>
<DICH_DATA CI_END="0.22555183046407157" CI_START="0.02862876525930857" EFFECT_SIZE="0.08035714285714286" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="42" LOG_CI_END="-0.6467536440385835" LOG_CI_START="-1.5431973824231298" LOG_EFFECT_SIZE="-1.0949755132308567" ORDER="1295" O_E="0.0" SE="0.5265754893951541" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.27728174603174605" WEIGHT="7.4996104995843655"/>
<DICH_DATA CI_END="0.8329649070073382" CI_START="0.011099581809988622" EFFECT_SIZE="0.09615384615384616" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="26" LOG_CI_END="-0.07937329512875725" LOG_CI_START="-1.9546933834688034" LOG_EFFECT_SIZE="-1.0170333392987803" MODIFIED="2013-09-06 09:32:07 +1200" MODIFIED_BY="[Empty name]" ORDER="340" O_E="0.0" SE="1.1015723028750943" STUDY_ID="STD-Ten-2011" TOTAL_1="28" TOTAL_2="27" VAR="1.2134615384615384" WEIGHT="2.0680744104914464"/>
<DICH_DATA CI_END="1.0378833407772317" CI_START="0.26392473906748054" EFFECT_SIZE="0.5233766233766234" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="35" LOG_CI_END="0.016148541080863985" LOG_CI_START="-0.5785198991436089" LOG_EFFECT_SIZE="-0.2811856790313724" ORDER="1296" O_E="0.0" SE="0.3493111854441091" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.1220183042763688" WEIGHT="6.192233546685008"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2016-06-23 13:43:11 +1200" MODIFIED_BY="Helen E Nagels" NO="7">
<NAME>Blastocyst versus cleavage stage transfer: Failure rate to transfer embryos (per couple)</NAME>
<DICH_OUTCOME CHI2="17.222120557078892" CI_END="3.552019548478676" CI_START="1.7593649830949039" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="OR" EFFECT_SIZE="2.4998597586388627" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="47" I2="36.12865521674323" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="0.5504753472453744" LOG_CI_START="0.24535594389258095" LOG_EFFECT_SIZE="0.3979156455689777" METHOD="MH" MODIFIED="2016-06-23 13:43:11 +1200" MODIFIED_BY="Helen E Nagels" NO="1" P_CHI2="0.10147491792735197" P_Q="1.0" P_Z="3.185983776290166E-7" Q="0.0" RANDOM="NO" SCALE="145.84123654772853" SORT_BY="USER" STUDIES="17" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1274" TOTAL_2="1303" WEIGHT="100.0" Z="5.112099234793297">
<NAME>Failure to transfer any embryos (per couple)</NAME>
<GROUP_LABEL_1>Day 5/6</GROUP_LABEL_1>
<GROUP_LABEL_2>Day 2/3</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Day 5/6</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Day 2/3</GRAPH_LABEL_2>
<DICH_DATA CI_END="116.92147276879233" CI_START="0.25494965981967993" EFFECT_SIZE="5.459770114942529" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.067894277189429" LOG_CI_START="-0.5935455631769329" LOG_EFFECT_SIZE="0.7371743570062481" MODIFIED="2012-05-15 20:45:03 +1200" MODIFIED_BY="[Empty name]" ORDER="352" O_E="0.0" SE="1.5633429365708837" STUDY_ID="STD-Gardner-1998" TOTAL_1="45" TOTAL_2="47" VAR="2.444041137326074" WEIGHT="1.1001654616369505"/>
<DICH_DATA CI_END="1.6533557284298217" CI_START="0.004826246853715644" EFFECT_SIZE="0.08932806324110672" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.21836630443240318" LOG_CI_START="-2.316390468489237" LOG_EFFECT_SIZE="-1.049012082028417" MODIFIED="2016-06-16 17:04:45 +1200" MODIFIED_BY="[Empty name]" ORDER="375" O_E="0.0" SE="1.4889286756625568" STUDY_ID="STD-Aziminekoo-2015" TOTAL_1="57" TOTAL_2="61" VAR="2.2169086012102555" WEIGHT="12.530716000311282"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1315" O_E="0.0" SE="0.0" STUDY_ID="STD-Bungum-2003" TOTAL_1="61" TOTAL_2="57" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1316" O_E="0.0" SE="0.0" STUDY_ID="STD-Coskun-2000" TOTAL_1="100" TOTAL_2="101" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1317" O_E="0.0" SE="0.0" STUDY_ID="STD-Devreker-2000" TOTAL_1="11" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="83.3142654137605" CI_START="1.3105889873758483" EFFECT_SIZE="10.44943820224719" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="1" LOG_CI_END="1.9207193694745879" LOG_CI_START="0.11746651434345691" LOG_EFFECT_SIZE="1.0190929419090222" ORDER="1318" O_E="0.0" SE="1.0592396533496198" STUDY_ID="STD-Emiliani-2003" TOTAL_1="99" TOTAL_2="94" VAR="1.1219886432282227" WEIGHT="2.192599428754625"/>
<DICH_DATA CI_END="2.4693501679980634" CI_START="0.11408506577248703" EFFECT_SIZE="0.5307692307692308" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3925826797440677" LOG_CI_START="-0.9427712028832306" LOG_EFFECT_SIZE="-0.27509426156958144" ORDER="1319" O_E="0.0" SE="0.7843934807636005" STUDY_ID="STD-Frattarelli-2003" TOTAL_1="29" TOTAL_2="28" VAR="0.615273132664437" WEIGHT="10.844139496836892"/>
<DICH_DATA CI_END="7.938045469576164" CI_START="0.3688440996955174" EFFECT_SIZE="1.711111111111111" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.8997135822417752" LOG_CI_START="-0.4331571594474989" LOG_EFFECT_SIZE="0.23327821139713817" ORDER="1321" O_E="0.0" SE="0.7829348714848592" STUDY_ID="STD-Hreinsson-2004" TOTAL_1="64" TOTAL_2="80" VAR="0.612987012987013" WEIGHT="5.943422608843296"/>
<DICH_DATA CI_END="383.3441359802024" CI_START="1.2537593683185215" EFFECT_SIZE="21.923076923076923" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" LOG_CI_END="2.583588824235221" LOG_CI_START="0.09821419116812588" LOG_EFFECT_SIZE="1.3409015077016735" ORDER="1322" O_E="0.0" SE="1.4599213622664624" STUDY_ID="STD-Karaki-2002" TOTAL_1="80" TOTAL_2="82" VAR="2.131370384001963" WEIGHT="1.0364749183714528"/>
<DICH_DATA CI_END="4.799890306848417" CI_START="1.3884796183752275" EFFECT_SIZE="2.581578947368421" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="16" LOG_CI_END="0.6812313124433402" LOG_CI_START="0.14253950908293642" LOG_EFFECT_SIZE="0.41188541076313834" ORDER="1323" O_E="0.0" SE="0.3164302318613337" STUDY_ID="STD-Kolibianakis-2004" TOTAL_1="226" TOTAL_2="234" VAR="0.10012809163581737" WEIGHT="31.42261692327586"/>
<DICH_DATA CI_END="28.256438993059202" CI_START="0.9268794070306736" EFFECT_SIZE="5.117647058823529" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.4511174291646818" LOG_CI_START="-0.03297676668399265" LOG_EFFECT_SIZE="0.7090703312403446" ORDER="1324" O_E="0.0" SE="0.8717642770262618" STUDY_ID="STD-Levitas-2004" TOTAL_1="23" TOTAL_2="31" VAR="0.759972954699121" WEIGHT="2.9937239807506972"/>
<DICH_DATA CI_END="142.75753783216032" CI_START="0.3592018287814299" EFFECT_SIZE="7.160919540229885" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.154599048984327" LOG_CI_START="-0.44466146090322484" LOG_EFFECT_SIZE="0.854968794040551" ORDER="1325" O_E="0.0" SE="1.5268184900549808" STUDY_ID="STD-Levron-2002" TOTAL_1="46" TOTAL_2="44" VAR="2.331174701573772" WEIGHT="1.124082102107319"/>
<DICH_DATA CI_END="56.4681272709263" CI_START="0.766023582688113" EFFECT_SIZE="6.576923076923077" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.7518033848789156" LOG_CI_START="-0.11575786003624391" LOG_EFFECT_SIZE="0.8180227624213359" ORDER="1326" O_E="0.0" SE="1.0970147198404216" STUDY_ID="STD-Motta-1998" TOTAL_1="58" TOTAL_2="58" VAR="1.2034412955465588" WEIGHT="2.131434314895527"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1327" O_E="0.0" SE="0.0" STUDY_ID="STD-Papanikolaou-2005" TOTAL_1="80" TOTAL_2="84" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.5906641150280016" CI_START="0.5525371487716073" EFFECT_SIZE="1.4085365853658536" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="8" LOG_CI_END="0.5551747813966246" LOG_CI_START="-0.2576385177077318" LOG_EFFECT_SIZE="0.1487681318444464" ORDER="1328" O_E="0.0" SE="0.4774505553846195" STUDY_ID="STD-Papanikolaou-2006" TOTAL_1="175" TOTAL_2="176" VAR="0.22795903283708163" WEIGHT="17.772696211515452"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1329" O_E="0.0" SE="0.0" STUDY_ID="STD-Rienzi-2002" TOTAL_1="50" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="9.36971051275886" CI_START="1.2788280389659499" EFFECT_SIZE="3.4615384615384617" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="6" LOG_CI_END="0.971726173101913" LOG_CI_START="0.10681214983510075" LOG_EFFECT_SIZE="0.5392691614685069" MODIFIED="2016-06-16 17:04:54 +1200" MODIFIED_BY="[Empty name]" ORDER="1330" O_E="0.0" SE="0.5080547786603902" STUDY_ID="STD-Van-der-Auwera-2002" TOTAL_1="70" TOTAL_2="66" VAR="0.2581196581196581" WEIGHT="10.907928552700637"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2016-06-29 16:56:41 +1200" MODIFIED_BY="Helen E Nagels">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2016-06-29 16:50:46 +1200" MODIFIED_BY="Helen E Nagels" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram: Results of search from review inception to 2016</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAm4AAAMTCAYAAAAYY5u4AABv1UlEQVR42uydf2Qd2f//P1RVVVWJ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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2016-06-25 07:30:05 +1200" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADnCAMAAAD7EqYIAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2016-06-25 07:30:05 +1200" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAUkAAARECAIAAAB3TnSGAAA4cUlEQVR42u3dvY4fRfr28ZGQEIED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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2016-06-25 07:30:05 +1200" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Blastocyst versus cleavage stage transfer: Live birth rate, outcome: 1.1 Live birth per couple.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAy0AAAHQCAMAAACbXXXaAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2016-06-29 16:56:41 +1200" MODIFIED_BY="Helen E Nagels" NO="5" REF_ID="CMP-002.05" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Blastocyst versus cleavage stage transfer: Cumulative pregnancy rate following fresh and frozen transfer, outcome: 2.5 Cumulative pregnancy rate from fresh and frozen transfers: grouped by vitrification or slow freezing.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA0EAAAHgCAMAAABU/JaJAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2016-06-25 07:30:05 +1200" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-003.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Blastocyst versus cleavage stage transfer: Clinical pregnancy rate, outcome: 2.1 clinical pregnancy rate per couple.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAy0AAAKwCAMAAACiQWAdAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2016-06-23 13:43:31 +1200" MODIFIED_BY="Helen E Nagels" NO="7" REF_ID="CMP-001.01" SETTINGS="SHOW_STUDY_NAMES:NO;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_CI_LINES:YES;SHOW_EFFECT_ESTIMATE:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Blastocyst versus cleavage stage transfer: Live birth rate, outcome: 1.1 Live birth per couple.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2016-06-23 09:10:42 +1200" MODIFIED_BY="Clare Dooley" NO="8" REF_ID="CMP-003.01" SETTINGS="SHOW_STUDY_NAMES:NO;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_CI_LINES:YES;SHOW_EFFECT_ESTIMATE:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 2 Blastocyst versus cleavage stage transfer: Clinical pregnancy rate, outcome: 2.1 clinical pregnancy rate per couple.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2016-06-13 14:09:00 +1200" MODIFIED_BY="Helen E Nagels">
<APPENDIX ID="APP-01" MODIFIED="2016-06-13 13:48:41 +1200" MODIFIED_BY="Helen E Nagels" NO="1">
<TITLE MODIFIED="2016-06-13 13:48:32 +1200" MODIFIED_BY="Helen E Nagels">CGF search</TITLE>
<APPENDIX_BODY MODIFIED="2016-05-05 14:28:06 +1200" MODIFIED_BY="[Empty name]">
<P>CGFG search strategy (18.04.16)</P>
<P>Keywords CONTAINS "day 2"or"day 3"or "day 3 embryo transfer" or "day 4 embryo transfer" or "cleavage stage" or "cleavage transfer" or "pronuclear morphology" or "early cleavage assessment" or "early cleavage medium" or "early cleavage status" or Title CONTAINS "day 2"or"day 3"or "day 3 embryo transfer" or "day 4 embryo transfer" or "cleavage stage" or "cleavage transfer" or "pronuclear morphology" or "early cleavage assessment" or "early cleavage medium" or "early cleavage status"</P>
<P>AND</P>
<P>Keywords CONTAINS "day 5" or "day 5 transfer" or "day 6 transfer" or "Blastocyst" or "blastocyst culture technique" or "blastocyst media" or "blastocyst stage" or "blastocyst transfer" or Title CONTAINS "day 5" or "day 5 transfer" or "day 6 transfer" or "Blastocyst" or "blastocyst culture technique" or "blastocyst media" or "blastocyst stage" or "blastocyst transfer" (136 hits)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2016-06-13 14:09:00 +1200" MODIFIED_BY="Helen E Nagels" NO="2">
<TITLE MODIFIED="2016-06-13 13:50:38 +1200" MODIFIED_BY="Helen E Nagels">CENTRAL search</TITLE>
<APPENDIX_BODY MODIFIED="2016-06-13 14:09:00 +1200" MODIFIED_BY="Helen E Nagels">
<P>1 MESH DESCRIPTOR Embryo Transfer EXPLODE ALL TREES 886<BR/>2 MESH DESCRIPTOR Fertilization in Vitro EXPLODE ALL TREES 1737<BR/>3 MESH DESCRIPTOR Sperm Injections, Intracytoplasmic EXPLODE ALL TREES 437<BR/>4 MESH DESCRIPTOR Oocyte Donation EXPLODE ALL TREES 61<BR/>5 (embryo transfer*):TI,AB,KY 1790<BR/>6 (in vitro fertili?ation):TI,AB,KY 1801<BR/>7 (intracytoplasmic sperm injection*):TI,AB,KY 941<BR/>8 ((ivf or icsi)):TI,AB,KY 3235<BR/>9 ET:TI,AB,KY 18137<BR/>10 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 21997<BR/>11 (day 2):TI,AB,KY 2969<BR/>12 (day 3):TI,AB,KY 3497<BR/>13 48*:TI,AB,KY 53104<BR/>14 72*:TI,AB,KY 33864<BR/>15 cleav*:TI,AB,KY 733<BR/>16 pronuclear:TI,AB,KY 48<BR/>17 day2:TI,AB,KY 11<BR/>18 day3:TI,AB,KY 15<BR/>19 ((early adj3 embryo*)):TI,AB,KY 83<BR/>20 ((day two or day three)):TI,AB,KY 426<BR/>21 MESH DESCRIPTOR Cleavage Stage, Ovum EXPLODE ALL TREES 62<BR/>22 #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 86461<BR/>23 MESH DESCRIPTOR Blastocyst EXPLODE ALL TREES 129<BR/>24 Blastocyst*:TI,AB,KY 481<BR/>25 ((day 5 or day 6)):TI,AB,KY 3509<BR/>26 ((day5 or day6)):TI,AB,KY 9<BR/>27 ((day five or day six)):TI,AB,KY 229<BR/>28 #23 OR #24 OR #25 OR #26 OR #27 4120<BR/>29 #10 AND #22 AND #28 303<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2016-06-13 13:52:35 +1200" MODIFIED_BY="Helen E Nagels" NO="3">
<TITLE MODIFIED="2016-05-05 14:23:44 +1200" MODIFIED_BY="[Empty name]">MEDLINE search</TITLE>
<APPENDIX_BODY MODIFIED="2016-05-05 14:24:19 +1200" MODIFIED_BY="[Empty name]">
<P>MEDLINE (18.04.2016)<BR/>
</P>
<P>1 exp embryo transfer/ or exp fertilization in vitro/ or exp sperm injections, intracytoplasmic/ or exp oocyte donation/ (36008)<BR/>2 embryo transfer$.tw. (9137)<BR/>3 in vitro fertili?ation.tw. (18546)<BR/>4 intracytoplasmic sperm injection$.tw. (5560)<BR/>5 (ivf or icsi).tw. (21404)<BR/>6 ET.tw. (188210)<BR/>7 or/1-6 (231210)<BR/>8 day 2.tw. (18667)<BR/>9 day3.tw. (35)<BR/>10 48$.tw. (531140)<BR/>11 72$.tw. (345751)<BR/>12 cleav$.tw. (162019)<BR/>13 pronuclear.tw. (2060)<BR/>14 day 3.tw. (24496)<BR/>15 day2.tw. (33)<BR/>16 (early adj3 embryo$).tw. (23848)<BR/>17 (day two or day three).tw. (2469)<BR/>18 exp Cleavage Stage, Ovum/ (2136)<BR/>19 or/8-18 (1041484)<BR/>20 exp Blastocyst/ (22554)<BR/>21 Blastocyst$.tw. (17851)<BR/>22 (day 5 or day 6).tw. (30007)<BR/>23 (day5 or day6).tw. (28)<BR/>24 (day five or day six).tw. (1441)<BR/>25 or/20-24 (62035)<BR/>26 7 and 19 and 25 (4010)<BR/>27 randomized controlled trial.pt. (413691)<BR/>28 controlled clinical trial.pt. (90548)<BR/>29 randomized.ab. (343328)<BR/>30 placebo.tw. (173474)<BR/>31 clinical trials as topic.sh. (176165)<BR/>32 randomly.ab. (247064)<BR/>33 trial.ti. (149327)<BR/>34 (crossover or cross-over or cross over).tw. (66966)<BR/>35 or/27-34 (1033793)<BR/>36 exp animals/ not humans.sh. (4227002)<BR/>37 35 not 36 (950680)<BR/>38 26 and 37 (272)<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2016-06-13 13:52:34 +1200" MODIFIED_BY="Helen E Nagels" NO="4">
<TITLE MODIFIED="2016-05-05 14:24:45 +1200" MODIFIED_BY="[Empty name]">EMBASE search</TITLE>
<APPENDIX_BODY MODIFIED="2016-05-05 14:25:06 +1200" MODIFIED_BY="[Empty name]">
<P>EMBASE (18.04.2016)</P>
<P>1 exp embryo transfer/ (23824)<BR/>
<BR/>2 exp fertilization in vitro/ (42931)<BR/>
<BR/>3 exp intracytoplasmic sperm injection/ (15087)<BR/>
<BR/>4 exp oocyte donation/ (3307)<BR/>
<BR/>5 embryo transfer$.tw. (13659)<BR/>
<BR/>6 in vitro fertili?ation.tw. (23385)<BR/>
<BR/>7 intracytoplasmic sperm injection$.tw. (7307)<BR/>
<BR/>8 (ivf or icsi).tw. (34559)<BR/>
<BR/>9 ET.tw. (549055)<BR/>
<BR/>10 or/1-9 (612746)<BR/>
<BR/>11 day 2.tw. (26857)<BR/>
<BR/>12 day3.tw. (375)<BR/>
<BR/>13 48$.tw. (758206)<BR/>
<BR/>14 72$.tw. (501641)<BR/>
<BR/>15 cleav$.tw. (182785)<BR/>
<BR/>16 pronuclear.tw. (2422)<BR/>
<BR/>17 day 3.tw. (35731)<BR/>
<BR/>18 day2.tw. (254)<BR/>
<BR/>19 (early adj3 embryo$).tw. (25993)<BR/>
<BR/>20 (day two or day three).tw. (4136)<BR/>
<BR/>21 exp oocyte cleavage/ (2702)<BR/>
<BR/>22 or/11-21 (1429399)<BR/>
<BR/>23 exp BLASTOCYST/ (18376)<BR/>
<BR/>24 Blastocyst$.tw. (22053)<BR/>
<BR/>25 (day 5 or day 6).tw. (41160)<BR/>
<BR/>26 (day5 or day6).tw. (271)<BR/>
<BR/>27 (day five or day six).tw. (2124)<BR/>
<BR/>28 or/23-27 (66323)<BR/>
<BR/>29 10 and 22 and 28 (6457)<BR/>
<BR/>30 Clinical Trial/ (856738)<BR/>
<BR/>31 Randomized Controlled Trial/ (398937)<BR/>
<BR/>32 exp randomization/ (70252)<BR/>
<BR/>33 Single Blind Procedure/ (21917)<BR/>
<BR/>34 Double Blind Procedure/ (127696)<BR/>
<BR/>35 Crossover Procedure/ (46777)<BR/>
<BR/>36 Placebo/ (273267)<BR/>
<BR/>37 Randomi?ed controlled trial$.tw. (133653)<BR/>
<BR/>38 Rct.tw. (19983)<BR/>
<BR/>39 random allocation.tw. (1511)<BR/>
<BR/>40 randomly allocated.tw. (24417)<BR/>
<BR/>41 allocated randomly.tw. (2100)<BR/>
<BR/>42 (allocated adj2 random).tw. (751)<BR/>
<BR/>43 Single blind$.tw. (17185)<BR/>
<BR/>44 Double blind$.tw. (160672)<BR/>
<BR/>45 ((treble or triple) adj blind$).tw. (539)<BR/>
<BR/>46 placebo$.tw. (230656)<BR/>
<BR/>47 prospective study/ (329881)<BR/>
<BR/>48 or/30-47 (1560826)<BR/>
<BR/>49 case study/ (37386)<BR/>
<BR/>50 case report.tw. (303496)<BR/>
<BR/>51 abstract report/ or letter/ (955992)<BR/>
<BR/>52 or/49-51 (1289953)<BR/>
<BR/>53 48 not 52 (1519996)<BR/>
<BR/>54 29 and 53 (713)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2016-06-13 13:52:34 +1200" MODIFIED_BY="Helen E Nagels" NO="5">
<TITLE MODIFIED="2016-05-05 14:26:24 +1200" MODIFIED_BY="[Empty name]">PsycINFO search</TITLE>
<APPENDIX_BODY MODIFIED="2016-05-05 14:26:39 +1200" MODIFIED_BY="[Empty name]">
<P>PsycINFO (18.04.2016)</P>
<P>1 exp reproductive technology/ (1554)<BR/>2 embryo transfer$.tw. (105)<BR/>3 in vitro fertili?ation.tw. (617)<BR/>4 intracytoplasmic sperm injection$.tw. (44)<BR/>5 (ivf or icsi).tw. (483)<BR/>6 ET.tw. (108660)<BR/>7 or/1-6 (110440)<BR/>8 day 2.tw. (1598)<BR/>9 day3.tw. (1)<BR/>10 48$.tw. (60219)<BR/>11 72$.tw. (37004)<BR/>12 cleav$.tw. (2937)<BR/>13 pronuclear.tw. (13)<BR/>14 day 3.tw. (1377)<BR/>15 day2.tw. (4)<BR/>16 (early adj3 embryo$).tw. (526)<BR/>17 (day two or day three).tw. (292)<BR/>18 exp embryo/ (1541)<BR/>19 or/8-18 (101907)<BR/>20 Blastocyst$.tw. (65)<BR/>21 (day 5 or day 6).tw. (1633)<BR/>22 (day5 or day6).tw. (1)<BR/>23 (day five or day six).tw. (139)<BR/>24 or/20-23 (1836)<BR/>25 7 and 19 and 24 (13)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2016-06-13 13:52:33 +1200" MODIFIED_BY="Helen E Nagels" NO="6">
<TITLE MODIFIED="2016-05-05 14:27:14 +1200" MODIFIED_BY="[Empty name]">CINAHL search</TITLE>
<APPENDIX_BODY MODIFIED="2016-05-05 14:27:18 +1200" MODIFIED_BY="[Empty name]">
<P>CINAHL (18.04.16)</P>
<TABLE COLS="3" ROWS="21">
<TR>
<TD>
<P/>
<P>
<B># </B>
</P>
</TD>
<TD>
<P/>
<P>
<B>Query </B>
</P>
</TD>
<TD>
<P/>
<P>
<B>Results </B>
</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S20</P>
</TD>
<TD>
<P/>
<P>S9 AND S14 AND S19</P>
</TD>
<TD>
<P/>
<P>66</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S19</P>
</TD>
<TD>
<P/>
<P>S15 OR S16 OR S17 OR S18</P>
</TD>
<TD>
<P/>
<P>24,644</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S18</P>
</TD>
<TD>
<P/>
<P>TX(day five or day six)</P>
</TD>
<TD>
<P/>
<P>23,967</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S17</P>
</TD>
<TD>
<P/>
<P>TX blastocyst*</P>
</TD>
<TD>
<P/>
<P>706</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S16</P>
</TD>
<TD>
<P/>
<P>TX morula</P>
</TD>
<TD>
<P/>
<P>8</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S15</P>
</TD>
<TD>
<P/>
<P>(MM "Blastocyst")</P>
</TD>
<TD>
<P/>
<P>337</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S14</P>
</TD>
<TD>
<P/>
<P>S10 OR S11 OR S12 OR S13</P>
</TD>
<TD>
<P/>
<P>42,864</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S13</P>
</TD>
<TD>
<P/>
<P>TX pronuclear</P>
</TD>
<TD>
<P/>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S12</P>
</TD>
<TD>
<P/>
<P>(MM "Cleavage Stage, Ovum")</P>
</TD>
<TD>
<P/>
<P>7</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S11</P>
</TD>
<TD>
<P/>
<P>TX (day two or day three)</P>
</TD>
<TD>
<P/>
<P>41,824</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S10</P>
</TD>
<TD>
<P/>
<P>TX cleavage</P>
</TD>
<TD>
<P/>
<P>1,086</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S9</P>
</TD>
<TD>
<P/>
<P>S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8</P>
</TD>
<TD>
<P/>
<P>4,298</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S8</P>
</TD>
<TD>
<P/>
<P>TX intracytoplasmic sperm injection*</P>
</TD>
<TD>
<P/>
<P>278</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S7</P>
</TD>
<TD>
<P/>
<P>TX embryo* N3 transfer*</P>
</TD>
<TD>
<P/>
<P>897</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S6</P>
</TD>
<TD>
<P/>
<P>TX ovar* N3 hyperstimulat*</P>
</TD>
<TD>
<P/>
<P>375</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S5</P>
</TD>
<TD>
<P/>
<P>TX ovari* N3 stimulat*</P>
</TD>
<TD>
<P/>
<P>288</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S4</P>
</TD>
<TD>
<P/>
<P>TX IVF or TX ICSI</P>
</TD>
<TD>
<P/>
<P>1,527</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S3</P>
</TD>
<TD>
<P/>
<P>(MM "Fertilization in Vitro")</P>
</TD>
<TD>
<P/>
<P>1,599</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>S2</P>
</TD>
<TD>
<P/>
<P>TX vitro fertilization</P>
</TD>
<TD>
<P/>
<P>3,285</P>
</TD>
</TR>
<TR>
<TD>
<P>S1</P>
</TD>
<TD>
<P>TX vitro fertilisation</P>
</TD>
<TD>
<P>3,285</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-07" MODIFIED="2016-06-13 13:52:32 +1200" MODIFIED_BY="Helen E Nagels" NO="7">
<TITLE MODIFIED="2016-05-05 14:25:45 +1200" MODIFIED_BY="[Empty name]">EBM reviews</TITLE>
<APPENDIX_BODY MODIFIED="2016-05-05 14:25:49 +1200" MODIFIED_BY="[Empty name]">
<P>EBM Reviews - Cochrane Central Register of Controlled Trials (18.04.2016)</P>
<P>#1MESH DESCRIPTOR Embryo Transfer EXPLODE ALL TREES886<BR/>
<BR/>#2MESH DESCRIPTOR Fertilization in Vitro EXPLODE ALL TREES1737<BR/>
<BR/>#3MESH DESCRIPTOR Sperm Injections, Intracytoplasmic EXPLODE ALL TREES437<BR/>
<BR/>#4MESH DESCRIPTOR Oocyte Donation EXPLODE ALL TREES61<BR/>
<BR/>#5(embryo transfer*):TI,AB,KY1790<BR/>
<BR/>#6(in vitro fertili?ation):TI,AB,KY1801<BR/>
<BR/>#7(intracytoplasmic sperm injection*):TI,AB,KY941<BR/>
<BR/>#8((ivf or icsi)):TI,AB,KY3235<BR/>
<BR/>#9ET:TI,AB,KY18137<BR/>
<BR/>#10#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #921997<BR/>
<BR/>#11(day 2):TI,AB,KY2969<BR/>
<BR/>#12(day 3):TI,AB,KY3497<BR/>
<BR/>#1348*:TI,AB,KY53104<BR/>
<BR/>#1472*:TI,AB,KY33864<BR/>
<BR/>#15cleav*:TI,AB,KY733<BR/>
<BR/>#16pronuclear:TI,AB,KY48<BR/>
<BR/>#17day2:TI,AB,KY11<BR/>
<BR/>#18day3:TI,AB,KY15<BR/>
<BR/>#19((early adj3 embryo*)):TI,AB,KY83<BR/>
<BR/>#20((day two or day three)):TI,AB,KY426<BR/>
<BR/>#21MESH DESCRIPTOR Cleavage Stage, Ovum EXPLODE ALL TREES62<BR/>
<BR/>#22#11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #2186461<BR/>
<BR/>#23MESH DESCRIPTOR Blastocyst EXPLODE ALL TREES129<BR/>
<BR/>#24Blastocyst*:TI,AB,KY481<BR/>
<BR/>#25((day 5 or day 6)):TI,AB,KY3509<BR/>
<BR/>#26((day5 or day6)):TI,AB,KY9<BR/>
<BR/>#27((day five or day six)):TI,AB,KY229<BR/>
<BR/>#28#23 OR #24 OR #25 OR #26 OR #274120<BR/>
<BR/>#29#10 AND #22 AND #28303</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-08" MODIFIED="2016-06-13 13:52:31 +1200" MODIFIED_BY="Helen E Nagels" NO="8">
<TITLE MODIFIED="2016-06-13 13:48:16 +1200" MODIFIED_BY="Helen E Nagels">ClinicalTrials.gov search</TITLE>
<APPENDIX_BODY MODIFIED="2016-06-12 12:32:30 +1200" MODIFIED_BY="[Empty name]">
<P>ClinicalTrials.gov search strategy (11.05.16)</P>
<P>"embryo" and "day" and "transfer" (262 hits)</P>
<P>OR</P>
<P>"blastocyst" and "transfer" (87 hits)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-09" MODIFIED="2016-06-13 13:52:30 +1200" MODIFIED_BY="Helen E Nagels" NO="9">
<TITLE MODIFIED="2016-06-13 13:48:21 +1200" MODIFIED_BY="Helen E Nagels">WHO portal (ICTRP) search</TITLE>
<APPENDIX_BODY MODIFIED="2016-06-12 12:32:30 +1200" MODIFIED_BY="[Empty name]">
<P>WHO portal (ICTRP) search strategy (12.05.16)</P>
<P>"embryo" and "day" and "transfer" (3 hits)</P>
<P>OR</P>
<P>"blastocyst" and "transfer" (24 hits)</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;27 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="160">
<FLOWCHARTBOX TEXT="&lt;p&gt;27 studies (34 articles) included in qualitative synthesis&lt;/p&gt;" WIDTH="160">
<FLOWCHARTBOX TEXT="&lt;p&gt;23 studies included in last published version (&lt;a href=&quot;Glujovsky 2012&quot; link_type=&quot;REFERENCE&quot; protected=&quot;true&quot;&gt;Glujovsky 2012&lt;/a&gt;)&lt;/p&gt;" WIDTH="160"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;45 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;741 records screened&lt;/p&gt;" WIDTH="160">
<FLOWCHARTBOX TEXT="&lt;p&gt;741 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;741 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;No additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;696 records discarded as clearly irrelevant&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;8 studies excluded:&lt;br&gt;4 quasi-randomised studies&lt;/p&gt;&lt;p&gt;4 did not meet inclusion criteria&lt;/p&gt;&lt;p&gt;------&lt;/p&gt;&lt;p&gt;3 studies classified as ongoing&lt;/p&gt;" WIDTH="140"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>